data_2jw5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jw5 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.769 0.319 . . . . 1.0 110.782 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -90.24 -46.05 8.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.383 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 43' ' ' SER . 6.6 tp -62.42 -31.83 72.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.742 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 91.5 p -48.02 -14.71 0.05 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.532 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 41' ' ' LEU . 32.9 t -64.55 -16.34 62.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.567 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.35 168.24 19.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.281 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.445 HH12 ' CA ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -118.11 112.19 19.86 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.966 0.413 . . . . 1.0 110.428 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.58 166.29 12.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.782 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.554 ' HD1' ' N ' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -155.12 121.35 5.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.376 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.554 ' N ' ' HD1' ' A' ' 47' ' ' HIS . 54.6 t -108.73 135.05 48.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.97 0.414 . . . . 1.0 110.215 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.6 t -86.0 103.44 12.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.412 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.469 ' H ' ' HD2' ' A' ' 50' ' ' ARG . 6.8 mpt_? -63.55 -38.86 92.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.72 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.7 p -66.05 -30.56 71.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.404 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.31 -67.48 1.33 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.21 -0.756 . . . . 1.0 111.21 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 55' ' ' ARG . 3.1 mt -61.9 -94.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.971 -0.292 . . . . 1.0 110.214 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 53' ' ' ILE . . . 34.24 32.27 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.163 -0.775 . . . . 1.0 111.163 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 53' ' ' ILE . 30.0 mtm180 -70.54 -60.34 2.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.829 0.347 . . . . 1.0 110.364 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 170.72 -53.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.352 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.5 ttt-85 -101.99 -41.39 6.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.365 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.473 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -56.59 -41.4 76.92 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.048 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 61' ' ' PHE . 8.0 pt-20 -45.62 -46.44 14.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.734 -0.212 . . . . 1.0 110.584 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.8 tp -41.27 -17.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.12 0.486 . . . . 1.0 110.548 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.598 ' N ' ' O ' ' A' ' 59' ' ' GLU . 3.3 m-85 -49.42 -51.1 37.6 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.173 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.406 ' CD ' ' HZ2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -61.58 -40.09 93.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.542 -0.299 . . . . 1.0 110.675 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.406 ' HZ2' ' CD ' ' A' ' 62' ' ' GLU . 13.9 mptt -61.68 -43.28 99.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.228 0.537 . . . . 1.0 110.249 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -63.6 -40.53 97.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.309 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.2 mt -64.32 -54.12 34.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.934 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.9 m -64.01 -40.43 89.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.128 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -59.64 -18.62 43.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.273 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.3 m170 -97.3 1.86 50.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.487 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.07 0.51 59.98 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.057 -0.817 . . . . 1.0 111.057 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.63 98.2 2.4 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.738 -0.945 . . . . 1.0 110.738 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.414 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 83.7 mt-30 -70.86 145.43 50.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.87 0.367 . . . . 1.0 110.568 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.34 156.65 48.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.084 0.469 . . . . 1.0 110.359 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.1 m -163.19 158.28 17.91 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.566 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.95 -153.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.952 2.435 . . . . 1.0 111.944 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -47.62 -26.66 1.56 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.505 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' A' ' 77' ' ' GLY . 74.7 mt-30 -66.58 -20.12 65.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.281 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.445 ' CA ' HH12 ' A' ' 45' ' ' ARG . . . -37.51 103.88 0.03 OUTLIER Glycine 0 CA--C 1.538 1.475 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.9 -28.76 24.71 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.647 2.232 . . . . 1.0 111.928 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.82 60.96 0.4 Allowed Glycine 0 CA--C 1.521 0.413 0 N-CA-C 111.099 -0.8 . . . . 1.0 111.099 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.5 p -91.63 97.6 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.489 0.661 . . . . 1.0 110.249 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.19 -19.02 19.66 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.42 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -109.97 140.78 43.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.472 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.5 mm -131.1 106.18 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.614 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.4 t -91.21 131.35 38.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.52 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.573 ' C ' ' H ' ' A' ' 87' ' ' GLU . 27.9 m -132.73 162.59 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.607 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.607 ' C ' ' H ' ' A' ' 88' ' ' GLY . 15.3 t70 -68.92 18.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.375 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.573 ' H ' ' C ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER 68.87 -20.1 0.16 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.668 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -61.82 -67.71 1.98 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.2 ptp -63.54 145.82 54.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.641 0.258 . . . . 1.0 110.35 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -83.63 168.52 16.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.638 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.546 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.98 -53.32 59.18 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.466 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.546 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 15.7 pt-20 -50.39 -38.86 44.89 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.502 0.501 . . . . 1.0 110.107 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -74.81 -40.97 60.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.974 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -46.19 -27.89 1.11 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.642 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 4.1 mm? -56.07 -59.51 4.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.268 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -78.1 -25.95 47.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.477 -0.329 . . . . 1.0 110.551 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.451 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -61.45 -42.24 98.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.932 -179.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -93.4 6.14 49.18 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.283 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.451 ' NH1' ' O ' ' A' ' 97' ' ' LEU . 31.6 mmt-85 69.67 54.88 0.37 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.791 0.329 . . . . 1.0 111.065 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 95' ' ' LEU . 6.4 tp -146.78 116.83 4.56 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.781 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.35 -7.48 19.71 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.767 2.311 . . . . 1.0 112.876 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -179.85 140.68 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.699 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.7 mp -84.45 148.56 52.67 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.973 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.475 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 37.0 Cg_exo -59.34 -173.68 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.63 2.22 . . . . 1.0 111.657 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 29.8 Cg_exo -62.45 133.75 44.55 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.676 2.251 . . . . 1.0 111.798 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 72.42 -51.59 1.43 Allowed Glycine 0 C--O 1.22 -0.729 0 N-CA-C 110.935 -0.866 . . . . 1.0 110.935 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.537 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -17.8 129.71 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.905 0.415 . . . . 1.0 111.065 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -132.11 158.28 42.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.103 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.434 ' CD1' ' N ' ' A' ' 109' ' ' LEU . 3.4 mp -107.84 117.61 34.58 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.553 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.465 HG22 ' CE3' ' A' ' 114' ' ' TRP . 3.6 m -108.84 175.45 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.479 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -104.36 -174.67 2.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.811 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.413 ' OG ' ' OE2' ' A' ' 87' ' ' GLU . 70.0 p -64.04 -37.67 88.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.896 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.38 -44.45 76.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.586 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.614 ' CE2' ' SG ' ' A' ' 118' ' ' CYS . 60.8 t90 -57.51 -48.21 79.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.476 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 tt -58.77 -52.69 64.61 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.231 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.1 m -42.15 -57.43 2.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.519 -0.309 . . . . 1.0 110.629 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 121' ' ' GLU . 60.8 mt -55.0 -50.7 68.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.378 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.614 ' SG ' ' CE2' ' A' ' 114' ' ' TRP . 55.9 m -45.87 -33.52 3.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.456 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 65.5 mt -80.13 -50.93 9.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.915 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -70.18 -54.57 12.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.63 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 117' ' ' LEU . 79.9 mt-10 -75.54 7.6 3.55 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.538 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 121' ' ' GLU . 74.4 mtt85 25.09 53.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.54 0.525 . . . . 1.0 111.503 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -159.0 -170.24 2.95 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.306 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.4 tp -108.04 96.85 6.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.422 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.473 ' CG1' ' OE1' ' A' ' 121' ' ' GLU . 2.4 m -78.56 154.44 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.622 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -61.09 119.85 9.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.329 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 129' ' ' GLY . 5.3 m -62.45 -42.05 94.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.719 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.453 ' N ' ' CG2' ' A' ' 127' ' ' VAL . . . -44.44 -19.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.553 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . -70.75 -40.71 64.81 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -135.95 34.65 2.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.682 0.277 . . . . 1.0 110.617 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.7 t -100.49 137.48 38.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.763 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 134' ' ' ILE . 39.6 mt -72.65 -71.85 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.373 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.568 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 20.6 t80 65.74 -36.55 0.23 Allowed 'General case' 0 C--O 1.208 -1.101 0 CA-C-O 118.306 -0.854 . . . . 1.0 110.804 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.596 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 156.3 -55.51 0.0 OUTLIER Pre-proline 0 N--CA 1.449 -0.506 0 O-C-N 124.736 1.272 . . . . 1.0 110.667 -178.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 29.8 Cg_endo . . . . . 0 C--N 1.304 -1.771 0 C-N-CA 122.617 2.212 . . . . 1.0 111.695 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.856 0.36 . . . . 1.0 110.417 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 1.9 p-90 -107.32 -32.54 7.72 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.528 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.436 ' CD1' ' CZ3' ' A' ' 40' ' ' TRP . 1.6 mt -79.32 -9.53 59.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.035 0.445 . . . . 1.0 110.633 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.7 t -67.04 -21.75 65.9 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.81 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.6 t -63.64 -15.71 59.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.846 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.15 169.52 17.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.392 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -118.86 107.33 13.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.415 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.46 151.18 20.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.26 -0.427 . . . . 1.0 109.927 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -136.71 120.76 17.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.583 . . . . 1.0 110.556 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.3 t -96.48 135.9 29.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.861 -0.609 . . . . 1.0 109.969 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.5 m -85.92 126.93 40.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.923 -0.581 . . . . 1.0 111.123 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -71.4 -37.2 71.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.988 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.1 m -57.0 -48.79 77.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.615 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . -90.5 -83.61 1.39 Allowed Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.458 -1.057 . . . . 1.0 110.458 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 mm -53.23 78.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.71 0.766 . . . . 1.0 110.266 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 52' ' ' GLY . . . -166.7 25.78 0.15 Allowed Glycine 0 C--N 1.313 -0.75 0 CA-C-N 114.884 -1.053 . . . . 1.0 111.462 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.452 ' NH2' ' OD2' ' A' ' 86' ' ' ASP . 11.9 ptp180 -72.62 -37.33 68.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.844 0.354 . . . . 1.0 110.77 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -179.32 -81.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.609 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -90.7 -20.27 22.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.53 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.48 -27.25 9.95 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 120.967 0.413 . . . . 1.0 110.399 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.437 ' C ' ' N ' ' A' ' 61' ' ' PHE . 2.1 pt-20 -70.58 -35.66 73.17 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.717 0.294 . . . . 1.0 110.57 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.3 tp -46.2 -19.35 0.07 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.967 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.437 ' N ' ' C ' ' A' ' 59' ' ' GLU . 5.1 m-85 -61.23 -44.6 97.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.956 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 63' ' ' LYS . 8.9 pt-20 -62.47 -40.42 96.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.975 0.417 . . . . 1.0 110.672 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.445 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 39.0 mttp -65.71 -41.9 91.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.665 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.543 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 25.5 mt-30 -63.14 -19.03 64.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.618 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 70.6 mt -83.38 -57.42 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.83 0.348 . . . . 1.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.5 m -64.58 -32.78 59.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.052 0.454 . . . . 1.0 110.604 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -70.56 -21.44 62.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.508 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 64' ' ' GLN . 60.1 m170 -96.26 14.71 23.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.978 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.22 2.3 57.99 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.984 -0.847 . . . . 1.0 110.984 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.59 -146.0 2.47 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.096 -1.202 . . . . 1.0 110.096 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 171.98 149.05 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.14 -0.318 . . . . 1.0 110.14 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.6 mt -107.9 113.67 27.04 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.444 ' O ' ' O ' ' A' ' 74' ' ' PRO . 2.5 m -135.36 91.07 19.29 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.205 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 73' ' ' CYS . 52.5 Cg_exo -52.37 -162.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.599 2.199 . . . . 1.0 112.003 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -61.23 -33.62 73.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.565 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.09 -19.54 65.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.485 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.24 -161.51 14.04 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.056 -0.818 . . . . 1.0 111.056 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.95 -37.48 78.2 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.805 2.337 . . . . 1.0 111.924 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.417 ' O ' HG11 ' A' ' 80' ' ' VAL . . . 160.15 -40.75 0.45 Allowed Glycine 0 C--O 1.223 -0.59 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 79' ' ' GLY . 0.4 OUTLIER 80.41 162.29 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 N-CA-C 110.106 -0.331 . . . . 1.0 110.106 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.69 -41.93 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.936 0.398 . . . . 1.0 110.74 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -110.29 137.12 48.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.974 0.416 . . . . 1.0 110.993 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.417 HG22 HD11 ' A' ' 83' ' ' ILE . 77.3 mt -133.02 109.38 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.955 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.1 t -88.08 138.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.249 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.469 ' C ' ' H ' ' A' ' 87' ' ' GLU . 35.3 m -134.64 152.57 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.378 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' GLY . 66.4 t0 -74.45 43.41 0.18 Allowed 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.655 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.494 ' CD ' ' NZ ' ' A' ' 111' ' ' LYS . 2.8 mt-10 40.66 22.19 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.633 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . -100.06 -64.58 0.81 Allowed Glycine 0 N--CA 1.463 0.457 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.2 ptp -77.73 156.19 30.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.857 0.36 . . . . 1.0 110.548 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -93.07 173.95 7.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.498 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.651 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.69 -50.4 73.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.164 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.651 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 15.4 pt-20 -51.67 -38.31 54.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.055 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.487 HH21 HH21 ' A' ' 96' ' ' ARG . 69.7 ttt180 -83.15 -21.84 33.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.604 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.404 ' O ' ' CD2' ' A' ' 98' ' ' LEU . . . -62.04 -35.41 78.52 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.389 -0.524 . . . . 1.0 111.912 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.432 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 7.6 mp -60.83 -41.84 96.56 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.853 0.359 . . . . 1.0 110.649 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.487 HH21 HH21 ' A' ' 93' ' ' ARG . 13.7 ptt85 -69.47 -23.69 63.69 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.252 -0.579 . . . . 1.0 109.798 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.9 -41.29 91.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.37 0.605 . . . . 1.0 111.19 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.433 HD21 ' H ' ' A' ' 98' ' ' LEU . 2.4 pt? -114.9 5.98 15.27 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.877 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.467 ' CD ' ' N ' ' A' ' 99' ' ' ARG . 1.2 mpt_? 58.05 57.35 4.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.609 -0.269 . . . . 1.0 110.441 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.2 tp -104.89 110.3 64.28 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 120.597 -0.441 . . . . 1.0 110.354 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.08 -40.94 58.98 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.151 1.901 . . . . 1.0 112.268 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -173.69 135.64 0.53 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.708 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.9 mp -53.28 111.69 2.94 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.187 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.453 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 46.9 Cg_exo -50.49 -174.49 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 122.097 1.865 . . . . 1.0 112.235 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 31.3 Cg_exo -58.57 113.58 1.62 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.836 2.357 . . . . 1.0 112.058 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 91.79 -66.53 2.23 Favored Glycine 0 C--O 1.221 -0.714 0 N-CA-C 110.413 -1.075 . . . . 1.0 110.413 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.52 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -13.42 125.68 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.109 0.535 . . . . 1.0 111.487 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -133.6 156.34 48.02 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.967 0.413 . . . . 1.0 110.35 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.85 112.89 24.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.917 -0.583 . . . . 1.0 109.614 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 m -107.27 168.74 3.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 123.705 0.628 . . . . 1.0 109.843 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.494 ' NZ ' ' CD ' ' A' ' 87' ' ' GLU . 3.6 mtpp -102.64 -177.67 3.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.746 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.9 m -60.48 -39.87 89.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.459 -0.791 . . . . 1.0 110.767 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.24 -39.32 66.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.687 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.421 ' CZ2' ' SG ' ' A' ' 118' ' ' CYS . 76.1 t90 -60.76 -47.05 88.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.848 0.356 . . . . 1.0 110.714 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -52.28 66.02 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.219 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.2 p -51.06 -42.27 60.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.154 -0.475 . . . . 1.0 109.973 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 mt -61.32 -52.71 63.54 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.405 -0.518 . . . . 1.0 109.651 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.549 ' O ' ' N ' ' A' ' 122' ' ' ARG . 2.2 m -50.48 -36.37 33.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.702 -0.481 . . . . 1.0 109.702 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.6 mt -69.15 -52.92 23.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.148 0.499 . . . . 1.0 110.575 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -60.66 -27.42 67.81 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.096 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -103.32 -4.31 24.4 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.325 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.549 ' N ' ' O ' ' A' ' 118' ' ' CYS . 37.8 mmt180 44.23 47.95 7.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.717 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.49 ' O ' ' SG ' ' A' ' 118' ' ' CYS . 0.2 OUTLIER -172.36 -175.5 1.4 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.51 -179.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -86.37 126.73 34.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.973 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.4 m -114.15 155.4 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.572 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -60.94 159.21 11.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.052 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 129' ' ' GLY . 3.6 m -114.67 3.23 7.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.493 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.35 67.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.006 0.431 . . . . 1.0 110.582 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 159.27 -34.3 0.47 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.186 -0.765 . . . . 1.0 111.186 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -103.77 1.24 31.43 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.063 0.459 . . . . 1.0 110.428 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 t -90.13 140.99 29.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.906 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 134' ' ' ILE . 60.7 mt -92.27 -72.46 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 116.266 -0.424 . . . . 1.0 109.883 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.528 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 19.1 t80 64.77 -36.13 0.19 Allowed 'General case' 0 C--O 1.222 -0.345 0 O-C-N 123.945 0.778 . . . . 1.0 111.303 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.591 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 155.17 -55.43 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.414 0 O-C-N 124.581 1.175 . . . . 1.0 110.14 -178.438 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.6 Cg_endo . . . . . 0 N--CA 1.492 1.411 0 C-N-CA 122.216 1.944 . . . . 1.0 111.974 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 120.782 0.325 . . . . 1.0 110.478 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.479 ' NE1' ' NH2' ' A' ' 122' ' ' ARG . 8.5 p-90 -100.08 -59.05 1.78 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.015 0.436 . . . . 1.0 110.276 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 43' ' ' SER . 5.6 tp -62.7 -30.39 71.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.671 -0.695 . . . . 1.0 110.267 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.2 t -48.13 -14.17 0.05 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.676 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 41' ' ' LEU . 42.1 p -68.3 -13.48 62.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.8 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.93 169.08 18.37 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.8 0.333 . . . . 1.0 110.547 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -122.08 137.92 54.64 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.154 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.13 166.17 16.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.467 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -153.76 129.19 9.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.713 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.3 m -100.8 137.42 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.373 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.539 ' O ' ' O ' ' A' ' 52' ' ' GLY . 13.5 t -98.35 135.25 33.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.857 -0.611 . . . . 1.0 109.996 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.482 ' CD ' ' H ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -62.05 -43.52 98.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.739 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.486 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 13.1 m -51.7 -21.35 2.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.384 0.612 . . . . 1.0 110.548 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 49' ' ' VAL . . . -156.99 120.17 0.96 Allowed Glycine 0 C--O 1.219 -0.782 0 N-CA-C 109.383 -1.487 . . . . 1.0 109.383 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.515 ' CB ' ' O ' ' A' ' 52' ' ' GLY . 4.7 mm 115.28 -6.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.047 1.339 . . . . 1.0 109.52 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.01 22.74 30.08 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.754 -0.939 . . . . 1.0 110.754 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -60.97 -57.1 14.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.638 0.256 . . . . 1.0 110.588 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.466 ' O ' ' CG ' ' A' ' 59' ' ' GLU . . . 179.74 -67.44 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.386 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -91.06 -27.5 18.56 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.581 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.406 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -57.36 -32.63 66.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.319 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 61' ' ' PHE . 3.3 pt-20 -66.48 -39.5 88.79 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 116.159 -0.473 . . . . 1.0 109.775 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 tp -41.67 -17.51 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.183 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.579 ' N ' ' O ' ' A' ' 59' ' ' GLU . 6.1 m-85 -60.49 -42.89 97.24 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.22 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 1.3 pt-20 -67.74 -32.12 72.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.664 0.268 . . . . 1.0 111.159 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -70.67 -56.77 5.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.877 0.37 . . . . 1.0 111.013 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.522 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -51.96 -31.23 28.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.76 -0.655 . . . . 1.0 109.527 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 31.0 mt -65.74 -46.99 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.67 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.81 -43.72 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.439 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -58.7 -26.93 64.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.179 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.515 ' CE1' HE21 ' A' ' 64' ' ' GLN . 43.0 m170 -79.27 -2.11 39.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.549 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.44 -1.35 58.64 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.928 -0.869 . . . . 1.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.75 88.6 1.54 Allowed Glycine 0 N--CA 1.461 0.363 0 N-CA-C 110.689 -0.965 . . . . 1.0 110.689 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.518 ' N ' ' CD ' ' A' ' 71' ' ' GLN . 2.6 pm0 -59.82 146.34 42.19 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.7 mt -92.29 110.82 22.22 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 91.1 m -119.97 86.88 37.56 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.628 ' C ' ' H ' ' A' ' 76' ' ' GLN . 14.3 Cg_endo -55.21 -159.71 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 122.004 1.803 . . . . 1.0 112.64 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -54.61 -0.6 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.035 -0.529 . . . . 1.0 110.588 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.628 ' H ' ' C ' ' A' ' 74' ' ' PRO . 4.5 pt20 -62.78 -19.67 64.24 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.109 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 79' ' ' GLY . . . -156.12 160.32 30.01 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 120.755 -0.736 . . . . 1.0 111.599 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.535 ' O ' ' O ' ' A' ' 79' ' ' GLY . 49.5 Cg_exo -52.17 -10.97 0.86 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.231 1.954 . . . . 1.0 112.09 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.548 ' O ' ' C ' ' A' ' 80' ' ' VAL . . . -53.0 -118.31 0.01 OUTLIER Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.712 -0.955 . . . . 1.0 110.712 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.548 ' C ' ' O ' ' A' ' 79' ' ' GLY . 2.3 p 10.6 74.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.592 0.71 . . . . 1.0 111.889 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.19 -24.23 27.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.352 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.63 ' CD2' ' CZ2' ' A' ' 114' ' ' TRP . 79.2 m80 -116.67 140.22 49.65 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.808 0.337 . . . . 1.0 110.262 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.444 ' O ' ' O ' ' A' ' 110' ' ' VAL . 2.9 mm -128.68 111.3 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.427 -0.583 . . . . 1.0 109.427 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -96.14 133.68 36.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.204 0.526 . . . . 1.0 110.379 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.438 ' C ' ' H ' ' A' ' 87' ' ' GLU . 17.8 m -127.82 165.61 26.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.562 -0.744 . . . . 1.0 110.536 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 88' ' ' GLY . 26.2 p-10 -77.06 14.26 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.636 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.438 ' H ' ' C ' ' A' ' 85' ' ' VAL . 35.8 mt-10 64.81 -2.91 0.62 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.343 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -75.27 -49.87 8.98 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.305 -0.718 . . . . 1.0 111.305 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.0 ptp -88.87 156.38 18.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.82 0.343 . . . . 1.0 110.709 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -83.55 166.27 18.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.283 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.698 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -58.8 -47.58 84.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.993 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.698 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 17.5 pt-20 -53.69 -38.23 64.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.888 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.23 -47.04 63.16 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.197 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.07 -31.07 17.64 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.99 -0.684 . . . . 1.0 111.349 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.03 -47.58 85.28 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.346 -0.541 . . . . 1.0 111.267 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -70.91 -42.54 69.79 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.582 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.486 ' CD1' ' OG1' ' A' ' 51' ' ' THR . 3.8 mm? -64.36 -43.64 93.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.826 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.49 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -84.67 -4.27 58.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.545 -179.189 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.405 ' O ' ' CB ' ' A' ' 75' ' ' ALA . 75.1 mmt-85 68.57 60.94 0.37 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.038 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.7 tp -129.58 111.45 17.68 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.764 -0.198 . . . . 1.0 110.799 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.66 -42.64 61.13 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.916 1.744 . . . . 1.0 111.947 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -174.34 130.31 0.36 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.567 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 104' ' ' PRO . 69.5 mt -37.37 100.48 0.2 Allowed Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.094 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' LEU . 54.8 Cg_exo -46.01 -178.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.276 1.984 . . . . 1.0 112.407 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.14 -43.42 59.28 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.634 2.222 . . . . 1.0 112.65 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.39 68.98 0.25 Allowed Glycine 0 N--CA 1.468 0.775 0 N-CA-C 110.97 -0.852 . . . . 1.0 110.97 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.64 138.6 7.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.82 0.343 . . . . 1.0 110.587 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -146.02 151.93 38.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.256 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.88 113.26 25.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.962 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 83' ' ' ILE . 12.0 m -110.63 166.33 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.501 -0.772 . . . . 1.0 109.885 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' A' ' 130' ' ' PHE . 28.8 mtmm -98.4 -176.99 3.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.731 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.3 t -62.94 -39.55 94.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.569 -0.742 . . . . 1.0 110.527 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.42 -41.86 66.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.227 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.63 ' CZ2' ' CD2' ' A' ' 82' ' ' HIS . 75.1 t90 -61.6 -53.64 53.58 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.613 -0.435 . . . . 1.0 110.592 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.443 ' O ' ' SG ' ' A' ' 118' ' ' CYS . 3.3 tt -61.94 -53.12 60.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.472 -0.491 . . . . 1.0 109.817 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 80.9 p -51.59 -46.71 63.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.492 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.4 mt -64.91 -54.99 21.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.355 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 115' ' ' LEU . 1.4 p -50.17 -30.91 12.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.386 0.612 . . . . 1.0 110.284 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.402 HD11 HE22 ' A' ' 64' ' ' GLN . 2.3 tp -70.01 -52.8 21.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.265 -0.88 . . . . 1.0 110.614 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -66.95 -37.87 85.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.564 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' A' ' 123' ' ' ARG . 78.3 mm-40 -78.98 9.03 4.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.181 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.479 ' NH2' ' NE1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER 36.06 32.68 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.788 -0.642 . . . . 1.0 111.092 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.438 ' CG ' ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -158.09 177.24 11.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.076 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.402 ' O ' ' NH1' ' A' ' 123' ' ' ARG . 5.6 tt -92.65 122.11 34.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.033 0.444 . . . . 1.0 110.766 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.2 m -100.0 152.23 4.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.347 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -62.18 150.21 39.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.286 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 129' ' ' GLY . 2.3 m -102.46 6.31 10.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.468 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.6 56.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.78 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 168.34 -37.75 0.21 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.527 ' O ' ' NZ ' ' A' ' 111' ' ' LYS . 50.4 m-85 -89.47 -18.24 27.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.728 0.299 . . . . 1.0 110.517 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.8 t -72.15 137.58 47.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.1 0.476 . . . . 1.0 110.78 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 134' ' ' ILE . 59.1 mt -83.62 -69.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.333 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.486 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 16.7 t80 62.34 -31.47 0.09 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.368 -0.833 . . . . 1.0 112.133 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.604 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 151.7 -55.12 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 124.6 1.16 . . . . 1.0 109.854 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.5 Cg_endo . . . . . 0 N--CA 1.497 1.688 0 C-N-CA 121.824 1.682 . . . . 1.0 112.137 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 120.698 0.285 . . . . 1.0 110.566 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.633 ' N ' ' CD1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -109.99 -40.16 4.83 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.182 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.462 ' CD1' ' CZ3' ' A' ' 40' ' ' TRP . 8.7 mt -79.61 1.86 24.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.42 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.2 t -54.99 -48.6 73.1 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.309 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.6 p -72.11 -37.28 69.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.929 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.2 mt -73.9 140.78 45.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.982 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.425 ' HB2' ' H ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -124.94 102.81 7.71 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.979 178.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.2 169.05 10.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.21 0.529 . . . . 1.0 110.845 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -156.33 124.14 5.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.672 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.4 m -103.04 143.72 14.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.047 0.451 . . . . 1.0 110.221 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 52' ' ' GLY . 18.9 m -97.07 161.21 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.449 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.553 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -81.25 -60.79 2.15 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.42 -0.354 . . . . 1.0 110.708 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.9 p -46.88 -12.08 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.983 0.42 . . . . 1.0 110.261 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.611 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -151.43 118.71 0.93 Allowed Glycine 0 C--O 1.205 -1.703 0 N-CA-C 109.46 -1.456 . . . . 1.0 109.46 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.611 ' HB ' ' O ' ' A' ' 52' ' ' GLY . 4.6 mm 102.22 -16.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.816 0.846 . . . . 1.0 110.452 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.5 29.13 1.23 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.661 -0.976 . . . . 1.0 110.661 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' A' ' 53' ' ' ILE . 32.6 mtt180 -66.66 -60.92 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.764 0.316 . . . . 1.0 110.56 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 172.47 -61.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.249 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -87.7 -32.47 19.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.311 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.12 83.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.363 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.541 ' C ' ' H ' ' A' ' 61' ' ' PHE . 9.3 pt-20 -66.42 -42.26 88.04 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.382 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.3 tp -45.84 -13.54 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.111 0.481 . . . . 1.0 110.833 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.541 ' H ' ' C ' ' A' ' 59' ' ' GLU . 3.8 m-30 -56.72 -47.64 79.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.884 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.09 -40.09 94.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.437 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -55.95 -46.41 78.56 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.632 -0.427 . . . . 1.0 110.222 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.485 ' O ' ' CD2' ' A' ' 68' ' ' HIS . 77.9 mt-30 -65.02 -38.85 92.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.147 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 77.5 mt -64.05 -43.69 97.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.48 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.16 -45.03 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.252 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -60.18 -26.01 66.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.318 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 64' ' ' GLN . 42.9 m170 -79.9 0.45 31.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.387 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.31 -19.31 54.42 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.871 -0.892 . . . . 1.0 110.871 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.34 94.04 0.63 Allowed Glycine 0 C--O 1.224 -0.478 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -77.13 145.23 37.9 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.975 -0.29 . . . . 1.0 110.439 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.495 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 4.6 mt -107.18 145.58 32.41 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.938 0.399 . . . . 1.0 110.302 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 72' ' ' LEU . 3.8 m -163.44 91.21 1.16 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.381 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 77' ' ' GLY . 43.7 Cg_endo -70.02 -167.09 0.22 Allowed 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.599 2.199 . . . . 1.0 111.989 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 77' ' ' GLY . . . -38.63 -27.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.837 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 74' ' ' PRO . 1.7 pt20 -64.03 1.58 0.67 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.399 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 75' ' ' ALA . . . 162.78 161.78 12.76 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.063 -0.815 . . . . 1.0 111.063 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.03 143.72 73.28 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.63 2.22 . . . . 1.0 111.817 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.42 66.01 0.38 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.224 -0.751 . . . . 1.0 111.224 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.421 ' O ' ' CG2' ' A' ' 80' ' ' VAL . 2.7 p -160.79 67.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.423 0.63 . . . . 1.0 110.475 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.425 ' H ' ' HB2' ' A' ' 45' ' ' ARG . 15.3 t -74.26 -33.29 63.24 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.003 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -117.37 146.0 43.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.938 0.399 . . . . 1.0 110.848 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.5 mt -137.51 111.43 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.839 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.15 140.59 16.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.121 0.486 . . . . 1.0 110.633 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.502 ' C ' ' H ' ' A' ' 87' ' ' GLU . 28.2 m -131.16 166.64 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.83 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.612 ' C ' ' H ' ' A' ' 88' ' ' GLY . 49.4 p-10 -73.07 14.16 0.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.665 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.502 ' H ' ' C ' ' A' ' 85' ' ' VAL . 18.6 mt-10 65.82 -15.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.776 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.612 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -64.13 -49.47 66.51 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.917 -0.873 . . . . 1.0 110.917 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.5 ptp -90.03 158.13 17.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.862 0.363 . . . . 1.0 110.471 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -89.1 -179.64 5.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.667 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -67.67 -37.59 82.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.37 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.538 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 15.2 pt-20 -58.91 -46.05 88.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.979 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.482 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 1.9 tmm_? -79.36 -24.34 42.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.022 -0.536 . . . . 1.0 111.231 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.55 -37.47 70.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.569 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.96 -36.27 78.96 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.11 -0.236 . . . . 1.0 110.674 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.536 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 6.6 mmp_? -62.65 -36.86 84.22 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.247 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.61 -42.21 99.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.054 0.454 . . . . 1.0 111.266 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.44 ' N ' HD21 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -97.32 5.31 50.12 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.668 -0.696 . . . . 1.0 109.663 -178.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.536 ' NH1' ' O ' ' A' ' 96' ' ' ARG . 51.2 mmt-85 51.01 24.32 1.81 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.267 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.7 tp -86.53 121.37 72.23 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.776 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.07 -17.17 36.34 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.465 2.11 . . . . 1.0 112.399 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 176.78 152.8 0.2 Allowed 'General case' 0 C--O 1.235 0.297 0 O-C-N 123.323 0.389 . . . . 1.0 110.453 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.528 ' N ' ' CD1' ' A' ' 103' ' ' LEU . 3.8 mp -86.47 140.6 33.98 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.949 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.02 164.41 35.75 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.416 2.077 . . . . 1.0 111.952 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -40.69 135.19 2.16 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.6 2.2 . . . . 1.0 112.191 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 107' ' ' ALA . . . 80.74 -69.56 3.19 Favored Glycine 0 C--O 1.228 -0.226 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 106' ' ' GLY . . . -29.02 150.6 0.0 OUTLIER 'General case' 0 C--N 1.345 0.379 0 O-C-N 123.924 0.426 . . . . 1.0 110.964 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -162.88 153.59 16.8 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.48 -0.488 . . . . 1.0 110.372 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.52 ' O ' ' OG ' ' A' ' 131' ' ' SER . 0.4 OUTLIER -85.37 112.56 20.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.915 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.2 m -104.68 172.58 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 123.475 0.484 . . . . 1.0 109.743 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -102.21 -173.73 2.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.661 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.1 m -63.57 -36.92 85.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.714 -0.675 . . . . 1.0 110.834 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.93 -36.23 65.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.502 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 89.3 t90 -68.67 -44.71 73.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.906 0.384 . . . . 1.0 110.542 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.97 -59.28 3.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.111 0.481 . . . . 1.0 111.037 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.7 m -45.17 -58.24 3.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.614 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.8 mp -60.01 -52.99 63.04 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 120.629 -0.429 . . . . 1.0 110.645 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 46.5 t -55.39 -31.21 61.63 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.696 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.23 -55.25 12.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.029 0.442 . . . . 1.0 111.872 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -77.06 -38.94 51.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.993 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 62.7 mm-40 -53.17 -48.3 68.1 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.432 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 121' ' ' GLU . 7.0 tpt180 86.61 27.35 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.733 0.645 . . . . 1.0 111.168 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.42 ' C ' ' CD ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -159.49 -171.45 3.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.445 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.1 tp -91.7 135.65 33.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.439 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 m -120.42 154.44 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.331 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 126' ' ' ASP . 54.6 p-10 -61.73 146.14 50.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.343 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 129' ' ' GLY . 9.0 t -104.64 -23.48 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 110.218 -0.29 . . . . 1.0 110.218 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.16 68.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.978 0.418 . . . . 1.0 110.499 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 165.81 -27.17 0.18 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.141 -0.783 . . . . 1.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -106.7 -3.01 21.02 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.667 0.27 . . . . 1.0 110.583 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.52 ' OG ' ' O ' ' A' ' 109' ' ' LEU . 3.2 m -104.7 125.61 50.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.976 0.417 . . . . 1.0 110.767 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.572 ' C ' ' H ' ' A' ' 134' ' ' ILE . 3.2 mp -64.63 -50.09 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.331 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.526 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 17.0 t80 65.67 -36.7 0.23 Allowed 'General case' 0 C--O 1.217 -0.615 0 O-C-N 124.278 0.986 . . . . 1.0 111.212 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 156.67 -54.65 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.311 0 O-C-N 124.663 1.227 . . . . 1.0 110.452 -178.658 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 27.5 Cg_endo . . . . . 0 C--N 1.309 -1.54 0 C-N-CA 122.331 2.021 . . . . 1.0 111.682 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.629 0.252 . . . . 1.0 110.568 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.579 ' N ' ' CD1' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -102.17 -50.89 3.51 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.832 0.349 . . . . 1.0 110.462 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.435 ' H ' ' CE1' ' A' ' 68' ' ' HIS . 2.2 tp -80.87 -0.65 39.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.733 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.6 p -66.95 -15.59 63.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.424 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.3 p -67.19 -15.56 63.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.517 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.441 ' C ' ' CD1' ' A' ' 44' ' ' LEU . 4.2 pp -136.21 168.84 18.64 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.387 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -116.65 118.09 31.63 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.009 0.433 . . . . 1.0 110.334 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.6 161.47 14.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.475 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -153.96 118.09 4.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.375 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 76.1 t -107.32 135.09 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.241 0.543 . . . . 1.0 110.379 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.0 t -73.7 99.1 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.447 -0.797 . . . . 1.0 110.206 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.514 HH21 HH12 ' A' ' 99' ' ' ARG . 84.8 mtm-85 -58.34 -37.8 75.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.42 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.9 p -75.92 -17.26 59.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.539 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.44 -59.5 0.97 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.202 -0.759 . . . . 1.0 111.202 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mt -86.42 71.32 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.161 0.505 . . . . 1.0 110.341 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -117.03 23.38 9.97 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 110.783 -0.927 . . . . 1.0 110.783 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.47 ' O ' ' CB ' ' A' ' 56' ' ' ALA . 4.2 ptm180 -75.03 -63.41 1.27 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.551 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 58' ' ' ALA . . . 159.93 138.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? 68.54 -42.14 0.47 Allowed 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 124.191 0.932 . . . . 1.0 110.327 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' A' ' 56' ' ' ALA . . . -65.37 -28.65 69.43 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.868 -0.605 . . . . 1.0 110.532 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.72 -39.75 80.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.395 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.99 -19.05 0.63 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.182 0.515 . . . . 1.0 110.582 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -44.18 -50.96 8.51 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.732 -0.667 . . . . 1.0 111.036 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.45 -43.98 92.55 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.626 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -62.41 -43.06 99.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.375 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -59.21 -26.13 64.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.272 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 80.8 mt -86.28 -23.32 6.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.366 0.603 . . . . 1.0 110.38 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.4 t -79.06 -37.66 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 O-C-N 122.056 -0.403 . . . . 1.0 110.706 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -68.08 -38.87 82.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.127 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.492 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -68.49 -6.41 24.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.274 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.44 7.11 52.25 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.465 -1.054 . . . . 1.0 110.465 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.7 96.89 2.19 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 110.267 -1.133 . . . . 1.0 110.267 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -68.32 144.13 54.92 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.734 -0.387 . . . . 1.0 110.287 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.0 mt -91.81 135.29 34.03 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.054 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.8 m -104.61 103.62 41.06 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.378 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.527 ' C ' ' H ' ' A' ' 76' ' ' GLN . 56.3 Cg_endo -75.17 168.35 24.9 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.397 2.065 . . . . 1.0 111.955 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.57 -7.39 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.558 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.527 ' H ' ' C ' ' A' ' 74' ' ' PRO . 42.0 mt-30 -76.43 -9.6 58.77 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 110.151 -0.315 . . . . 1.0 110.151 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -145.35 147.87 19.25 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.69 -16.44 33.66 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.698 2.266 . . . . 1.0 111.989 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -42.82 -25.92 0.39 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.437 -0.665 . . . . 1.0 111.437 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 p -64.79 138.88 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.965 0.412 . . . . 1.0 110.471 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.99 -34.27 0.23 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.536 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -108.78 125.05 51.52 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.619 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.412 ' O ' ' O ' ' A' ' 110' ' ' VAL . 22.5 mm -118.95 106.92 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.23 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.08 135.29 29.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.339 -0.846 . . . . 1.0 110.088 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.576 ' C ' ' H ' ' A' ' 87' ' ' GLU . 27.7 m -135.41 155.65 37.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.412 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.59 ' C ' ' H ' ' A' ' 88' ' ' GLY . 53.5 p-10 -71.29 22.5 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.581 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.576 ' H ' ' C ' ' A' ' 85' ' ' VAL . 29.9 mt-10 65.96 -13.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 1.0 111.017 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -61.81 -41.76 99.66 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.074 -0.811 . . . . 1.0 111.074 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.6 ptp -103.41 154.32 19.54 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.782 0.325 . . . . 1.0 110.53 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -90.16 172.81 8.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.133 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.594 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -58.53 -54.66 44.57 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.544 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.594 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 1.3 pp20? -52.07 -40.18 60.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.866 -0.606 . . . . 1.0 110.098 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -71.97 -39.13 69.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.832 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.91 -28.65 62.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.936 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.5 mp -61.82 -46.36 89.82 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.023 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.1 mmp_? -70.91 -40.98 71.84 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.38 -0.528 . . . . 1.0 111.345 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.92 -44.93 83.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.168 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.416 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.86 -13.93 59.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.63 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.514 HH12 HH21 ' A' ' 50' ' ' ARG . 2.9 mtp180 77.93 60.91 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 123.977 0.798 . . . . 1.0 111.937 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 mt -148.71 114.02 3.73 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 120.12 -0.632 . . . . 1.0 110.116 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.49 -11.45 24.47 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.128 1.886 . . . . 1.0 112.602 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 179.43 133.8 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.427 0.454 . . . . 1.0 110.207 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 mt -88.85 146.66 37.29 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.958 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.65 165.7 26.61 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 122.206 1.937 . . . . 1.0 112.311 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -43.48 140.63 3.99 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.117 1.878 . . . . 1.0 112.282 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.48 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 82.31 -64.46 4.26 Favored Glycine 0 N--CA 1.453 -0.181 0 N-CA-C 110.305 -1.118 . . . . 1.0 110.305 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.48 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -22.33 134.87 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 O-C-N 124.134 0.549 . . . . 1.0 110.868 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 108' ' ' GLN . 0.0 OUTLIER -143.69 157.52 44.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.897 0.38 . . . . 1.0 110.145 -177.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.0 mp -108.24 121.8 45.64 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.773 -0.648 . . . . 1.0 110.778 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.412 ' O ' ' O ' ' A' ' 83' ' ' ILE . 3.1 m -108.06 -178.23 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.109 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -109.28 -176.63 3.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.501 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.4 m -60.98 -37.79 83.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.817 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.06 -47.34 78.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.944 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.484 ' O ' ' SG ' ' A' ' 118' ' ' CYS . 72.9 t90 -56.43 -37.9 70.86 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.312 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.56 -61.16 1.94 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.268 -0.573 . . . . 1.0 110.929 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.9 t -49.39 -52.21 30.0 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.388 -0.525 . . . . 1.0 110.47 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.1 mp -48.93 -44.88 40.88 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.068 -0.514 . . . . 1.0 109.937 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 114' ' ' TRP . 74.5 m -60.25 -43.42 96.11 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.362 -0.535 . . . . 1.0 110.832 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 65.9 mt -50.21 -57.9 6.77 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.589 -0.444 . . . . 1.0 111.386 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -73.22 -49.01 30.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.727 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 74.6 mm-40 -54.27 -48.35 71.31 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.472 -0.491 . . . . 1.0 110.362 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 121' ' ' GLU . 8.7 tpp180 79.48 39.59 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.836 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.418 ' C ' ' CD ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -165.48 -173.18 2.69 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.428 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.3 tp -82.52 122.24 27.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.014 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.411 ' CG2' ' SG ' ' A' ' 118' ' ' CYS . 40.2 t -97.19 154.7 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-O 121.274 0.559 . . . . 1.0 110.432 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -69.29 115.38 8.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.394 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.415 ' O ' ' CB ' ' A' ' 131' ' ' SER . 5.0 m -64.16 -39.64 86.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.607 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.41 ' N ' ' CG2' ' A' ' 127' ' ' VAL . . . -53.73 -25.52 19.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.506 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.69 -38.6 93.31 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.243 -0.743 . . . . 1.0 111.243 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.74 43.01 1.98 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.848 0.356 . . . . 1.0 110.883 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 127' ' ' VAL . 8.7 t -107.84 132.9 52.93 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.288 0.566 . . . . 1.0 111.182 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.581 ' C ' ' H ' ' A' ' 134' ' ' ILE . 54.8 mt -75.64 -69.23 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 CA-C-N 115.084 -0.962 . . . . 1.0 109.881 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.493 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 15.8 t80 65.83 -36.58 0.24 Allowed 'General case' 0 C--O 1.223 -0.335 0 O-C-N 124.514 1.134 . . . . 1.0 111.578 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.581 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 156.03 -55.78 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.512 0 O-C-N 125.009 1.443 . . . . 1.0 109.752 -178.279 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 30.0 Cg_endo . . . . . 0 N--CA 1.49 1.298 0 C-N-CA 122.169 1.912 . . . . 1.0 112.01 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 120.944 0.402 . . . . 1.0 110.643 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 1.1 p-90 -86.83 -49.81 7.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.094 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -35.11 78.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.73 0.776 . . . . 1.0 110.019 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.66 -33.77 64.38 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.338 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 t -43.54 -25.67 0.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.795 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.83 167.87 18.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.343 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -115.94 112.65 22.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 1.0 110.167 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.36 165.95 12.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.49 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.529 ' CE1' ' O ' ' A' ' 73' ' ' CYS . 49.1 t60 -144.33 122.11 11.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.154 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.469 ' O ' ' NH1' ' A' ' 50' ' ' ARG . 71.5 t -110.95 133.97 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.341 -0.391 . . . . 1.0 110.31 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.2 m -71.94 134.01 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.39 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.486 ' N ' ' CD ' ' A' ' 50' ' ' ARG . 9.6 mpt_? -64.27 -40.75 96.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.546 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.483 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 7.6 p -104.19 138.19 41.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.1 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.26 -16.44 56.9 Favored Glycine 0 C--O 1.226 -0.402 0 N-CA-C 111.012 -0.835 . . . . 1.0 111.012 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.565 ' C ' ' H ' ' A' ' 55' ' ' ARG . 1.5 mm -117.75 -23.23 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.991 0.424 . . . . 1.0 110.248 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.37 35.01 0.44 Allowed Glycine 0 C--N 1.314 -0.678 0 C-N-CA 120.242 -0.98 . . . . 1.0 111.25 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.565 ' H ' ' C ' ' A' ' 53' ' ' ILE . 2.0 ptp180 -76.71 -60.96 2.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.582 0.229 . . . . 1.0 110.602 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.619 ' C ' ' H ' ' A' ' 58' ' ' ALA . . . 171.68 125.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.06 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.7 ttp85 68.74 -32.34 0.22 Allowed 'General case' 0 CA--C 1.518 -0.275 0 O-C-N 123.502 0.501 . . . . 1.0 110.323 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 56' ' ' ALA . . . -63.55 -36.5 83.99 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.63 0.728 . . . . 1.0 110.09 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 61' ' ' PHE . 12.3 pt-20 -60.36 -39.19 86.3 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.353 -0.539 . . . . 1.0 110.852 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.0 tp -42.29 -17.95 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.313 0.577 . . . . 1.0 110.854 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.559 ' N ' ' O ' ' A' ' 59' ' ' GLU . 2.3 m-85 -51.39 -51.25 56.28 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.988 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.89 -37.38 84.36 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.047 -0.353 . . . . 1.0 110.047 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -62.47 -45.83 91.24 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.095 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -64.83 -18.5 65.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.254 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 69' ' ' GLY . 61.4 mt -85.53 -56.95 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.902 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 m -65.32 -40.57 88.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.36 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -53.83 -41.45 67.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.22 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -96.89 10.95 37.58 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.397 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 97.13 139.94 11.0 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.656 -0.977 . . . . 1.0 110.656 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.84 61.11 0.13 Allowed Glycine 0 N--CA 1.466 0.664 0 N-CA-C 110.475 -1.05 . . . . 1.0 110.475 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -51.68 145.51 9.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.991 0.424 . . . . 1.0 110.405 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.3 mt -81.6 155.61 25.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.788 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.529 ' O ' ' CE1' ' A' ' 47' ' ' HIS . 1.3 m -158.56 156.39 27.15 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.409 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -59.98 125.87 18.81 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.546 2.164 . . . . 1.0 111.853 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 77' ' ' GLY . . . -77.55 -0.27 25.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.989 -0.551 . . . . 1.0 110.623 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -61.52 0.73 0.28 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.865 0.364 . . . . 1.0 110.623 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 75' ' ' ALA . . . -166.25 -172.44 33.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -53.5 -4.28 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.912 2.408 . . . . 1.0 111.97 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 77' ' ' GLY . . . -38.75 -61.29 1.35 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 m -106.41 -168.09 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.994 0.426 . . . . 1.0 110.202 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 t -140.41 -30.06 0.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.864 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -121.08 150.9 40.5 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.618 0.247 . . . . 1.0 110.788 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.3 mt -134.21 111.0 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.3 t -93.93 144.02 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.951 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 87' ' ' GLU . 32.2 m -134.3 154.7 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.569 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.549 ' C ' ' H ' ' A' ' 88' ' ' GLY . 31.3 t70 -71.82 19.83 0.06 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.747 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.546 ' H ' ' C ' ' A' ' 85' ' ' VAL . 0.8 OUTLIER 69.0 -39.16 0.42 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.363 -0.38 . . . . 1.0 111.048 179.037 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -38.99 -57.15 2.08 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.515 ' SD ' ' N ' ' A' ' 89' ' ' MET . 0.0 OUTLIER -87.1 160.17 18.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.81 0.338 . . . . 1.0 110.534 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -97.15 -177.05 3.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.056 0.455 . . . . 1.0 110.362 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -62.5 -47.04 85.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.846 -0.615 . . . . 1.0 110.576 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.627 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 10.6 pt-20 -53.36 -50.89 64.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.921 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.451 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 29.5 ttp180 -71.25 -42.8 68.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.118 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -43.84 -35.16 1.82 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.943 -0.572 . . . . 1.0 110.783 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.9 mp -59.93 -61.15 2.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.049 0.452 . . . . 1.0 110.884 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.537 HH21 ' C ' ' A' ' 100' ' ' LEU . 5.9 mmp_? -68.31 -22.2 64.73 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.236 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.483 ' CD1' ' OG1' ' A' ' 51' ' ' THR . 0.2 OUTLIER -63.82 -36.96 85.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.994 -178.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.9 13.99 22.13 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.784 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 63.06 59.65 1.3 Allowed 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 120.547 -0.461 . . . . 1.0 110.991 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.537 ' C ' HH21 ' A' ' 96' ' ' ARG . 13.8 tp -124.56 127.83 25.11 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.848 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.18 -44.88 11.06 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.037 1.825 . . . . 1.0 112.058 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.536 ' NE2' ' OH ' ' A' ' 91' ' ' TYR . 1.5 mm-40 176.6 136.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.228 0.537 . . . . 1.0 110.578 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.7 mt -41.91 116.21 1.63 Allowed Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 115.423 -0.808 . . . . 1.0 111.45 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -71.46 141.72 39.13 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.703 1.602 . . . . 1.0 111.922 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -40.77 93.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.451 2.101 . . . . 1.0 112.63 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.61 -56.55 0.59 Allowed Glycine 0 N--CA 1.465 0.585 0 N-CA-C 111.156 -0.778 . . . . 1.0 111.156 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.73 160.28 32.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.857 0.361 . . . . 1.0 110.947 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -149.16 156.6 42.42 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.44 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 131' ' ' SER . 1.3 mt -92.88 111.63 23.31 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.953 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.1 m -103.83 170.3 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -101.84 171.04 7.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.129 0.49 . . . . 1.0 111.607 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.2 m -56.05 -35.11 66.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.38 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.6 -38.18 86.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.729 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 74.8 t90 -60.47 -49.89 75.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.369 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.9 tp -63.05 -53.77 48.52 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.194 -0.603 . . . . 1.0 110.561 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.9 t -50.81 -46.67 59.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.3 mt -51.31 -48.77 62.25 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.356 -0.538 . . . . 1.0 109.813 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 122' ' ' ARG . 55.9 m -51.75 -34.89 41.32 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 38.9 mt -70.31 -54.53 12.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.002 0.43 . . . . 1.0 110.519 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -65.62 -38.35 89.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.231 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 80.7 mm-40 -79.79 -42.81 23.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.15 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 118' ' ' CYS . 5.2 tpp85 82.16 40.07 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.856 -0.611 . . . . 1.0 111.114 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -169.61 -173.44 1.65 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.342 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.6 tt -92.2 121.56 33.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.607 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 m -103.69 151.77 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.244 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 126' ' ' ASP . 48.4 p30 -66.78 147.71 52.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.24 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.3 m -101.29 -136.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.383 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 74.59 -60.69 0.51 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.326 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.05 -53.55 33.01 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -69.98 -42.52 73.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.934 0.397 . . . . 1.0 110.502 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 109' ' ' LEU . 15.1 p -58.56 153.53 16.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.628 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 134' ' ' ILE . 2.9 mp -90.08 -57.46 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.238 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.516 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 17.6 t80 65.12 -35.63 0.19 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.263 0.977 . . . . 1.0 111.433 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.605 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 155.26 -56.06 0.0 OUTLIER Pre-proline 0 C--N 1.346 0.441 0 O-C-N 124.84 1.338 . . . . 1.0 109.862 -178.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.3 Cg_endo . . . . . 0 N--CA 1.49 1.301 0 C-N-CA 122.212 1.941 . . . . 1.0 112.012 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.856 0.36 . . . . 1.0 110.777 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.612 ' CZ2' ' ND1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -97.16 -33.87 11.33 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.167 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.435 ' HG ' ' CE3' ' A' ' 40' ' ' TRP . 29.1 mt -83.03 -0.86 50.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.237 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.489 ' HG ' ' N ' ' A' ' 43' ' ' SER . 16.3 p -58.55 -41.8 86.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.662 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.489 ' N ' ' HG ' ' A' ' 42' ' ' SER . 56.8 m -61.58 -60.82 3.1 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.25 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 pp -74.94 167.4 21.97 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -124.51 121.75 35.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 1.0 111.023 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.63 124.85 49.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.865 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -111.11 120.58 42.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.247 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.433 ' H ' HD21 ' A' ' 72' ' ' LEU . 51.3 t -111.1 132.39 59.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.967 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.486 HG23 ' H ' ' A' ' 53' ' ' ILE . 27.0 m -78.58 84.09 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.434 0.635 . . . . 1.0 110.27 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.401 HH11 ' CD1' ' A' ' 72' ' ' LEU . 76.1 mtm-85 -54.52 -43.67 72.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.464 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.443 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 66.7 p -62.14 -22.92 66.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.323 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.03 -74.42 1.11 Allowed Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.258 -0.737 . . . . 1.0 111.258 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.486 ' H ' HG23 ' A' ' 49' ' ' VAL . 5.3 mt -53.37 122.16 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 CA-C-O 121.942 0.877 . . . . 1.0 109.978 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -174.64 25.97 0.07 OUTLIER Glycine 0 C--N 1.302 -1.326 0 CA-C-N 114.315 -1.311 . . . . 1.0 112.066 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -75.31 -47.32 28.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.829 0.347 . . . . 1.0 111.305 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -168.84 -114.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.932 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.443 ' CD ' ' N ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -63.5 -19.58 64.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.334 -0.393 . . . . 1.0 110.677 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -40.61 -47.54 2.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.056 0.455 . . . . 1.0 110.639 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -68.37 -37.48 80.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.183 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 57' ' ' ARG . 4.9 tp -48.77 -18.38 0.26 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.196 0.522 . . . . 1.0 111.019 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -69.38 -43.35 73.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.924 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.434 ' CG ' ' N ' ' A' ' 63' ' ' LYS . 9.5 pt-20 -58.48 -39.51 80.17 Favored 'General case' 0 C--N 1.317 -0.83 0 O-C-N 123.356 0.41 . . . . 1.0 110.494 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.434 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 41.1 mttp -63.44 -40.36 96.93 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.575 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -65.66 -18.88 65.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.711 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.469 ' O ' ' O ' ' A' ' 69' ' ' GLY . 71.0 mt -85.29 -62.37 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.079 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.7 m -45.09 -35.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.729 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -65.57 -46.09 80.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.91 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.612 ' ND1' ' CZ2' ' A' ' 40' ' ' TRP . 1.3 m170 -97.7 23.67 7.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.436 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 83.44 -179.4 52.55 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.134 -0.787 . . . . 1.0 111.134 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 71' ' ' GLN . . . 74.87 27.73 64.14 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.891 -0.883 . . . . 1.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -44.18 170.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.835 0.35 . . . . 1.0 110.733 -179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.433 HD21 ' H ' ' A' ' 48' ' ' VAL . 40.6 mt -73.46 147.26 44.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.249 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.44 ' O ' ' CG2' ' A' ' 80' ' ' VAL . 0.8 OUTLIER -161.59 96.26 1.3 Allowed Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.47 147.47 12.59 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.497 2.131 . . . . 1.0 112.232 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 77' ' ' GLY . . . -51.47 -46.8 63.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.717 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.593 ' NE2' ' H ' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -65.13 1.37 1.01 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.125 0.488 . . . . 1.0 110.29 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 75' ' ' ALA . . . -93.31 -117.78 2.66 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 110.772 -0.931 . . . . 1.0 110.772 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.46 -57.65 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.528 2.152 . . . . 1.0 112.381 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.43 ' O ' HG13 ' A' ' 80' ' ' VAL . . . -162.78 -73.57 0.02 OUTLIER Glycine 0 C--O 1.224 -0.473 0 C-N-CA 120.681 -0.771 . . . . 1.0 111.497 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 73' ' ' CYS . 0.4 OUTLIER 74.83 162.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 123.87 0.394 . . . . 1.0 110.256 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.53 -30.48 0.11 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.251 -0.432 . . . . 1.0 111.274 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -111.84 141.81 45.01 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.153 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.1 mp -132.74 108.32 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.973 -0.558 . . . . 1.0 109.784 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.2 t -92.96 135.25 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 115.802 -0.636 . . . . 1.0 111.043 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.572 ' C ' ' H ' ' A' ' 87' ' ' GLU . 30.0 m -132.34 159.26 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.475 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.58 ' C ' ' H ' ' A' ' 88' ' ' GLY . 47.4 p30 -67.05 12.31 0.08 Allowed 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.465 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.572 ' H ' ' C ' ' A' ' 85' ' ' VAL . 7.9 mt-10 70.5 -22.95 0.17 Allowed 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.291 0.369 . . . . 1.0 110.842 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.58 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -58.74 -46.63 93.15 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.686 -0.966 . . . . 1.0 110.686 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.2 ptp -88.85 145.04 25.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.848 0.356 . . . . 1.0 110.178 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -80.08 173.19 12.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.385 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.615 ' CG ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.19 -53.02 63.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.561 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.615 ' N ' ' CG ' ' A' ' 91' ' ' TYR . 14.2 pt-20 -53.47 -41.44 66.18 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 123.55 0.531 . . . . 1.0 110.521 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.675 ' HE ' ' CZ ' ' A' ' 96' ' ' ARG . 46.5 ttt180 -69.64 -40.15 76.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.082 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.48 ' O ' ' CD2' ' A' ' 98' ' ' LEU . . . -51.5 -26.48 8.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.938 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.1 mp -57.15 -41.04 78.41 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.735 -0.603 . . . . 1.0 110.802 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.675 ' CZ ' ' HE ' ' A' ' 93' ' ' ARG . 23.3 ptt180 -63.39 -34.18 77.17 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.413 -0.515 . . . . 1.0 109.986 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.443 ' CD1' ' OG1' ' A' ' 51' ' ' THR . 3.3 mm? -60.53 -47.9 84.13 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.794 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.484 ' O ' ' NE2' ' A' ' 76' ' ' GLN . 0.1 OUTLIER -93.14 16.36 13.16 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.742 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 41.97 56.2 3.56 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.527 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.8 tp -132.2 113.9 14.75 Favored Pre-proline 0 C--O 1.219 -0.526 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.597 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.16 2.07 5.96 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.361 2.041 . . . . 1.0 112.723 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 179.96 142.61 0.16 Allowed 'General case' 0 C--O 1.238 0.466 0 O-C-N 123.429 0.455 . . . . 1.0 110.742 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.3 mm? -84.8 145.0 43.05 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-O 120.888 0.375 . . . . 1.0 111.119 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.566 ' C ' ' H ' ' A' ' 106' ' ' GLY . 44.2 Cg_endo -69.18 161.99 43.62 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.353 2.035 . . . . 1.0 111.88 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.97 23.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.874 2.383 . . . . 1.0 111.974 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 104' ' ' PRO . . . -161.5 63.6 0.27 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -172.82 149.33 1.95 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.655 0.264 . . . . 1.0 110.469 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -139.32 156.05 47.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.063 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.9 mp -101.65 113.27 26.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.628 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.401 HG23 ' CE3' ' A' ' 114' ' ' TRP . 3.5 m -107.13 163.99 4.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.137 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm -93.71 -172.75 2.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.685 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.2 t -65.35 -41.18 94.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.985 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.63 -51.44 48.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.661 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.625 ' CE2' ' SG ' ' A' ' 118' ' ' CYS . 63.5 t90 -50.55 -49.58 55.65 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.484 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 tt -57.95 -50.97 71.56 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.32 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.7 t -48.54 -51.96 24.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.06 0.457 . . . . 1.0 110.08 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.1 mp -57.44 -50.98 71.27 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.448 -0.501 . . . . 1.0 110.259 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.625 ' SG ' ' CE2' ' A' ' 114' ' ' TRP . 56.3 m -44.35 -27.06 0.39 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.049 0.452 . . . . 1.0 110.099 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 80.2 mt -83.36 -47.68 11.2 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.564 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -68.44 -54.2 18.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.472 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 122' ' ' ARG . 78.4 mt-10 -77.86 5.4 9.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.508 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.456 ' C ' ' O ' ' A' ' 121' ' ' GLU . 81.4 mtt85 28.63 44.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.52 0.513 . . . . 1.0 111.257 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.445 ' CG ' ' O ' ' A' ' 121' ' ' GLU . 0.9 OUTLIER -159.99 167.83 27.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.532 -179.134 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 tp -74.08 100.08 3.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.046 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.409 ' CG2' ' N ' ' A' ' 126' ' ' ASP . 0.3 OUTLIER -80.44 154.93 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 121.252 0.548 . . . . 1.0 110.091 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 126' ' ' ASP . 14.6 p-10 -59.81 117.73 5.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.434 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 129' ' ' GLY . 13.0 m -68.03 -44.57 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.691 -0.686 . . . . 1.0 111.077 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.463 ' N ' ' CG2' ' A' ' 127' ' ' VAL . . . -43.85 -18.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.685 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . -69.9 -38.39 75.32 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.344 -0.702 . . . . 1.0 111.344 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -129.48 13.76 6.02 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.625 0.25 . . . . 1.0 110.679 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.5 p -73.16 136.4 44.78 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.848 0.356 . . . . 1.0 110.69 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.573 ' C ' ' H ' ' A' ' 134' ' ' ILE . 59.1 mt -74.52 -66.93 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.875 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.548 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 25.1 t80 66.26 -36.14 0.24 Allowed 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 123.878 0.736 . . . . 1.0 111.42 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 155.72 -55.3 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 O-C-N 124.768 1.293 . . . . 1.0 110.271 -178.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.3 Cg_endo . . . . . 0 C--N 1.31 -1.46 0 C-N-CA 122.498 2.132 . . . . 1.0 111.994 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 120.88 0.371 . . . . 1.0 110.539 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.601 ' N ' ' CD1' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -101.07 -38.22 8.25 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.355 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -76.49 -12.39 60.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.886 0.374 . . . . 1.0 110.9 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t -69.69 -17.78 63.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.996 0.427 . . . . 1.0 110.402 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.7 t -74.1 -13.9 60.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.107 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.42 168.99 18.4 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.993 0.425 . . . . 1.0 110.046 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.403 ' H ' ' HB ' ' A' ' 81' ' ' THR . 93.5 mtt180 -114.99 124.1 50.8 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.602 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -107.44 155.08 20.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.828 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.627 ' CE1' ' NH1' ' A' ' 50' ' ' ARG . 25.0 t-80 -155.25 123.32 5.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.528 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.2 m -99.52 145.37 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.849 0.357 . . . . 1.0 110.243 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.68 143.94 13.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.579 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.627 ' NH1' ' CE1' ' A' ' 47' ' ' HIS . 8.4 mpt_? -63.33 -42.62 98.98 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.857 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 p -100.99 136.28 41.09 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.946 0.403 . . . . 1.0 110.437 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.67 -19.85 53.01 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.048 -0.821 . . . . 1.0 111.048 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.468 ' CG2' ' O ' ' A' ' 53' ' ' ILE . 40.6 mm -127.51 3.81 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.096 0.474 . . . . 1.0 110.586 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.59 26.29 24.52 Favored Glycine 0 N--CA 1.467 0.724 0 N-CA-C 110.39 -1.084 . . . . 1.0 110.39 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.671 HH22 HH21 ' A' ' 57' ' ' ARG . 16.2 mtm-85 -63.25 -47.2 83.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 1.0 110.723 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 55' ' ' ARG . . . 165.52 -62.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.171 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.671 HH21 HH22 ' A' ' 55' ' ' ARG . 5.1 ppt_? -92.04 -25.56 18.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.598 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.64 -37.87 88.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.475 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 61' ' ' PHE . 3.1 pt-20 -65.32 -39.96 93.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.295 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 tp -44.19 -16.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.228 0.537 . . . . 1.0 110.886 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 59' ' ' GLU . 6.6 m-85 -58.91 -43.54 91.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.657 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.456 ' CG ' ' N ' ' A' ' 63' ' ' LYS . 13.8 pt-20 -67.2 -42.61 83.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.988 0.423 . . . . 1.0 111.063 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.456 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 95.2 mttt -63.86 -44.62 92.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.19 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -56.0 -37.58 69.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.806 -0.634 . . . . 1.0 109.995 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.505 ' O ' ' O ' ' A' ' 69' ' ' GLY . 67.8 mt -63.62 -44.43 98.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.667 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.7 t -59.37 -44.74 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.812 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -55.97 -35.62 66.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.69 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.444 ' N ' ' CD2' ' A' ' 68' ' ' HIS . 1.9 m170 -103.99 16.55 26.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.136 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 90.58 153.18 28.65 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.868 -0.893 . . . . 1.0 110.868 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.0 51.43 0.6 Allowed Glycine 0 N--CA 1.468 0.786 0 N-CA-C 110.058 -1.217 . . . . 1.0 110.058 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -43.46 143.23 0.96 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 1.0 110.401 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 3.0 mm? -80.07 136.39 36.55 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.059 0.457 . . . . 1.0 110.143 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 79' ' ' GLY . 69.3 m -141.61 103.45 5.9 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.971 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.501 ' O ' ' N ' ' A' ' 77' ' ' GLY . 58.7 Cg_endo -73.94 167.59 26.85 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.712 1.608 . . . . 1.0 111.747 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -44.09 -48.31 8.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.531 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -67.75 -19.64 65.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.473 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 74' ' ' PRO . . . -78.77 -165.89 29.5 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.252 -0.739 . . . . 1.0 111.252 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.33 -42.28 61.46 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.751 2.301 . . . . 1.0 112.351 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 73' ' ' CYS . . . 170.19 -161.85 35.01 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.024 -0.83 . . . . 1.0 111.024 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -169.8 138.83 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.403 ' HB ' ' H ' ' A' ' 45' ' ' ARG . 95.4 m -104.21 -47.99 3.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.781 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -124.94 155.05 40.2 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.95 0.405 . . . . 1.0 111.087 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.415 ' N ' HD13 ' A' ' 83' ' ' ILE . 4.4 mp -134.34 113.19 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.056 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.43 134.96 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.362 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.567 ' C ' ' H ' ' A' ' 87' ' ' GLU . 3.7 m -127.21 163.68 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.646 -0.707 . . . . 1.0 110.708 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.56 19.0 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.229 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.567 ' H ' ' C ' ' A' ' 85' ' ' VAL . 12.9 mt-10 70.02 -51.76 0.64 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.51 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.14 -28.52 61.43 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.699 -0.961 . . . . 1.0 110.699 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.6 tpp -72.66 140.45 47.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.051 0.453 . . . . 1.0 110.823 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -88.18 153.63 21.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.769 -0.651 . . . . 1.0 109.67 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -56.26 -45.87 79.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.015 179.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.566 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 11.6 pt-20 -53.92 -49.72 68.01 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.621 -0.432 . . . . 1.0 111.135 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.484 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 21.9 ttm105 -70.51 -38.01 74.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.085 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.452 ' O ' ' CD2' ' A' ' 98' ' ' LEU . . . -46.56 -43.37 17.07 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 116.048 -0.523 . . . . 1.0 111.923 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.8 mp -58.3 -39.92 80.62 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.774 -0.579 . . . . 1.0 110.773 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.53 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 84.3 mmt-85 -69.24 -29.42 67.34 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.742 -0.383 . . . . 1.0 110.947 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.26 -40.98 94.69 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.379 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.452 ' CD2' ' O ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -109.51 15.58 22.85 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.024 0.44 . . . . 1.0 110.655 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.53 ' NH1' ' O ' ' A' ' 96' ' ' ARG . 60.7 mmt-85 50.38 57.44 6.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.544 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.8 tp -107.24 115.07 60.4 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 121.075 -0.25 . . . . 1.0 110.458 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.22 -48.01 20.03 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.839 1.693 . . . . 1.0 112.384 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -175.98 137.51 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.645 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.8 mt -37.06 100.76 0.21 Allowed Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.267 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -43.18 157.44 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.099 1.866 . . . . 1.0 112.176 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.91 85.37 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.509 2.139 . . . . 1.0 111.898 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 137.33 -36.19 1.98 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.154 -0.778 . . . . 1.0 111.154 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.12 153.05 32.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.602 0.239 . . . . 1.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -144.23 155.48 43.89 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.12 114.5 24.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.463 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 m -110.63 171.31 3.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 123.759 0.662 . . . . 1.0 109.478 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.555 ' NZ ' ' O ' ' A' ' 130' ' ' PHE . 30.1 mtmm -104.82 -178.49 3.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.832 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.1 t -60.13 -39.24 85.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.099 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.07 -49.59 60.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.523 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 75.0 t90 -56.18 -46.33 79.42 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.2 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.43 -55.98 11.46 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.051 0.453 . . . . 1.0 110.377 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -41.37 -57.08 2.28 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.696 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.5 mp -58.64 -47.12 85.51 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 123' ' ' ARG . 0.5 OUTLIER -44.92 -42.62 8.28 Favored 'General case' 0 C--O 1.214 -0.766 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.725 177.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.48 -49.44 69.07 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 119.676 -0.81 . . . . 1.0 110.94 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -71.59 -51.91 20.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.971 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -70.62 -39.08 73.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.799 -0.637 . . . . 1.0 111.431 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 67.1 mtt85 63.99 54.38 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.269 0.557 . . . . 1.0 111.133 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.643 ' C ' ' HE ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -152.1 -164.72 2.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.239 -0.891 . . . . 1.0 111.125 -179.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.8 tp -119.94 91.67 3.6 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.593 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.441 ' CG2' ' NH2' ' A' ' 123' ' ' ARG . 29.0 m -81.2 153.32 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.952 0.406 . . . . 1.0 110.158 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -69.97 121.89 18.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.21 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 129' ' ' GLY . 17.6 m -72.44 -126.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.886 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 63.81 -63.3 0.14 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 1.0 110.71 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . -59.53 -46.21 94.33 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.616 -0.994 . . . . 1.0 110.616 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.555 ' O ' ' NZ ' ' A' ' 111' ' ' LYS . 60.0 m-85 -86.54 -7.67 58.18 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.948 -0.389 . . . . 1.0 109.948 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.2 p -78.66 157.58 28.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.925 0.393 . . . . 1.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.592 ' C ' ' H ' ' A' ' 134' ' ' ILE . 62.2 mt -93.37 -59.67 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.406 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.475 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 16.3 t80 63.62 -32.97 0.12 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.941 -1.027 . . . . 1.0 111.904 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.592 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.6 OUTLIER 152.46 -55.64 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 124.848 1.259 . . . . 1.0 109.634 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 34.6 Cg_endo . . . . . 0 N--CA 1.496 1.638 0 C-N-CA 121.783 1.656 . . . . 1.0 112.074 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 120.856 0.36 . . . . 1.0 110.387 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.569 ' CZ2' ' NE ' ' A' ' 122' ' ' ARG . 3.6 p-90 -140.26 -38.46 0.45 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.392 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.99 -6.23 59.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.762 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.6 m -64.01 -33.03 74.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.903 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.9 p -57.16 -43.45 82.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.939 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.59 107.87 19.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.125 0.488 . . . . 1.0 110.732 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -68.72 110.21 4.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.519 -0.764 . . . . 1.0 109.338 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.2 162.83 14.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.875 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -148.08 131.92 17.05 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.945 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.5 t -121.98 116.49 49.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.35 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 53' ' ' ILE . 15.7 t -56.95 81.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.717 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 48' ' ' VAL . 33.1 ptt-85 -70.27 -8.3 49.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.779 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.6 p -92.89 0.43 57.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.61 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 54' ' ' GLY . . . -147.44 -46.67 0.03 OUTLIER Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.123 -0.791 . . . . 1.0 111.123 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.404 ' N ' ' O ' ' A' ' 49' ' ' VAL . 3.8 tt -64.24 3.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.774 0.321 . . . . 1.0 110.422 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 52' ' ' GLY . . . -70.24 50.99 0.78 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.38 -43.66 69.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.803 0.335 . . . . 1.0 110.236 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -177.21 -81.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.035 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 60' ' ' LEU . 8.9 ptm180 -95.47 -21.12 18.51 Favored 'General case' 0 C--O 1.207 -1.138 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.923 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.59 -37.05 17.0 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.89 -0.724 . . . . 1.0 111.033 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -51.55 -26.1 7.99 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.559 -0.456 . . . . 1.0 110.804 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -63.64 -22.87 67.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.201 0.524 . . . . 1.0 110.96 -179.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.485 ' CE2' ' OG ' ' A' ' 112' ' ' SER . 21.7 m-85 -52.62 -46.71 67.17 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.923 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -65.71 -36.01 82.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.833 0.349 . . . . 1.0 110.645 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.528 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 5.7 mptp? -62.79 -48.67 78.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.19 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.434 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 62.4 mt-30 -60.38 -37.75 81.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.931 -0.577 . . . . 1.0 109.711 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 69' ' ' GLY . 57.8 mt -61.6 -48.08 90.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.095 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.6 t -62.8 -46.54 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 120.583 -0.447 . . . . 1.0 110.297 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 63' ' ' LYS . 1.2 mp0 -67.32 -35.03 78.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.24 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.63 ' HD1' ' CD2' ' A' ' 119' ' ' LEU . 61.7 m170 -88.19 0.28 56.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.542 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 98.72 147.27 21.83 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.72 -0.952 . . . . 1.0 110.72 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.47 55.53 0.71 Allowed Glycine 0 N--CA 1.464 0.554 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -40.19 145.13 0.17 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.679 0.276 . . . . 1.0 110.676 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.425 ' C ' ' SG ' ' A' ' 73' ' ' CYS . 8.8 mt -74.54 140.38 44.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.258 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.425 ' SG ' ' C ' ' A' ' 72' ' ' LEU . 2.6 m -145.12 87.87 7.01 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.233 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.16 -150.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.808 2.339 . . . . 1.0 111.849 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.53 -26.21 68.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.454 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -64.04 -20.56 66.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.52 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.1 -166.64 24.93 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.77 -43.47 57.62 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.71 2.274 . . . . 1.0 112.072 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . 131.48 31.17 0.52 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.896 -0.882 . . . . 1.0 110.896 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 79' ' ' GLY . 31.1 m 37.44 -158.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 120.758 0.313 . . . . 1.0 110.904 179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 t -142.04 -18.44 0.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.706 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.781 ' NE2' HE21 ' A' ' 108' ' ' GLN . 68.7 m80 -130.98 160.03 35.73 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.022 0.439 . . . . 1.0 110.744 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 110' ' ' VAL . 5.1 mm -138.15 112.69 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.702 -0.681 . . . . 1.0 111.473 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.1 t -94.59 129.78 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.477 ' C ' ' H ' ' A' ' 87' ' ' GLU . 16.0 m -132.02 167.02 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.392 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 88' ' ' GLY . 49.1 t0 -77.91 30.06 0.17 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.219 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' A' ' 85' ' ' VAL . 31.3 mt-10 64.72 -66.65 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.873 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . -48.64 -17.33 0.76 Allowed Glycine 0 CA--C 1.52 0.381 0 N-CA-C 110.871 -0.892 . . . . 1.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.487 ' SD ' ' CD1' ' A' ' 97' ' ' LEU . 3.4 ttm -77.4 147.37 36.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.122 0.486 . . . . 1.0 110.495 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 91' ' ' TYR . 92.1 m-20 -100.64 142.75 31.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.591 -0.731 . . . . 1.0 109.855 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.601 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -36.73 -56.4 0.84 Allowed 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.285 -179.55 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.601 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 5.0 pt-20 -56.1 -59.57 4.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.773 -0.648 . . . . 1.0 109.953 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.571 ' H ' ' CG ' ' A' ' 92' ' ' GLU . 79.0 ttt180 -42.51 -42.22 3.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.857 0.36 . . . . 1.0 110.22 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.88 -48.61 75.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.73 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 99' ' ' ARG . 7.9 mp -57.48 -44.38 84.85 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.325 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.455 ' C ' ' CD ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -62.24 -42.43 99.31 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.807 179.275 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.487 ' CD1' ' SD ' ' A' ' 89' ' ' MET . 24.8 mt -63.19 -51.75 65.08 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.737 -0.385 . . . . 1.0 111.228 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.411 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -77.73 -18.5 56.47 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.173 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 95' ' ' LEU . 3.2 mtp180 76.35 63.54 0.05 OUTLIER 'General case' 0 CA--C 1.509 -0.608 0 O-C-N 124.469 1.106 . . . . 1.0 111.685 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.7 tp -136.45 118.3 11.61 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 120.465 -0.494 . . . . 1.0 111.089 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.98 -38.62 56.55 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.919 1.746 . . . . 1.0 112.067 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -163.19 136.48 5.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.609 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.8 mt -75.99 148.8 82.03 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.024 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.34 167.75 17.81 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.033 1.822 . . . . 1.0 112.467 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 107' ' ' ALA . 33.6 Cg_exo -56.1 146.35 70.78 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.497 2.131 . . . . 1.0 112.296 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.05 -19.52 6.5 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.901 -0.879 . . . . 1.0 110.901 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 105' ' ' PRO . . . -61.97 151.76 34.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 1.0 110.428 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.781 HE21 ' NE2' ' A' ' 82' ' ' HIS . 5.9 pt20 -156.73 128.86 7.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.365 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.9 mp -84.11 127.64 34.04 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.711 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.467 ' O ' ' O ' ' A' ' 83' ' ' ILE . 3.8 m -121.31 176.14 4.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 O-C-N 123.723 0.639 . . . . 1.0 109.973 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -106.75 -176.57 3.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.738 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.485 ' OG ' ' CE2' ' A' ' 61' ' ' PHE . 6.8 t -60.05 -41.36 92.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.57 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.32 -48.24 62.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.611 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.544 ' CZ2' ' SG ' ' A' ' 118' ' ' CYS . 78.3 t90 -54.19 -41.1 68.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.002 0.429 . . . . 1.0 110.259 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.04 -55.56 27.95 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.129 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 80.1 p -49.21 -42.87 41.6 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.055 0.455 . . . . 1.0 109.828 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.35 -55.74 22.05 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.426 -0.51 . . . . 1.0 109.896 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.544 ' SG ' ' CZ2' ' A' ' 114' ' ' TRP . 0.0 OUTLIER -44.63 -33.68 1.9 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 -179.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.63 ' CD2' ' HD1' ' A' ' 68' ' ' HIS . 94.0 mt -77.05 -51.33 11.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.568 -0.742 . . . . 1.0 111.184 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -65.56 -49.14 69.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.231 -0.441 . . . . 1.0 111.314 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.433 ' O ' ' CG ' ' A' ' 123' ' ' ARG . 65.2 mm-40 -77.48 1.44 19.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.282 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.569 ' NE ' ' CZ2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 38.79 32.24 0.05 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.585 179.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 121' ' ' GLU . 4.5 ppt_? -158.29 174.32 15.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.254 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.6 tt -82.15 126.17 31.74 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.943 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.0 m -108.96 154.74 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.539 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 40.3 p-10 -62.09 144.33 55.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.042 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.6 m -103.03 11.17 8.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.509 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.64 53.35 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.609 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.68 -34.47 0.12 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.089 -0.804 . . . . 1.0 111.089 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -99.74 5.92 45.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.022 0.439 . . . . 1.0 110.655 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.6 t -99.15 141.28 32.12 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.356 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.531 ' C ' ' H ' ' A' ' 134' ' ' ILE . 54.7 mt -88.18 -55.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-N 115.635 -0.711 . . . . 1.0 110.205 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.5 ' O ' HG12 ' A' ' 134' ' ' ILE . 10.9 t80 65.71 -40.6 0.32 Allowed 'General case' 0 C--O 1.221 -0.426 0 O-C-N 124.375 1.047 . . . . 1.0 111.461 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.546 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 159.38 -54.55 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 O-C-N 124.665 1.228 . . . . 1.0 109.915 -178.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 36.5 Cg_endo . . . . . 0 N--CA 1.491 1.351 0 C-N-CA 122.15 1.9 . . . . 1.0 111.929 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.689 0.281 . . . . 1.0 110.307 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.554 ' CZ2' ' CZ ' ' A' ' 122' ' ' ARG . 1.6 p-90 -123.45 -50.62 1.87 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.547 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.4 ' CD1' ' CZ3' ' A' ' 40' ' ' TRP . 1.3 mt -67.13 -21.75 65.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.757 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.0 t -61.37 -18.57 59.34 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.326 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.7 p -65.32 -15.0 62.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.333 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.55 168.35 19.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.308 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -119.55 115.58 24.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.604 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.62 168.18 10.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.114 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -153.91 120.06 5.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.629 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.1 t -100.05 135.9 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.09 0.471 . . . . 1.0 110.252 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.3 m -86.71 125.04 40.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.685 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.2 mmt85 -74.53 -39.11 62.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.745 -0.661 . . . . 1.0 111.246 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.1 p -59.51 -22.51 61.74 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.617 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . -115.85 -91.58 1.71 Allowed Glycine 0 N--CA 1.465 0.603 0 N-CA-C 110.738 -0.945 . . . . 1.0 110.738 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.513 ' C ' ' H ' ' A' ' 55' ' ' ARG . 4.1 mm -40.23 -27.6 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.741 0.305 . . . . 1.0 110.806 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 52' ' ' GLY . . . -69.81 41.64 0.44 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.801 -0.92 . . . . 1.0 110.801 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.513 ' H ' ' C ' ' A' ' 53' ' ' ILE . 1.9 ptp180 -80.11 -61.14 2.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.835 0.35 . . . . 1.0 110.953 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.427 ' H ' ' HG3' ' A' ' 55' ' ' ARG . . . -150.28 -89.87 0.07 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.761 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -92.71 -24.62 18.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.03 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.44 -16.83 0.64 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.571 0.701 . . . . 1.0 110.05 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 61' ' ' PHE . 21.1 pt-20 -73.29 -34.84 65.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.154 0.502 . . . . 1.0 111.207 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 tp -46.29 -17.31 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.392 0.615 . . . . 1.0 110.866 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.475 ' N ' ' O ' ' A' ' 59' ' ' GLU . 1.8 m-85 -57.22 -51.11 70.64 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.802 -0.636 . . . . 1.0 112.073 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -58.15 -36.99 73.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.111 0.482 . . . . 1.0 110.563 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -44.75 96.19 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.244 0.545 . . . . 1.0 110.287 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -62.76 -18.7 63.05 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.256 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' A' ' 69' ' ' GLY . 92.3 mt -86.29 -56.19 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.961 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 67' ' ' GLN . 3.4 m -62.81 -38.6 82.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.913 0.387 . . . . 1.0 110.891 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.407 ' N ' ' CG2' ' A' ' 66' ' ' VAL . 85.0 mt-30 -61.45 -40.01 92.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.699 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -95.68 14.66 22.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.771 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 96.32 144.72 17.61 Favored Glycine 0 N--CA 1.464 0.524 0 N-CA-C 110.618 -0.993 . . . . 1.0 110.618 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.07 44.73 1.35 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.707 -0.957 . . . . 1.0 110.707 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -40.95 160.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.786 0.327 . . . . 1.0 110.689 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.9 mt -69.92 136.62 50.79 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 68.4 m -131.1 96.9 20.95 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.341 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.99 -178.71 4.85 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.527 2.151 . . . . 1.0 112.024 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -54.68 -47.82 73.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.766 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -64.03 -18.98 64.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.915 0.388 . . . . 1.0 110.352 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.87 -158.45 19.38 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.088 -0.805 . . . . 1.0 111.088 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -47.96 -44.99 26.25 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.412 2.075 . . . . 1.0 112.417 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.43 ' O ' ' CB ' ' A' ' 80' ' ' VAL . . . 156.44 -44.58 0.52 Allowed Glycine 0 C--O 1.223 -0.576 0 C-N-CA 120.467 -0.873 . . . . 1.0 111.128 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.43 ' CB ' ' O ' ' A' ' 79' ' ' GLY . 0.4 OUTLIER 82.91 166.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 124.038 0.493 . . . . 1.0 110.166 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.58 -35.22 0.31 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.904 -0.318 . . . . 1.0 110.453 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -117.26 144.06 45.23 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.655 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.405 ' O ' ' O ' ' A' ' 110' ' ' VAL . 58.2 mt -131.58 112.59 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.555 -0.458 . . . . 1.0 110.885 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 t -90.3 127.64 42.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.521 ' C ' ' H ' ' A' ' 87' ' ' GLU . 28.7 m -133.16 166.44 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.885 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.544 ' C ' ' H ' ' A' ' 88' ' ' GLY . 39.8 p-10 -73.66 17.48 0.16 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.76 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' A' ' 85' ' ' VAL . 3.7 mt-10 73.71 -32.11 0.23 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.092 -0.504 . . . . 1.0 111.224 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -67.95 -20.35 72.55 Favored Glycine 0 C--N 1.314 -0.672 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.414 ' CE ' HH12 ' A' ' 93' ' ' ARG . 9.4 ttm -82.11 160.16 23.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.791 0.329 . . . . 1.0 110.826 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -113.52 142.06 46.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.83 -0.623 . . . . 1.0 109.891 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.57 ' CG ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -46.49 -53.27 11.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.497 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.57 ' N ' ' CG ' ' A' ' 91' ' ' TYR . 17.1 pt-20 -51.83 -38.25 55.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.645 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.414 HH12 ' CE ' ' A' ' 89' ' ' MET . 79.7 ttt-85 -80.44 -22.17 41.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.789 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.34 -37.32 77.54 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.334 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 99' ' ' ARG . 7.5 mp -60.6 -38.0 83.22 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.995 -0.282 . . . . 1.0 110.319 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -61.9 -35.88 79.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.79 0.329 . . . . 1.0 110.627 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.24 -40.56 96.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.049 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.407 ' N ' HD21 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -108.72 8.77 27.0 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.188 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 95' ' ' LEU . 1.6 mpt_? 45.96 58.24 4.55 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.8 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.52 112.44 58.88 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.147 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.74 -41.75 37.75 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.057 1.838 . . . . 1.0 112.72 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -162.08 128.59 3.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.958 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 60.4 mt -52.71 124.6 35.3 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-N 116.088 -0.506 . . . . 1.0 111.214 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.449 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 44.2 Cg_exo -49.67 -174.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.365 2.044 . . . . 1.0 112.419 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 32.1 Cg_exo -58.18 129.36 32.62 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.724 2.283 . . . . 1.0 111.908 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 72.18 -53.32 1.43 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-O 118.906 -0.941 . . . . 1.0 110.751 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -7.79 116.26 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 O-C-N 124.262 0.625 . . . . 1.0 111.178 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -127.71 142.74 51.25 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.593 -0.276 . . . . 1.0 110.411 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.626 ' H ' ' CD2' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -93.38 120.96 34.27 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.442 HG23 ' CE3' ' A' ' 114' ' ' TRP . 3.5 m -110.25 168.0 4.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.996 -1.002 . . . . 1.0 110.606 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.21 -177.72 3.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.897 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.0 m -61.48 -41.63 97.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.11 -0.95 . . . . 1.0 110.511 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.47 -48.14 62.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.547 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.442 ' CE3' HG23 ' A' ' 110' ' ' VAL . 34.5 t90 -56.02 -41.22 74.59 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.229 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.6 tp -65.67 -56.64 11.06 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.142 -0.623 . . . . 1.0 110.613 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.405 ' H ' ' HG ' ' A' ' 116' ' ' SER . 2.0 m -46.22 -53.58 10.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.363 0.601 . . . . 1.0 110.061 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.2 mp -52.23 -49.23 64.39 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.268 -0.573 . . . . 1.0 109.863 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.524 ' SG ' ' O ' ' A' ' 123' ' ' ARG . 12.8 t -52.15 -37.33 54.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.775 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.598 ' O ' ' NH2' ' A' ' 122' ' ' ARG . 90.2 mt -69.6 -57.5 5.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.42 0.629 . . . . 1.0 111.509 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -66.21 -21.24 66.3 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.469 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 75.9 mm-40 -88.82 -45.24 9.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.609 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.598 ' NH2' ' O ' ' A' ' 119' ' ' LEU . 0.1 OUTLIER 81.61 33.86 0.1 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.9 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.524 ' O ' ' SG ' ' A' ' 118' ' ' CYS . 0.0 OUTLIER -161.7 -176.12 5.11 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.579 -0.449 . . . . 1.0 110.536 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 tp -79.22 123.89 27.84 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.333 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.18 155.18 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 121.017 0.437 . . . . 1.0 110.623 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 126' ' ' ASP . 45.3 p-10 -61.38 107.94 0.86 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.251 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 128' ' ' ALA . 9.1 m -60.36 -42.82 92.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.65 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.455 ' N ' ' CG2' ' A' ' 127' ' ' VAL . . . -55.72 -22.66 24.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.48 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.9 -37.62 94.66 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.916 -0.873 . . . . 1.0 110.916 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.587 ' N ' ' CD1' ' A' ' 130' ' ' PHE . 0.3 OUTLIER -143.42 58.51 1.39 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.707 0.289 . . . . 1.0 110.899 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 127' ' ' VAL . 33.9 m -119.17 150.8 39.43 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.141 0.496 . . . . 1.0 110.795 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 134' ' ' ILE . 60.9 mt -81.34 -63.75 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 CA-C-N 115.301 -0.863 . . . . 1.0 110.181 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.512 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 19.4 t80 66.34 -35.66 0.23 Allowed 'General case' 0 C--O 1.221 -0.425 0 O-C-N 124.208 0.943 . . . . 1.0 111.347 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.587 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 155.7 -55.51 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.37 0 O-C-N 124.905 1.378 . . . . 1.0 110.048 -178.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 24.9 Cg_endo . . . . . 0 N--CA 1.491 1.361 0 C-N-CA 122.324 2.016 . . . . 1.0 111.821 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.455 ' OE1' ' N ' ' A' ' 39' ' ' GLU . 39.9 mp0 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.894 0.378 . . . . 1.0 110.58 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.416 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 14.8 p-90 -163.81 -55.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.086 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tt -68.91 -18.18 64.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.372 0.606 . . . . 1.0 110.123 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 68' ' ' HIS . 15.8 m -61.5 -42.17 98.39 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.713 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.8 m -52.84 -60.61 3.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.882 0.373 . . . . 1.0 110.714 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.0 169.28 18.32 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.655 -0.498 . . . . 1.0 109.655 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -123.71 120.02 31.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.935 0.398 . . . . 1.0 110.738 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.7 158.29 15.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.235 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.486 ' CE1' ' CD1' ' A' ' 98' ' ' LEU . 59.6 t-80 -156.04 114.88 3.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.231 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.7 m -101.23 139.9 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.739 -0.467 . . . . 1.0 109.739 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 53' ' ' ILE . 58.5 t -81.69 89.9 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.036 0.446 . . . . 1.0 110.527 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -58.24 -31.18 67.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.664 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 m -92.9 34.99 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.992 0.425 . . . . 1.0 110.364 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -178.87 -4.6 0.02 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.091 -0.804 . . . . 1.0 111.091 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.548 ' C ' ' H ' ' A' ' 55' ' ' ARG . 0.9 OUTLIER -127.04 -1.35 4.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-O 120.748 0.309 . . . . 1.0 110.314 179.293 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.45 37.32 0.57 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.105 -0.798 . . . . 1.0 111.105 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.548 ' H ' ' C ' ' A' ' 53' ' ' ILE . 1.6 ptp180 -61.0 -37.76 83.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.829 0.347 . . . . 1.0 110.244 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -172.9 -103.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.401 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.603 ' H ' ' CD ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -85.98 -19.13 30.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.491 179.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.447 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -43.21 -36.53 1.78 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.573 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 61' ' ' PHE . 12.5 pt-20 -66.12 -44.46 84.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.342 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.1 tp -43.17 -18.13 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.775 0.798 . . . . 1.0 110.818 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 59' ' ' GLU . 6.5 m-85 -58.11 -48.38 80.37 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.562 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -60.47 -31.04 70.07 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.034 0.445 . . . . 1.0 111.544 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.438 ' H ' ' HG2' ' A' ' 63' ' ' LYS . 17.0 mmmt -65.96 -56.52 11.3 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.451 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -57.84 -30.06 65.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.421 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 68.5 mt -66.87 -39.82 84.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.411 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.8 t -59.8 -41.62 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.232 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -68.24 -16.46 63.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.521 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.431 ' O ' ' OG ' ' A' ' 42' ' ' SER . 34.0 m170 -88.81 7.32 34.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.65 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.82 -7.22 82.18 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.052 -0.819 . . . . 1.0 111.052 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.56 98.06 2.3 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.589 -1.004 . . . . 1.0 110.589 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -79.54 144.31 34.04 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.89 -0.324 . . . . 1.0 110.756 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.57 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 2.5 mm? -80.66 137.27 36.32 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 120.898 0.38 . . . . 1.0 110.531 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.8 m -133.68 90.54 27.87 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.465 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.5 -177.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.824 2.349 . . . . 1.0 112.139 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.457 ' C ' ' H ' ' A' ' 77' ' ' GLY . . . -56.43 -41.73 76.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.514 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -64.14 -1.55 1.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.319 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 75' ' ' ALA . . . -136.56 86.67 0.24 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.318 -1.113 . . . . 1.0 110.318 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.76 139.26 59.18 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.626 2.218 . . . . 1.0 112.058 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.81 1.17 1.63 Allowed Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.3 p -88.34 103.71 13.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.048 0.451 . . . . 1.0 110.6 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.99 -39.25 15.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.399 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.5 ' CD2' ' CZ2' ' A' ' 114' ' ' TRP . 77.5 m80 -106.58 138.82 42.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.951 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.411 ' O ' ' O ' ' A' ' 110' ' ' VAL . 85.7 mt -133.58 107.36 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.258 -0.428 . . . . 1.0 109.934 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.43 134.97 27.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.533 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.51 162.8 37.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.394 -0.821 . . . . 1.0 110.975 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 88' ' ' GLY . 67.8 t0 -63.99 103.45 0.59 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 116.027 -0.533 . . . . 1.0 109.635 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 86' ' ' ASP . 69.1 mt-10 -24.63 87.15 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 124.191 0.932 . . . . 1.0 110.926 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . 156.77 -25.41 0.5 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 -178.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.445 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 11.9 ttm -70.14 146.71 50.63 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.913 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -90.09 151.57 21.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.453 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.55 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.74 -46.86 87.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.108 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.55 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 10.5 pt-20 -57.99 -45.45 86.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.947 0.403 . . . . 1.0 110.776 -178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.484 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 4.8 tmm_? -72.13 -21.82 61.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.13 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.49 -30.62 71.71 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.802 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 99' ' ' ARG . 7.0 mp -72.18 -44.81 62.46 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.212 0.32 . . . . 1.0 110.973 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -59.79 -48.28 82.32 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.25 -45.76 75.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.568 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.486 ' CD1' ' CE1' ' A' ' 47' ' ' HIS . 54.8 tp -72.77 -16.18 61.64 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.969 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.57 ' N ' ' O ' ' A' ' 95' ' ' LEU . 23.0 mmt85 67.35 27.15 8.27 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.11 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.5 tp -98.02 116.99 65.58 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.8 -23.26 35.72 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.22 1.947 . . . . 1.0 112.578 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -174.42 133.88 0.4 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.328 -0.397 . . . . 1.0 110.714 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 104' ' ' PRO . 1.0 OUTLIER -73.79 135.44 77.75 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.093 -178.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.533 ' O ' ' O ' ' A' ' 103' ' ' LEU . 60.7 Cg_exo -44.72 -174.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.645 2.23 . . . . 1.0 112.061 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 52.5 Cg_exo -51.95 -68.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.565 2.176 . . . . 1.0 113.087 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . -82.45 -50.43 4.77 Favored Glycine 0 CA--C 1.502 -0.753 0 N-CA-C 110.662 -0.975 . . . . 1.0 110.662 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.52 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -11.46 123.83 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 124.64 0.847 . . . . 1.0 111.44 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -130.76 154.26 48.17 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 110.018 -0.364 . . . . 1.0 110.018 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.86 110.36 22.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.783 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 83' ' ' ILE . 13.9 m -107.25 169.07 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.661 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -96.52 -168.97 1.81 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.658 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -70.69 -34.66 72.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.878 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.419 ' O ' ' OG ' ' A' ' 116' ' ' SER . . . -57.21 -46.75 82.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.688 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.5 ' CZ2' ' CD2' ' A' ' 82' ' ' HIS . 79.0 t90 -52.02 -59.83 3.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.628 -0.429 . . . . 1.0 110.678 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 119' ' ' LEU . 32.0 tp -60.63 -51.24 70.25 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.441 -0.504 . . . . 1.0 110.503 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 117' ' ' LEU . 56.9 p -41.27 -60.71 1.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.087 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.439 ' N ' ' OG ' ' A' ' 116' ' ' SER . 11.0 mp -61.14 -49.62 76.51 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.055 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 123' ' ' ARG . 9.3 t -55.49 -25.96 39.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 1.0 110.081 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -70.62 -52.27 22.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.478 0.656 . . . . 1.0 111.419 -178.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -78.39 -30.66 47.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.505 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' A' ' 122' ' ' ARG . 0.4 OUTLIER -62.38 -48.5 79.45 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 118.473 -0.775 . . . . 1.0 110.165 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' A' ' 121' ' ' GLU . 17.0 mmm180 90.27 32.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.816 1.323 . . . . 1.0 111.358 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.54 ' O ' ' SG ' ' A' ' 118' ' ' CYS . 0.0 OUTLIER -173.9 163.18 4.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.435 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.4 tp -65.76 129.32 39.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.962 0.411 . . . . 1.0 111.175 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.3 m -113.32 154.0 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.364 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -61.96 146.92 48.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.431 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.4 m -108.01 0.98 9.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.249 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.98 61.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.602 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 171.48 -28.15 0.11 Allowed Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -108.47 -11.53 15.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.718 0.295 . . . . 1.0 110.39 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -74.6 135.32 42.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.08 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 134' ' ' ILE . 57.5 mt -79.45 -65.95 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.129 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.53 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 19.7 t80 66.14 -36.33 0.24 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 118.438 -0.791 . . . . 1.0 111.154 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.588 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 155.67 -55.27 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 O-C-N 124.825 1.328 . . . . 1.0 110.272 -178.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 22.7 Cg_endo . . . . . 0 C--N 1.311 -1.401 0 C-N-CA 122.391 2.06 . . . . 1.0 111.982 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 39' ' ' GLU . 57.8 mp0 . . . . . 0 CA--C 1.519 -0.224 0 CA-C-O 120.822 0.344 . . . . 1.0 110.433 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.513 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 3.5 p-90 -98.42 -56.69 2.39 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.391 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.15 -11.68 1.23 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.737 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.41 ' H ' ' C ' ' A' ' 40' ' ' TRP . 77.5 p -68.7 -32.55 72.44 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.644 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -61.02 -15.32 30.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.571 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.72 115.28 11.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.854 0.359 . . . . 1.0 110.628 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -75.31 139.94 42.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.078 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.33 169.74 9.73 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.458 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.714 ' HD1' ' N ' ' A' ' 48' ' ' VAL . 1.5 t-80 -147.89 120.09 8.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.439 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.714 ' N ' ' HD1' ' A' ' 47' ' ' HIS . 21.3 t -97.1 127.16 49.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.508 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.644 ' O ' ' N ' ' A' ' 53' ' ' ILE . 15.0 t -80.7 88.92 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.424 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -49.56 -36.84 24.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.548 -0.296 . . . . 1.0 110.571 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.0 p -76.26 -24.24 54.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.541 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -110.14 1.58 29.84 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.367 -0.693 . . . . 1.0 111.367 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.644 ' N ' ' O ' ' A' ' 49' ' ' VAL . 35.0 mt -146.18 91.47 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.285 0.564 . . . . 1.0 110.309 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -145.45 19.68 1.87 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.076 -0.81 . . . . 1.0 111.076 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.502 ' O ' ' CB ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -58.25 -55.97 28.08 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.288 -0.264 . . . . 1.0 110.288 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 55' ' ' ARG . . . 158.14 -40.14 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 O-C-N 123.436 0.46 . . . . 1.0 110.576 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.43 ' O ' ' CD2' ' A' ' 60' ' ' LEU . 70.3 ttp85 -94.27 -60.66 1.68 Allowed 'General case' 0 C--O 1.211 -0.928 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.829 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.634 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -40.96 -43.08 2.03 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-O 121.262 0.553 . . . . 1.0 110.578 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 61' ' ' PHE . 11.3 pt-20 -45.45 -48.52 13.8 Favored 'General case' 0 C--N 1.314 -0.971 0 O-C-N 121.77 -0.581 . . . . 1.0 111.094 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.441 HD21 ' N ' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -39.45 -19.02 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.507 0.504 . . . . 1.0 109.962 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.634 ' CD2' ' O ' ' A' ' 58' ' ' ALA . 8.6 m-85 -52.73 -48.96 66.32 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.676 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.462 ' CG ' ' N ' ' A' ' 63' ' ' LYS . 13.9 pt-20 -63.02 -43.46 98.67 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.489 0.493 . . . . 1.0 110.528 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.462 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 17.5 mtpp -61.23 -42.58 98.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.223 0.535 . . . . 1.0 110.177 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.536 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 86.9 mm-40 -67.35 -31.27 71.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.205 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 69' ' ' GLY . 46.5 mt -74.96 -57.86 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.047 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.0 m -55.22 -42.75 67.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.271 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -65.81 -40.29 91.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.584 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 64' ' ' GLN . 46.5 m170 -86.01 -3.59 58.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.503 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 99.17 171.17 30.96 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.876 -0.89 . . . . 1.0 110.876 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 71' ' ' GLN . . . 102.17 -45.51 1.36 Allowed Glycine 0 N--CA 1.464 0.545 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 70' ' ' GLY . 25.1 mm100 54.92 158.65 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.7 0.286 . . . . 1.0 110.634 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.613 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -89.58 130.32 35.91 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.757 -0.461 . . . . 1.0 109.757 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 73.3 m -118.85 88.73 36.53 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.621 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 77' ' ' GLY . 31.8 Cg_exo -56.67 162.45 8.47 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.833 2.355 . . . . 1.0 112.055 178.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -47.23 -33.84 5.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.397 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -75.94 -20.51 57.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.896 0.379 . . . . 1.0 110.592 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 74' ' ' PRO . . . -85.9 -161.99 35.85 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.029 -0.828 . . . . 1.0 111.029 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -43.8 -41.63 11.78 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.563 2.175 . . . . 1.0 111.986 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.462 ' O ' ' CG1' ' A' ' 80' ' ' VAL . . . 136.19 -40.78 1.49 Allowed Glycine 0 C--O 1.22 -0.779 0 CA-C-O 119.219 -0.767 . . . . 1.0 111.695 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.513 ' CG1' ' N ' ' A' ' 81' ' ' THR . 0.3 OUTLIER 77.96 -171.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 124.034 0.491 . . . . 1.0 109.909 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.513 ' N ' ' CG1' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -144.29 -32.19 0.43 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.824 177.56 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.663 ' CD2' HE22 ' A' ' 108' ' ' GLN . 74.9 m80 -111.69 136.51 50.83 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.614 -0.266 . . . . 1.0 110.672 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 110' ' ' VAL . 30.2 mm -123.28 106.29 17.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -93.53 134.06 32.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.814 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 87' ' ' GLU . 3.1 m -132.79 157.44 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.206 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.576 ' O ' ' C ' ' A' ' 87' ' ' GLU . 10.1 t0 -54.78 77.72 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 123.373 0.42 . . . . 1.0 110.116 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' A' ' 85' ' ' VAL . 6.8 pt-20 -3.88 79.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 O-C-N 124.17 0.919 . . . . 1.0 111.76 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . 170.1 -22.11 0.08 OUTLIER Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.601 -0.727 . . . . 1.0 111.288 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.6 tpp -72.71 156.14 39.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.775 0.322 . . . . 1.0 110.786 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -96.35 144.1 26.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.135 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.604 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -51.47 -44.94 62.6 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.205 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.604 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 16.5 pt-20 -59.65 -44.16 93.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.929 0.395 . . . . 1.0 110.526 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.46 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 38.8 ttm105 -71.94 -41.16 68.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.767 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.15 -34.46 22.42 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.935 -0.575 . . . . 1.0 111.045 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.411 ' N ' HD13 ' A' ' 95' ' ' LEU . 5.6 mp -62.55 -47.3 84.49 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.66 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.548 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -73.0 -35.77 66.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.257 -178.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.62 -34.54 75.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.51 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.466 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -105.61 -1.94 24.05 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.204 -0.453 . . . . 1.0 111.005 -179.431 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.548 ' NH1' ' O ' ' A' ' 96' ' ' ARG . 72.9 mmt-85 70.57 61.68 0.2 Allowed 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 123.322 0.389 . . . . 1.0 110.858 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 95' ' ' LEU . 9.3 tp -125.79 122.36 24.57 Favored Pre-proline 0 N--CA 1.449 -0.518 0 O-C-N 123.255 0.347 . . . . 1.0 111.376 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.83 -36.51 23.44 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.384 2.056 . . . . 1.0 112.012 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 179.47 139.63 0.11 Allowed 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.576 0.548 . . . . 1.0 110.915 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.7 mt -45.14 120.27 4.4 Favored Pre-proline 0 N--CA 1.445 -0.72 0 CA-C-N 115.843 -0.617 . . . . 1.0 111.166 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.15 165.36 32.9 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.409 2.073 . . . . 1.0 112.031 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.15 113.54 1.24 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.575 2.183 . . . . 1.0 111.805 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.84 62.58 1.67 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -164.09 143.13 7.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 1.0 110.641 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.663 HE22 ' CD2' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -140.16 152.99 46.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.088 0.471 . . . . 1.0 110.132 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.06 109.4 20.87 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.15 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 83' ' ' ILE . 3.0 m -108.23 167.14 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.026 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -102.24 -171.18 1.92 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.838 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.4 t -64.84 -44.42 89.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.895 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.08 -38.0 49.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.514 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 75.2 t90 -61.65 -52.31 64.86 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.907 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 119' ' ' LEU . 3.0 tt -63.13 -55.7 23.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.993 0.425 . . . . 1.0 110.986 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.9 t -43.94 -59.55 2.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.392 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.427 ' O ' ' OE2' ' A' ' 121' ' ' GLU . 9.4 mp -60.01 -49.82 76.15 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.464 -0.494 . . . . 1.0 110.364 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 123' ' ' ARG . 3.1 t -58.72 -22.08 56.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.142 -0.318 . . . . 1.0 110.142 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.535 ' O ' ' NH1' ' A' ' 122' ' ' ARG . 6.7 tp -71.22 -53.52 14.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.001 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.459 ' C ' ' H ' ' A' ' 122' ' ' ARG . 77.0 mt-30 -76.75 -33.08 58.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.603 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.535 ' O ' ' C ' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -77.26 18.17 0.42 Allowed 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.8 -178.496 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.535 ' C ' ' O ' ' A' ' 121' ' ' GLU . 81.6 mmt-85 20.56 52.77 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.719 0.637 . . . . 1.0 111.353 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.509 ' O ' ' SG ' ' A' ' 118' ' ' CYS . 0.5 OUTLIER -170.67 167.8 7.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.727 -0.669 . . . . 1.0 110.357 -178.342 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.0 tt -83.77 114.76 21.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.044 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.428 ' CG1' ' N ' ' A' ' 126' ' ' ASP . 55.2 t -80.45 155.7 4.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.155 0.502 . . . . 1.0 110.601 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.428 ' N ' ' CG1' ' A' ' 125' ' ' VAL . 66.2 t0 -66.46 117.26 8.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.505 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 131' ' ' SER . 2.9 m -64.14 -41.4 92.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.603 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.463 ' N ' ' CG2' ' A' ' 127' ' ' VAL . . . -53.75 -6.64 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.455 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 127' ' ' VAL . . . -87.86 -34.38 10.09 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -134.33 12.12 3.83 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.713 0.292 . . . . 1.0 110.433 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 127' ' ' VAL . 5.1 t -75.48 141.29 43.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.895 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.563 ' C ' ' H ' ' A' ' 134' ' ' ILE . 45.3 mt -83.25 -66.36 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.124 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.533 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 21.1 t80 66.76 -37.89 0.31 Allowed 'General case' 0 C--O 1.211 -0.926 0 O-C-N 124.011 0.819 . . . . 1.0 111.003 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.582 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 157.36 -54.66 0.0 OUTLIER Pre-proline 0 N--CA 1.45 -0.441 0 O-C-N 124.658 1.224 . . . . 1.0 110.755 -178.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 29.9 Cg_endo . . . . . 0 C--N 1.31 -1.476 0 C-N-CA 122.479 2.12 . . . . 1.0 111.684 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.394 0 N-CA-C 109.504 -1.438 . . . . 1.0 109.504 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.4 m -70.63 150.16 46.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.669 0.271 . . . . 1.0 110.391 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -117.96 55.77 0.87 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.525 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.8 t -138.43 144.48 40.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.539 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.99 -67.07 0.11 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -80.39 94.36 6.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.868 0.366 . . . . 1.0 110.616 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.538 ' C ' ' H ' ' A' ' 38' ' ' GLU . 1.7 tt0 -60.53 -47.18 87.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.592 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.641 ' C ' ' H ' ' A' ' 39' ' ' GLU . . . 57.24 2.78 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.66 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.538 ' H ' ' C ' ' A' ' 36' ' ' GLU . 99.4 mt-10 56.77 -3.15 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.455 -0.338 . . . . 1.0 110.91 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.641 ' H ' ' C ' ' A' ' 37' ' ' ALA . 96.1 mt-10 37.45 75.27 0.07 Allowed 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.782 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -90.24 -46.05 8.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.383 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.474 ' C ' ' H ' ' A' ' 43' ' ' SER . 6.6 tp -62.42 -31.83 72.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.742 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 91.5 p -48.02 -14.71 0.05 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.532 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 41' ' ' LEU . 32.9 t -64.55 -16.34 62.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.567 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.35 168.24 19.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.281 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.445 HH12 ' CA ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -118.11 112.19 19.86 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.966 0.413 . . . . 1.0 110.428 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.58 166.29 12.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.782 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.554 ' HD1' ' N ' ' A' ' 48' ' ' VAL . 1.0 OUTLIER -155.12 121.35 5.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.376 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.554 ' N ' ' HD1' ' A' ' 47' ' ' HIS . 54.6 t -108.73 135.05 48.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.97 0.414 . . . . 1.0 110.215 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.6 t -86.0 103.44 12.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.412 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.469 ' H ' ' HD2' ' A' ' 50' ' ' ARG . 6.8 mpt_? -63.55 -38.86 92.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.72 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.7 p -66.05 -30.56 71.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.404 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.31 -67.48 1.33 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.21 -0.756 . . . . 1.0 111.21 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.501 ' O ' ' N ' ' A' ' 55' ' ' ARG . 3.1 mt -61.9 -94.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.971 -0.292 . . . . 1.0 110.214 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 53' ' ' ILE . . . 34.24 32.27 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.163 -0.775 . . . . 1.0 111.163 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 53' ' ' ILE . 30.0 mtm180 -70.54 -60.34 2.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.829 0.347 . . . . 1.0 110.364 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 170.72 -53.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.352 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.5 ttt-85 -101.99 -41.39 6.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.365 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.473 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -56.59 -41.4 76.92 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.048 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 61' ' ' PHE . 8.0 pt-20 -45.62 -46.44 14.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.734 -0.212 . . . . 1.0 110.584 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.8 tp -41.27 -17.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.12 0.486 . . . . 1.0 110.548 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.598 ' N ' ' O ' ' A' ' 59' ' ' GLU . 3.3 m-85 -49.42 -51.1 37.6 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.173 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.406 ' CD ' ' HZ2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -61.58 -40.09 93.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.542 -0.299 . . . . 1.0 110.675 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.406 ' HZ2' ' CD ' ' A' ' 62' ' ' GLU . 13.9 mptt -61.68 -43.28 99.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.228 0.537 . . . . 1.0 110.249 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -63.6 -40.53 97.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.309 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 81.2 mt -64.32 -54.12 34.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.934 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.9 m -64.01 -40.43 89.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.128 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -59.64 -18.62 43.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.273 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.3 m170 -97.3 1.86 50.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.487 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.07 0.51 59.98 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.057 -0.817 . . . . 1.0 111.057 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -91.63 98.2 2.4 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.738 -0.945 . . . . 1.0 110.738 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.414 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 83.7 mt-30 -70.86 145.43 50.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.87 0.367 . . . . 1.0 110.568 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.34 156.65 48.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.084 0.469 . . . . 1.0 110.359 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.1 m -163.19 158.28 17.91 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.566 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.95 -153.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.952 2.435 . . . . 1.0 111.944 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -47.62 -26.66 1.56 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.505 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' A' ' 77' ' ' GLY . 74.7 mt-30 -66.58 -20.12 65.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.281 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.445 ' CA ' HH12 ' A' ' 45' ' ' ARG . . . -37.51 103.88 0.03 OUTLIER Glycine 0 CA--C 1.538 1.475 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.9 -28.76 24.71 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.647 2.232 . . . . 1.0 111.928 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.82 60.96 0.4 Allowed Glycine 0 CA--C 1.521 0.413 0 N-CA-C 111.099 -0.8 . . . . 1.0 111.099 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.5 p -91.63 97.6 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.489 0.661 . . . . 1.0 110.249 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.19 -19.02 19.66 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.42 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -109.97 140.78 43.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.472 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.5 mm -131.1 106.18 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.614 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.4 t -91.21 131.35 38.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.52 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.573 ' C ' ' H ' ' A' ' 87' ' ' GLU . 27.9 m -132.73 162.59 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.607 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.607 ' C ' ' H ' ' A' ' 88' ' ' GLY . 15.3 t70 -68.92 18.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.375 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.573 ' H ' ' C ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER 68.87 -20.1 0.16 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.668 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -61.82 -67.71 1.98 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.2 ptp -63.54 145.82 54.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.641 0.258 . . . . 1.0 110.35 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -83.63 168.52 16.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.638 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.546 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.98 -53.32 59.18 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.466 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.546 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 15.7 pt-20 -50.39 -38.86 44.89 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.502 0.501 . . . . 1.0 110.107 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -74.81 -40.97 60.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.974 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -46.19 -27.89 1.11 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.642 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 95' ' ' LEU . 4.1 mm? -56.07 -59.51 4.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.268 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 41.2 ptt180 -78.1 -25.95 47.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.477 -0.329 . . . . 1.0 110.551 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.451 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -61.45 -42.24 98.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.932 -179.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -93.4 6.14 49.18 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.283 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.451 ' NH1' ' O ' ' A' ' 97' ' ' LEU . 31.6 mmt-85 69.67 54.88 0.37 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.791 0.329 . . . . 1.0 111.065 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 95' ' ' LEU . 6.4 tp -146.78 116.83 4.56 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.781 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.35 -7.48 19.71 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.767 2.311 . . . . 1.0 112.876 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -179.85 140.68 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.699 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.7 mp -84.45 148.56 52.67 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.973 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.475 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 37.0 Cg_exo -59.34 -173.68 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.63 2.22 . . . . 1.0 111.657 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 29.8 Cg_exo -62.45 133.75 44.55 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.676 2.251 . . . . 1.0 111.798 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 72.42 -51.59 1.43 Allowed Glycine 0 C--O 1.22 -0.729 0 N-CA-C 110.935 -0.866 . . . . 1.0 110.935 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.537 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -17.8 129.71 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.905 0.415 . . . . 1.0 111.065 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -132.11 158.28 42.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.103 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.434 ' CD1' ' N ' ' A' ' 109' ' ' LEU . 3.4 mp -107.84 117.61 34.58 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.553 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.465 HG22 ' CE3' ' A' ' 114' ' ' TRP . 3.6 m -108.84 175.45 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.479 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -104.36 -174.67 2.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.811 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.413 ' OG ' ' OE2' ' A' ' 87' ' ' GLU . 70.0 p -64.04 -37.67 88.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.896 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.38 -44.45 76.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.586 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.614 ' CE2' ' SG ' ' A' ' 118' ' ' CYS . 60.8 t90 -57.51 -48.21 79.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.476 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 tt -58.77 -52.69 64.61 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.231 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.1 m -42.15 -57.43 2.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.519 -0.309 . . . . 1.0 110.629 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 121' ' ' GLU . 60.8 mt -55.0 -50.7 68.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.378 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.614 ' SG ' ' CE2' ' A' ' 114' ' ' TRP . 55.9 m -45.87 -33.52 3.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.456 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 65.5 mt -80.13 -50.93 9.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.915 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -70.18 -54.57 12.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.63 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 117' ' ' LEU . 79.9 mt-10 -75.54 7.6 3.55 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.538 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 121' ' ' GLU . 74.4 mtt85 25.09 53.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.54 0.525 . . . . 1.0 111.503 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -159.0 -170.24 2.95 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.306 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.4 tp -108.04 96.85 6.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.422 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.473 ' CG1' ' OE1' ' A' ' 121' ' ' GLU . 2.4 m -78.56 154.44 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.622 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -61.09 119.85 9.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.329 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 129' ' ' GLY . 5.3 m -62.45 -42.05 94.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.719 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.453 ' N ' ' CG2' ' A' ' 127' ' ' VAL . . . -44.44 -19.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.553 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . -70.75 -40.71 64.81 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -135.95 34.65 2.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.682 0.277 . . . . 1.0 110.617 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.7 t -100.49 137.48 38.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.763 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 134' ' ' ILE . 39.6 mt -72.65 -71.85 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.373 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.568 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 20.6 t80 65.74 -36.55 0.23 Allowed 'General case' 0 C--O 1.208 -1.101 0 CA-C-O 118.306 -0.854 . . . . 1.0 110.804 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.596 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 156.3 -55.51 0.0 OUTLIER Pre-proline 0 N--CA 1.449 -0.506 0 O-C-N 124.736 1.272 . . . . 1.0 110.667 -178.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 29.8 Cg_endo . . . . . 0 C--N 1.304 -1.771 0 C-N-CA 122.617 2.212 . . . . 1.0 111.695 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.502 -1.439 . . . . 1.0 109.502 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 99.3 p -78.5 -7.26 57.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.723 0.297 . . . . 1.0 110.594 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -92.63 7.96 41.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.445 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.4 t -152.95 152.5 31.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.611 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.69 -44.55 97.34 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -171.47 80.63 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.37 . . . . 1.0 110.655 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 38' ' ' GLU . 20.7 pt-20 -65.97 -42.39 89.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.596 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 61.28 2.52 0.63 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.525 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.486 ' H ' ' C ' ' A' ' 36' ' ' GLU . 96.8 mt-10 -76.8 -120.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.605 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 48.12 63.4 2.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.417 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 1.9 p-90 -107.32 -32.54 7.72 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.528 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.436 ' CD1' ' CZ3' ' A' ' 40' ' ' TRP . 1.6 mt -79.32 -9.53 59.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.035 0.445 . . . . 1.0 110.633 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.7 t -67.04 -21.75 65.9 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.81 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.6 t -63.64 -15.71 59.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.846 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.15 169.52 17.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.392 -179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -118.86 107.33 13.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.415 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.46 151.18 20.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.26 -0.427 . . . . 1.0 109.927 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -136.71 120.76 17.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.583 . . . . 1.0 110.556 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.3 t -96.48 135.9 29.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.861 -0.609 . . . . 1.0 109.969 179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.5 m -85.92 126.93 40.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.923 -0.581 . . . . 1.0 111.123 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -71.4 -37.2 71.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.988 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 99.1 m -57.0 -48.79 77.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.615 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . -90.5 -83.61 1.39 Allowed Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.458 -1.057 . . . . 1.0 110.458 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.3 mm -53.23 78.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.71 0.766 . . . . 1.0 110.266 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 52' ' ' GLY . . . -166.7 25.78 0.15 Allowed Glycine 0 C--N 1.313 -0.75 0 CA-C-N 114.884 -1.053 . . . . 1.0 111.462 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.452 ' NH2' ' OD2' ' A' ' 86' ' ' ASP . 11.9 ptp180 -72.62 -37.33 68.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.844 0.354 . . . . 1.0 110.77 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -179.32 -81.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.609 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -90.7 -20.27 22.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.53 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.48 -27.25 9.95 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 120.967 0.413 . . . . 1.0 110.399 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.437 ' C ' ' N ' ' A' ' 61' ' ' PHE . 2.1 pt-20 -70.58 -35.66 73.17 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.717 0.294 . . . . 1.0 110.57 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.3 tp -46.2 -19.35 0.07 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.967 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.437 ' N ' ' C ' ' A' ' 59' ' ' GLU . 5.1 m-85 -61.23 -44.6 97.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.956 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.445 ' CG ' ' N ' ' A' ' 63' ' ' LYS . 8.9 pt-20 -62.47 -40.42 96.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.975 0.417 . . . . 1.0 110.672 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.445 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 39.0 mttp -65.71 -41.9 91.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.665 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.543 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 25.5 mt-30 -63.14 -19.03 64.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.618 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 70.6 mt -83.38 -57.42 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.83 0.348 . . . . 1.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.5 m -64.58 -32.78 59.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.052 0.454 . . . . 1.0 110.604 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -70.56 -21.44 62.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.508 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 64' ' ' GLN . 60.1 m170 -96.26 14.71 23.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.978 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.22 2.3 57.99 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.984 -0.847 . . . . 1.0 110.984 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.59 -146.0 2.47 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.096 -1.202 . . . . 1.0 110.096 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 171.98 149.05 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.14 -0.318 . . . . 1.0 110.14 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.6 mt -107.9 113.67 27.04 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.444 ' O ' ' O ' ' A' ' 74' ' ' PRO . 2.5 m -135.36 91.07 19.29 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.205 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 73' ' ' CYS . 52.5 Cg_exo -52.37 -162.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.599 2.199 . . . . 1.0 112.003 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -61.23 -33.62 73.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.565 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.09 -19.54 65.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.485 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.24 -161.51 14.04 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.056 -0.818 . . . . 1.0 111.056 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.95 -37.48 78.2 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.805 2.337 . . . . 1.0 111.924 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.417 ' O ' HG11 ' A' ' 80' ' ' VAL . . . 160.15 -40.75 0.45 Allowed Glycine 0 C--O 1.223 -0.59 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.417 HG11 ' O ' ' A' ' 79' ' ' GLY . 0.4 OUTLIER 80.41 162.29 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 N-CA-C 110.106 -0.331 . . . . 1.0 110.106 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.69 -41.93 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.936 0.398 . . . . 1.0 110.74 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -110.29 137.12 48.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.974 0.416 . . . . 1.0 110.993 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.417 HG22 HD11 ' A' ' 83' ' ' ILE . 77.3 mt -133.02 109.38 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.955 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.1 t -88.08 138.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.249 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.469 ' C ' ' H ' ' A' ' 87' ' ' GLU . 35.3 m -134.64 152.57 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.378 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' GLY . 66.4 t0 -74.45 43.41 0.18 Allowed 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.655 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.494 ' CD ' ' NZ ' ' A' ' 111' ' ' LYS . 2.8 mt-10 40.66 22.19 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.633 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . -100.06 -64.58 0.81 Allowed Glycine 0 N--CA 1.463 0.457 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.2 ptp -77.73 156.19 30.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.857 0.36 . . . . 1.0 110.548 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -93.07 173.95 7.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.498 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.651 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.69 -50.4 73.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.164 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.651 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 15.4 pt-20 -51.67 -38.31 54.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.055 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.487 HH21 HH21 ' A' ' 96' ' ' ARG . 69.7 ttt180 -83.15 -21.84 33.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.604 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.404 ' O ' ' CD2' ' A' ' 98' ' ' LEU . . . -62.04 -35.41 78.52 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.389 -0.524 . . . . 1.0 111.912 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.432 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 7.6 mp -60.83 -41.84 96.56 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.853 0.359 . . . . 1.0 110.649 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.487 HH21 HH21 ' A' ' 93' ' ' ARG . 13.7 ptt85 -69.47 -23.69 63.69 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.252 -0.579 . . . . 1.0 109.798 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.9 -41.29 91.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.37 0.605 . . . . 1.0 111.19 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.433 HD21 ' H ' ' A' ' 98' ' ' LEU . 2.4 pt? -114.9 5.98 15.27 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.877 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.467 ' CD ' ' N ' ' A' ' 99' ' ' ARG . 1.2 mpt_? 58.05 57.35 4.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.609 -0.269 . . . . 1.0 110.441 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.2 tp -104.89 110.3 64.28 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 120.597 -0.441 . . . . 1.0 110.354 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.08 -40.94 58.98 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.151 1.901 . . . . 1.0 112.268 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -173.69 135.64 0.53 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.708 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.9 mp -53.28 111.69 2.94 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.187 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.453 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 46.9 Cg_exo -50.49 -174.49 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 122.097 1.865 . . . . 1.0 112.235 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 31.3 Cg_exo -58.57 113.58 1.62 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.836 2.357 . . . . 1.0 112.058 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 91.79 -66.53 2.23 Favored Glycine 0 C--O 1.221 -0.714 0 N-CA-C 110.413 -1.075 . . . . 1.0 110.413 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.52 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -13.42 125.68 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.109 0.535 . . . . 1.0 111.487 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -133.6 156.34 48.02 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.967 0.413 . . . . 1.0 110.35 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.85 112.89 24.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.917 -0.583 . . . . 1.0 109.614 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 m -107.27 168.74 3.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 123.705 0.628 . . . . 1.0 109.843 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.494 ' NZ ' ' CD ' ' A' ' 87' ' ' GLU . 3.6 mtpp -102.64 -177.67 3.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.746 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.9 m -60.48 -39.87 89.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.459 -0.791 . . . . 1.0 110.767 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.24 -39.32 66.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.687 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.421 ' CZ2' ' SG ' ' A' ' 118' ' ' CYS . 76.1 t90 -60.76 -47.05 88.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.848 0.356 . . . . 1.0 110.714 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -52.28 66.02 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.219 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.2 p -51.06 -42.27 60.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.154 -0.475 . . . . 1.0 109.973 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 mt -61.32 -52.71 63.54 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.405 -0.518 . . . . 1.0 109.651 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.549 ' O ' ' N ' ' A' ' 122' ' ' ARG . 2.2 m -50.48 -36.37 33.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.702 -0.481 . . . . 1.0 109.702 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.6 mt -69.15 -52.92 23.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.148 0.499 . . . . 1.0 110.575 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -60.66 -27.42 67.81 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.096 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -103.32 -4.31 24.4 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.325 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.549 ' N ' ' O ' ' A' ' 118' ' ' CYS . 37.8 mmt180 44.23 47.95 7.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.717 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.49 ' O ' ' SG ' ' A' ' 118' ' ' CYS . 0.2 OUTLIER -172.36 -175.5 1.4 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.51 -179.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -86.37 126.73 34.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.973 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.4 m -114.15 155.4 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.572 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -60.94 159.21 11.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.052 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 129' ' ' GLY . 3.6 m -114.67 3.23 7.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.493 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.35 67.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.006 0.431 . . . . 1.0 110.582 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 159.27 -34.3 0.47 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.186 -0.765 . . . . 1.0 111.186 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -103.77 1.24 31.43 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.063 0.459 . . . . 1.0 110.428 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 t -90.13 140.99 29.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.906 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.591 ' C ' ' H ' ' A' ' 134' ' ' ILE . 60.7 mt -92.27 -72.46 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 116.266 -0.424 . . . . 1.0 109.883 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.528 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 19.1 t80 64.77 -36.13 0.19 Allowed 'General case' 0 C--O 1.222 -0.345 0 O-C-N 123.945 0.778 . . . . 1.0 111.303 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.591 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 155.17 -55.43 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.414 0 O-C-N 124.581 1.175 . . . . 1.0 110.14 -178.438 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.6 Cg_endo . . . . . 0 N--CA 1.492 1.411 0 C-N-CA 122.216 1.944 . . . . 1.0 111.974 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.599 -1.4 . . . . 1.0 109.599 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.2 t -68.54 131.11 44.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.753 0.311 . . . . 1.0 110.53 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -64.72 -41.82 95.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.929 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 m 38.54 67.82 0.38 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.192 -0.458 . . . . 1.0 111.041 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -114.59 6.98 22.49 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 56.3 mp0 -86.6 114.96 23.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.748 0.308 . . . . 1.0 110.474 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 38' ' ' GLU . 79.9 tt0 -67.26 -51.37 53.9 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.746 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 39' ' ' GLU . . . 40.51 28.42 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.827 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 36' ' ' GLU . 98.7 mt-10 57.09 4.5 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.778 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 37' ' ' ALA . 95.4 mt-10 -104.77 75.17 1.18 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.478 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.479 ' NE1' ' NH2' ' A' ' 122' ' ' ARG . 8.5 p-90 -100.08 -59.05 1.78 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.015 0.436 . . . . 1.0 110.276 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 43' ' ' SER . 5.6 tp -62.7 -30.39 71.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.671 -0.695 . . . . 1.0 110.267 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.2 t -48.13 -14.17 0.05 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.676 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 41' ' ' LEU . 42.1 p -68.3 -13.48 62.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.8 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.93 169.08 18.37 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.8 0.333 . . . . 1.0 110.547 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -122.08 137.92 54.64 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.154 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.13 166.17 16.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.467 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -153.76 129.19 9.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.713 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.3 m -100.8 137.42 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.373 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.539 ' O ' ' O ' ' A' ' 52' ' ' GLY . 13.5 t -98.35 135.25 33.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.857 -0.611 . . . . 1.0 109.996 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.482 ' CD ' ' H ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -62.05 -43.52 98.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.739 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.486 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 13.1 m -51.7 -21.35 2.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.384 0.612 . . . . 1.0 110.548 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 49' ' ' VAL . . . -156.99 120.17 0.96 Allowed Glycine 0 C--O 1.219 -0.782 0 N-CA-C 109.383 -1.487 . . . . 1.0 109.383 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.515 ' CB ' ' O ' ' A' ' 52' ' ' GLY . 4.7 mm 115.28 -6.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.047 1.339 . . . . 1.0 109.52 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.01 22.74 30.08 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.754 -0.939 . . . . 1.0 110.754 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -60.97 -57.1 14.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.638 0.256 . . . . 1.0 110.588 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.466 ' O ' ' CG ' ' A' ' 59' ' ' GLU . . . 179.74 -67.44 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.386 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -91.06 -27.5 18.56 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.581 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.406 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -57.36 -32.63 66.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.319 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 61' ' ' PHE . 3.3 pt-20 -66.48 -39.5 88.79 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 116.159 -0.473 . . . . 1.0 109.775 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 tp -41.67 -17.51 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.183 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.579 ' N ' ' O ' ' A' ' 59' ' ' GLU . 6.1 m-85 -60.49 -42.89 97.24 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.22 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 1.3 pt-20 -67.74 -32.12 72.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.664 0.268 . . . . 1.0 111.159 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -70.67 -56.77 5.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.877 0.37 . . . . 1.0 111.013 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.522 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -51.96 -31.23 28.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.76 -0.655 . . . . 1.0 109.527 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 31.0 mt -65.74 -46.99 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.67 178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.81 -43.72 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.439 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -58.7 -26.93 64.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.179 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.515 ' CE1' HE21 ' A' ' 64' ' ' GLN . 43.0 m170 -79.27 -2.11 39.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.549 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.44 -1.35 58.64 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.928 -0.869 . . . . 1.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.75 88.6 1.54 Allowed Glycine 0 N--CA 1.461 0.363 0 N-CA-C 110.689 -0.965 . . . . 1.0 110.689 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.518 ' N ' ' CD ' ' A' ' 71' ' ' GLN . 2.6 pm0 -59.82 146.34 42.19 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.7 mt -92.29 110.82 22.22 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 91.1 m -119.97 86.88 37.56 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.628 ' C ' ' H ' ' A' ' 76' ' ' GLN . 14.3 Cg_endo -55.21 -159.71 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 122.004 1.803 . . . . 1.0 112.64 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -54.61 -0.6 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.035 -0.529 . . . . 1.0 110.588 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.628 ' H ' ' C ' ' A' ' 74' ' ' PRO . 4.5 pt20 -62.78 -19.67 64.24 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.109 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 79' ' ' GLY . . . -156.12 160.32 30.01 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 120.755 -0.736 . . . . 1.0 111.599 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.535 ' O ' ' O ' ' A' ' 79' ' ' GLY . 49.5 Cg_exo -52.17 -10.97 0.86 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.231 1.954 . . . . 1.0 112.09 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.548 ' O ' ' C ' ' A' ' 80' ' ' VAL . . . -53.0 -118.31 0.01 OUTLIER Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.712 -0.955 . . . . 1.0 110.712 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.548 ' C ' ' O ' ' A' ' 79' ' ' GLY . 2.3 p 10.6 74.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.592 0.71 . . . . 1.0 111.889 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.19 -24.23 27.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.352 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.63 ' CD2' ' CZ2' ' A' ' 114' ' ' TRP . 79.2 m80 -116.67 140.22 49.65 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.808 0.337 . . . . 1.0 110.262 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.444 ' O ' ' O ' ' A' ' 110' ' ' VAL . 2.9 mm -128.68 111.3 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.427 -0.583 . . . . 1.0 109.427 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -96.14 133.68 36.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.204 0.526 . . . . 1.0 110.379 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.438 ' C ' ' H ' ' A' ' 87' ' ' GLU . 17.8 m -127.82 165.61 26.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.562 -0.744 . . . . 1.0 110.536 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 88' ' ' GLY . 26.2 p-10 -77.06 14.26 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.636 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.438 ' H ' ' C ' ' A' ' 85' ' ' VAL . 35.8 mt-10 64.81 -2.91 0.62 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.343 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.499 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -75.27 -49.87 8.98 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.305 -0.718 . . . . 1.0 111.305 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.0 ptp -88.87 156.38 18.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.82 0.343 . . . . 1.0 110.709 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -83.55 166.27 18.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.283 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.698 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -58.8 -47.58 84.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.993 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.698 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 17.5 pt-20 -53.69 -38.23 64.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.888 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -70.23 -47.04 63.16 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.197 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.07 -31.07 17.64 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.99 -0.684 . . . . 1.0 111.349 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.03 -47.58 85.28 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.346 -0.541 . . . . 1.0 111.267 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -70.91 -42.54 69.79 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.582 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.486 ' CD1' ' OG1' ' A' ' 51' ' ' THR . 3.8 mm? -64.36 -43.64 93.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.826 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.49 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -84.67 -4.27 58.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.545 -179.189 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.405 ' O ' ' CB ' ' A' ' 75' ' ' ALA . 75.1 mmt-85 68.57 60.94 0.37 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.038 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.7 tp -129.58 111.45 17.68 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.764 -0.198 . . . . 1.0 110.799 178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.66 -42.64 61.13 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.916 1.744 . . . . 1.0 111.947 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -174.34 130.31 0.36 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.567 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 104' ' ' PRO . 69.5 mt -37.37 100.48 0.2 Allowed Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.094 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' LEU . 54.8 Cg_exo -46.01 -178.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.276 1.984 . . . . 1.0 112.407 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.14 -43.42 59.28 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.634 2.222 . . . . 1.0 112.65 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.39 68.98 0.25 Allowed Glycine 0 N--CA 1.468 0.775 0 N-CA-C 110.97 -0.852 . . . . 1.0 110.97 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.64 138.6 7.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.82 0.343 . . . . 1.0 110.587 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -146.02 151.93 38.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.256 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.88 113.26 25.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.962 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 83' ' ' ILE . 12.0 m -110.63 166.33 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.501 -0.772 . . . . 1.0 109.885 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' A' ' 130' ' ' PHE . 28.8 mtmm -98.4 -176.99 3.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.731 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.3 t -62.94 -39.55 94.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.569 -0.742 . . . . 1.0 110.527 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.42 -41.86 66.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.227 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.63 ' CZ2' ' CD2' ' A' ' 82' ' ' HIS . 75.1 t90 -61.6 -53.64 53.58 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.613 -0.435 . . . . 1.0 110.592 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.443 ' O ' ' SG ' ' A' ' 118' ' ' CYS . 3.3 tt -61.94 -53.12 60.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.472 -0.491 . . . . 1.0 109.817 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 80.9 p -51.59 -46.71 63.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.492 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.4 mt -64.91 -54.99 21.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.355 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 115' ' ' LEU . 1.4 p -50.17 -30.91 12.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.386 0.612 . . . . 1.0 110.284 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.402 HD11 HE22 ' A' ' 64' ' ' GLN . 2.3 tp -70.01 -52.8 21.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.265 -0.88 . . . . 1.0 110.614 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -66.95 -37.87 85.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.564 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' A' ' 123' ' ' ARG . 78.3 mm-40 -78.98 9.03 4.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.181 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.479 ' NH2' ' NE1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER 36.06 32.68 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.788 -0.642 . . . . 1.0 111.092 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.438 ' CG ' ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -158.09 177.24 11.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.076 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.402 ' O ' ' NH1' ' A' ' 123' ' ' ARG . 5.6 tt -92.65 122.11 34.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.033 0.444 . . . . 1.0 110.766 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 3.2 m -100.0 152.23 4.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.347 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -62.18 150.21 39.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.286 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 129' ' ' GLY . 2.3 m -102.46 6.31 10.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.468 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.6 56.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.78 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 168.34 -37.75 0.21 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.527 ' O ' ' NZ ' ' A' ' 111' ' ' LYS . 50.4 m-85 -89.47 -18.24 27.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.728 0.299 . . . . 1.0 110.517 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.8 t -72.15 137.58 47.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.1 0.476 . . . . 1.0 110.78 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 134' ' ' ILE . 59.1 mt -83.62 -69.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.333 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.486 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 16.7 t80 62.34 -31.47 0.09 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.368 -0.833 . . . . 1.0 112.133 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.604 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 151.7 -55.12 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 124.6 1.16 . . . . 1.0 109.854 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.5 Cg_endo . . . . . 0 N--CA 1.497 1.688 0 C-N-CA 121.824 1.682 . . . . 1.0 112.137 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.505 -1.438 . . . . 1.0 109.505 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.7 m -152.83 101.76 2.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.851 0.358 . . . . 1.0 110.488 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -63.19 -41.24 99.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.528 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.6 m -100.24 134.96 42.41 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.583 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.3 -40.4 97.86 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -109.03 136.14 49.04 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.97 0.414 . . . . 1.0 110.381 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.554 ' CD ' ' H ' ' A' ' 36' ' ' GLU . 1.4 pm0 -66.97 -50.06 63.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.357 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 53.45 34.8 19.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.512 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -165.56 -38.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.663 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -138.95 92.21 2.58 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.566 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.633 ' N ' ' CD1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -109.99 -40.16 4.83 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.182 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.462 ' CD1' ' CZ3' ' A' ' 40' ' ' TRP . 8.7 mt -79.61 1.86 24.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.42 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.2 t -54.99 -48.6 73.1 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.309 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.6 p -72.11 -37.28 69.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.929 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.2 mt -73.9 140.78 45.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.982 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.425 ' HB2' ' H ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -124.94 102.81 7.71 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.979 178.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.2 169.05 10.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.21 0.529 . . . . 1.0 110.845 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -156.33 124.14 5.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.672 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.4 m -103.04 143.72 14.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.047 0.451 . . . . 1.0 110.221 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.476 ' O ' ' O ' ' A' ' 52' ' ' GLY . 18.9 m -97.07 161.21 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.449 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.553 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -81.25 -60.79 2.15 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.42 -0.354 . . . . 1.0 110.708 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.9 p -46.88 -12.08 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.983 0.42 . . . . 1.0 110.261 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.611 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -151.43 118.71 0.93 Allowed Glycine 0 C--O 1.205 -1.703 0 N-CA-C 109.46 -1.456 . . . . 1.0 109.46 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.611 ' HB ' ' O ' ' A' ' 52' ' ' GLY . 4.6 mm 102.22 -16.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.816 0.846 . . . . 1.0 110.452 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.5 29.13 1.23 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.661 -0.976 . . . . 1.0 110.661 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' A' ' 53' ' ' ILE . 32.6 mtt180 -66.66 -60.92 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.764 0.316 . . . . 1.0 110.56 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 172.47 -61.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.249 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -87.7 -32.47 19.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.311 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.12 83.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.363 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.541 ' C ' ' H ' ' A' ' 61' ' ' PHE . 9.3 pt-20 -66.42 -42.26 88.04 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.382 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.3 tp -45.84 -13.54 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.111 0.481 . . . . 1.0 110.833 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.541 ' H ' ' C ' ' A' ' 59' ' ' GLU . 3.8 m-30 -56.72 -47.64 79.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.884 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.09 -40.09 94.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.437 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -55.95 -46.41 78.56 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.632 -0.427 . . . . 1.0 110.222 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.485 ' O ' ' CD2' ' A' ' 68' ' ' HIS . 77.9 mt-30 -65.02 -38.85 92.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.147 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 77.5 mt -64.05 -43.69 97.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.48 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.16 -45.03 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.252 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -60.18 -26.01 66.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.318 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 64' ' ' GLN . 42.9 m170 -79.9 0.45 31.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.387 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.31 -19.31 54.42 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.871 -0.892 . . . . 1.0 110.871 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.34 94.04 0.63 Allowed Glycine 0 C--O 1.224 -0.478 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -77.13 145.23 37.9 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.975 -0.29 . . . . 1.0 110.439 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.495 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 4.6 mt -107.18 145.58 32.41 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.938 0.399 . . . . 1.0 110.302 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.495 ' SG ' ' O ' ' A' ' 72' ' ' LEU . 3.8 m -163.44 91.21 1.16 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.381 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 77' ' ' GLY . 43.7 Cg_endo -70.02 -167.09 0.22 Allowed 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.599 2.199 . . . . 1.0 111.989 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 77' ' ' GLY . . . -38.63 -27.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.837 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 74' ' ' PRO . 1.7 pt20 -64.03 1.58 0.67 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.399 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 75' ' ' ALA . . . 162.78 161.78 12.76 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.063 -0.815 . . . . 1.0 111.063 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.03 143.72 73.28 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.63 2.22 . . . . 1.0 111.817 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.42 66.01 0.38 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.224 -0.751 . . . . 1.0 111.224 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.421 ' O ' ' CG2' ' A' ' 80' ' ' VAL . 2.7 p -160.79 67.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.423 0.63 . . . . 1.0 110.475 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.425 ' H ' ' HB2' ' A' ' 45' ' ' ARG . 15.3 t -74.26 -33.29 63.24 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.003 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -117.37 146.0 43.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.938 0.399 . . . . 1.0 110.848 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.5 mt -137.51 111.43 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.839 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -95.15 140.59 16.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.121 0.486 . . . . 1.0 110.633 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.502 ' C ' ' H ' ' A' ' 87' ' ' GLU . 28.2 m -131.16 166.64 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.83 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.612 ' C ' ' H ' ' A' ' 88' ' ' GLY . 49.4 p-10 -73.07 14.16 0.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.665 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.502 ' H ' ' C ' ' A' ' 85' ' ' VAL . 18.6 mt-10 65.82 -15.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.776 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.612 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -64.13 -49.47 66.51 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.917 -0.873 . . . . 1.0 110.917 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.5 ptp -90.03 158.13 17.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.862 0.363 . . . . 1.0 110.471 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -89.1 -179.64 5.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.667 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -67.67 -37.59 82.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.37 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.538 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 15.2 pt-20 -58.91 -46.05 88.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.979 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.482 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 1.9 tmm_? -79.36 -24.34 42.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.022 -0.536 . . . . 1.0 111.231 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.55 -37.47 70.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.569 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 7.4 mp -60.96 -36.27 78.96 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.11 -0.236 . . . . 1.0 110.674 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.536 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 6.6 mmp_? -62.65 -36.86 84.22 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.247 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -62.61 -42.21 99.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.054 0.454 . . . . 1.0 111.266 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.44 ' N ' HD21 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -97.32 5.31 50.12 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.668 -0.696 . . . . 1.0 109.663 -178.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.536 ' NH1' ' O ' ' A' ' 96' ' ' ARG . 51.2 mmt-85 51.01 24.32 1.81 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.267 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.7 tp -86.53 121.37 72.23 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.776 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.07 -17.17 36.34 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.465 2.11 . . . . 1.0 112.399 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 176.78 152.8 0.2 Allowed 'General case' 0 C--O 1.235 0.297 0 O-C-N 123.323 0.389 . . . . 1.0 110.453 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.528 ' N ' ' CD1' ' A' ' 103' ' ' LEU . 3.8 mp -86.47 140.6 33.98 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.949 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.02 164.41 35.75 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.416 2.077 . . . . 1.0 111.952 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -40.69 135.19 2.16 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.6 2.2 . . . . 1.0 112.191 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 107' ' ' ALA . . . 80.74 -69.56 3.19 Favored Glycine 0 C--O 1.228 -0.226 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 106' ' ' GLY . . . -29.02 150.6 0.0 OUTLIER 'General case' 0 C--N 1.345 0.379 0 O-C-N 123.924 0.426 . . . . 1.0 110.964 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -162.88 153.59 16.8 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.48 -0.488 . . . . 1.0 110.372 -178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.52 ' O ' ' OG ' ' A' ' 131' ' ' SER . 0.4 OUTLIER -85.37 112.56 20.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.915 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.2 m -104.68 172.58 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 123.475 0.484 . . . . 1.0 109.743 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -102.21 -173.73 2.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.661 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.1 m -63.57 -36.92 85.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.714 -0.675 . . . . 1.0 110.834 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.93 -36.23 65.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.502 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 89.3 t90 -68.67 -44.71 73.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.906 0.384 . . . . 1.0 110.542 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.97 -59.28 3.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.111 0.481 . . . . 1.0 111.037 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.7 m -45.17 -58.24 3.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.614 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.8 mp -60.01 -52.99 63.04 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 120.629 -0.429 . . . . 1.0 110.645 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 46.5 t -55.39 -31.21 61.63 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.696 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.23 -55.25 12.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.029 0.442 . . . . 1.0 111.872 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -77.06 -38.94 51.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.993 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 62.7 mm-40 -53.17 -48.3 68.1 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.432 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 121' ' ' GLU . 7.0 tpt180 86.61 27.35 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.733 0.645 . . . . 1.0 111.168 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.42 ' C ' ' CD ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -159.49 -171.45 3.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.445 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.1 tp -91.7 135.65 33.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.439 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 m -120.42 154.44 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.331 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 126' ' ' ASP . 54.6 p-10 -61.73 146.14 50.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.343 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 129' ' ' GLY . 9.0 t -104.64 -23.48 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 110.218 -0.29 . . . . 1.0 110.218 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.16 68.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.978 0.418 . . . . 1.0 110.499 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 165.81 -27.17 0.18 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.141 -0.783 . . . . 1.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -106.7 -3.01 21.02 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.667 0.27 . . . . 1.0 110.583 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.52 ' OG ' ' O ' ' A' ' 109' ' ' LEU . 3.2 m -104.7 125.61 50.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.976 0.417 . . . . 1.0 110.767 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.572 ' C ' ' H ' ' A' ' 134' ' ' ILE . 3.2 mp -64.63 -50.09 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.331 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.526 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 17.0 t80 65.67 -36.7 0.23 Allowed 'General case' 0 C--O 1.217 -0.615 0 O-C-N 124.278 0.986 . . . . 1.0 111.212 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 156.67 -54.65 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.311 0 O-C-N 124.663 1.227 . . . . 1.0 110.452 -178.658 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 27.5 Cg_endo . . . . . 0 C--N 1.309 -1.54 0 C-N-CA 122.331 2.021 . . . . 1.0 111.682 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.458 -1.457 . . . . 1.0 109.458 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 83.0 p -72.0 146.29 47.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 1.0 110.491 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 34' ' ' GLY . 37.2 t30 -63.67 -40.28 96.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.592 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 t 65.89 -67.39 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.811 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 77.55 -6.02 48.21 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.789 -0.924 . . . . 1.0 110.789 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -156.8 73.31 0.76 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.728 0.299 . . . . 1.0 110.244 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.454 ' CG ' ' N ' ' A' ' 37' ' ' ALA . 14.6 pt-20 -65.46 -44.56 86.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.58 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.454 ' N ' ' CG ' ' A' ' 36' ' ' GLU . . . 38.67 50.34 1.6 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.114 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -66.26 -39.03 89.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.694 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 46.36 84.96 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.568 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.579 ' N ' ' CD1' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -102.17 -50.89 3.51 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.832 0.349 . . . . 1.0 110.462 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.435 ' H ' ' CE1' ' A' ' 68' ' ' HIS . 2.2 tp -80.87 -0.65 39.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.733 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.6 p -66.95 -15.59 63.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.424 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.3 p -67.19 -15.56 63.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.517 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.441 ' C ' ' CD1' ' A' ' 44' ' ' LEU . 4.2 pp -136.21 168.84 18.64 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.387 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -116.65 118.09 31.63 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.009 0.433 . . . . 1.0 110.334 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.6 161.47 14.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.475 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -153.96 118.09 4.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.375 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 76.1 t -107.32 135.09 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.241 0.543 . . . . 1.0 110.379 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.0 t -73.7 99.1 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.447 -0.797 . . . . 1.0 110.206 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.514 HH21 HH12 ' A' ' 99' ' ' ARG . 84.8 mtm-85 -58.34 -37.8 75.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.42 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.9 p -75.92 -17.26 59.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.539 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.44 -59.5 0.97 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.202 -0.759 . . . . 1.0 111.202 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mt -86.42 71.32 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.161 0.505 . . . . 1.0 110.341 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -117.03 23.38 9.97 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 110.783 -0.927 . . . . 1.0 110.783 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.47 ' O ' ' CB ' ' A' ' 56' ' ' ALA . 4.2 ptm180 -75.03 -63.41 1.27 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.551 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 58' ' ' ALA . . . 159.93 138.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? 68.54 -42.14 0.47 Allowed 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 124.191 0.932 . . . . 1.0 110.327 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' A' ' 56' ' ' ALA . . . -65.37 -28.65 69.43 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.868 -0.605 . . . . 1.0 110.532 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.72 -39.75 80.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.395 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.99 -19.05 0.63 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.182 0.515 . . . . 1.0 110.582 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -44.18 -50.96 8.51 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.732 -0.667 . . . . 1.0 111.036 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.45 -43.98 92.55 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.626 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -62.41 -43.06 99.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.375 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -59.21 -26.13 64.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.272 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 80.8 mt -86.28 -23.32 6.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.366 0.603 . . . . 1.0 110.38 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.4 t -79.06 -37.66 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 O-C-N 122.056 -0.403 . . . . 1.0 110.706 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -68.08 -38.87 82.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.127 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.492 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -68.49 -6.41 24.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.274 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.44 7.11 52.25 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.465 -1.054 . . . . 1.0 110.465 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.7 96.89 2.19 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 110.267 -1.133 . . . . 1.0 110.267 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -68.32 144.13 54.92 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.734 -0.387 . . . . 1.0 110.287 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.0 mt -91.81 135.29 34.03 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.054 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.8 m -104.61 103.62 41.06 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.378 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.527 ' C ' ' H ' ' A' ' 76' ' ' GLN . 56.3 Cg_endo -75.17 168.35 24.9 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.397 2.065 . . . . 1.0 111.955 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.57 -7.39 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.558 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.527 ' H ' ' C ' ' A' ' 74' ' ' PRO . 42.0 mt-30 -76.43 -9.6 58.77 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 110.151 -0.315 . . . . 1.0 110.151 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -145.35 147.87 19.25 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.69 -16.44 33.66 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.698 2.266 . . . . 1.0 111.989 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -42.82 -25.92 0.39 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.437 -0.665 . . . . 1.0 111.437 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.8 p -64.79 138.88 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.965 0.412 . . . . 1.0 110.471 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.99 -34.27 0.23 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.536 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -108.78 125.05 51.52 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.619 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.412 ' O ' ' O ' ' A' ' 110' ' ' VAL . 22.5 mm -118.95 106.92 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.23 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.08 135.29 29.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.339 -0.846 . . . . 1.0 110.088 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.576 ' C ' ' H ' ' A' ' 87' ' ' GLU . 27.7 m -135.41 155.65 37.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.412 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.59 ' C ' ' H ' ' A' ' 88' ' ' GLY . 53.5 p-10 -71.29 22.5 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.581 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.576 ' H ' ' C ' ' A' ' 85' ' ' VAL . 29.9 mt-10 65.96 -13.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 1.0 111.017 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -61.81 -41.76 99.66 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.074 -0.811 . . . . 1.0 111.074 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.6 ptp -103.41 154.32 19.54 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.782 0.325 . . . . 1.0 110.53 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -90.16 172.81 8.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.133 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.594 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -58.53 -54.66 44.57 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.544 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.594 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 1.3 pp20? -52.07 -40.18 60.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.866 -0.606 . . . . 1.0 110.098 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -71.97 -39.13 69.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.832 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.91 -28.65 62.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.936 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.5 mp -61.82 -46.36 89.82 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.023 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.1 mmp_? -70.91 -40.98 71.84 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.38 -0.528 . . . . 1.0 111.345 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.92 -44.93 83.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.168 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.416 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.86 -13.93 59.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.63 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.514 HH12 HH21 ' A' ' 50' ' ' ARG . 2.9 mtp180 77.93 60.91 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 123.977 0.798 . . . . 1.0 111.937 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.3 mt -148.71 114.02 3.73 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 120.12 -0.632 . . . . 1.0 110.116 178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.49 -11.45 24.47 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.128 1.886 . . . . 1.0 112.602 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 179.43 133.8 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.427 0.454 . . . . 1.0 110.207 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.8 mt -88.85 146.66 37.29 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.958 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.65 165.7 26.61 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 122.206 1.937 . . . . 1.0 112.311 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -43.48 140.63 3.99 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.117 1.878 . . . . 1.0 112.282 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.48 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 82.31 -64.46 4.26 Favored Glycine 0 N--CA 1.453 -0.181 0 N-CA-C 110.305 -1.118 . . . . 1.0 110.305 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.48 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -22.33 134.87 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 O-C-N 124.134 0.549 . . . . 1.0 110.868 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.484 ' NE2' ' O ' ' A' ' 108' ' ' GLN . 0.0 OUTLIER -143.69 157.52 44.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.897 0.38 . . . . 1.0 110.145 -177.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.0 mp -108.24 121.8 45.64 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.773 -0.648 . . . . 1.0 110.778 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.412 ' O ' ' O ' ' A' ' 83' ' ' ILE . 3.1 m -108.06 -178.23 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.109 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -109.28 -176.63 3.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.501 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.4 m -60.98 -37.79 83.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.817 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.06 -47.34 78.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.944 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.484 ' O ' ' SG ' ' A' ' 118' ' ' CYS . 72.9 t90 -56.43 -37.9 70.86 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.312 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.56 -61.16 1.94 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.268 -0.573 . . . . 1.0 110.929 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.9 t -49.39 -52.21 30.0 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.388 -0.525 . . . . 1.0 110.47 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.1 mp -48.93 -44.88 40.88 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.068 -0.514 . . . . 1.0 109.937 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 114' ' ' TRP . 74.5 m -60.25 -43.42 96.11 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.362 -0.535 . . . . 1.0 110.832 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 65.9 mt -50.21 -57.9 6.77 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.589 -0.444 . . . . 1.0 111.386 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -73.22 -49.01 30.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.727 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 74.6 mm-40 -54.27 -48.35 71.31 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.472 -0.491 . . . . 1.0 110.362 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 121' ' ' GLU . 8.7 tpp180 79.48 39.59 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.836 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.418 ' C ' ' CD ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -165.48 -173.18 2.69 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.428 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.3 tp -82.52 122.24 27.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.014 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.411 ' CG2' ' SG ' ' A' ' 118' ' ' CYS . 40.2 t -97.19 154.7 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-O 121.274 0.559 . . . . 1.0 110.432 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -69.29 115.38 8.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.394 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.415 ' O ' ' CB ' ' A' ' 131' ' ' SER . 5.0 m -64.16 -39.64 86.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.607 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.41 ' N ' ' CG2' ' A' ' 127' ' ' VAL . . . -53.73 -25.52 19.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.506 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.69 -38.6 93.31 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.243 -0.743 . . . . 1.0 111.243 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.74 43.01 1.98 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.848 0.356 . . . . 1.0 110.883 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 127' ' ' VAL . 8.7 t -107.84 132.9 52.93 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.288 0.566 . . . . 1.0 111.182 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.581 ' C ' ' H ' ' A' ' 134' ' ' ILE . 54.8 mt -75.64 -69.23 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 CA-C-N 115.084 -0.962 . . . . 1.0 109.881 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.493 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 15.8 t80 65.83 -36.58 0.24 Allowed 'General case' 0 C--O 1.223 -0.335 0 O-C-N 124.514 1.134 . . . . 1.0 111.578 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.581 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 156.03 -55.78 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.512 0 O-C-N 125.009 1.443 . . . . 1.0 109.752 -178.279 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 30.0 Cg_endo . . . . . 0 N--CA 1.49 1.298 0 C-N-CA 122.169 1.912 . . . . 1.0 112.01 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.428 -1.469 . . . . 1.0 109.428 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.2 p -61.19 -41.85 97.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.804 0.335 . . . . 1.0 110.546 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -136.17 130.48 33.28 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.584 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 96.6 p -76.81 158.8 30.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.366 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 150.35 -78.97 0.21 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -135.18 126.14 27.65 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.99 0.424 . . . . 1.0 110.341 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.719 ' C ' ' H ' ' A' ' 38' ' ' GLU . 3.6 pm0 -108.03 23.3 14.7 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.767 -0.652 . . . . 1.0 111.062 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.17 26.36 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.415 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.719 ' H ' ' C ' ' A' ' 36' ' ' GLU . 94.6 mt-10 -145.89 29.66 1.09 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.49 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -130.31 70.89 1.44 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.643 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 1.1 p-90 -86.83 -49.81 7.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.094 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.58 -35.11 78.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.73 0.776 . . . . 1.0 110.019 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.66 -33.77 64.38 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.338 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 t -43.54 -25.67 0.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.795 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.83 167.87 18.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.343 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -115.94 112.65 22.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 1.0 110.167 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.36 165.95 12.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.49 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.529 ' CE1' ' O ' ' A' ' 73' ' ' CYS . 49.1 t60 -144.33 122.11 11.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.154 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.469 ' O ' ' NH1' ' A' ' 50' ' ' ARG . 71.5 t -110.95 133.97 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.341 -0.391 . . . . 1.0 110.31 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.2 m -71.94 134.01 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.39 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.486 ' N ' ' CD ' ' A' ' 50' ' ' ARG . 9.6 mpt_? -64.27 -40.75 96.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.546 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.483 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 7.6 p -104.19 138.19 41.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.1 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.26 -16.44 56.9 Favored Glycine 0 C--O 1.226 -0.402 0 N-CA-C 111.012 -0.835 . . . . 1.0 111.012 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.565 ' C ' ' H ' ' A' ' 55' ' ' ARG . 1.5 mm -117.75 -23.23 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.991 0.424 . . . . 1.0 110.248 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.37 35.01 0.44 Allowed Glycine 0 C--N 1.314 -0.678 0 C-N-CA 120.242 -0.98 . . . . 1.0 111.25 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.565 ' H ' ' C ' ' A' ' 53' ' ' ILE . 2.0 ptp180 -76.71 -60.96 2.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.582 0.229 . . . . 1.0 110.602 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.619 ' C ' ' H ' ' A' ' 58' ' ' ALA . . . 171.68 125.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.06 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.7 ttp85 68.74 -32.34 0.22 Allowed 'General case' 0 CA--C 1.518 -0.275 0 O-C-N 123.502 0.501 . . . . 1.0 110.323 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.619 ' H ' ' C ' ' A' ' 56' ' ' ALA . . . -63.55 -36.5 83.99 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.63 0.728 . . . . 1.0 110.09 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 61' ' ' PHE . 12.3 pt-20 -60.36 -39.19 86.3 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.353 -0.539 . . . . 1.0 110.852 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.0 tp -42.29 -17.95 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.313 0.577 . . . . 1.0 110.854 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.559 ' N ' ' O ' ' A' ' 59' ' ' GLU . 2.3 m-85 -51.39 -51.25 56.28 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.988 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.89 -37.38 84.36 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.047 -0.353 . . . . 1.0 110.047 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -62.47 -45.83 91.24 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.095 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -64.83 -18.5 65.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.254 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 69' ' ' GLY . 61.4 mt -85.53 -56.95 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.902 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.2 m -65.32 -40.57 88.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.36 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -53.83 -41.45 67.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.22 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -96.89 10.95 37.58 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.397 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 97.13 139.94 11.0 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.656 -0.977 . . . . 1.0 110.656 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.84 61.11 0.13 Allowed Glycine 0 N--CA 1.466 0.664 0 N-CA-C 110.475 -1.05 . . . . 1.0 110.475 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -51.68 145.51 9.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.991 0.424 . . . . 1.0 110.405 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.3 mt -81.6 155.61 25.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.788 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.529 ' O ' ' CE1' ' A' ' 47' ' ' HIS . 1.3 m -158.56 156.39 27.15 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.409 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -59.98 125.87 18.81 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.546 2.164 . . . . 1.0 111.853 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.525 ' C ' ' H ' ' A' ' 77' ' ' GLY . . . -77.55 -0.27 25.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.989 -0.551 . . . . 1.0 110.623 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -61.52 0.73 0.28 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.865 0.364 . . . . 1.0 110.623 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 75' ' ' ALA . . . -166.25 -172.44 33.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -53.5 -4.28 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.912 2.408 . . . . 1.0 111.97 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 77' ' ' GLY . . . -38.75 -61.29 1.35 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 m -106.41 -168.09 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.994 0.426 . . . . 1.0 110.202 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 t -140.41 -30.06 0.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.864 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -121.08 150.9 40.5 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.618 0.247 . . . . 1.0 110.788 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.3 mt -134.21 111.0 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.3 t -93.93 144.02 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.951 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 87' ' ' GLU . 32.2 m -134.3 154.7 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.569 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.549 ' C ' ' H ' ' A' ' 88' ' ' GLY . 31.3 t70 -71.82 19.83 0.06 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.747 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.546 ' H ' ' C ' ' A' ' 85' ' ' VAL . 0.8 OUTLIER 69.0 -39.16 0.42 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.363 -0.38 . . . . 1.0 111.048 179.037 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -38.99 -57.15 2.08 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.515 ' SD ' ' N ' ' A' ' 89' ' ' MET . 0.0 OUTLIER -87.1 160.17 18.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.81 0.338 . . . . 1.0 110.534 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -97.15 -177.05 3.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.056 0.455 . . . . 1.0 110.362 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -62.5 -47.04 85.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.846 -0.615 . . . . 1.0 110.576 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.627 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 10.6 pt-20 -53.36 -50.89 64.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.921 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.451 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 29.5 ttp180 -71.25 -42.8 68.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.118 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -43.84 -35.16 1.82 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.943 -0.572 . . . . 1.0 110.783 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.9 mp -59.93 -61.15 2.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.049 0.452 . . . . 1.0 110.884 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.537 HH21 ' C ' ' A' ' 100' ' ' LEU . 5.9 mmp_? -68.31 -22.2 64.73 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.236 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.483 ' CD1' ' OG1' ' A' ' 51' ' ' THR . 0.2 OUTLIER -63.82 -36.96 85.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.994 -178.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.9 13.99 22.13 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.784 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 63.06 59.65 1.3 Allowed 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 120.547 -0.461 . . . . 1.0 110.991 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.537 ' C ' HH21 ' A' ' 96' ' ' ARG . 13.8 tp -124.56 127.83 25.11 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.848 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.18 -44.88 11.06 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.037 1.825 . . . . 1.0 112.058 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.536 ' NE2' ' OH ' ' A' ' 91' ' ' TYR . 1.5 mm-40 176.6 136.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.228 0.537 . . . . 1.0 110.578 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.7 mt -41.91 116.21 1.63 Allowed Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 115.423 -0.808 . . . . 1.0 111.45 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -71.46 141.72 39.13 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.703 1.602 . . . . 1.0 111.922 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -40.77 93.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.451 2.101 . . . . 1.0 112.63 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.61 -56.55 0.59 Allowed Glycine 0 N--CA 1.465 0.585 0 N-CA-C 111.156 -0.778 . . . . 1.0 111.156 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.73 160.28 32.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.857 0.361 . . . . 1.0 110.947 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -149.16 156.6 42.42 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.44 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 131' ' ' SER . 1.3 mt -92.88 111.63 23.31 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.953 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.1 m -103.83 170.3 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -101.84 171.04 7.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.129 0.49 . . . . 1.0 111.607 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.2 m -56.05 -35.11 66.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.38 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.6 -38.18 86.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.729 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 74.8 t90 -60.47 -49.89 75.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.369 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 34.9 tp -63.05 -53.77 48.52 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.194 -0.603 . . . . 1.0 110.561 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.9 t -50.81 -46.67 59.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.3 mt -51.31 -48.77 62.25 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.356 -0.538 . . . . 1.0 109.813 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 122' ' ' ARG . 55.9 m -51.75 -34.89 41.32 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 38.9 mt -70.31 -54.53 12.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.002 0.43 . . . . 1.0 110.519 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -65.62 -38.35 89.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.231 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 80.7 mm-40 -79.79 -42.81 23.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.15 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 118' ' ' CYS . 5.2 tpp85 82.16 40.07 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.856 -0.611 . . . . 1.0 111.114 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -169.61 -173.44 1.65 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.342 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.6 tt -92.2 121.56 33.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.607 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.7 m -103.69 151.77 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.244 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 126' ' ' ASP . 48.4 p30 -66.78 147.71 52.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.24 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.3 m -101.29 -136.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.383 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 74.59 -60.69 0.51 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.326 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.05 -53.55 33.01 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -69.98 -42.52 73.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.934 0.397 . . . . 1.0 110.502 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 109' ' ' LEU . 15.1 p -58.56 153.53 16.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.628 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.605 ' C ' ' H ' ' A' ' 134' ' ' ILE . 2.9 mp -90.08 -57.46 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.238 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.516 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 17.6 t80 65.12 -35.63 0.19 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.263 0.977 . . . . 1.0 111.433 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.605 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 155.26 -56.06 0.0 OUTLIER Pre-proline 0 C--N 1.346 0.441 0 O-C-N 124.84 1.338 . . . . 1.0 109.862 -178.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.3 Cg_endo . . . . . 0 N--CA 1.49 1.301 0 C-N-CA 122.212 1.941 . . . . 1.0 112.012 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.588 -1.405 . . . . 1.0 109.588 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.3 t -63.33 -24.79 68.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 1.0 110.57 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.413 ' O ' ' O ' ' A' ' 33' ' ' SER . 23.8 t-20 -64.18 -41.38 97.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.57 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.413 ' O ' ' O ' ' A' ' 32' ' ' ASN . 5.3 p 60.84 129.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.604 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.92 -42.98 98.15 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -155.6 146.01 21.89 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.395 -0.224 . . . . 1.0 110.395 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.531 ' C ' ' H ' ' A' ' 38' ' ' GLU . 2.1 mp0 -95.64 77.31 3.29 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.871 0.843 . . . . 1.0 110.47 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.27 -1.49 0.34 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.982 -1.008 . . . . 1.0 110.194 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.531 ' H ' ' C ' ' A' ' 36' ' ' GLU . 57.6 mp0 -74.01 -170.51 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.598 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 55.1 65.08 1.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.777 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.612 ' CZ2' ' ND1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -97.16 -33.87 11.33 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.167 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.435 ' HG ' ' CE3' ' A' ' 40' ' ' TRP . 29.1 mt -83.03 -0.86 50.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.237 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.489 ' HG ' ' N ' ' A' ' 43' ' ' SER . 16.3 p -58.55 -41.8 86.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.662 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.489 ' N ' ' HG ' ' A' ' 42' ' ' SER . 56.8 m -61.58 -60.82 3.1 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.25 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 pp -74.94 167.4 21.97 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -124.51 121.75 35.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 1.0 111.023 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.63 124.85 49.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.865 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -111.11 120.58 42.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.247 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.433 ' H ' HD21 ' A' ' 72' ' ' LEU . 51.3 t -111.1 132.39 59.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.967 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.486 HG23 ' H ' ' A' ' 53' ' ' ILE . 27.0 m -78.58 84.09 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.434 0.635 . . . . 1.0 110.27 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.401 HH11 ' CD1' ' A' ' 72' ' ' LEU . 76.1 mtm-85 -54.52 -43.67 72.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.464 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.443 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 66.7 p -62.14 -22.92 66.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.323 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.03 -74.42 1.11 Allowed Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.258 -0.737 . . . . 1.0 111.258 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.486 ' H ' HG23 ' A' ' 49' ' ' VAL . 5.3 mt -53.37 122.16 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 CA-C-O 121.942 0.877 . . . . 1.0 109.978 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -174.64 25.97 0.07 OUTLIER Glycine 0 C--N 1.302 -1.326 0 CA-C-N 114.315 -1.311 . . . . 1.0 112.066 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -75.31 -47.32 28.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.829 0.347 . . . . 1.0 111.305 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -168.84 -114.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.932 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.443 ' CD ' ' N ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -63.5 -19.58 64.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.334 -0.393 . . . . 1.0 110.677 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -40.61 -47.54 2.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.056 0.455 . . . . 1.0 110.639 -178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -68.37 -37.48 80.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.183 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 57' ' ' ARG . 4.9 tp -48.77 -18.38 0.26 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.196 0.522 . . . . 1.0 111.019 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -69.38 -43.35 73.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.924 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.434 ' CG ' ' N ' ' A' ' 63' ' ' LYS . 9.5 pt-20 -58.48 -39.51 80.17 Favored 'General case' 0 C--N 1.317 -0.83 0 O-C-N 123.356 0.41 . . . . 1.0 110.494 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.434 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 41.1 mttp -63.44 -40.36 96.93 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.575 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -65.66 -18.88 65.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.711 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.469 ' O ' ' O ' ' A' ' 69' ' ' GLY . 71.0 mt -85.29 -62.37 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.079 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.7 m -45.09 -35.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.729 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -65.57 -46.09 80.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.91 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.612 ' ND1' ' CZ2' ' A' ' 40' ' ' TRP . 1.3 m170 -97.7 23.67 7.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.436 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 83.44 -179.4 52.55 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.134 -0.787 . . . . 1.0 111.134 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 71' ' ' GLN . . . 74.87 27.73 64.14 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.891 -0.883 . . . . 1.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -44.18 170.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.835 0.35 . . . . 1.0 110.733 -179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.433 HD21 ' H ' ' A' ' 48' ' ' VAL . 40.6 mt -73.46 147.26 44.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.249 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.44 ' O ' ' CG2' ' A' ' 80' ' ' VAL . 0.8 OUTLIER -161.59 96.26 1.3 Allowed Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.47 147.47 12.59 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.497 2.131 . . . . 1.0 112.232 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 77' ' ' GLY . . . -51.47 -46.8 63.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.717 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.593 ' NE2' ' H ' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -65.13 1.37 1.01 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.125 0.488 . . . . 1.0 110.29 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 75' ' ' ALA . . . -93.31 -117.78 2.66 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 110.772 -0.931 . . . . 1.0 110.772 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.46 -57.65 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.528 2.152 . . . . 1.0 112.381 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.43 ' O ' HG13 ' A' ' 80' ' ' VAL . . . -162.78 -73.57 0.02 OUTLIER Glycine 0 C--O 1.224 -0.473 0 C-N-CA 120.681 -0.771 . . . . 1.0 111.497 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' A' ' 73' ' ' CYS . 0.4 OUTLIER 74.83 162.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 123.87 0.394 . . . . 1.0 110.256 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.53 -30.48 0.11 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.251 -0.432 . . . . 1.0 111.274 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -111.84 141.81 45.01 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.153 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.1 mp -132.74 108.32 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.973 -0.558 . . . . 1.0 109.784 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.2 t -92.96 135.25 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 115.802 -0.636 . . . . 1.0 111.043 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.572 ' C ' ' H ' ' A' ' 87' ' ' GLU . 30.0 m -132.34 159.26 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.475 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.58 ' C ' ' H ' ' A' ' 88' ' ' GLY . 47.4 p30 -67.05 12.31 0.08 Allowed 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.465 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.572 ' H ' ' C ' ' A' ' 85' ' ' VAL . 7.9 mt-10 70.5 -22.95 0.17 Allowed 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.291 0.369 . . . . 1.0 110.842 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.58 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -58.74 -46.63 93.15 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.686 -0.966 . . . . 1.0 110.686 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.2 ptp -88.85 145.04 25.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.848 0.356 . . . . 1.0 110.178 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -80.08 173.19 12.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.385 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.615 ' CG ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.19 -53.02 63.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.561 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.615 ' N ' ' CG ' ' A' ' 91' ' ' TYR . 14.2 pt-20 -53.47 -41.44 66.18 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 123.55 0.531 . . . . 1.0 110.521 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.675 ' HE ' ' CZ ' ' A' ' 96' ' ' ARG . 46.5 ttt180 -69.64 -40.15 76.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.082 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.48 ' O ' ' CD2' ' A' ' 98' ' ' LEU . . . -51.5 -26.48 8.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.938 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.1 mp -57.15 -41.04 78.41 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.735 -0.603 . . . . 1.0 110.802 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.675 ' CZ ' ' HE ' ' A' ' 93' ' ' ARG . 23.3 ptt180 -63.39 -34.18 77.17 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.413 -0.515 . . . . 1.0 109.986 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.443 ' CD1' ' OG1' ' A' ' 51' ' ' THR . 3.3 mm? -60.53 -47.9 84.13 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.794 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.484 ' O ' ' NE2' ' A' ' 76' ' ' GLN . 0.1 OUTLIER -93.14 16.36 13.16 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.742 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 41.97 56.2 3.56 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.527 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.8 tp -132.2 113.9 14.75 Favored Pre-proline 0 C--O 1.219 -0.526 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.597 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.16 2.07 5.96 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.361 2.041 . . . . 1.0 112.723 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 179.96 142.61 0.16 Allowed 'General case' 0 C--O 1.238 0.466 0 O-C-N 123.429 0.455 . . . . 1.0 110.742 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.3 mm? -84.8 145.0 43.05 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-O 120.888 0.375 . . . . 1.0 111.119 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.566 ' C ' ' H ' ' A' ' 106' ' ' GLY . 44.2 Cg_endo -69.18 161.99 43.62 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.353 2.035 . . . . 1.0 111.88 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.97 23.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.874 2.383 . . . . 1.0 111.974 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 104' ' ' PRO . . . -161.5 63.6 0.27 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -172.82 149.33 1.95 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.655 0.264 . . . . 1.0 110.469 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -139.32 156.05 47.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.063 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.9 mp -101.65 113.27 26.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.628 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.401 HG23 ' CE3' ' A' ' 114' ' ' TRP . 3.5 m -107.13 163.99 4.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.137 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm -93.71 -172.75 2.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.685 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.2 t -65.35 -41.18 94.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.985 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.63 -51.44 48.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.661 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.625 ' CE2' ' SG ' ' A' ' 118' ' ' CYS . 63.5 t90 -50.55 -49.58 55.65 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.484 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 tt -57.95 -50.97 71.56 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.32 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.7 t -48.54 -51.96 24.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.06 0.457 . . . . 1.0 110.08 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.1 mp -57.44 -50.98 71.27 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.448 -0.501 . . . . 1.0 110.259 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.625 ' SG ' ' CE2' ' A' ' 114' ' ' TRP . 56.3 m -44.35 -27.06 0.39 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.049 0.452 . . . . 1.0 110.099 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 80.2 mt -83.36 -47.68 11.2 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.564 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -68.44 -54.2 18.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.472 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 122' ' ' ARG . 78.4 mt-10 -77.86 5.4 9.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.508 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.456 ' C ' ' O ' ' A' ' 121' ' ' GLU . 81.4 mtt85 28.63 44.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.52 0.513 . . . . 1.0 111.257 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.445 ' CG ' ' O ' ' A' ' 121' ' ' GLU . 0.9 OUTLIER -159.99 167.83 27.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.532 -179.134 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 tp -74.08 100.08 3.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.046 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.409 ' CG2' ' N ' ' A' ' 126' ' ' ASP . 0.3 OUTLIER -80.44 154.93 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 121.252 0.548 . . . . 1.0 110.091 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 126' ' ' ASP . 14.6 p-10 -59.81 117.73 5.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.434 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 129' ' ' GLY . 13.0 m -68.03 -44.57 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.691 -0.686 . . . . 1.0 111.077 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.463 ' N ' ' CG2' ' A' ' 127' ' ' VAL . . . -43.85 -18.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.685 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . -69.9 -38.39 75.32 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.344 -0.702 . . . . 1.0 111.344 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -129.48 13.76 6.02 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.625 0.25 . . . . 1.0 110.679 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.5 p -73.16 136.4 44.78 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.848 0.356 . . . . 1.0 110.69 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.573 ' C ' ' H ' ' A' ' 134' ' ' ILE . 59.1 mt -74.52 -66.93 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.875 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.548 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 25.1 t80 66.26 -36.14 0.24 Allowed 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 123.878 0.736 . . . . 1.0 111.42 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.584 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 155.72 -55.3 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 O-C-N 124.768 1.293 . . . . 1.0 110.271 -178.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.3 Cg_endo . . . . . 0 C--N 1.31 -1.46 0 C-N-CA 122.498 2.132 . . . . 1.0 111.994 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.505 -1.438 . . . . 1.0 109.505 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.1 m -70.91 150.47 45.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.761 0.315 . . . . 1.0 110.417 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -83.7 98.62 9.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.494 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.5 p -159.59 163.44 35.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.548 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.86 -88.05 0.07 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.756 -0.938 . . . . 1.0 110.756 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.51 125.7 32.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.87 0.367 . . . . 1.0 110.325 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 38' ' ' GLU . 20.5 pt-20 -62.61 -44.45 96.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.675 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.404 ' N ' ' CG ' ' A' ' 36' ' ' GLU . . . 51.58 5.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.831 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.547 ' H ' ' C ' ' A' ' 36' ' ' GLU . 96.7 mt-10 -145.1 106.32 4.19 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.869 0.366 . . . . 1.0 110.338 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -106.62 92.54 4.15 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.539 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.601 ' N ' ' CD1' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -101.07 -38.22 8.25 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.355 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -76.49 -12.39 60.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.886 0.374 . . . . 1.0 110.9 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t -69.69 -17.78 63.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.996 0.427 . . . . 1.0 110.402 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.7 t -74.1 -13.9 60.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.107 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.42 168.99 18.4 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.993 0.425 . . . . 1.0 110.046 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.403 ' H ' ' HB ' ' A' ' 81' ' ' THR . 93.5 mtt180 -114.99 124.1 50.8 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.602 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -107.44 155.08 20.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.828 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.627 ' CE1' ' NH1' ' A' ' 50' ' ' ARG . 25.0 t-80 -155.25 123.32 5.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.528 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.2 m -99.52 145.37 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.849 0.357 . . . . 1.0 110.243 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.68 143.94 13.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.579 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.627 ' NH1' ' CE1' ' A' ' 47' ' ' HIS . 8.4 mpt_? -63.33 -42.62 98.98 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.857 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 p -100.99 136.28 41.09 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.946 0.403 . . . . 1.0 110.437 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.67 -19.85 53.01 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.048 -0.821 . . . . 1.0 111.048 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.468 ' CG2' ' O ' ' A' ' 53' ' ' ILE . 40.6 mm -127.51 3.81 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.096 0.474 . . . . 1.0 110.586 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.59 26.29 24.52 Favored Glycine 0 N--CA 1.467 0.724 0 N-CA-C 110.39 -1.084 . . . . 1.0 110.39 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.671 HH22 HH21 ' A' ' 57' ' ' ARG . 16.2 mtm-85 -63.25 -47.2 83.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 1.0 110.723 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 55' ' ' ARG . . . 165.52 -62.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.171 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.671 HH21 HH22 ' A' ' 55' ' ' ARG . 5.1 ppt_? -92.04 -25.56 18.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.598 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.64 -37.87 88.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.475 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 61' ' ' PHE . 3.1 pt-20 -65.32 -39.96 93.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.295 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 tp -44.19 -16.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.228 0.537 . . . . 1.0 110.886 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 59' ' ' GLU . 6.6 m-85 -58.91 -43.54 91.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.657 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.456 ' CG ' ' N ' ' A' ' 63' ' ' LYS . 13.8 pt-20 -67.2 -42.61 83.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.988 0.423 . . . . 1.0 111.063 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.456 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 95.2 mttt -63.86 -44.62 92.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.19 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -56.0 -37.58 69.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.806 -0.634 . . . . 1.0 109.995 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.505 ' O ' ' O ' ' A' ' 69' ' ' GLY . 67.8 mt -63.62 -44.43 98.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.667 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.7 t -59.37 -44.74 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.812 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.444 ' O ' ' OE1' ' A' ' 36' ' ' GLU . 99.6 mm-40 -55.97 -35.62 66.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.69 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.444 ' N ' ' CD2' ' A' ' 68' ' ' HIS . 1.9 m170 -103.99 16.55 26.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.136 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 90.58 153.18 28.65 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.868 -0.893 . . . . 1.0 110.868 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.0 51.43 0.6 Allowed Glycine 0 N--CA 1.468 0.786 0 N-CA-C 110.058 -1.217 . . . . 1.0 110.058 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -43.46 143.23 0.96 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 1.0 110.401 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.558 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 3.0 mm? -80.07 136.39 36.55 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.059 0.457 . . . . 1.0 110.143 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 79' ' ' GLY . 69.3 m -141.61 103.45 5.9 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.971 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.501 ' O ' ' N ' ' A' ' 77' ' ' GLY . 58.7 Cg_endo -73.94 167.59 26.85 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.712 1.608 . . . . 1.0 111.747 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -44.09 -48.31 8.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.531 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -67.75 -19.64 65.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.473 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 74' ' ' PRO . . . -78.77 -165.89 29.5 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.252 -0.739 . . . . 1.0 111.252 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.33 -42.28 61.46 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.751 2.301 . . . . 1.0 112.351 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 73' ' ' CYS . . . 170.19 -161.85 35.01 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.024 -0.83 . . . . 1.0 111.024 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -169.8 138.83 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.403 ' HB ' ' H ' ' A' ' 45' ' ' ARG . 95.4 m -104.21 -47.99 3.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.781 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -124.94 155.05 40.2 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.95 0.405 . . . . 1.0 111.087 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.415 ' N ' HD13 ' A' ' 83' ' ' ILE . 4.4 mp -134.34 113.19 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.056 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.43 134.96 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.362 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.567 ' C ' ' H ' ' A' ' 87' ' ' GLU . 3.7 m -127.21 163.68 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.646 -0.707 . . . . 1.0 110.708 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -69.56 19.0 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.229 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.567 ' H ' ' C ' ' A' ' 85' ' ' VAL . 12.9 mt-10 70.02 -51.76 0.64 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.51 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.14 -28.52 61.43 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.699 -0.961 . . . . 1.0 110.699 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.6 tpp -72.66 140.45 47.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.051 0.453 . . . . 1.0 110.823 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -88.18 153.63 21.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.769 -0.651 . . . . 1.0 109.67 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -56.26 -45.87 79.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.015 179.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.566 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 11.6 pt-20 -53.92 -49.72 68.01 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.621 -0.432 . . . . 1.0 111.135 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.484 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 21.9 ttm105 -70.51 -38.01 74.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.085 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.452 ' O ' ' CD2' ' A' ' 98' ' ' LEU . . . -46.56 -43.37 17.07 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 116.048 -0.523 . . . . 1.0 111.923 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.8 mp -58.3 -39.92 80.62 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.774 -0.579 . . . . 1.0 110.773 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.53 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 84.3 mmt-85 -69.24 -29.42 67.34 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.742 -0.383 . . . . 1.0 110.947 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.0 mp -65.26 -40.98 94.69 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.379 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.452 ' CD2' ' O ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -109.51 15.58 22.85 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.024 0.44 . . . . 1.0 110.655 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.53 ' NH1' ' O ' ' A' ' 96' ' ' ARG . 60.7 mmt-85 50.38 57.44 6.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.544 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.8 tp -107.24 115.07 60.4 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 121.075 -0.25 . . . . 1.0 110.458 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.22 -48.01 20.03 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.839 1.693 . . . . 1.0 112.384 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -175.98 137.51 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.645 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.8 mt -37.06 100.76 0.21 Allowed Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.267 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -43.18 157.44 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.099 1.866 . . . . 1.0 112.176 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.91 85.37 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.509 2.139 . . . . 1.0 111.898 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 137.33 -36.19 1.98 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.154 -0.778 . . . . 1.0 111.154 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.12 153.05 32.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.602 0.239 . . . . 1.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -144.23 155.48 43.89 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.12 114.5 24.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.463 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 m -110.63 171.31 3.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 123.759 0.662 . . . . 1.0 109.478 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.555 ' NZ ' ' O ' ' A' ' 130' ' ' PHE . 30.1 mtmm -104.82 -178.49 3.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.832 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.1 t -60.13 -39.24 85.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.099 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.07 -49.59 60.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.523 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 75.0 t90 -56.18 -46.33 79.42 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.2 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.43 -55.98 11.46 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.051 0.453 . . . . 1.0 110.377 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -41.37 -57.08 2.28 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.696 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.5 mp -58.64 -47.12 85.51 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.439 ' HA ' ' CZ ' ' A' ' 123' ' ' ARG . 0.5 OUTLIER -44.92 -42.62 8.28 Favored 'General case' 0 C--O 1.214 -0.766 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.725 177.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.48 -49.44 69.07 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 119.676 -0.81 . . . . 1.0 110.94 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -71.59 -51.91 20.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.971 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -70.62 -39.08 73.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.799 -0.637 . . . . 1.0 111.431 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 67.1 mtt85 63.99 54.38 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.269 0.557 . . . . 1.0 111.133 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.643 ' C ' ' HE ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -152.1 -164.72 2.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.239 -0.891 . . . . 1.0 111.125 -179.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.8 tp -119.94 91.67 3.6 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.593 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.441 ' CG2' ' NH2' ' A' ' 123' ' ' ARG . 29.0 m -81.2 153.32 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.952 0.406 . . . . 1.0 110.158 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -69.97 121.89 18.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.21 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 129' ' ' GLY . 17.6 m -72.44 -126.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.886 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . 63.81 -63.3 0.14 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 1.0 110.71 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . -59.53 -46.21 94.33 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.616 -0.994 . . . . 1.0 110.616 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.555 ' O ' ' NZ ' ' A' ' 111' ' ' LYS . 60.0 m-85 -86.54 -7.67 58.18 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.948 -0.389 . . . . 1.0 109.948 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.2 p -78.66 157.58 28.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.925 0.393 . . . . 1.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.592 ' C ' ' H ' ' A' ' 134' ' ' ILE . 62.2 mt -93.37 -59.67 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.406 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.475 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 16.3 t80 63.62 -32.97 0.12 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.941 -1.027 . . . . 1.0 111.904 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.592 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.6 OUTLIER 152.46 -55.64 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 124.848 1.259 . . . . 1.0 109.634 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 34.6 Cg_endo . . . . . 0 N--CA 1.496 1.638 0 C-N-CA 121.783 1.656 . . . . 1.0 112.074 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.459 -1.456 . . . . 1.0 109.459 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.1 m -133.29 152.51 51.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.869 0.366 . . . . 1.0 110.485 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -153.22 46.04 0.66 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.559 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.4 p -153.31 155.58 36.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.599 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.72 -40.1 90.09 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.951 -0.86 . . . . 1.0 110.951 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -58.97 142.12 51.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.558 0.218 . . . . 1.0 110.444 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -42.75 -73.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.896 0.379 . . . . 1.0 110.707 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 53.4 15.72 0.75 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.255 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.58 139.23 57.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.488 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -95.31 133.98 38.6 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.387 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.569 ' CZ2' ' NE ' ' A' ' 122' ' ' ARG . 3.6 p-90 -140.26 -38.46 0.45 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.392 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.99 -6.23 59.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.762 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.6 m -64.01 -33.03 74.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.903 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.9 p -57.16 -43.45 82.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.939 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.59 107.87 19.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.125 0.488 . . . . 1.0 110.732 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -68.72 110.21 4.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.519 -0.764 . . . . 1.0 109.338 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.2 162.83 14.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.875 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -148.08 131.92 17.05 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.945 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 50' ' ' ARG . 1.5 t -121.98 116.49 49.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.35 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 53' ' ' ILE . 15.7 t -56.95 81.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.717 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 48' ' ' VAL . 33.1 ptt-85 -70.27 -8.3 49.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.779 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.6 p -92.89 0.43 57.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.61 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 54' ' ' GLY . . . -147.44 -46.67 0.03 OUTLIER Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.123 -0.791 . . . . 1.0 111.123 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.404 ' N ' ' O ' ' A' ' 49' ' ' VAL . 3.8 tt -64.24 3.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.774 0.321 . . . . 1.0 110.422 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 52' ' ' GLY . . . -70.24 50.99 0.78 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.38 -43.66 69.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.803 0.335 . . . . 1.0 110.236 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -177.21 -81.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.035 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 60' ' ' LEU . 8.9 ptm180 -95.47 -21.12 18.51 Favored 'General case' 0 C--O 1.207 -1.138 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.923 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.59 -37.05 17.0 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.89 -0.724 . . . . 1.0 111.033 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -51.55 -26.1 7.99 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.559 -0.456 . . . . 1.0 110.804 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -63.64 -22.87 67.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.201 0.524 . . . . 1.0 110.96 -179.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.485 ' CE2' ' OG ' ' A' ' 112' ' ' SER . 21.7 m-85 -52.62 -46.71 67.17 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.923 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -65.71 -36.01 82.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.833 0.349 . . . . 1.0 110.645 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.528 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 5.7 mptp? -62.79 -48.67 78.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.19 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.434 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 62.4 mt-30 -60.38 -37.75 81.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.931 -0.577 . . . . 1.0 109.711 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 69' ' ' GLY . 57.8 mt -61.6 -48.08 90.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.095 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.6 t -62.8 -46.54 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 120.583 -0.447 . . . . 1.0 110.297 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 63' ' ' LYS . 1.2 mp0 -67.32 -35.03 78.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.24 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.63 ' HD1' ' CD2' ' A' ' 119' ' ' LEU . 61.7 m170 -88.19 0.28 56.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.542 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 98.72 147.27 21.83 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.72 -0.952 . . . . 1.0 110.72 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.47 55.53 0.71 Allowed Glycine 0 N--CA 1.464 0.554 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -40.19 145.13 0.17 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.679 0.276 . . . . 1.0 110.676 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.425 ' C ' ' SG ' ' A' ' 73' ' ' CYS . 8.8 mt -74.54 140.38 44.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.258 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.425 ' SG ' ' C ' ' A' ' 72' ' ' LEU . 2.6 m -145.12 87.87 7.01 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.233 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.16 -150.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.808 2.339 . . . . 1.0 111.849 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.53 -26.21 68.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.454 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -64.04 -20.56 66.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.52 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.1 -166.64 24.93 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.77 -43.47 57.62 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.71 2.274 . . . . 1.0 112.072 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . 131.48 31.17 0.52 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.896 -0.882 . . . . 1.0 110.896 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.434 ' O ' ' O ' ' A' ' 79' ' ' GLY . 31.1 m 37.44 -158.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 120.758 0.313 . . . . 1.0 110.904 179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.5 t -142.04 -18.44 0.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.706 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.781 ' NE2' HE21 ' A' ' 108' ' ' GLN . 68.7 m80 -130.98 160.03 35.73 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.022 0.439 . . . . 1.0 110.744 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 110' ' ' VAL . 5.1 mm -138.15 112.69 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.702 -0.681 . . . . 1.0 111.473 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.1 t -94.59 129.78 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.477 ' C ' ' H ' ' A' ' 87' ' ' GLU . 16.0 m -132.02 167.02 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.392 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 88' ' ' GLY . 49.1 t0 -77.91 30.06 0.17 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.219 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' A' ' 85' ' ' VAL . 31.3 mt-10 64.72 -66.65 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.873 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . -48.64 -17.33 0.76 Allowed Glycine 0 CA--C 1.52 0.381 0 N-CA-C 110.871 -0.892 . . . . 1.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.487 ' SD ' ' CD1' ' A' ' 97' ' ' LEU . 3.4 ttm -77.4 147.37 36.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.122 0.486 . . . . 1.0 110.495 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 91' ' ' TYR . 92.1 m-20 -100.64 142.75 31.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.591 -0.731 . . . . 1.0 109.855 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.601 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -36.73 -56.4 0.84 Allowed 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.285 -179.55 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.601 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 5.0 pt-20 -56.1 -59.57 4.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.773 -0.648 . . . . 1.0 109.953 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.571 ' H ' ' CG ' ' A' ' 92' ' ' GLU . 79.0 ttt180 -42.51 -42.22 3.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.857 0.36 . . . . 1.0 110.22 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.88 -48.61 75.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.73 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 99' ' ' ARG . 7.9 mp -57.48 -44.38 84.85 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.325 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.455 ' C ' ' CD ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -62.24 -42.43 99.31 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.807 179.275 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.487 ' CD1' ' SD ' ' A' ' 89' ' ' MET . 24.8 mt -63.19 -51.75 65.08 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.737 -0.385 . . . . 1.0 111.228 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.411 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -77.73 -18.5 56.47 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.173 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 95' ' ' LEU . 3.2 mtp180 76.35 63.54 0.05 OUTLIER 'General case' 0 CA--C 1.509 -0.608 0 O-C-N 124.469 1.106 . . . . 1.0 111.685 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.7 tp -136.45 118.3 11.61 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 120.465 -0.494 . . . . 1.0 111.089 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.98 -38.62 56.55 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.919 1.746 . . . . 1.0 112.067 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -163.19 136.48 5.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.609 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.8 mt -75.99 148.8 82.03 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.024 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.34 167.75 17.81 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.033 1.822 . . . . 1.0 112.467 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 107' ' ' ALA . 33.6 Cg_exo -56.1 146.35 70.78 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.497 2.131 . . . . 1.0 112.296 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.05 -19.52 6.5 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.901 -0.879 . . . . 1.0 110.901 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' A' ' 105' ' ' PRO . . . -61.97 151.76 34.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 1.0 110.428 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.781 HE21 ' NE2' ' A' ' 82' ' ' HIS . 5.9 pt20 -156.73 128.86 7.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.365 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.9 mp -84.11 127.64 34.04 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.711 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.467 ' O ' ' O ' ' A' ' 83' ' ' ILE . 3.8 m -121.31 176.14 4.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 O-C-N 123.723 0.639 . . . . 1.0 109.973 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -106.75 -176.57 3.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.738 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.485 ' OG ' ' CE2' ' A' ' 61' ' ' PHE . 6.8 t -60.05 -41.36 92.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.57 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.32 -48.24 62.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.611 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.544 ' CZ2' ' SG ' ' A' ' 118' ' ' CYS . 78.3 t90 -54.19 -41.1 68.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.002 0.429 . . . . 1.0 110.259 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.04 -55.56 27.95 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.129 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 80.1 p -49.21 -42.87 41.6 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.055 0.455 . . . . 1.0 109.828 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.35 -55.74 22.05 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.426 -0.51 . . . . 1.0 109.896 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.544 ' SG ' ' CZ2' ' A' ' 114' ' ' TRP . 0.0 OUTLIER -44.63 -33.68 1.9 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 -179.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.63 ' CD2' ' HD1' ' A' ' 68' ' ' HIS . 94.0 mt -77.05 -51.33 11.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.568 -0.742 . . . . 1.0 111.184 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -65.56 -49.14 69.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.231 -0.441 . . . . 1.0 111.314 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.433 ' O ' ' CG ' ' A' ' 123' ' ' ARG . 65.2 mm-40 -77.48 1.44 19.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.282 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.569 ' NE ' ' CZ2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 38.79 32.24 0.05 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.585 179.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 121' ' ' GLU . 4.5 ppt_? -158.29 174.32 15.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.254 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.6 tt -82.15 126.17 31.74 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.943 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.0 m -108.96 154.74 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.539 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 40.3 p-10 -62.09 144.33 55.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.042 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.6 m -103.03 11.17 8.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.509 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.64 53.35 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.609 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.68 -34.47 0.12 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.089 -0.804 . . . . 1.0 111.089 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -99.74 5.92 45.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.022 0.439 . . . . 1.0 110.655 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.6 t -99.15 141.28 32.12 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.356 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.531 ' C ' ' H ' ' A' ' 134' ' ' ILE . 54.7 mt -88.18 -55.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-N 115.635 -0.711 . . . . 1.0 110.205 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.5 ' O ' HG12 ' A' ' 134' ' ' ILE . 10.9 t80 65.71 -40.6 0.32 Allowed 'General case' 0 C--O 1.221 -0.426 0 O-C-N 124.375 1.047 . . . . 1.0 111.461 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.546 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 159.38 -54.55 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 O-C-N 124.665 1.228 . . . . 1.0 109.915 -178.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 36.5 Cg_endo . . . . . 0 N--CA 1.491 1.351 0 C-N-CA 122.15 1.9 . . . . 1.0 111.929 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.495 -1.442 . . . . 1.0 109.495 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.2 t -61.28 -43.89 98.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.817 0.341 . . . . 1.0 110.572 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.5 t30 56.81 45.54 21.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.619 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.5 p -155.37 162.49 40.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.45 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.6 -22.39 41.19 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 56.5 mp0 -88.86 151.01 22.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.941 0.401 . . . . 1.0 110.47 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.469 ' O ' ' C ' ' A' ' 37' ' ' ALA . 10.1 pt-20 -61.19 -52.18 65.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.712 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . 25.3 60.75 0.06 Allowed 'General case' 0 N--CA 1.468 0.466 0 O-C-N 123.781 0.676 . . . . 1.0 110.959 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -127.3 40.92 3.62 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.483 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -45.6 137.06 5.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.307 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.554 ' CZ2' ' CZ ' ' A' ' 122' ' ' ARG . 1.6 p-90 -123.45 -50.62 1.87 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.547 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.4 ' CD1' ' CZ3' ' A' ' 40' ' ' TRP . 1.3 mt -67.13 -21.75 65.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.757 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.0 t -61.37 -18.57 59.34 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.326 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.7 p -65.32 -15.0 62.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.333 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.55 168.35 19.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.308 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -119.55 115.58 24.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.604 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.62 168.18 10.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.114 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -153.91 120.06 5.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.629 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.1 t -100.05 135.9 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.09 0.471 . . . . 1.0 110.252 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.3 m -86.71 125.04 40.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.685 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.2 mmt85 -74.53 -39.11 62.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.745 -0.661 . . . . 1.0 111.246 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.1 p -59.51 -22.51 61.74 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.617 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . -115.85 -91.58 1.71 Allowed Glycine 0 N--CA 1.465 0.603 0 N-CA-C 110.738 -0.945 . . . . 1.0 110.738 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.513 ' C ' ' H ' ' A' ' 55' ' ' ARG . 4.1 mm -40.23 -27.6 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.741 0.305 . . . . 1.0 110.806 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 52' ' ' GLY . . . -69.81 41.64 0.44 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.801 -0.92 . . . . 1.0 110.801 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.513 ' H ' ' C ' ' A' ' 53' ' ' ILE . 1.9 ptp180 -80.11 -61.14 2.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.835 0.35 . . . . 1.0 110.953 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.427 ' H ' ' HG3' ' A' ' 55' ' ' ARG . . . -150.28 -89.87 0.07 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.761 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -92.71 -24.62 18.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.03 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.44 -16.83 0.64 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.571 0.701 . . . . 1.0 110.05 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 61' ' ' PHE . 21.1 pt-20 -73.29 -34.84 65.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.154 0.502 . . . . 1.0 111.207 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 tp -46.29 -17.31 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.392 0.615 . . . . 1.0 110.866 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.475 ' N ' ' O ' ' A' ' 59' ' ' GLU . 1.8 m-85 -57.22 -51.11 70.64 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.802 -0.636 . . . . 1.0 112.073 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -58.15 -36.99 73.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.111 0.482 . . . . 1.0 110.563 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -44.75 96.19 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.244 0.545 . . . . 1.0 110.287 -178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -62.76 -18.7 63.05 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.256 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.487 ' O ' ' O ' ' A' ' 69' ' ' GLY . 92.3 mt -86.29 -56.19 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.961 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 67' ' ' GLN . 3.4 m -62.81 -38.6 82.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.913 0.387 . . . . 1.0 110.891 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.407 ' N ' ' CG2' ' A' ' 66' ' ' VAL . 85.0 mt-30 -61.45 -40.01 92.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.699 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -95.68 14.66 22.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.771 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 96.32 144.72 17.61 Favored Glycine 0 N--CA 1.464 0.524 0 N-CA-C 110.618 -0.993 . . . . 1.0 110.618 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.07 44.73 1.35 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.707 -0.957 . . . . 1.0 110.707 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -40.95 160.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.786 0.327 . . . . 1.0 110.689 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.9 mt -69.92 136.62 50.79 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 68.4 m -131.1 96.9 20.95 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.341 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.99 -178.71 4.85 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.527 2.151 . . . . 1.0 112.024 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -54.68 -47.82 73.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.766 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -64.03 -18.98 64.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.915 0.388 . . . . 1.0 110.352 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.87 -158.45 19.38 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.088 -0.805 . . . . 1.0 111.088 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -47.96 -44.99 26.25 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.412 2.075 . . . . 1.0 112.417 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.43 ' O ' ' CB ' ' A' ' 80' ' ' VAL . . . 156.44 -44.58 0.52 Allowed Glycine 0 C--O 1.223 -0.576 0 C-N-CA 120.467 -0.873 . . . . 1.0 111.128 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.43 ' CB ' ' O ' ' A' ' 79' ' ' GLY . 0.4 OUTLIER 82.91 166.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 124.038 0.493 . . . . 1.0 110.166 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.58 -35.22 0.31 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.904 -0.318 . . . . 1.0 110.453 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -117.26 144.06 45.23 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.655 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.405 ' O ' ' O ' ' A' ' 110' ' ' VAL . 58.2 mt -131.58 112.59 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.555 -0.458 . . . . 1.0 110.885 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 t -90.3 127.64 42.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.521 ' C ' ' H ' ' A' ' 87' ' ' GLU . 28.7 m -133.16 166.44 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.885 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.544 ' C ' ' H ' ' A' ' 88' ' ' GLY . 39.8 p-10 -73.66 17.48 0.16 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.76 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' A' ' 85' ' ' VAL . 3.7 mt-10 73.71 -32.11 0.23 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.092 -0.504 . . . . 1.0 111.224 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -67.95 -20.35 72.55 Favored Glycine 0 C--N 1.314 -0.672 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.414 ' CE ' HH12 ' A' ' 93' ' ' ARG . 9.4 ttm -82.11 160.16 23.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.791 0.329 . . . . 1.0 110.826 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -113.52 142.06 46.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.83 -0.623 . . . . 1.0 109.891 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.57 ' CG ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -46.49 -53.27 11.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.497 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.57 ' N ' ' CG ' ' A' ' 91' ' ' TYR . 17.1 pt-20 -51.83 -38.25 55.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.645 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.414 HH12 ' CE ' ' A' ' 89' ' ' MET . 79.7 ttt-85 -80.44 -22.17 41.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.789 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.34 -37.32 77.54 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.334 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 99' ' ' ARG . 7.5 mp -60.6 -38.0 83.22 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.995 -0.282 . . . . 1.0 110.319 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -61.9 -35.88 79.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.79 0.329 . . . . 1.0 110.627 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.24 -40.56 96.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.049 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.407 ' N ' HD21 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -108.72 8.77 27.0 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.188 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 95' ' ' LEU . 1.6 mpt_? 45.96 58.24 4.55 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.8 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.52 112.44 58.88 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.147 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.74 -41.75 37.75 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.057 1.838 . . . . 1.0 112.72 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -162.08 128.59 3.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.958 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 60.4 mt -52.71 124.6 35.3 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-N 116.088 -0.506 . . . . 1.0 111.214 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.449 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 44.2 Cg_exo -49.67 -174.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.365 2.044 . . . . 1.0 112.419 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 32.1 Cg_exo -58.18 129.36 32.62 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.724 2.283 . . . . 1.0 111.908 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 72.18 -53.32 1.43 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-O 118.906 -0.941 . . . . 1.0 110.751 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -7.79 116.26 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 O-C-N 124.262 0.625 . . . . 1.0 111.178 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -127.71 142.74 51.25 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.593 -0.276 . . . . 1.0 110.411 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.626 ' H ' ' CD2' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -93.38 120.96 34.27 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.442 HG23 ' CE3' ' A' ' 114' ' ' TRP . 3.5 m -110.25 168.0 4.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.996 -1.002 . . . . 1.0 110.606 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.21 -177.72 3.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.897 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.0 m -61.48 -41.63 97.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.11 -0.95 . . . . 1.0 110.511 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.47 -48.14 62.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.547 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.442 ' CE3' HG23 ' A' ' 110' ' ' VAL . 34.5 t90 -56.02 -41.22 74.59 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.229 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.6 tp -65.67 -56.64 11.06 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.142 -0.623 . . . . 1.0 110.613 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.405 ' H ' ' HG ' ' A' ' 116' ' ' SER . 2.0 m -46.22 -53.58 10.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.363 0.601 . . . . 1.0 110.061 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.2 mp -52.23 -49.23 64.39 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.268 -0.573 . . . . 1.0 109.863 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.524 ' SG ' ' O ' ' A' ' 123' ' ' ARG . 12.8 t -52.15 -37.33 54.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.775 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.598 ' O ' ' NH2' ' A' ' 122' ' ' ARG . 90.2 mt -69.6 -57.5 5.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.42 0.629 . . . . 1.0 111.509 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -66.21 -21.24 66.3 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.469 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 75.9 mm-40 -88.82 -45.24 9.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.609 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.598 ' NH2' ' O ' ' A' ' 119' ' ' LEU . 0.1 OUTLIER 81.61 33.86 0.1 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.9 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.524 ' O ' ' SG ' ' A' ' 118' ' ' CYS . 0.0 OUTLIER -161.7 -176.12 5.11 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.579 -0.449 . . . . 1.0 110.536 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 tp -79.22 123.89 27.84 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.333 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.18 155.18 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 121.017 0.437 . . . . 1.0 110.623 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 126' ' ' ASP . 45.3 p-10 -61.38 107.94 0.86 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.251 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 128' ' ' ALA . 9.1 m -60.36 -42.82 92.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.65 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.455 ' N ' ' CG2' ' A' ' 127' ' ' VAL . . . -55.72 -22.66 24.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.48 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.9 -37.62 94.66 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.916 -0.873 . . . . 1.0 110.916 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.587 ' N ' ' CD1' ' A' ' 130' ' ' PHE . 0.3 OUTLIER -143.42 58.51 1.39 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.707 0.289 . . . . 1.0 110.899 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 127' ' ' VAL . 33.9 m -119.17 150.8 39.43 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.141 0.496 . . . . 1.0 110.795 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.587 ' C ' ' H ' ' A' ' 134' ' ' ILE . 60.9 mt -81.34 -63.75 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 CA-C-N 115.301 -0.863 . . . . 1.0 110.181 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.512 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 19.4 t80 66.34 -35.66 0.23 Allowed 'General case' 0 C--O 1.221 -0.425 0 O-C-N 124.208 0.943 . . . . 1.0 111.347 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.587 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 155.7 -55.51 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.37 0 O-C-N 124.905 1.378 . . . . 1.0 110.048 -178.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 24.9 Cg_endo . . . . . 0 N--CA 1.491 1.361 0 C-N-CA 122.324 2.016 . . . . 1.0 111.821 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.586 -1.406 . . . . 1.0 109.586 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.5 m 54.29 30.68 12.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 1.0 110.612 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 11.3 p30 -67.93 116.15 8.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.536 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.2 m -89.26 -2.33 58.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.423 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.78 -57.87 11.57 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.024 -0.83 . . . . 1.0 111.024 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.472 ' HG3' ' H ' ' A' ' 36' ' ' GLU . 6.1 tp10 42.52 -160.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 1.0 110.552 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.472 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 21.3 pt-20 -65.14 -43.56 91.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.305 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 60.33 43.83 13.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.005 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 39' ' ' GLU . 3.9 pt-20 -153.76 -28.2 0.13 Allowed 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 110.207 -0.294 . . . . 1.0 110.207 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.455 ' OE1' ' N ' ' A' ' 39' ' ' GLU . 39.9 mp0 50.57 173.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.58 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.416 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 14.8 p-90 -163.81 -55.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.086 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 tt -68.91 -18.18 64.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.372 0.606 . . . . 1.0 110.123 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 68' ' ' HIS . 15.8 m -61.5 -42.17 98.39 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.713 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.8 m -52.84 -60.61 3.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.882 0.373 . . . . 1.0 110.714 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.0 169.28 18.32 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.655 -0.498 . . . . 1.0 109.655 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -123.71 120.02 31.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.935 0.398 . . . . 1.0 110.738 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -96.7 158.29 15.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.235 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.486 ' CE1' ' CD1' ' A' ' 98' ' ' LEU . 59.6 t-80 -156.04 114.88 3.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.231 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.7 m -101.23 139.9 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.739 -0.467 . . . . 1.0 109.739 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 53' ' ' ILE . 58.5 t -81.69 89.9 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.036 0.446 . . . . 1.0 110.527 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -58.24 -31.18 67.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.664 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 m -92.9 34.99 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.992 0.425 . . . . 1.0 110.364 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -178.87 -4.6 0.02 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.091 -0.804 . . . . 1.0 111.091 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.548 ' C ' ' H ' ' A' ' 55' ' ' ARG . 0.9 OUTLIER -127.04 -1.35 4.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-O 120.748 0.309 . . . . 1.0 110.314 179.293 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.45 37.32 0.57 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.105 -0.798 . . . . 1.0 111.105 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.548 ' H ' ' C ' ' A' ' 53' ' ' ILE . 1.6 ptp180 -61.0 -37.76 83.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.829 0.347 . . . . 1.0 110.244 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -172.9 -103.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.401 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.603 ' H ' ' CD ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -85.98 -19.13 30.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.491 179.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.447 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -43.21 -36.53 1.78 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.573 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 61' ' ' PHE . 12.5 pt-20 -66.12 -44.46 84.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.342 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.1 tp -43.17 -18.13 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.775 0.798 . . . . 1.0 110.818 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 59' ' ' GLU . 6.5 m-85 -58.11 -48.38 80.37 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.562 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -60.47 -31.04 70.07 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.034 0.445 . . . . 1.0 111.544 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.438 ' H ' ' HG2' ' A' ' 63' ' ' LYS . 17.0 mmmt -65.96 -56.52 11.3 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.451 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -57.84 -30.06 65.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.421 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 68.5 mt -66.87 -39.82 84.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.411 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.8 t -59.8 -41.62 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.232 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -68.24 -16.46 63.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.521 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.431 ' O ' ' OG ' ' A' ' 42' ' ' SER . 34.0 m170 -88.81 7.32 34.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.65 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.82 -7.22 82.18 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.052 -0.819 . . . . 1.0 111.052 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.56 98.06 2.3 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.589 -1.004 . . . . 1.0 110.589 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -79.54 144.31 34.04 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.89 -0.324 . . . . 1.0 110.756 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.57 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 2.5 mm? -80.66 137.27 36.32 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 120.898 0.38 . . . . 1.0 110.531 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.8 m -133.68 90.54 27.87 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.465 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.5 -177.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.824 2.349 . . . . 1.0 112.139 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.457 ' C ' ' H ' ' A' ' 77' ' ' GLY . . . -56.43 -41.73 76.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.514 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -64.14 -1.55 1.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.319 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 75' ' ' ALA . . . -136.56 86.67 0.24 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.318 -1.113 . . . . 1.0 110.318 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.76 139.26 59.18 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.626 2.218 . . . . 1.0 112.058 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.81 1.17 1.63 Allowed Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.3 p -88.34 103.71 13.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.048 0.451 . . . . 1.0 110.6 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.99 -39.25 15.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.399 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.5 ' CD2' ' CZ2' ' A' ' 114' ' ' TRP . 77.5 m80 -106.58 138.82 42.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.951 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.411 ' O ' ' O ' ' A' ' 110' ' ' VAL . 85.7 mt -133.58 107.36 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.258 -0.428 . . . . 1.0 109.934 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.43 134.97 27.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.533 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.51 162.8 37.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.394 -0.821 . . . . 1.0 110.975 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 88' ' ' GLY . 67.8 t0 -63.99 103.45 0.59 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 116.027 -0.533 . . . . 1.0 109.635 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 86' ' ' ASP . 69.1 mt-10 -24.63 87.15 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 124.191 0.932 . . . . 1.0 110.926 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . 156.77 -25.41 0.5 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 -178.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.445 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 11.9 ttm -70.14 146.71 50.63 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.913 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -90.09 151.57 21.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.453 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.55 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.74 -46.86 87.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.108 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.55 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 10.5 pt-20 -57.99 -45.45 86.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.947 0.403 . . . . 1.0 110.776 -178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.484 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 4.8 tmm_? -72.13 -21.82 61.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.13 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.49 -30.62 71.71 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.802 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 99' ' ' ARG . 7.0 mp -72.18 -44.81 62.46 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.212 0.32 . . . . 1.0 110.973 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -59.79 -48.28 82.32 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.25 -45.76 75.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.568 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.486 ' CD1' ' CE1' ' A' ' 47' ' ' HIS . 54.8 tp -72.77 -16.18 61.64 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.969 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.57 ' N ' ' O ' ' A' ' 95' ' ' LEU . 23.0 mmt85 67.35 27.15 8.27 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.11 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.5 tp -98.02 116.99 65.58 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.8 -23.26 35.72 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.22 1.947 . . . . 1.0 112.578 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -174.42 133.88 0.4 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.328 -0.397 . . . . 1.0 110.714 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 104' ' ' PRO . 1.0 OUTLIER -73.79 135.44 77.75 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.093 -178.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.533 ' O ' ' O ' ' A' ' 103' ' ' LEU . 60.7 Cg_exo -44.72 -174.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.645 2.23 . . . . 1.0 112.061 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 52.5 Cg_exo -51.95 -68.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.565 2.176 . . . . 1.0 113.087 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . -82.45 -50.43 4.77 Favored Glycine 0 CA--C 1.502 -0.753 0 N-CA-C 110.662 -0.975 . . . . 1.0 110.662 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.52 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -11.46 123.83 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 124.64 0.847 . . . . 1.0 111.44 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -130.76 154.26 48.17 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 110.018 -0.364 . . . . 1.0 110.018 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.86 110.36 22.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.783 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 83' ' ' ILE . 13.9 m -107.25 169.07 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.661 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -96.52 -168.97 1.81 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.658 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -70.69 -34.66 72.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.878 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.419 ' O ' ' OG ' ' A' ' 116' ' ' SER . . . -57.21 -46.75 82.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.688 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.5 ' CZ2' ' CD2' ' A' ' 82' ' ' HIS . 79.0 t90 -52.02 -59.83 3.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.628 -0.429 . . . . 1.0 110.678 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 119' ' ' LEU . 32.0 tp -60.63 -51.24 70.25 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.441 -0.504 . . . . 1.0 110.503 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 117' ' ' LEU . 56.9 p -41.27 -60.71 1.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.087 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.439 ' N ' ' OG ' ' A' ' 116' ' ' SER . 11.0 mp -61.14 -49.62 76.51 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.055 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.54 ' SG ' ' O ' ' A' ' 123' ' ' ARG . 9.3 t -55.49 -25.96 39.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 1.0 110.081 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -70.62 -52.27 22.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.478 0.656 . . . . 1.0 111.419 -178.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -78.39 -30.66 47.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.505 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' A' ' 122' ' ' ARG . 0.4 OUTLIER -62.38 -48.5 79.45 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 118.473 -0.775 . . . . 1.0 110.165 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' A' ' 121' ' ' GLU . 17.0 mmm180 90.27 32.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.816 1.323 . . . . 1.0 111.358 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.54 ' O ' ' SG ' ' A' ' 118' ' ' CYS . 0.0 OUTLIER -173.9 163.18 4.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.435 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.4 tp -65.76 129.32 39.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.962 0.411 . . . . 1.0 111.175 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.3 m -113.32 154.0 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.364 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -61.96 146.92 48.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.431 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.4 m -108.01 0.98 9.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.249 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.98 61.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.602 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 171.48 -28.15 0.11 Allowed Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -108.47 -11.53 15.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.718 0.295 . . . . 1.0 110.39 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -74.6 135.32 42.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.08 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 134' ' ' ILE . 57.5 mt -79.45 -65.95 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.129 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.53 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 19.7 t80 66.14 -36.33 0.24 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 118.438 -0.791 . . . . 1.0 111.154 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.588 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 155.67 -55.27 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 O-C-N 124.825 1.328 . . . . 1.0 110.272 -178.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 22.7 Cg_endo . . . . . 0 C--N 1.311 -1.401 0 C-N-CA 122.391 2.06 . . . . 1.0 111.982 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.427 -1.469 . . . . 1.0 109.427 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 t -152.32 36.69 0.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.744 0.306 . . . . 1.0 110.485 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.478 ' CG ' ' H ' ' A' ' 33' ' ' SER . 49.2 t-20 -71.73 -129.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.589 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.478 ' H ' ' CG ' ' A' ' 32' ' ' ASN . 95.5 p -73.58 162.51 29.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.454 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -136.19 28.66 2.89 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.902 -0.879 . . . . 1.0 110.902 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -57.79 139.8 53.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.997 0.427 . . . . 1.0 110.577 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -65.43 -43.38 90.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.424 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 38.5 62.57 0.99 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.966 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -92.48 138.04 31.85 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.329 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 39' ' ' GLU . 57.8 mp0 -115.72 95.21 5.02 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.433 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.513 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 3.5 p-90 -98.42 -56.69 2.39 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.391 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.15 -11.68 1.23 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.737 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.41 ' H ' ' C ' ' A' ' 40' ' ' TRP . 77.5 p -68.7 -32.55 72.44 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.644 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -61.02 -15.32 30.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.571 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.72 115.28 11.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.854 0.359 . . . . 1.0 110.628 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -75.31 139.94 42.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.078 179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.33 169.74 9.73 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.458 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.714 ' HD1' ' N ' ' A' ' 48' ' ' VAL . 1.5 t-80 -147.89 120.09 8.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.439 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.714 ' N ' ' HD1' ' A' ' 47' ' ' HIS . 21.3 t -97.1 127.16 49.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.508 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.644 ' O ' ' N ' ' A' ' 53' ' ' ILE . 15.0 t -80.7 88.92 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.424 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -49.56 -36.84 24.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.548 -0.296 . . . . 1.0 110.571 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.0 p -76.26 -24.24 54.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.541 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -110.14 1.58 29.84 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.367 -0.693 . . . . 1.0 111.367 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.644 ' N ' ' O ' ' A' ' 49' ' ' VAL . 35.0 mt -146.18 91.47 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.285 0.564 . . . . 1.0 110.309 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -145.45 19.68 1.87 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.076 -0.81 . . . . 1.0 111.076 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.502 ' O ' ' CB ' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -58.25 -55.97 28.08 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.288 -0.264 . . . . 1.0 110.288 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 55' ' ' ARG . . . 158.14 -40.14 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 O-C-N 123.436 0.46 . . . . 1.0 110.576 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.43 ' O ' ' CD2' ' A' ' 60' ' ' LEU . 70.3 ttp85 -94.27 -60.66 1.68 Allowed 'General case' 0 C--O 1.211 -0.928 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.829 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.634 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -40.96 -43.08 2.03 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-O 121.262 0.553 . . . . 1.0 110.578 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 61' ' ' PHE . 11.3 pt-20 -45.45 -48.52 13.8 Favored 'General case' 0 C--N 1.314 -0.971 0 O-C-N 121.77 -0.581 . . . . 1.0 111.094 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.441 HD21 ' N ' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -39.45 -19.02 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.507 0.504 . . . . 1.0 109.962 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.634 ' CD2' ' O ' ' A' ' 58' ' ' ALA . 8.6 m-85 -52.73 -48.96 66.32 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.676 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.462 ' CG ' ' N ' ' A' ' 63' ' ' LYS . 13.9 pt-20 -63.02 -43.46 98.67 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.489 0.493 . . . . 1.0 110.528 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.462 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 17.5 mtpp -61.23 -42.58 98.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.223 0.535 . . . . 1.0 110.177 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.536 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 86.9 mm-40 -67.35 -31.27 71.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.205 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' A' ' 69' ' ' GLY . 46.5 mt -74.96 -57.86 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.047 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.0 m -55.22 -42.75 67.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.271 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -65.81 -40.29 91.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.584 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 64' ' ' GLN . 46.5 m170 -86.01 -3.59 58.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.503 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 99.17 171.17 30.96 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.876 -0.89 . . . . 1.0 110.876 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 71' ' ' GLN . . . 102.17 -45.51 1.36 Allowed Glycine 0 N--CA 1.464 0.545 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 70' ' ' GLY . 25.1 mm100 54.92 158.65 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.7 0.286 . . . . 1.0 110.634 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.613 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -89.58 130.32 35.91 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.757 -0.461 . . . . 1.0 109.757 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 73.3 m -118.85 88.73 36.53 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.621 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 77' ' ' GLY . 31.8 Cg_exo -56.67 162.45 8.47 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.833 2.355 . . . . 1.0 112.055 178.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -47.23 -33.84 5.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.397 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -75.94 -20.51 57.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.896 0.379 . . . . 1.0 110.592 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 74' ' ' PRO . . . -85.9 -161.99 35.85 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.029 -0.828 . . . . 1.0 111.029 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -43.8 -41.63 11.78 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.563 2.175 . . . . 1.0 111.986 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.462 ' O ' ' CG1' ' A' ' 80' ' ' VAL . . . 136.19 -40.78 1.49 Allowed Glycine 0 C--O 1.22 -0.779 0 CA-C-O 119.219 -0.767 . . . . 1.0 111.695 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.513 ' CG1' ' N ' ' A' ' 81' ' ' THR . 0.3 OUTLIER 77.96 -171.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 124.034 0.491 . . . . 1.0 109.909 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.513 ' N ' ' CG1' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -144.29 -32.19 0.43 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.824 177.56 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.663 ' CD2' HE22 ' A' ' 108' ' ' GLN . 74.9 m80 -111.69 136.51 50.83 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.614 -0.266 . . . . 1.0 110.672 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 110' ' ' VAL . 30.2 mm -123.28 106.29 17.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -93.53 134.06 32.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.814 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 87' ' ' GLU . 3.1 m -132.79 157.44 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.206 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.576 ' O ' ' C ' ' A' ' 87' ' ' GLU . 10.1 t0 -54.78 77.72 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 123.373 0.42 . . . . 1.0 110.116 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' A' ' 85' ' ' VAL . 6.8 pt-20 -3.88 79.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 O-C-N 124.17 0.919 . . . . 1.0 111.76 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . 170.1 -22.11 0.08 OUTLIER Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.601 -0.727 . . . . 1.0 111.288 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.6 tpp -72.71 156.14 39.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.775 0.322 . . . . 1.0 110.786 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -96.35 144.1 26.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.135 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.604 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -51.47 -44.94 62.6 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.205 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.604 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 16.5 pt-20 -59.65 -44.16 93.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.929 0.395 . . . . 1.0 110.526 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.46 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 38.8 ttm105 -71.94 -41.16 68.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.767 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.15 -34.46 22.42 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.935 -0.575 . . . . 1.0 111.045 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.411 ' N ' HD13 ' A' ' 95' ' ' LEU . 5.6 mp -62.55 -47.3 84.49 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.66 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.548 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -73.0 -35.77 66.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.257 -178.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.62 -34.54 75.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.51 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.466 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -105.61 -1.94 24.05 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.204 -0.453 . . . . 1.0 111.005 -179.431 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.548 ' NH1' ' O ' ' A' ' 96' ' ' ARG . 72.9 mmt-85 70.57 61.68 0.2 Allowed 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 123.322 0.389 . . . . 1.0 110.858 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 95' ' ' LEU . 9.3 tp -125.79 122.36 24.57 Favored Pre-proline 0 N--CA 1.449 -0.518 0 O-C-N 123.255 0.347 . . . . 1.0 111.376 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.83 -36.51 23.44 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.384 2.056 . . . . 1.0 112.012 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 179.47 139.63 0.11 Allowed 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.576 0.548 . . . . 1.0 110.915 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.7 mt -45.14 120.27 4.4 Favored Pre-proline 0 N--CA 1.445 -0.72 0 CA-C-N 115.843 -0.617 . . . . 1.0 111.166 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.15 165.36 32.9 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.409 2.073 . . . . 1.0 112.031 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.15 113.54 1.24 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.575 2.183 . . . . 1.0 111.805 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.84 62.58 1.67 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -164.09 143.13 7.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 1.0 110.641 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.663 HE22 ' CD2' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -140.16 152.99 46.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.088 0.471 . . . . 1.0 110.132 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.06 109.4 20.87 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.15 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.437 ' O ' ' O ' ' A' ' 83' ' ' ILE . 3.0 m -108.23 167.14 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.026 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -102.24 -171.18 1.92 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.838 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.4 t -64.84 -44.42 89.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.895 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.08 -38.0 49.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.514 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 75.2 t90 -61.65 -52.31 64.86 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.907 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 119' ' ' LEU . 3.0 tt -63.13 -55.7 23.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.993 0.425 . . . . 1.0 110.986 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.9 t -43.94 -59.55 2.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.392 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.427 ' O ' ' OE2' ' A' ' 121' ' ' GLU . 9.4 mp -60.01 -49.82 76.15 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.464 -0.494 . . . . 1.0 110.364 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.509 ' SG ' ' O ' ' A' ' 123' ' ' ARG . 3.1 t -58.72 -22.08 56.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.142 -0.318 . . . . 1.0 110.142 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.535 ' O ' ' NH1' ' A' ' 122' ' ' ARG . 6.7 tp -71.22 -53.52 14.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.001 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.459 ' C ' ' H ' ' A' ' 122' ' ' ARG . 77.0 mt-30 -76.75 -33.08 58.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.603 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.535 ' O ' ' C ' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -77.26 18.17 0.42 Allowed 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.8 -178.496 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.535 ' C ' ' O ' ' A' ' 121' ' ' GLU . 81.6 mmt-85 20.56 52.77 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.719 0.637 . . . . 1.0 111.353 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.509 ' O ' ' SG ' ' A' ' 118' ' ' CYS . 0.5 OUTLIER -170.67 167.8 7.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.727 -0.669 . . . . 1.0 110.357 -178.342 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.0 tt -83.77 114.76 21.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.044 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.428 ' CG1' ' N ' ' A' ' 126' ' ' ASP . 55.2 t -80.45 155.7 4.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.155 0.502 . . . . 1.0 110.601 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.428 ' N ' ' CG1' ' A' ' 125' ' ' VAL . 66.2 t0 -66.46 117.26 8.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.505 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 131' ' ' SER . 2.9 m -64.14 -41.4 92.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.603 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.463 ' N ' ' CG2' ' A' ' 127' ' ' VAL . . . -53.75 -6.64 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.455 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 127' ' ' VAL . . . -87.86 -34.38 10.09 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -134.33 12.12 3.83 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.713 0.292 . . . . 1.0 110.433 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 127' ' ' VAL . 5.1 t -75.48 141.29 43.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.895 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.563 ' C ' ' H ' ' A' ' 134' ' ' ILE . 45.3 mt -83.25 -66.36 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.124 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.533 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 21.1 t80 66.76 -37.89 0.31 Allowed 'General case' 0 C--O 1.211 -0.926 0 O-C-N 124.011 0.819 . . . . 1.0 111.003 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.582 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 157.36 -54.66 0.0 OUTLIER Pre-proline 0 N--CA 1.45 -0.441 0 O-C-N 124.658 1.224 . . . . 1.0 110.755 -178.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 29.9 Cg_endo . . . . . 0 C--N 1.31 -1.476 0 C-N-CA 122.479 2.12 . . . . 1.0 111.684 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.769 0.319 . . . . 1.0 110.782 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -90.24 -46.05 8.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.383 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.539 ' CD2' HG23 ' A' ' 65' ' ' ILE . 6.6 tp -62.42 -31.83 72.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.742 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 91.5 p -48.02 -14.71 0.05 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.532 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.459 ' N ' ' C ' ' A' ' 41' ' ' LEU . 32.9 t -64.55 -16.34 62.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.567 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.35 168.24 19.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.281 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.463 HH12 ' CA ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -118.11 112.19 19.86 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.966 0.413 . . . . 1.0 110.428 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.575 ' CB ' HD13 ' A' ' 65' ' ' ILE . . . -93.58 166.29 12.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.782 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -155.12 121.35 5.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.376 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.604 HG13 HD12 ' A' ' 53' ' ' ILE . 54.6 t -108.73 135.05 48.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.97 0.414 . . . . 1.0 110.215 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 52' ' ' GLY . 13.6 t -86.0 103.44 12.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.412 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.528 ' H ' ' HD2' ' A' ' 50' ' ' ARG . 6.8 mpt_? -63.55 -38.86 92.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.72 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.7 p -66.05 -30.56 71.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.404 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.567 ' H ' HG12 ' A' ' 49' ' ' VAL . . . -87.31 -67.48 1.33 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.21 -0.756 . . . . 1.0 111.21 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.604 HD12 HG13 ' A' ' 48' ' ' VAL . 3.1 mt -61.9 -94.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.971 -0.292 . . . . 1.0 110.214 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 53' ' ' ILE . . . 34.24 32.27 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.163 -0.775 . . . . 1.0 111.163 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.53 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 30.0 mtm180 -70.54 -60.34 2.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.829 0.347 . . . . 1.0 110.364 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 55' ' ' ARG . . . 170.72 -53.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.352 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.5 ttt-85 -101.99 -41.39 6.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.365 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.473 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -56.59 -41.4 76.92 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.048 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 61' ' ' PHE . 8.0 pt-20 -45.62 -46.44 14.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.734 -0.212 . . . . 1.0 110.584 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.8 tp -41.27 -17.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.12 0.486 . . . . 1.0 110.548 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.766 ' CD1' HD13 ' A' ' 115' ' ' LEU . 3.3 m-85 -49.42 -51.1 37.6 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.173 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.477 ' CD ' ' HZ2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -61.58 -40.09 93.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.542 -0.299 . . . . 1.0 110.675 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HZ2' ' CD ' ' A' ' 62' ' ' GLU . 13.9 mptt -61.68 -43.28 99.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.228 0.537 . . . . 1.0 110.249 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -63.6 -40.53 97.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.309 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 1.083 HD11 HD11 ' A' ' 115' ' ' LEU . 81.2 mt -64.32 -54.12 34.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.934 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.495 HG23 ' N ' ' A' ' 67' ' ' GLN . 28.9 m -64.01 -40.43 89.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.128 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.495 ' N ' HG23 ' A' ' 66' ' ' VAL . 55.9 tt0 -59.64 -18.62 43.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.273 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.3 m170 -97.3 1.86 50.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.487 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.07 0.51 59.98 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.057 -0.817 . . . . 1.0 111.057 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.686 ' O ' HG22 ' A' ' 65' ' ' ILE . . . -91.63 98.2 2.4 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.738 -0.945 . . . . 1.0 110.738 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.414 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 83.7 mt-30 -70.86 145.43 50.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.87 0.367 . . . . 1.0 110.568 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.626 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -136.34 156.65 48.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.084 0.469 . . . . 1.0 110.359 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.1 m -163.19 158.28 17.91 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.566 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.95 -153.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.952 2.435 . . . . 1.0 111.944 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 99' ' ' ARG . . . -47.62 -26.66 1.56 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.505 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' A' ' 77' ' ' GLY . 74.7 mt-30 -66.58 -20.12 65.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.281 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.463 ' CA ' HH12 ' A' ' 45' ' ' ARG . . . -37.51 103.88 0.03 OUTLIER Glycine 0 CA--C 1.538 1.475 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.44 ' HD2' HH22 ' A' ' 45' ' ' ARG . 52.2 Cg_exo -50.9 -28.76 24.71 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.647 2.232 . . . . 1.0 111.928 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.82 60.96 0.4 Allowed Glycine 0 CA--C 1.521 0.413 0 N-CA-C 111.099 -0.8 . . . . 1.0 111.099 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 80' ' ' VAL . 1.5 p -91.63 97.6 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.489 0.661 . . . . 1.0 110.249 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.19 -19.02 19.66 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.42 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -109.97 140.78 43.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.472 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.5 mm -131.1 106.18 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.614 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.4 t -91.21 131.35 38.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.52 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' A' ' 87' ' ' GLU . 27.9 m -132.73 162.59 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.607 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.586 ' C ' ' H ' ' A' ' 88' ' ' GLY . 15.3 t70 -68.92 18.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.375 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.563 ' H ' ' C ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER 68.87 -20.1 0.16 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.668 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -61.82 -67.71 1.98 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.2 ptp -63.54 145.82 54.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.641 0.258 . . . . 1.0 110.35 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -83.63 168.52 16.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.638 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.546 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.98 -53.32 59.18 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.466 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.546 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 15.7 pt-20 -50.39 -38.86 44.89 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.502 0.501 . . . . 1.0 110.107 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.441 ' HG3' ' HE ' ' A' ' 96' ' ' ARG . 67.7 ttt180 -74.81 -40.97 60.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.974 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -46.19 -27.89 1.11 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.642 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.594 HD22 ' N ' ' A' ' 95' ' ' LEU . 4.1 mm? -56.07 -59.51 4.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.268 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.441 ' HE ' ' HG3' ' A' ' 93' ' ' ARG . 41.2 ptt180 -78.1 -25.95 47.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.477 -0.329 . . . . 1.0 110.551 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.451 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -61.45 -42.24 98.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.932 -179.159 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -93.4 6.14 49.18 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.283 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 31.6 mmt-85 69.67 54.88 0.37 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.791 0.329 . . . . 1.0 111.065 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 95' ' ' LEU . 6.4 tp -146.78 116.83 4.56 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.781 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.35 -7.48 19.71 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.767 2.311 . . . . 1.0 112.876 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -179.85 140.68 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.699 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.516 ' CD1' HD11 ' A' ' 95' ' ' LEU . 1.7 mp -84.45 148.56 52.67 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.973 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.475 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 37.0 Cg_exo -59.34 -173.68 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.63 2.22 . . . . 1.0 111.657 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 29.8 Cg_exo -62.45 133.75 44.55 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.676 2.251 . . . . 1.0 111.798 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 72.42 -51.59 1.43 Allowed Glycine 0 C--O 1.22 -0.729 0 N-CA-C 110.935 -0.866 . . . . 1.0 110.935 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.537 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -17.8 129.71 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.905 0.415 . . . . 1.0 111.065 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -132.11 158.28 42.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.103 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.677 HD12 ' N ' ' A' ' 109' ' ' LEU . 3.4 mp -107.84 117.61 34.58 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.553 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.672 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.6 m -108.84 175.45 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.479 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -104.36 -174.67 2.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.811 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.0 p -64.04 -37.67 88.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.896 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.38 -44.45 76.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.586 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.672 ' CE3' HG21 ' A' ' 110' ' ' VAL . 60.8 t90 -57.51 -48.21 79.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.476 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 1.083 HD11 HD11 ' A' ' 65' ' ' ILE . 1.3 tt -58.77 -52.69 64.61 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.231 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.1 m -42.15 -57.43 2.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.519 -0.309 . . . . 1.0 110.629 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 121' ' ' GLU . 60.8 mt -55.0 -50.7 68.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.378 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.614 ' SG ' ' CE2' ' A' ' 114' ' ' TRP . 55.9 m -45.87 -33.52 3.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.456 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 65.5 mt -80.13 -50.93 9.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.915 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -70.18 -54.57 12.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.63 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 117' ' ' LEU . 79.9 mt-10 -75.54 7.6 3.55 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.538 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 121' ' ' GLU . 74.4 mtt85 25.09 53.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.54 0.525 . . . . 1.0 111.503 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -159.0 -170.24 2.95 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.306 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.4 tp -108.04 96.85 6.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.422 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.527 HG23 ' CD1' ' A' ' 114' ' ' TRP . 2.4 m -78.56 154.44 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.622 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -61.09 119.85 9.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.329 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.566 ' HB ' HG12 ' A' ' 110' ' ' VAL . 5.3 m -62.45 -42.05 94.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.719 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.52 ' N ' HG23 ' A' ' 127' ' ' VAL . . . -44.44 -19.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.553 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . -70.75 -40.71 64.81 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -135.95 34.65 2.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.682 0.277 . . . . 1.0 110.617 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.7 t -100.49 137.48 38.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.763 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 134' ' ' ILE . 39.6 mt -72.65 -71.85 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.373 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.568 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 20.6 t80 65.74 -36.55 0.23 Allowed 'General case' 0 C--O 1.208 -1.101 0 CA-C-O 118.306 -0.854 . . . . 1.0 110.804 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.624 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 156.3 -55.51 0.0 OUTLIER Pre-proline 0 N--CA 1.449 -0.506 0 O-C-N 124.736 1.272 . . . . 1.0 110.667 -178.612 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 29.8 Cg_endo . . . . . 0 C--N 1.304 -1.771 0 C-N-CA 122.617 2.212 . . . . 1.0 111.695 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.856 0.36 . . . . 1.0 110.417 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.469 ' CZ3' HD12 ' A' ' 41' ' ' LEU . 1.9 p-90 -107.32 -32.54 7.72 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.528 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.476 HD23 HD11 ' A' ' 44' ' ' LEU . 1.6 mt -79.32 -9.53 59.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.035 0.445 . . . . 1.0 110.633 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.7 t -67.04 -21.75 65.9 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.81 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.6 t -63.64 -15.71 59.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.846 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.476 HD11 HD23 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -138.15 169.52 17.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.392 -179.725 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -118.86 107.33 13.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.415 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.513 ' HB3' HG21 ' A' ' 65' ' ' ILE . . . -92.46 151.18 20.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.26 -0.427 . . . . 1.0 109.927 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -136.71 120.76 17.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.583 . . . . 1.0 110.556 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.403 ' CG1' HG21 ' A' ' 53' ' ' ILE . 88.3 t -96.48 135.9 29.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.861 -0.609 . . . . 1.0 109.969 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.447 HG23 ' H ' ' A' ' 53' ' ' ILE . 29.5 m -85.92 126.93 40.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.923 -0.581 . . . . 1.0 111.123 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -71.4 -37.2 71.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.988 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.604 ' OG1' HD11 ' A' ' 97' ' ' LEU . 99.1 m -57.0 -48.79 77.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.615 -178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . -90.5 -83.61 1.39 Allowed Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.458 -1.057 . . . . 1.0 110.458 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.447 ' H ' HG23 ' A' ' 49' ' ' VAL . 5.3 mm -53.23 78.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.71 0.766 . . . . 1.0 110.266 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 52' ' ' GLY . . . -166.7 25.78 0.15 Allowed Glycine 0 C--N 1.313 -0.75 0 CA-C-N 114.884 -1.053 . . . . 1.0 111.462 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.452 ' NH2' ' OD2' ' A' ' 86' ' ' ASP . 11.9 ptp180 -72.62 -37.33 68.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.844 0.354 . . . . 1.0 110.77 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -179.32 -81.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.609 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -90.7 -20.27 22.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.53 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.48 -27.25 9.95 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 120.967 0.413 . . . . 1.0 110.399 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.437 ' C ' ' N ' ' A' ' 61' ' ' PHE . 2.1 pt-20 -70.58 -35.66 73.17 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.717 0.294 . . . . 1.0 110.57 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.3 tp -46.2 -19.35 0.07 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.967 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.437 ' N ' ' C ' ' A' ' 59' ' ' GLU . 5.1 m-85 -61.23 -44.6 97.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.956 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.553 ' HA ' HD12 ' A' ' 65' ' ' ILE . 8.9 pt-20 -62.47 -40.42 96.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.975 0.417 . . . . 1.0 110.672 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.445 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 39.0 mttp -65.71 -41.9 91.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.665 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.543 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 90.9 mt-30 -63.14 -19.03 64.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.618 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 1.13 HD11 HD11 ' A' ' 115' ' ' LEU . 70.6 mt -83.38 -57.42 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.83 0.348 . . . . 1.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 71' ' ' GLN . 3.5 m -64.58 -32.78 59.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.052 0.454 . . . . 1.0 110.604 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -70.56 -21.44 62.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.508 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 64' ' ' GLN . 60.1 m170 -96.26 14.71 23.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.978 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.22 2.3 57.99 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.984 -0.847 . . . . 1.0 110.984 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.59 -146.0 2.47 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.096 -1.202 . . . . 1.0 110.096 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.412 ' HA ' HG12 ' A' ' 66' ' ' VAL . 0.0 OUTLIER 171.98 149.05 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.14 -0.318 . . . . 1.0 110.14 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.6 mt -107.9 113.67 27.04 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.444 ' O ' ' O ' ' A' ' 74' ' ' PRO . 2.5 m -135.36 91.07 19.29 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.205 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 73' ' ' CYS . 52.5 Cg_exo -52.37 -162.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.599 2.199 . . . . 1.0 112.003 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -61.23 -33.62 73.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.565 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.09 -19.54 65.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.485 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.24 -161.51 14.04 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.056 -0.818 . . . . 1.0 111.056 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.95 -37.48 78.2 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.805 2.337 . . . . 1.0 111.924 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.566 ' O ' HG12 ' A' ' 80' ' ' VAL . . . 160.15 -40.75 0.45 Allowed Glycine 0 C--O 1.223 -0.59 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 79' ' ' GLY . 0.4 OUTLIER 80.41 162.29 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 N-CA-C 110.106 -0.331 . . . . 1.0 110.106 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.69 -41.93 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.936 0.398 . . . . 1.0 110.74 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -110.29 137.12 48.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.974 0.416 . . . . 1.0 110.993 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 77.3 mt -133.02 109.38 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.955 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.512 HG21 HD12 ' A' ' 115' ' ' LEU . 31.1 t -88.08 138.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.249 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 87' ' ' GLU . 35.3 m -134.64 152.57 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.378 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' GLY . 66.4 t0 -74.45 43.41 0.18 Allowed 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.655 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.494 ' CD ' ' NZ ' ' A' ' 111' ' ' LYS . 2.8 mt-10 40.66 22.19 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.633 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . -100.06 -64.58 0.81 Allowed Glycine 0 N--CA 1.463 0.457 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.442 ' CE ' HG21 ' A' ' 49' ' ' VAL . 13.2 ptp -77.73 156.19 30.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.857 0.36 . . . . 1.0 110.548 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -93.07 173.95 7.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.498 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.651 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.69 -50.4 73.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.164 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.651 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 15.4 pt-20 -51.67 -38.31 54.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.055 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.516 HH21 HH21 ' A' ' 96' ' ' ARG . 69.7 ttt180 -83.15 -21.84 33.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.604 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.404 ' O ' ' CD2' ' A' ' 98' ' ' LEU . . . -62.04 -35.41 78.52 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.389 -0.524 . . . . 1.0 111.912 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 95' ' ' LEU . 7.6 mp -60.83 -41.84 96.56 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.853 0.359 . . . . 1.0 110.649 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.516 HH21 HH21 ' A' ' 93' ' ' ARG . 13.7 ptt85 -69.47 -23.69 63.69 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.252 -0.579 . . . . 1.0 109.798 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.604 HD11 ' OG1' ' A' ' 51' ' ' THR . 0.2 OUTLIER -65.9 -41.29 91.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.37 0.605 . . . . 1.0 111.19 -177.553 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.766 HD23 ' H ' ' A' ' 98' ' ' LEU . 2.4 pt? -114.9 5.98 15.27 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.877 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.467 ' CD ' ' N ' ' A' ' 99' ' ' ARG . 1.2 mpt_? 58.05 57.35 4.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.609 -0.269 . . . . 1.0 110.441 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.2 tp -104.89 110.3 64.28 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 120.597 -0.441 . . . . 1.0 110.354 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.08 -40.94 58.98 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.151 1.901 . . . . 1.0 112.268 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -173.69 135.64 0.53 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.708 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.9 mp -53.28 111.69 2.94 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.187 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.453 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 46.9 Cg_exo -50.49 -174.49 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 122.097 1.865 . . . . 1.0 112.235 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 31.3 Cg_exo -58.57 113.58 1.62 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.836 2.357 . . . . 1.0 112.058 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 91.79 -66.53 2.23 Favored Glycine 0 C--O 1.221 -0.714 0 N-CA-C 110.413 -1.075 . . . . 1.0 110.413 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.52 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -13.42 125.68 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.109 0.535 . . . . 1.0 111.487 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -133.6 156.34 48.02 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.967 0.413 . . . . 1.0 110.35 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.85 112.89 24.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.917 -0.583 . . . . 1.0 109.614 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.551 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.4 m -107.27 168.74 3.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 123.705 0.628 . . . . 1.0 109.843 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.494 ' NZ ' ' CD ' ' A' ' 87' ' ' GLU . 3.6 mtpp -102.64 -177.67 3.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.746 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.9 m -60.48 -39.87 89.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.459 -0.791 . . . . 1.0 110.767 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.24 -39.32 66.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.687 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.551 ' CE3' HG21 ' A' ' 110' ' ' VAL . 76.1 t90 -60.76 -47.05 88.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.848 0.356 . . . . 1.0 110.714 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 1.13 HD11 HD11 ' A' ' 65' ' ' ILE . 0.6 OUTLIER -60.14 -52.28 66.02 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.219 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.2 p -51.06 -42.27 60.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.154 -0.475 . . . . 1.0 109.973 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 mt -61.32 -52.71 63.54 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.405 -0.518 . . . . 1.0 109.651 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.549 ' O ' ' N ' ' A' ' 122' ' ' ARG . 2.2 m -50.48 -36.37 33.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.702 -0.481 . . . . 1.0 109.702 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.6 mt -69.15 -52.92 23.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.148 0.499 . . . . 1.0 110.575 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -60.66 -27.42 67.81 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.096 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -103.32 -4.31 24.4 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.325 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.549 ' N ' ' O ' ' A' ' 118' ' ' CYS . 37.8 mmt180 44.23 47.95 7.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.717 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.517 ' HE ' HG12 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -172.36 -175.5 1.4 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.51 -179.287 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -86.37 126.73 34.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.973 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.517 HG12 ' HE ' ' A' ' 123' ' ' ARG . 20.4 m -114.15 155.4 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.572 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -60.94 159.21 11.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.052 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' GLY . 3.6 m -114.67 3.23 7.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.493 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.35 67.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.006 0.431 . . . . 1.0 110.582 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 159.27 -34.3 0.47 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.186 -0.765 . . . . 1.0 111.186 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -103.77 1.24 31.43 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.063 0.459 . . . . 1.0 110.428 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 t -90.13 140.99 29.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.906 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.581 ' C ' ' H ' ' A' ' 134' ' ' ILE . 60.7 mt -92.27 -72.46 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 116.266 -0.424 . . . . 1.0 109.883 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.528 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 19.1 t80 64.77 -36.13 0.19 Allowed 'General case' 0 C--O 1.222 -0.345 0 O-C-N 123.945 0.778 . . . . 1.0 111.303 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.585 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 155.17 -55.43 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.414 0 O-C-N 124.581 1.175 . . . . 1.0 110.14 -178.438 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.6 Cg_endo . . . . . 0 N--CA 1.492 1.411 0 C-N-CA 122.216 1.944 . . . . 1.0 111.974 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 120.782 0.325 . . . . 1.0 110.478 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.577 ' CZ3' HD13 ' A' ' 41' ' ' LEU . 8.5 p-90 -100.08 -59.05 1.78 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.015 0.436 . . . . 1.0 110.276 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.577 HD13 ' CZ3' ' A' ' 40' ' ' TRP . 5.6 tp -62.7 -30.39 71.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.671 -0.695 . . . . 1.0 110.267 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.2 t -48.13 -14.17 0.05 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.676 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.471 ' N ' ' C ' ' A' ' 41' ' ' LEU . 42.1 p -68.3 -13.48 62.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.8 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.93 169.08 18.37 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.8 0.333 . . . . 1.0 110.547 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.41 HH11 ' HA3' ' A' ' 79' ' ' GLY . 93.7 mtt180 -122.08 137.92 54.64 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.154 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.698 ' HB3' HD13 ' A' ' 65' ' ' ILE . . . -124.13 166.17 16.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.467 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -153.76 129.19 9.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.713 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.3 m -100.8 137.42 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.373 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.539 ' O ' ' O ' ' A' ' 52' ' ' GLY . 13.5 t -98.35 135.25 33.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.857 -0.611 . . . . 1.0 109.996 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.554 ' CD ' ' H ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -62.05 -43.52 98.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.739 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.631 ' OG1' HD12 ' A' ' 97' ' ' LEU . 13.1 m -51.7 -21.35 2.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.384 0.612 . . . . 1.0 110.548 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 49' ' ' VAL . . . -156.99 120.17 0.96 Allowed Glycine 0 C--O 1.219 -0.782 0 N-CA-C 109.383 -1.487 . . . . 1.0 109.383 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.569 HG22 ' O ' ' A' ' 53' ' ' ILE . 4.7 mm 115.28 -6.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.047 1.339 . . . . 1.0 109.52 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.01 22.74 30.08 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.754 -0.939 . . . . 1.0 110.754 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -60.97 -57.1 14.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.638 0.256 . . . . 1.0 110.588 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.466 ' O ' ' CG ' ' A' ' 59' ' ' GLU . . . 179.74 -67.44 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.386 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -91.06 -27.5 18.56 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.581 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.406 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -57.36 -32.63 66.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.319 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 61' ' ' PHE . 3.3 pt-20 -66.48 -39.5 88.79 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 116.159 -0.473 . . . . 1.0 109.775 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 tp -41.67 -17.51 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.183 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.604 ' HA ' HE21 ' A' ' 64' ' ' GLN . 6.1 m-85 -60.49 -42.89 97.24 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.22 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.504 ' HA ' HD12 ' A' ' 65' ' ' ILE . 1.3 pt-20 -67.74 -32.12 72.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.664 0.268 . . . . 1.0 111.159 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -70.67 -56.77 5.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.877 0.37 . . . . 1.0 111.013 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.604 HE21 ' HA ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -51.96 -31.23 28.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.76 -0.655 . . . . 1.0 109.527 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.808 HD11 HD11 ' A' ' 115' ' ' LEU . 31.0 mt -65.74 -46.99 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.67 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.81 -43.72 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.439 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -58.7 -26.93 64.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.179 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 64' ' ' GLN . 5.2 m-70 -79.27 -2.11 39.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.549 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.44 -1.35 58.64 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.928 -0.869 . . . . 1.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.75 88.6 1.54 Allowed Glycine 0 N--CA 1.461 0.363 0 N-CA-C 110.689 -0.965 . . . . 1.0 110.689 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.581 ' CD ' ' H ' ' A' ' 71' ' ' GLN . 2.6 pm0 -59.82 146.34 42.19 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.7 mt -92.29 110.82 22.22 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 91.1 m -119.97 86.88 37.56 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.603 ' C ' ' H ' ' A' ' 76' ' ' GLN . 14.3 Cg_endo -55.21 -159.71 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 122.004 1.803 . . . . 1.0 112.64 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -54.61 -0.6 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.035 -0.529 . . . . 1.0 110.588 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.603 ' H ' ' C ' ' A' ' 74' ' ' PRO . 16.4 pt20 -62.78 -19.67 64.24 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.109 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -156.12 160.32 30.01 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 120.755 -0.736 . . . . 1.0 111.599 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.535 ' O ' ' O ' ' A' ' 79' ' ' GLY . 49.5 Cg_exo -52.17 -10.97 0.86 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.231 1.954 . . . . 1.0 112.09 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.548 ' O ' ' C ' ' A' ' 80' ' ' VAL . . . -53.0 -118.31 0.01 OUTLIER Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.712 -0.955 . . . . 1.0 110.712 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 80' ' ' VAL . 2.3 p 10.6 74.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.592 0.71 . . . . 1.0 111.889 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.19 -24.23 27.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.352 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.63 ' CD2' ' CZ2' ' A' ' 114' ' ' TRP . 79.2 m80 -116.67 140.22 49.65 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.808 0.337 . . . . 1.0 110.262 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.611 HD13 ' O ' ' A' ' 82' ' ' HIS . 2.9 mm -128.68 111.3 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.427 -0.583 . . . . 1.0 109.427 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 115' ' ' LEU . 1.6 p -96.14 133.68 36.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.204 0.526 . . . . 1.0 110.379 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.8 m -127.82 165.61 26.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.562 -0.744 . . . . 1.0 110.536 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 88' ' ' GLY . 26.2 p-10 -77.06 14.26 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.636 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 64.81 -2.91 0.62 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.343 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -75.27 -49.87 8.98 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.305 -0.718 . . . . 1.0 111.305 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.0 ptp -88.87 156.38 18.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.82 0.343 . . . . 1.0 110.709 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -83.55 166.27 18.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.283 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.698 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -58.8 -47.58 84.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.993 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.698 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 17.5 pt-20 -53.69 -38.23 64.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.888 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.48 ' HG3' HD23 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -70.23 -47.04 63.16 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.197 179.656 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.07 -31.07 17.64 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.99 -0.684 . . . . 1.0 111.349 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.03 -47.58 85.28 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.346 -0.541 . . . . 1.0 111.267 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -70.91 -42.54 69.79 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.582 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.631 HD12 ' OG1' ' A' ' 51' ' ' THR . 3.8 mm? -64.36 -43.64 93.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.826 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.947 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -84.67 -4.27 58.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.545 -179.189 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.405 ' O ' ' CB ' ' A' ' 75' ' ' ALA . 75.1 mmt-85 68.57 60.94 0.37 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.038 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.517 ' HB2' HD11 ' A' ' 98' ' ' LEU . 7.7 tp -129.58 111.45 17.68 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.764 -0.198 . . . . 1.0 110.799 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.66 -42.64 61.13 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.916 1.744 . . . . 1.0 111.947 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -174.34 130.31 0.36 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.567 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 104' ' ' PRO . 69.5 mt -37.37 100.48 0.2 Allowed Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.094 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' LEU . 54.8 Cg_exo -46.01 -178.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.276 1.984 . . . . 1.0 112.407 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.14 -43.42 59.28 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.634 2.222 . . . . 1.0 112.65 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.39 68.98 0.25 Allowed Glycine 0 N--CA 1.468 0.775 0 N-CA-C 110.97 -0.852 . . . . 1.0 110.97 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.64 138.6 7.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.82 0.343 . . . . 1.0 110.587 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -146.02 151.93 38.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.256 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.88 113.26 25.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.962 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.704 HG21 ' CE3' ' A' ' 114' ' ' TRP . 12.0 m -110.63 166.33 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.501 -0.772 . . . . 1.0 109.885 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.51 ' NZ ' ' O ' ' A' ' 130' ' ' PHE . 28.8 mtmm -98.4 -176.99 3.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.731 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.3 t -62.94 -39.55 94.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.569 -0.742 . . . . 1.0 110.527 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.42 -41.86 66.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.227 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.704 ' CE3' HG21 ' A' ' 110' ' ' VAL . 75.1 t90 -61.6 -53.64 53.58 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.613 -0.435 . . . . 1.0 110.592 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.808 HD11 HD11 ' A' ' 65' ' ' ILE . 3.3 tt -61.94 -53.12 60.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.472 -0.491 . . . . 1.0 109.817 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 80.9 p -51.59 -46.71 63.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.492 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.4 mt -64.91 -54.99 21.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.355 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 1.4 p -50.17 -30.91 12.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.386 0.612 . . . . 1.0 110.284 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.582 HD11 ' OE1' ' A' ' 64' ' ' GLN . 2.3 tp -70.01 -52.8 21.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.265 -0.88 . . . . 1.0 110.614 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -66.95 -37.87 85.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.564 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' A' ' 123' ' ' ARG . 78.3 mm-40 -78.98 9.03 4.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.181 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.479 ' NH2' ' NE1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER 36.06 32.68 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.788 -0.642 . . . . 1.0 111.092 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.438 ' CG ' ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -158.09 177.24 11.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.076 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.402 ' O ' ' NH1' ' A' ' 123' ' ' ARG . 5.6 tt -92.65 122.11 34.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.033 0.444 . . . . 1.0 110.766 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.425 HG23 ' CD1' ' A' ' 114' ' ' TRP . 3.2 m -100.0 152.23 4.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.347 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -62.18 150.21 39.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.286 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 129' ' ' GLY . 2.3 m -102.46 6.31 10.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.468 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.6 56.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.78 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 168.34 -37.75 0.21 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.51 ' O ' ' NZ ' ' A' ' 111' ' ' LYS . 50.4 m-85 -89.47 -18.24 27.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.728 0.299 . . . . 1.0 110.517 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.8 t -72.15 137.58 47.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.1 0.476 . . . . 1.0 110.78 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 134' ' ' ILE . 59.1 mt -83.62 -69.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.333 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.486 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 16.7 t80 62.34 -31.47 0.09 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.368 -0.833 . . . . 1.0 112.133 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.588 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 151.7 -55.12 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 124.6 1.16 . . . . 1.0 109.854 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.5 Cg_endo . . . . . 0 N--CA 1.497 1.688 0 C-N-CA 121.824 1.682 . . . . 1.0 112.137 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 120.698 0.285 . . . . 1.0 110.566 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.633 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -109.99 -40.16 4.83 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.182 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.466 ' HG ' ' CE3' ' A' ' 40' ' ' TRP . 8.7 mt -79.61 1.86 24.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.42 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.2 t -54.99 -48.6 73.1 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.309 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.6 p -72.11 -37.28 69.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.929 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.2 mt -73.9 140.78 45.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.982 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.628 ' H ' HG22 ' A' ' 81' ' ' THR . 0.2 OUTLIER -124.94 102.81 7.71 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.979 178.853 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.482 ' O ' HD22 ' A' ' 72' ' ' LEU . . . -92.2 169.05 10.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.21 0.529 . . . . 1.0 110.845 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -156.33 124.14 5.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.672 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.572 HG12 HG13 ' A' ' 84' ' ' VAL . 14.4 m -103.04 143.72 14.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.047 0.451 . . . . 1.0 110.221 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 52' ' ' GLY . 18.9 m -97.07 161.21 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.449 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -81.25 -60.79 2.15 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.42 -0.354 . . . . 1.0 110.708 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.648 HG23 HD11 ' A' ' 97' ' ' LEU . 43.9 p -46.88 -12.08 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.983 0.42 . . . . 1.0 110.261 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.641 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -151.43 118.71 0.93 Allowed Glycine 0 C--O 1.205 -1.703 0 N-CA-C 109.46 -1.456 . . . . 1.0 109.46 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.641 ' HB ' ' O ' ' A' ' 52' ' ' GLY . 4.6 mm 102.22 -16.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.816 0.846 . . . . 1.0 110.452 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.5 29.13 1.23 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.661 -0.976 . . . . 1.0 110.661 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 32.6 mtt180 -66.66 -60.92 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.764 0.316 . . . . 1.0 110.56 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 55' ' ' ARG . . . 172.47 -61.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.249 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -87.7 -32.47 19.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.311 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.12 83.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.363 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 61' ' ' PHE . 9.3 pt-20 -66.42 -42.26 88.04 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.382 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.3 tp -45.84 -13.54 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.111 0.481 . . . . 1.0 110.833 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 59' ' ' GLU . 3.8 m-30 -56.72 -47.64 79.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.884 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' HA ' HD12 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -62.09 -40.09 94.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.437 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -55.95 -46.41 78.56 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.632 -0.427 . . . . 1.0 110.222 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.485 ' O ' ' CD2' ' A' ' 68' ' ' HIS . 77.9 mt-30 -65.02 -38.85 92.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.147 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 115' ' ' LEU . 77.5 mt -64.05 -43.69 97.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.48 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.16 -45.03 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.252 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -60.18 -26.01 66.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.318 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 64' ' ' GLN . 42.9 m170 -79.9 0.45 31.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.387 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.31 -19.31 54.42 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.871 -0.892 . . . . 1.0 110.871 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.34 94.04 0.63 Allowed Glycine 0 C--O 1.224 -0.478 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.44 ' C ' HD23 ' A' ' 72' ' ' LEU . 14.0 pt20 -77.13 145.23 37.9 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.975 -0.29 . . . . 1.0 110.439 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.483 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 4.6 mt -107.18 145.58 32.41 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.938 0.399 . . . . 1.0 110.302 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 72' ' ' LEU . 3.8 m -163.44 91.21 1.16 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.381 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 77' ' ' GLY . 43.7 Cg_endo -70.02 -167.09 0.22 Allowed 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.599 2.199 . . . . 1.0 111.989 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 98' ' ' LEU . . . -38.63 -27.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.837 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 74' ' ' PRO . 9.8 pt20 -64.03 1.58 0.67 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.399 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 74' ' ' PRO . . . 162.78 161.78 12.76 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.063 -0.815 . . . . 1.0 111.063 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.03 143.72 73.28 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.63 2.22 . . . . 1.0 111.817 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.403 ' HA2' ' HE ' ' A' ' 45' ' ' ARG . . . 116.42 66.01 0.38 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.224 -0.751 . . . . 1.0 111.224 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 80' ' ' VAL . 2.7 p -160.79 67.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.423 0.63 . . . . 1.0 110.475 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.628 HG22 ' H ' ' A' ' 45' ' ' ARG . 15.3 t -74.26 -33.29 63.24 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.003 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -117.37 146.0 43.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.938 0.399 . . . . 1.0 110.848 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.598 HD13 ' CD1' ' A' ' 98' ' ' LEU . 22.5 mt -137.51 111.43 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.839 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.572 HG13 HG12 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -95.15 140.59 16.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.121 0.486 . . . . 1.0 110.633 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.465 ' C ' ' H ' ' A' ' 87' ' ' GLU . 28.2 m -131.16 166.64 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.83 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.59 ' C ' ' H ' ' A' ' 88' ' ' GLY . 49.4 p-10 -73.07 14.16 0.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.665 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' A' ' 85' ' ' VAL . 18.6 mt-10 65.82 -15.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.776 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -64.13 -49.47 66.51 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.917 -0.873 . . . . 1.0 110.917 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.5 ptp -90.03 158.13 17.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.862 0.363 . . . . 1.0 110.471 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -89.1 -179.64 5.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.667 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -67.67 -37.59 82.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.37 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.538 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 15.2 pt-20 -58.91 -46.05 88.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.979 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.482 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 1.9 tmm_? -79.36 -24.34 42.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.022 -0.536 . . . . 1.0 111.231 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.55 -37.47 70.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.569 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.629 HD11 HD11 ' A' ' 103' ' ' LEU . 7.4 mp -60.96 -36.27 78.96 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.11 -0.236 . . . . 1.0 110.674 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.536 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 6.6 mmp_? -62.65 -36.86 84.22 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.247 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.648 HD11 HG23 ' A' ' 51' ' ' THR . 4.3 mm? -62.61 -42.21 99.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.054 0.454 . . . . 1.0 111.266 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.598 ' CD1' HD13 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -97.32 5.31 50.12 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.668 -0.696 . . . . 1.0 109.663 -178.781 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.536 ' NH1' ' O ' ' A' ' 96' ' ' ARG . 51.2 mmt-85 51.01 24.32 1.81 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.267 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.7 tp -86.53 121.37 72.23 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.776 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.07 -17.17 36.34 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.465 2.11 . . . . 1.0 112.399 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 176.78 152.8 0.2 Allowed 'General case' 0 C--O 1.235 0.297 0 O-C-N 123.323 0.389 . . . . 1.0 110.453 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.774 HD12 ' N ' ' A' ' 103' ' ' LEU . 3.8 mp -86.47 140.6 33.98 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.949 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.02 164.41 35.75 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.416 2.077 . . . . 1.0 111.952 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -40.69 135.19 2.16 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.6 2.2 . . . . 1.0 112.191 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 107' ' ' ALA . . . 80.74 -69.56 3.19 Favored Glycine 0 C--O 1.228 -0.226 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 106' ' ' GLY . . . -29.02 150.6 0.0 OUTLIER 'General case' 0 C--N 1.345 0.379 0 O-C-N 123.924 0.426 . . . . 1.0 110.964 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.511 ' OE1' HG11 ' A' ' 127' ' ' VAL . 9.7 pt20 -162.88 153.59 16.8 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.48 -0.488 . . . . 1.0 110.372 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.52 ' O ' ' OG ' ' A' ' 131' ' ' SER . 0.4 OUTLIER -85.37 112.56 20.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.915 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.472 HG21 ' CE3' ' A' ' 114' ' ' TRP . 11.2 m -104.68 172.58 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 123.475 0.484 . . . . 1.0 109.743 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -102.21 -173.73 2.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.661 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.1 m -63.57 -36.92 85.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.714 -0.675 . . . . 1.0 110.834 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.93 -36.23 65.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.502 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.472 ' CE3' HG21 ' A' ' 110' ' ' VAL . 89.3 t90 -68.67 -44.71 73.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.906 0.384 . . . . 1.0 110.542 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.54 HD11 HD11 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -66.97 -59.28 3.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.111 0.481 . . . . 1.0 111.037 -179.196 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.7 m -45.17 -58.24 3.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.614 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.8 mp -60.01 -52.99 63.04 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 120.629 -0.429 . . . . 1.0 110.645 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 46.5 t -55.39 -31.21 61.63 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.696 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.23 -55.25 12.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.029 0.442 . . . . 1.0 111.872 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -77.06 -38.94 51.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.993 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 62.7 mm-40 -53.17 -48.3 68.1 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.432 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 121' ' ' GLU . 7.0 tpt180 86.61 27.35 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.733 0.645 . . . . 1.0 111.168 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.42 ' C ' ' CD ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -159.49 -171.45 3.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.445 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.1 tp -91.7 135.65 33.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.439 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 m -120.42 154.44 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.331 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 126' ' ' ASP . 54.6 p-10 -61.73 146.14 50.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.343 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 129' ' ' GLY . 9.0 t -104.64 -23.48 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 110.218 -0.29 . . . . 1.0 110.218 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.16 68.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.978 0.418 . . . . 1.0 110.499 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 165.81 -27.17 0.18 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.141 -0.783 . . . . 1.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -106.7 -3.01 21.02 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.667 0.27 . . . . 1.0 110.583 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.52 ' OG ' ' O ' ' A' ' 109' ' ' LEU . 3.2 m -104.7 125.61 50.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.976 0.417 . . . . 1.0 110.767 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.58 ' C ' ' H ' ' A' ' 134' ' ' ILE . 3.2 mp -64.63 -50.09 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.331 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.526 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 17.0 t80 65.67 -36.7 0.23 Allowed 'General case' 0 C--O 1.217 -0.615 0 O-C-N 124.278 0.986 . . . . 1.0 111.212 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.615 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 156.67 -54.65 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.311 0 O-C-N 124.663 1.227 . . . . 1.0 110.452 -178.658 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 27.5 Cg_endo . . . . . 0 C--N 1.309 -1.54 0 C-N-CA 122.331 2.021 . . . . 1.0 111.682 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.629 0.252 . . . . 1.0 110.568 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.579 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -102.17 -50.89 3.51 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.832 0.349 . . . . 1.0 110.462 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.55 ' HG ' HD11 ' A' ' 44' ' ' LEU . 2.2 tp -80.87 -0.65 39.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.733 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.6 p -66.95 -15.59 63.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.424 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.3 p -67.19 -15.56 63.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.517 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.683 HD12 ' C ' ' A' ' 44' ' ' LEU . 4.2 pp -136.21 168.84 18.64 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.387 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -116.65 118.09 31.63 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.009 0.433 . . . . 1.0 110.334 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.598 ' CB ' HD13 ' A' ' 65' ' ' ILE . . . -95.6 161.47 14.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.475 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -153.96 118.09 4.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.375 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.53 HG13 HD12 ' A' ' 53' ' ' ILE . 76.1 t -107.32 135.09 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.241 0.543 . . . . 1.0 110.379 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.549 HG12 ' H ' ' A' ' 52' ' ' GLY . 19.0 t -73.7 99.1 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.447 -0.797 . . . . 1.0 110.206 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.529 HH21 HH12 ' A' ' 99' ' ' ARG . 84.8 mtm-85 -58.34 -37.8 75.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.42 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.9 p -75.92 -17.26 59.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.539 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.549 ' H ' HG12 ' A' ' 49' ' ' VAL . . . -97.44 -59.5 0.97 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.202 -0.759 . . . . 1.0 111.202 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.53 HD12 HG13 ' A' ' 48' ' ' VAL . 2.7 mt -86.42 71.32 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.161 0.505 . . . . 1.0 110.341 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -117.03 23.38 9.97 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 110.783 -0.927 . . . . 1.0 110.783 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.65 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 4.2 ptm180 -75.03 -63.41 1.27 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.551 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 55' ' ' ARG . . . 159.93 138.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? 68.54 -42.14 0.47 Allowed 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 124.191 0.932 . . . . 1.0 110.327 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' A' ' 56' ' ' ALA . . . -65.37 -28.65 69.43 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.868 -0.605 . . . . 1.0 110.532 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.72 -39.75 80.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.395 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.99 -19.05 0.63 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.182 0.515 . . . . 1.0 110.582 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -44.18 -50.96 8.51 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.732 -0.667 . . . . 1.0 111.036 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.415 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -64.45 -43.98 92.55 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.626 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -62.41 -43.06 99.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.375 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -59.21 -26.13 64.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.272 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.701 HD11 HD21 ' A' ' 115' ' ' LEU . 80.8 mt -86.28 -23.32 6.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.366 0.603 . . . . 1.0 110.38 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 62' ' ' GLU . 68.4 t -79.06 -37.66 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 O-C-N 122.056 -0.403 . . . . 1.0 110.706 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -68.08 -38.87 82.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.127 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.492 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -68.49 -6.41 24.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.274 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.44 7.11 52.25 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.465 -1.054 . . . . 1.0 110.465 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.7 96.89 2.19 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 110.267 -1.133 . . . . 1.0 110.267 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -68.32 144.13 54.92 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.734 -0.387 . . . . 1.0 110.287 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.0 mt -91.81 135.29 34.03 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.054 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.8 m -104.61 103.62 41.06 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.378 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 76' ' ' GLN . 56.3 Cg_endo -75.17 168.35 24.9 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.397 2.065 . . . . 1.0 111.955 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.57 -7.39 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.558 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 74' ' ' PRO . 42.0 mt-30 -76.43 -9.6 58.77 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 110.151 -0.315 . . . . 1.0 110.151 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -145.35 147.87 19.25 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.69 -16.44 33.66 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.698 2.266 . . . . 1.0 111.989 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -42.82 -25.92 0.39 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.437 -0.665 . . . . 1.0 111.437 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.435 HG11 HD11 ' A' ' 100' ' ' LEU . 12.8 p -64.79 138.88 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.965 0.412 . . . . 1.0 110.471 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.99 -34.27 0.23 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.536 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -108.78 125.05 51.52 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.619 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.412 ' O ' ' O ' ' A' ' 110' ' ' VAL . 22.5 mm -118.95 106.92 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.23 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.41 HG11 HD23 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -95.08 135.29 29.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.339 -0.846 . . . . 1.0 110.088 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.54 ' C ' ' H ' ' A' ' 87' ' ' GLU . 27.7 m -135.41 155.65 37.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.412 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 88' ' ' GLY . 53.5 p-10 -71.29 22.5 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.581 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 85' ' ' VAL . 29.9 mt-10 65.96 -13.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 1.0 111.017 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -61.81 -41.76 99.66 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.074 -0.811 . . . . 1.0 111.074 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.6 ptp -103.41 154.32 19.54 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.782 0.325 . . . . 1.0 110.53 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -90.16 172.81 8.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.133 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.594 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -58.53 -54.66 44.57 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.544 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.594 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 1.3 pp20? -52.07 -40.18 60.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.866 -0.606 . . . . 1.0 110.098 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -71.97 -39.13 69.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.832 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.91 -28.65 62.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.936 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.5 mp -61.82 -46.36 89.82 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.023 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.1 mmp_? -70.91 -40.98 71.84 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.38 -0.528 . . . . 1.0 111.345 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.92 -44.93 83.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.168 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.873 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.86 -13.93 59.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.63 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.529 HH12 HH21 ' A' ' 50' ' ' ARG . 2.9 mtp180 77.93 60.91 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 123.977 0.798 . . . . 1.0 111.937 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.736 HD12 HD11 ' A' ' 98' ' ' LEU . 3.3 mt -148.71 114.02 3.73 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 120.12 -0.632 . . . . 1.0 110.116 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.519 ' HD2' HD23 ' A' ' 100' ' ' LEU . 58.5 Cg_endo -73.49 -11.45 24.47 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.128 1.886 . . . . 1.0 112.602 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 179.43 133.8 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.427 0.454 . . . . 1.0 110.207 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.604 HD22 HD13 ' A' ' 100' ' ' LEU . 10.8 mt -88.85 146.66 37.29 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.958 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.65 165.7 26.61 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 122.206 1.937 . . . . 1.0 112.311 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -43.48 140.63 3.99 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.117 1.878 . . . . 1.0 112.282 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.48 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 82.31 -64.46 4.26 Favored Glycine 0 N--CA 1.453 -0.181 0 N-CA-C 110.305 -1.118 . . . . 1.0 110.305 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.48 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -22.33 134.87 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 O-C-N 124.134 0.549 . . . . 1.0 110.868 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.484 ' O ' ' NE2' ' A' ' 108' ' ' GLN . 0.0 OUTLIER -143.69 157.52 44.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.897 0.38 . . . . 1.0 110.145 -177.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 109' ' ' LEU . 4.0 mp -108.24 121.8 45.64 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.773 -0.648 . . . . 1.0 110.778 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.471 HG13 ' NE2' ' A' ' 108' ' ' GLN . 3.1 m -108.06 -178.23 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.109 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -109.28 -176.63 3.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.501 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.4 m -60.98 -37.79 83.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.817 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.445 ' O ' HD13 ' A' ' 117' ' ' LEU . . . -56.06 -47.34 78.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.944 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.461 ' CE3' HG21 ' A' ' 110' ' ' VAL . 72.9 t90 -56.43 -37.9 70.86 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.312 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.701 HD21 HD11 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -68.56 -61.16 1.94 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.268 -0.573 . . . . 1.0 110.929 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.9 t -49.39 -52.21 30.0 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.388 -0.525 . . . . 1.0 110.47 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 113' ' ' ALA . 7.1 mp -48.93 -44.88 40.88 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.068 -0.514 . . . . 1.0 109.937 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.529 ' SG ' HG23 ' A' ' 125' ' ' VAL . 74.5 m -60.25 -43.42 96.11 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.362 -0.535 . . . . 1.0 110.832 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 65.9 mt -50.21 -57.9 6.77 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.589 -0.444 . . . . 1.0 111.386 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -73.22 -49.01 30.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.727 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 74.6 mm-40 -54.27 -48.35 71.31 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.472 -0.491 . . . . 1.0 110.362 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 121' ' ' GLU . 8.7 tpp180 79.48 39.59 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.836 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.418 ' C ' ' CD ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -165.48 -173.18 2.69 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.428 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.3 tp -82.52 122.24 27.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.014 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.529 HG23 ' SG ' ' A' ' 118' ' ' CYS . 40.2 t -97.19 154.7 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-O 121.274 0.559 . . . . 1.0 110.432 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.449 ' N ' HG12 ' A' ' 125' ' ' VAL . 64.1 t0 -69.29 115.38 8.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.394 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.461 HG23 ' N ' ' A' ' 128' ' ' ALA . 5.0 m -64.16 -39.64 86.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.607 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.461 ' N ' HG23 ' A' ' 127' ' ' VAL . . . -53.73 -25.52 19.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.506 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.69 -38.6 93.31 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.243 -0.743 . . . . 1.0 111.243 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.74 43.01 1.98 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.848 0.356 . . . . 1.0 110.883 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 127' ' ' VAL . 8.7 t -107.84 132.9 52.93 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.288 0.566 . . . . 1.0 111.182 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.57 ' C ' ' H ' ' A' ' 134' ' ' ILE . 54.8 mt -75.64 -69.23 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 CA-C-N 115.084 -0.962 . . . . 1.0 109.881 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.493 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 15.8 t80 65.83 -36.58 0.24 Allowed 'General case' 0 C--O 1.223 -0.335 0 O-C-N 124.514 1.134 . . . . 1.0 111.578 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.57 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 156.03 -55.78 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.512 0 O-C-N 125.009 1.443 . . . . 1.0 109.752 -178.279 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 30.0 Cg_endo . . . . . 0 N--CA 1.49 1.298 0 C-N-CA 122.169 1.912 . . . . 1.0 112.01 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 120.944 0.402 . . . . 1.0 110.643 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 1.1 p-90 -86.83 -49.81 7.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.094 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.581 HD13 ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -62.58 -35.11 78.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.73 0.776 . . . . 1.0 110.019 -179.164 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.66 -33.77 64.38 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.338 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 t -43.54 -25.67 0.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.795 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.83 167.87 18.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.343 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.401 ' O ' HG22 ' A' ' 81' ' ' THR . 27.2 ttm180 -115.94 112.65 22.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 1.0 110.167 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.474 ' HB3' HD13 ' A' ' 65' ' ' ILE . . . -92.36 165.95 12.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.49 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.529 ' CE1' ' O ' ' A' ' 73' ' ' CYS . 49.1 t60 -144.33 122.11 11.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.154 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.469 ' O ' ' NH1' ' A' ' 50' ' ' ARG . 71.5 t -110.95 133.97 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.341 -0.391 . . . . 1.0 110.31 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.2 m -71.94 134.01 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.39 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.486 ' N ' ' CD ' ' A' ' 50' ' ' ARG . 9.6 mpt_? -64.27 -40.75 96.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.546 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.483 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 7.6 p -104.19 138.19 41.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.1 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.26 -16.44 56.9 Favored Glycine 0 C--O 1.226 -0.402 0 N-CA-C 111.012 -0.835 . . . . 1.0 111.012 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.523 ' C ' ' H ' ' A' ' 55' ' ' ARG . 1.5 mm -117.75 -23.23 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.991 0.424 . . . . 1.0 110.248 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.37 35.01 0.44 Allowed Glycine 0 C--N 1.314 -0.678 0 C-N-CA 120.242 -0.98 . . . . 1.0 111.25 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.523 ' H ' ' C ' ' A' ' 53' ' ' ILE . 2.0 ptp180 -76.71 -60.96 2.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.582 0.229 . . . . 1.0 110.602 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.591 ' C ' ' H ' ' A' ' 58' ' ' ALA . . . 171.68 125.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.06 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.7 ttp85 68.74 -32.34 0.22 Allowed 'General case' 0 CA--C 1.518 -0.275 0 O-C-N 123.502 0.501 . . . . 1.0 110.323 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 56' ' ' ALA . . . -63.55 -36.5 83.99 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.63 0.728 . . . . 1.0 110.09 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 61' ' ' PHE . 12.3 pt-20 -60.36 -39.19 86.3 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.353 -0.539 . . . . 1.0 110.852 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.0 tp -42.29 -17.95 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.313 0.577 . . . . 1.0 110.854 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.559 ' N ' ' O ' ' A' ' 59' ' ' GLU . 2.3 m-85 -51.39 -51.25 56.28 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.988 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.583 ' HA ' HD12 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -61.89 -37.38 84.36 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.047 -0.353 . . . . 1.0 110.047 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -62.47 -45.83 91.24 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.095 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -64.83 -18.5 65.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.254 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 62' ' ' GLU . 61.4 mt -85.53 -56.95 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.902 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.493 HG23 ' N ' ' A' ' 67' ' ' GLN . 12.2 m -65.32 -40.57 88.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.36 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.493 ' N ' HG23 ' A' ' 66' ' ' VAL . 53.3 tt0 -53.83 -41.45 67.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.22 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -96.89 10.95 37.58 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.397 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 97.13 139.94 11.0 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.656 -0.977 . . . . 1.0 110.656 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.84 61.11 0.13 Allowed Glycine 0 N--CA 1.466 0.664 0 N-CA-C 110.475 -1.05 . . . . 1.0 110.475 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -51.68 145.51 9.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.991 0.424 . . . . 1.0 110.405 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.3 mt -81.6 155.61 25.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.788 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.529 ' O ' ' CE1' ' A' ' 47' ' ' HIS . 1.3 m -158.56 156.39 27.15 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.409 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -59.98 125.87 18.81 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.546 2.164 . . . . 1.0 111.853 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.498 ' HB3' HD11 ' A' ' 98' ' ' LEU . . . -77.55 -0.27 25.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.989 -0.551 . . . . 1.0 110.623 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -61.52 0.73 0.28 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.865 0.364 . . . . 1.0 110.623 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 75' ' ' ALA . . . -166.25 -172.44 33.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -53.5 -4.28 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.912 2.408 . . . . 1.0 111.97 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 77' ' ' GLY . . . -38.75 -61.29 1.35 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 m -106.41 -168.09 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.994 0.426 . . . . 1.0 110.202 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.479 HG23 ' ND1' ' A' ' 82' ' ' HIS . 1.8 t -140.41 -30.06 0.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.864 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.479 ' ND1' HG23 ' A' ' 81' ' ' THR . 64.3 m80 -121.08 150.9 40.5 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.618 0.247 . . . . 1.0 110.788 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.3 mt -134.21 111.0 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.3 t -93.93 144.02 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.951 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.495 ' C ' ' H ' ' A' ' 87' ' ' GLU . 32.2 m -134.3 154.7 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.569 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 88' ' ' GLY . 31.3 t70 -71.82 19.83 0.06 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.747 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 85' ' ' VAL . 0.8 OUTLIER 69.0 -39.16 0.42 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.363 -0.38 . . . . 1.0 111.048 179.037 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -38.99 -57.15 2.08 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 89' ' ' MET . 0.0 OUTLIER -87.1 160.17 18.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.81 0.338 . . . . 1.0 110.534 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -97.15 -177.05 3.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.056 0.455 . . . . 1.0 110.362 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -62.5 -47.04 85.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.846 -0.615 . . . . 1.0 110.576 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.627 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 10.6 pt-20 -53.36 -50.89 64.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.921 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.451 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 29.5 ttp180 -71.25 -42.8 68.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.118 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -43.84 -35.16 1.82 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.943 -0.572 . . . . 1.0 110.783 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.9 mp -59.93 -61.15 2.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.049 0.452 . . . . 1.0 110.884 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.556 HH21 ' C ' ' A' ' 100' ' ' LEU . 5.9 mmp_? -68.31 -22.2 64.73 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.236 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -63.82 -36.96 85.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.994 -178.333 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.668 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -110.9 13.99 22.13 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.784 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 63.06 59.65 1.3 Allowed 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 120.547 -0.461 . . . . 1.0 110.991 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.556 ' C ' HH21 ' A' ' 96' ' ' ARG . 13.8 tp -124.56 127.83 25.11 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.848 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.18 -44.88 11.06 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.037 1.825 . . . . 1.0 112.058 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 176.6 136.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.228 0.537 . . . . 1.0 110.578 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.7 mt -41.91 116.21 1.63 Allowed Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 115.423 -0.808 . . . . 1.0 111.45 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -71.46 141.72 39.13 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.703 1.602 . . . . 1.0 111.922 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -40.77 93.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.451 2.101 . . . . 1.0 112.63 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.61 -56.55 0.59 Allowed Glycine 0 N--CA 1.465 0.585 0 N-CA-C 111.156 -0.778 . . . . 1.0 111.156 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.73 160.28 32.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.857 0.361 . . . . 1.0 110.947 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -149.16 156.6 42.42 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.44 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 131' ' ' SER . 1.3 mt -92.88 111.63 23.31 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.953 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.641 HG21 ' CE3' ' A' ' 114' ' ' TRP . 4.1 m -103.83 170.3 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -101.84 171.04 7.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.129 0.49 . . . . 1.0 111.607 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.2 m -56.05 -35.11 66.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.38 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.6 -38.18 86.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.729 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.641 ' CE3' HG21 ' A' ' 110' ' ' VAL . 74.8 t90 -60.47 -49.89 75.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.369 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.505 HD23 ' CD1' ' A' ' 61' ' ' PHE . 34.9 tp -63.05 -53.77 48.52 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.194 -0.603 . . . . 1.0 110.561 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.9 t -50.81 -46.67 59.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.3 mt -51.31 -48.77 62.25 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.356 -0.538 . . . . 1.0 109.813 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 122' ' ' ARG . 55.9 m -51.75 -34.89 41.32 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 38.9 mt -70.31 -54.53 12.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.002 0.43 . . . . 1.0 110.519 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -65.62 -38.35 89.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.231 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 80.7 mm-40 -79.79 -42.81 23.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.15 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 118' ' ' CYS . 5.2 tpp85 82.16 40.07 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.856 -0.611 . . . . 1.0 111.114 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -169.61 -173.44 1.65 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.342 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.6 tt -92.2 121.56 33.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.607 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.464 HG23 ' CD1' ' A' ' 114' ' ' TRP . 2.7 m -103.69 151.77 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.244 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 126' ' ' ASP . 48.4 p30 -66.78 147.71 52.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.24 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.578 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 31.3 m -101.29 -136.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.383 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 127' ' ' VAL . . . 74.59 -60.69 0.51 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.326 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.05 -53.55 33.01 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -69.98 -42.52 73.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.934 0.397 . . . . 1.0 110.502 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 109' ' ' LEU . 15.1 p -58.56 153.53 16.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.628 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 134' ' ' ILE . 2.9 mp -90.08 -57.46 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.238 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.516 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 17.6 t80 65.12 -35.63 0.19 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.263 0.977 . . . . 1.0 111.433 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.59 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 155.26 -56.06 0.0 OUTLIER Pre-proline 0 C--N 1.346 0.441 0 O-C-N 124.84 1.338 . . . . 1.0 109.862 -178.396 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.3 Cg_endo . . . . . 0 N--CA 1.49 1.301 0 C-N-CA 122.212 1.941 . . . . 1.0 112.012 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.856 0.36 . . . . 1.0 110.777 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.612 ' CZ2' ' ND1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -97.16 -33.87 11.33 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.167 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.448 ' HG ' ' CE3' ' A' ' 40' ' ' TRP . 29.1 mt -83.03 -0.86 50.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.237 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.3 p -58.55 -41.8 86.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.662 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.8 m -61.58 -60.82 3.1 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.25 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 pp -74.94 167.4 21.97 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -124.51 121.75 35.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 1.0 111.023 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.502 ' HB3' HD13 ' A' ' 65' ' ' ILE . . . -103.63 124.85 49.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.865 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -111.11 120.58 42.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.247 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.589 ' H ' HD22 ' A' ' 72' ' ' LEU . 51.3 t -111.1 132.39 59.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.967 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.743 HG23 ' H ' ' A' ' 53' ' ' ILE . 27.0 m -78.58 84.09 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.434 0.635 . . . . 1.0 110.27 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.621 HH11 HD13 ' A' ' 72' ' ' LEU . 76.1 mtm-85 -54.52 -43.67 72.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.464 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.443 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 66.7 p -62.14 -22.92 66.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.323 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.03 -74.42 1.11 Allowed Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.258 -0.737 . . . . 1.0 111.258 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.743 ' H ' HG23 ' A' ' 49' ' ' VAL . 5.3 mt -53.37 122.16 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 CA-C-O 121.942 0.877 . . . . 1.0 109.978 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -174.64 25.97 0.07 OUTLIER Glycine 0 C--N 1.302 -1.326 0 CA-C-N 114.315 -1.311 . . . . 1.0 112.066 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -75.31 -47.32 28.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.829 0.347 . . . . 1.0 111.305 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -168.84 -114.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.932 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.482 ' CD ' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -63.5 -19.58 64.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.334 -0.393 . . . . 1.0 110.677 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.403 ' CB ' HG23 ' A' ' 53' ' ' ILE . . . -40.61 -47.54 2.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.056 0.455 . . . . 1.0 110.639 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -68.37 -37.48 80.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.183 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 57' ' ' ARG . 4.9 tp -48.77 -18.38 0.26 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.196 0.522 . . . . 1.0 111.019 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.421 ' HB3' HD13 ' A' ' 115' ' ' LEU . 20.4 m-85 -69.38 -43.35 73.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.924 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.597 ' HA ' HD12 ' A' ' 65' ' ' ILE . 9.5 pt-20 -58.48 -39.51 80.17 Favored 'General case' 0 C--N 1.317 -0.83 0 O-C-N 123.356 0.41 . . . . 1.0 110.494 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.434 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 41.1 mttp -63.44 -40.36 96.93 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.575 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -65.66 -18.88 65.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.711 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.597 HD12 ' HA ' ' A' ' 62' ' ' GLU . 71.0 mt -85.29 -62.37 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.079 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.7 m -45.09 -35.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.729 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -65.57 -46.09 80.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.91 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.612 ' ND1' ' CZ2' ' A' ' 40' ' ' TRP . 1.3 m170 -97.7 23.67 7.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.436 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 83.44 -179.4 52.55 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.134 -0.787 . . . . 1.0 111.134 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 71' ' ' GLN . . . 74.87 27.73 64.14 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.891 -0.883 . . . . 1.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.527 ' O ' ' NE2' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -44.18 170.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.835 0.35 . . . . 1.0 110.733 -179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.621 HD13 HH11 ' A' ' 50' ' ' ARG . 40.6 mt -73.46 147.26 44.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.249 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.44 ' O ' ' CG2' ' A' ' 80' ' ' VAL . 0.8 OUTLIER -161.59 96.26 1.3 Allowed Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.47 147.47 12.59 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.497 2.131 . . . . 1.0 112.232 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 77' ' ' GLY . . . -51.47 -46.8 63.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.717 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.667 ' CD ' ' H ' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -65.13 1.37 1.01 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.125 0.488 . . . . 1.0 110.29 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 75' ' ' ALA . . . -93.31 -117.78 2.66 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 110.772 -0.931 . . . . 1.0 110.772 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.46 -57.65 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.528 2.152 . . . . 1.0 112.381 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.528 ' O ' HG12 ' A' ' 80' ' ' VAL . . . -162.78 -73.57 0.02 OUTLIER Glycine 0 C--O 1.224 -0.473 0 C-N-CA 120.681 -0.771 . . . . 1.0 111.497 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 79' ' ' GLY . 0.4 OUTLIER 74.83 162.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 123.87 0.394 . . . . 1.0 110.256 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.53 -30.48 0.11 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.251 -0.432 . . . . 1.0 111.274 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -111.84 141.81 45.01 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.153 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.1 mp -132.74 108.32 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.973 -0.558 . . . . 1.0 109.784 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.528 HG11 HD12 ' A' ' 115' ' ' LEU . 12.2 t -92.96 135.25 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 115.802 -0.636 . . . . 1.0 111.043 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.552 ' C ' ' H ' ' A' ' 87' ' ' GLU . 30.0 m -132.34 159.26 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.475 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 88' ' ' GLY . 47.4 p30 -67.05 12.31 0.08 Allowed 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.465 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.552 ' H ' ' C ' ' A' ' 85' ' ' VAL . 7.9 mt-10 70.5 -22.95 0.17 Allowed 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.291 0.369 . . . . 1.0 110.842 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -58.74 -46.63 93.15 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.686 -0.966 . . . . 1.0 110.686 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.2 ptp -88.85 145.04 25.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.848 0.356 . . . . 1.0 110.178 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -80.08 173.19 12.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.385 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.615 ' CG ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.19 -53.02 63.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.561 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.615 ' N ' ' CG ' ' A' ' 91' ' ' TYR . 14.2 pt-20 -53.47 -41.44 66.18 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 123.55 0.531 . . . . 1.0 110.521 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.716 ' HE ' ' CZ ' ' A' ' 96' ' ' ARG . 46.5 ttt180 -69.64 -40.15 76.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.082 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.48 ' O ' ' CD2' ' A' ' 98' ' ' LEU . . . -51.5 -26.48 8.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.938 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.1 mp -57.15 -41.04 78.41 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.735 -0.603 . . . . 1.0 110.802 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.716 ' CZ ' ' HE ' ' A' ' 93' ' ' ARG . 23.3 ptt180 -63.39 -34.18 77.17 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.413 -0.515 . . . . 1.0 109.986 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.445 ' HA ' HD13 ' A' ' 97' ' ' LEU . 3.3 mm? -60.53 -47.9 84.13 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.794 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.484 ' O ' ' NE2' ' A' ' 76' ' ' GLN . 0.1 OUTLIER -93.14 16.36 13.16 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.742 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 41.97 56.2 3.56 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.527 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.443 HD13 ' HB3' ' A' ' 75' ' ' ALA . 4.8 tp -132.2 113.9 14.75 Favored Pre-proline 0 C--O 1.219 -0.526 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.597 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.16 2.07 5.96 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.361 2.041 . . . . 1.0 112.723 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 179.96 142.61 0.16 Allowed 'General case' 0 C--O 1.238 0.466 0 O-C-N 123.429 0.455 . . . . 1.0 110.742 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.3 mm? -84.8 145.0 43.05 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-O 120.888 0.375 . . . . 1.0 111.119 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' A' ' 106' ' ' GLY . 44.2 Cg_endo -69.18 161.99 43.62 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.353 2.035 . . . . 1.0 111.88 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.97 23.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.874 2.383 . . . . 1.0 111.974 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 104' ' ' PRO . . . -161.5 63.6 0.27 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -172.82 149.33 1.95 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.655 0.264 . . . . 1.0 110.469 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -139.32 156.05 47.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.063 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.474 ' H ' HD12 ' A' ' 109' ' ' LEU . 1.9 mp -101.65 113.27 26.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.628 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.734 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.5 m -107.13 163.99 4.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.137 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm -93.71 -172.75 2.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.685 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.2 t -65.35 -41.18 94.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.985 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.63 -51.44 48.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.661 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.734 ' CE3' HG21 ' A' ' 110' ' ' VAL . 63.5 t90 -50.55 -49.58 55.65 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.484 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.528 HD12 HG11 ' A' ' 84' ' ' VAL . 2.0 tt -57.95 -50.97 71.56 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.32 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.7 t -48.54 -51.96 24.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.06 0.457 . . . . 1.0 110.08 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.1 mp -57.44 -50.98 71.27 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.448 -0.501 . . . . 1.0 110.259 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.625 ' SG ' ' CE2' ' A' ' 114' ' ' TRP . 56.3 m -44.35 -27.06 0.39 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.049 0.452 . . . . 1.0 110.099 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 80.2 mt -83.36 -47.68 11.2 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.564 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -68.44 -54.2 18.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.472 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 122' ' ' ARG . 78.4 mt-10 -77.86 5.4 9.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.508 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.456 ' C ' ' O ' ' A' ' 121' ' ' GLU . 81.4 mtt85 28.63 44.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.52 0.513 . . . . 1.0 111.257 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.445 ' CG ' ' O ' ' A' ' 121' ' ' GLU . 0.9 OUTLIER -159.99 167.83 27.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.532 -179.134 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 tp -74.08 100.08 3.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.046 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.508 HG13 ' CD1' ' A' ' 114' ' ' TRP . 0.3 OUTLIER -80.44 154.93 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 121.252 0.548 . . . . 1.0 110.091 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 126' ' ' ASP . 14.6 p-10 -59.81 117.73 5.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.434 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.562 HG23 ' N ' ' A' ' 128' ' ' ALA . 13.0 m -68.03 -44.57 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.691 -0.686 . . . . 1.0 111.077 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.562 ' N ' HG23 ' A' ' 127' ' ' VAL . . . -43.85 -18.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.685 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . -69.9 -38.39 75.32 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.344 -0.702 . . . . 1.0 111.344 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -129.48 13.76 6.02 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.625 0.25 . . . . 1.0 110.679 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.5 p -73.16 136.4 44.78 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.848 0.356 . . . . 1.0 110.69 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.569 ' C ' ' H ' ' A' ' 134' ' ' ILE . 59.1 mt -74.52 -66.93 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.875 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.548 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 25.1 t80 66.26 -36.14 0.24 Allowed 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 123.878 0.736 . . . . 1.0 111.42 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.617 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 155.72 -55.3 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 O-C-N 124.768 1.293 . . . . 1.0 110.271 -178.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.3 Cg_endo . . . . . 0 C--N 1.31 -1.46 0 C-N-CA 122.498 2.132 . . . . 1.0 111.994 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 120.88 0.371 . . . . 1.0 110.539 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.601 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -101.07 -38.22 8.25 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.355 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.507 HD23 HD11 ' A' ' 44' ' ' LEU . 6.4 mt -76.49 -12.39 60.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.886 0.374 . . . . 1.0 110.9 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t -69.69 -17.78 63.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.996 0.427 . . . . 1.0 110.402 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.7 t -74.1 -13.9 60.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.107 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.507 HD11 HD23 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -136.42 168.99 18.4 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.993 0.425 . . . . 1.0 110.046 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.494 ' H ' ' HB ' ' A' ' 81' ' ' THR . 93.5 mtt180 -114.99 124.1 50.8 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.602 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.723 ' O ' HD13 ' A' ' 72' ' ' LEU . . . -107.44 155.08 20.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.828 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.627 ' CE1' ' NH1' ' A' ' 50' ' ' ARG . 25.0 t-80 -155.25 123.32 5.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.528 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.2 m -99.52 145.37 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.849 0.357 . . . . 1.0 110.243 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.42 ' HB ' HD23 ' A' ' 97' ' ' LEU . 27.2 m -73.68 143.94 13.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.579 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.627 ' NH1' ' CE1' ' A' ' 47' ' ' HIS . 8.4 mpt_? -63.33 -42.62 98.98 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.857 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 p -100.99 136.28 41.09 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.946 0.403 . . . . 1.0 110.437 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.67 -19.85 53.01 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.048 -0.821 . . . . 1.0 111.048 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.632 HG22 ' O ' ' A' ' 53' ' ' ILE . 40.6 mm -127.51 3.81 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.096 0.474 . . . . 1.0 110.586 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.59 26.29 24.52 Favored Glycine 0 N--CA 1.467 0.724 0 N-CA-C 110.39 -1.084 . . . . 1.0 110.39 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.683 HH22 HH21 ' A' ' 57' ' ' ARG . 16.2 mtm-85 -63.25 -47.2 83.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 1.0 110.723 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 55' ' ' ARG . . . 165.52 -62.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.171 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.683 HH21 HH22 ' A' ' 55' ' ' ARG . 5.1 ppt_? -92.04 -25.56 18.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.598 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.44 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . . . -62.64 -37.87 88.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.475 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 61' ' ' PHE . 3.1 pt-20 -65.32 -39.96 93.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.295 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 tp -44.19 -16.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.228 0.537 . . . . 1.0 110.886 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 59' ' ' GLU . 6.6 m-85 -58.91 -43.54 91.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.657 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.476 ' HA ' HD12 ' A' ' 65' ' ' ILE . 13.8 pt-20 -67.2 -42.61 83.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.988 0.423 . . . . 1.0 111.063 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.456 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 95.2 mttt -63.86 -44.62 92.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.19 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -56.0 -37.58 69.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.806 -0.634 . . . . 1.0 109.995 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.91 HD11 HD11 ' A' ' 115' ' ' LEU . 67.8 mt -63.62 -44.43 98.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.667 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.406 ' CG2' HD23 ' A' ' 72' ' ' LEU . 73.7 t -59.37 -44.74 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.812 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -55.97 -35.62 66.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.69 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.415 ' HB3' ' CZ2' ' A' ' 40' ' ' TRP . 2.0 m-70 -103.99 16.55 26.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.136 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 90.58 153.18 28.65 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.868 -0.893 . . . . 1.0 110.868 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.0 51.43 0.6 Allowed Glycine 0 N--CA 1.468 0.786 0 N-CA-C 110.058 -1.217 . . . . 1.0 110.058 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -43.46 143.23 0.96 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 1.0 110.401 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 46' ' ' ALA . 3.0 mm? -80.07 136.39 36.55 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.059 0.457 . . . . 1.0 110.143 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 79' ' ' GLY . 69.3 m -141.61 103.45 5.9 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.971 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.489 ' O ' ' N ' ' A' ' 77' ' ' GLY . 58.7 Cg_endo -73.94 167.59 26.85 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.712 1.608 . . . . 1.0 111.747 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.487 ' HB2' HD12 ' A' ' 100' ' ' LEU . . . -44.09 -48.31 8.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.531 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -67.75 -19.64 65.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.473 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 74' ' ' PRO . . . -78.77 -165.89 29.5 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.252 -0.739 . . . . 1.0 111.252 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.33 -42.28 61.46 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.751 2.301 . . . . 1.0 112.351 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 73' ' ' CYS . . . 170.19 -161.85 35.01 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.024 -0.83 . . . . 1.0 111.024 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -169.8 138.83 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.494 ' HB ' ' H ' ' A' ' 45' ' ' ARG . 95.4 m -104.21 -47.99 3.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.781 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -124.94 155.05 40.2 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.95 0.405 . . . . 1.0 111.087 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 83' ' ' ILE . 4.4 mp -134.34 113.19 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.056 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.655 HG21 HD12 ' A' ' 115' ' ' LEU . 59.2 t -93.43 134.96 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.362 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.81 HG23 ' H ' ' A' ' 87' ' ' GLU . 3.7 m -127.21 163.68 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.646 -0.707 . . . . 1.0 110.708 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.416 ' HA ' HD11 ' A' ' 53' ' ' ILE . 8.5 p-10 -69.56 19.0 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.229 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.81 ' H ' HG23 ' A' ' 85' ' ' VAL . 12.9 mt-10 70.02 -51.76 0.64 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.51 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.14 -28.52 61.43 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.699 -0.961 . . . . 1.0 110.699 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.6 tpp -72.66 140.45 47.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.051 0.453 . . . . 1.0 110.823 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -88.18 153.63 21.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.769 -0.651 . . . . 1.0 109.67 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -56.26 -45.87 79.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.015 179.712 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.566 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 11.6 pt-20 -53.92 -49.72 68.01 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.621 -0.432 . . . . 1.0 111.135 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.484 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 21.9 ttm105 -70.51 -38.01 74.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.085 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.482 ' O ' HD23 ' A' ' 98' ' ' LEU . . . -46.56 -43.37 17.07 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 116.048 -0.523 . . . . 1.0 111.923 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.477 ' CD1' HD11 ' A' ' 109' ' ' LEU . 4.8 mp -58.3 -39.92 80.62 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.774 -0.579 . . . . 1.0 110.773 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.53 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 84.3 mmt-85 -69.24 -29.42 67.34 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.742 -0.383 . . . . 1.0 110.947 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.42 HD23 ' HB ' ' A' ' 49' ' ' VAL . 9.0 mp -65.26 -40.98 94.69 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.379 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -109.51 15.58 22.85 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.024 0.44 . . . . 1.0 110.655 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.53 ' NH1' ' O ' ' A' ' 96' ' ' ARG . 60.7 mmt-85 50.38 57.44 6.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.544 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' A' ' 75' ' ' ALA . 12.8 tp -107.24 115.07 60.4 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 121.075 -0.25 . . . . 1.0 110.458 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.22 -48.01 20.03 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.839 1.693 . . . . 1.0 112.384 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -175.98 137.51 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.645 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 103' ' ' LEU . 52.8 mt -37.06 100.76 0.21 Allowed Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.267 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.442 ' HD3' HD21 ' A' ' 100' ' ' LEU . 86.4 Cg_exo -43.18 157.44 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.099 1.866 . . . . 1.0 112.176 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.91 85.37 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.509 2.139 . . . . 1.0 111.898 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 137.33 -36.19 1.98 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.154 -0.778 . . . . 1.0 111.154 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.12 153.05 32.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.602 0.239 . . . . 1.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -144.23 155.48 43.89 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.477 HD11 ' CD1' ' A' ' 95' ' ' LEU . 0.8 OUTLIER -88.12 114.5 24.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.463 179.47 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.468 HG21 ' CE3' ' A' ' 114' ' ' TRP . 2.5 m -110.63 171.31 3.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 123.759 0.662 . . . . 1.0 109.478 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.555 ' NZ ' ' O ' ' A' ' 130' ' ' PHE . 30.1 mtmm -104.82 -178.49 3.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.832 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.1 t -60.13 -39.24 85.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.099 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.07 -49.59 60.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.523 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.518 ' CD1' HG12 ' A' ' 127' ' ' VAL . 75.0 t90 -56.18 -46.33 79.42 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.2 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.91 HD11 HD11 ' A' ' 65' ' ' ILE . 1.1 tt -67.43 -55.98 11.46 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.051 0.453 . . . . 1.0 110.377 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -41.37 -57.08 2.28 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.696 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.5 mp -58.64 -47.12 85.51 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 123' ' ' ARG . 0.5 OUTLIER -44.92 -42.62 8.28 Favored 'General case' 0 C--O 1.214 -0.766 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.725 177.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.48 -49.44 69.07 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 119.676 -0.81 . . . . 1.0 110.94 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -71.59 -51.91 20.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.971 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -70.62 -39.08 73.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.799 -0.637 . . . . 1.0 111.431 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 118' ' ' CYS . 67.1 mtt85 63.99 54.38 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.269 0.557 . . . . 1.0 111.133 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.894 ' NH2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -152.1 -164.72 2.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.239 -0.891 . . . . 1.0 111.125 -179.369 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.8 tp -119.94 91.67 3.6 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.593 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.894 HG22 ' NH2' ' A' ' 123' ' ' ARG . 29.0 m -81.2 153.32 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.952 0.406 . . . . 1.0 110.158 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -69.97 121.89 18.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.21 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 129' ' ' GLY . 17.6 m -72.44 -126.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.886 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.438 ' N ' HG23 ' A' ' 127' ' ' VAL . . . 63.81 -63.3 0.14 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 1.0 110.71 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . -59.53 -46.21 94.33 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.616 -0.994 . . . . 1.0 110.616 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.555 ' O ' ' NZ ' ' A' ' 111' ' ' LYS . 60.0 m-85 -86.54 -7.67 58.18 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.948 -0.389 . . . . 1.0 109.948 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.2 p -78.66 157.58 28.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.925 0.393 . . . . 1.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.575 ' C ' ' H ' ' A' ' 134' ' ' ILE . 62.2 mt -93.37 -59.67 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.406 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.475 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 16.3 t80 63.62 -32.97 0.12 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.941 -1.027 . . . . 1.0 111.904 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.575 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.6 OUTLIER 152.46 -55.64 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 124.848 1.259 . . . . 1.0 109.634 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 34.6 Cg_endo . . . . . 0 N--CA 1.496 1.638 0 C-N-CA 121.783 1.656 . . . . 1.0 112.074 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 120.856 0.36 . . . . 1.0 110.387 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.569 ' CZ2' ' NE ' ' A' ' 122' ' ' ARG . 3.6 p-90 -140.26 -38.46 0.45 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.392 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.99 -6.23 59.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.762 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.6 m -64.01 -33.03 74.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.903 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.499 ' OG ' HD23 ' A' ' 44' ' ' LEU . 3.9 p -57.16 -43.45 82.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.939 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.499 HD23 ' OG ' ' A' ' 43' ' ' SER . 0.1 OUTLIER -100.59 107.87 19.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.125 0.488 . . . . 1.0 110.732 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.553 ' O ' HG22 ' A' ' 81' ' ' THR . 2.7 mpt_? -68.72 110.21 4.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.519 -0.764 . . . . 1.0 109.338 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.626 ' HB3' HG21 ' A' ' 65' ' ' ILE . . . -91.2 162.83 14.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.875 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.691 ' HB2' HG11 ' A' ' 80' ' ' VAL . 85.0 t60 -148.08 131.92 17.05 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.945 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.733 HG12 HG21 ' A' ' 53' ' ' ILE . 1.5 t -121.98 116.49 49.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.35 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.462 ' O ' HG22 ' A' ' 53' ' ' ILE . 15.7 t -56.95 81.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.717 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 48' ' ' VAL . 33.1 ptt-85 -70.27 -8.3 49.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.779 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.6 p -92.89 0.43 57.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.61 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 54' ' ' GLY . . . -147.44 -46.67 0.03 OUTLIER Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.123 -0.791 . . . . 1.0 111.123 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.733 HG21 HG12 ' A' ' 48' ' ' VAL . 3.8 tt -64.24 3.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.774 0.321 . . . . 1.0 110.422 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 52' ' ' GLY . . . -70.24 50.99 0.78 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 53' ' ' ILE . 0.3 OUTLIER -70.38 -43.66 69.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.803 0.335 . . . . 1.0 110.236 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -177.21 -81.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.035 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 60' ' ' LEU . 8.9 ptm180 -95.47 -21.12 18.51 Favored 'General case' 0 C--O 1.207 -1.138 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.923 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.59 -37.05 17.0 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.89 -0.724 . . . . 1.0 111.033 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -51.55 -26.1 7.99 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.559 -0.456 . . . . 1.0 110.804 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.66 HD13 ' HB2' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -63.64 -22.87 67.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.201 0.524 . . . . 1.0 110.96 -179.589 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.509 ' HB2' HG11 ' A' ' 48' ' ' VAL . 21.7 m-85 -52.62 -46.71 67.17 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.923 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.695 ' HA ' HD12 ' A' ' 65' ' ' ILE . 5.3 pt-20 -65.71 -36.01 82.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.833 0.349 . . . . 1.0 110.645 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.66 ' HB2' HD13 ' A' ' 60' ' ' LEU . 5.7 mptp? -62.79 -48.67 78.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.19 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.434 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 62.4 mt-30 -60.38 -37.75 81.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.931 -0.577 . . . . 1.0 109.711 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.695 HD12 ' HA ' ' A' ' 62' ' ' GLU . 57.8 mt -61.6 -48.08 90.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.095 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.6 t -62.8 -46.54 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 120.583 -0.447 . . . . 1.0 110.297 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 63' ' ' LYS . 1.2 mp0 -67.32 -35.03 78.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.24 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.434 ' CG ' ' O ' ' A' ' 64' ' ' GLN . 61.7 m170 -88.19 0.28 56.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.542 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 98.72 147.27 21.83 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.72 -0.952 . . . . 1.0 110.72 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.47 55.53 0.71 Allowed Glycine 0 N--CA 1.464 0.554 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -40.19 145.13 0.17 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.679 0.276 . . . . 1.0 110.676 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.425 ' C ' ' SG ' ' A' ' 73' ' ' CYS . 8.8 mt -74.54 140.38 44.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.258 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.638 ' O ' HG13 ' A' ' 80' ' ' VAL . 2.6 m -145.12 87.87 7.01 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.233 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.16 -150.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.808 2.339 . . . . 1.0 111.849 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.53 -26.21 68.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.454 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -64.04 -20.56 66.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.52 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.1 -166.64 24.93 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.77 -43.47 57.62 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.71 2.274 . . . . 1.0 112.072 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . 131.48 31.17 0.52 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.896 -0.882 . . . . 1.0 110.896 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.691 HG11 ' HB2' ' A' ' 47' ' ' HIS . 31.1 m 37.44 -158.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 120.758 0.313 . . . . 1.0 110.904 179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.553 HG22 ' O ' ' A' ' 45' ' ' ARG . 2.5 t -142.04 -18.44 0.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.706 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.806 ' O ' HD13 ' A' ' 83' ' ' ILE . 68.7 m80 -130.98 160.03 35.73 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.022 0.439 . . . . 1.0 110.744 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.806 HD13 ' O ' ' A' ' 82' ' ' HIS . 5.1 mm -138.15 112.69 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.702 -0.681 . . . . 1.0 111.473 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.734 HG21 HD23 ' A' ' 115' ' ' LEU . 5.1 t -94.59 129.78 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.441 ' C ' ' H ' ' A' ' 87' ' ' GLU . 16.0 m -132.02 167.02 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.392 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 88' ' ' GLY . 49.1 t0 -77.91 30.06 0.17 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.219 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 85' ' ' VAL . 31.3 mt-10 64.72 -66.65 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.873 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . -48.64 -17.33 0.76 Allowed Glycine 0 CA--C 1.52 0.381 0 N-CA-C 110.871 -0.892 . . . . 1.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.487 ' SD ' ' CD1' ' A' ' 97' ' ' LEU . 3.4 ttm -77.4 147.37 36.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.122 0.486 . . . . 1.0 110.495 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 91' ' ' TYR . 92.1 m-20 -100.64 142.75 31.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.591 -0.731 . . . . 1.0 109.855 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.601 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -36.73 -56.4 0.84 Allowed 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.285 -179.55 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.601 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 5.0 pt-20 -56.1 -59.57 4.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.773 -0.648 . . . . 1.0 109.953 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.512 ' H ' ' CG ' ' A' ' 92' ' ' GLU . 79.0 ttt180 -42.51 -42.22 3.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.857 0.36 . . . . 1.0 110.22 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 91' ' ' TYR . . . -55.88 -48.61 75.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.73 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 99' ' ' ARG . 7.9 mp -57.48 -44.38 84.85 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.325 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.455 ' C ' ' CD ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -62.24 -42.43 99.31 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.807 179.275 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.487 ' CD1' ' SD ' ' A' ' 89' ' ' MET . 24.8 mt -63.19 -51.75 65.08 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.737 -0.385 . . . . 1.0 111.228 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.884 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -77.73 -18.5 56.47 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.173 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 95' ' ' LEU . 3.2 mtp180 76.35 63.54 0.05 OUTLIER 'General case' 0 CA--C 1.509 -0.608 0 O-C-N 124.469 1.106 . . . . 1.0 111.685 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.598 ' HB2' HD11 ' A' ' 98' ' ' LEU . 4.7 tp -136.45 118.3 11.61 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 120.465 -0.494 . . . . 1.0 111.089 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.98 -38.62 56.55 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.919 1.746 . . . . 1.0 112.067 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -163.19 136.48 5.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.609 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.501 HD11 HD21 ' A' ' 109' ' ' LEU . 11.8 mt -75.99 148.8 82.03 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.024 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.34 167.75 17.81 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.033 1.822 . . . . 1.0 112.467 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -56.1 146.35 70.78 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.497 2.131 . . . . 1.0 112.296 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.05 -19.52 6.5 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.901 -0.879 . . . . 1.0 110.901 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.97 151.76 34.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 1.0 110.428 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -156.73 128.86 7.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.365 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.501 HD21 HD11 ' A' ' 103' ' ' LEU . 1.9 mp -84.11 127.64 34.04 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.711 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.495 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.8 m -121.31 176.14 4.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 O-C-N 123.723 0.639 . . . . 1.0 109.973 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -106.75 -176.57 3.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.738 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.478 ' OG ' ' CE2' ' A' ' 61' ' ' PHE . 6.8 t -60.05 -41.36 92.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.57 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.32 -48.24 62.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.611 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.505 ' CZ2' ' SG ' ' A' ' 118' ' ' CYS . 78.3 t90 -54.19 -41.1 68.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.002 0.429 . . . . 1.0 110.259 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.734 HD23 HG21 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -62.04 -55.56 27.95 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.129 -179.435 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 80.1 p -49.21 -42.87 41.6 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.055 0.455 . . . . 1.0 109.828 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.35 -55.74 22.05 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.426 -0.51 . . . . 1.0 109.896 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.505 ' SG ' ' CZ2' ' A' ' 114' ' ' TRP . 0.0 OUTLIER -44.63 -33.68 1.9 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 -179.328 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 94.0 mt -77.05 -51.33 11.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.568 -0.742 . . . . 1.0 111.184 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -65.56 -49.14 69.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.231 -0.441 . . . . 1.0 111.314 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.433 ' O ' ' CG ' ' A' ' 123' ' ' ARG . 65.2 mm-40 -77.48 1.44 19.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.282 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.569 ' NE ' ' CZ2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 38.79 32.24 0.05 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.585 179.396 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 121' ' ' GLU . 4.5 ppt_? -158.29 174.32 15.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.254 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.6 tt -82.15 126.17 31.74 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.943 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.0 m -108.96 154.74 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.539 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 40.3 p-10 -62.09 144.33 55.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.042 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.6 m -103.03 11.17 8.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.509 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.64 53.35 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.609 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.68 -34.47 0.12 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.089 -0.804 . . . . 1.0 111.089 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -99.74 5.92 45.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.022 0.439 . . . . 1.0 110.655 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.6 t -99.15 141.28 32.12 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.356 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.519 ' C ' ' H ' ' A' ' 134' ' ' ILE . 54.7 mt -88.18 -55.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-N 115.635 -0.711 . . . . 1.0 110.205 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.522 ' O ' HG12 ' A' ' 134' ' ' ILE . 10.9 t80 65.71 -40.6 0.32 Allowed 'General case' 0 C--O 1.221 -0.426 0 O-C-N 124.375 1.047 . . . . 1.0 111.461 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.572 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 159.38 -54.55 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 O-C-N 124.665 1.228 . . . . 1.0 109.915 -178.731 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 36.5 Cg_endo . . . . . 0 N--CA 1.491 1.351 0 C-N-CA 122.15 1.9 . . . . 1.0 111.929 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.689 0.281 . . . . 1.0 110.307 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.599 ' CH2' HD12 ' A' ' 41' ' ' LEU . 1.6 p-90 -123.45 -50.62 1.87 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.547 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.599 HD12 ' CH2' ' A' ' 40' ' ' TRP . 1.3 mt -67.13 -21.75 65.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.757 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.0 t -61.37 -18.57 59.34 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.326 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.431 ' OG ' HD23 ' A' ' 44' ' ' LEU . 24.7 p -65.32 -15.0 62.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.333 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.441 ' N ' HD23 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -138.55 168.35 19.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.308 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -119.55 115.58 24.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.604 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.498 ' CB ' HD13 ' A' ' 65' ' ' ILE . . . -95.62 168.18 10.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.114 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -153.91 120.06 5.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.629 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.455 ' CG1' HG21 ' A' ' 53' ' ' ILE . 87.1 t -100.05 135.9 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.09 0.471 . . . . 1.0 110.252 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 49' ' ' VAL . 32.3 m -86.71 125.04 40.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.685 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.401 ' HG3' HH11 ' A' ' 50' ' ' ARG . 18.2 mmt85 -74.53 -39.11 62.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.745 -0.661 . . . . 1.0 111.246 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.751 ' OG1' HD11 ' A' ' 97' ' ' LEU . 45.1 p -59.51 -22.51 61.74 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.617 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . -115.85 -91.58 1.71 Allowed Glycine 0 N--CA 1.465 0.603 0 N-CA-C 110.738 -0.945 . . . . 1.0 110.738 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.485 ' C ' ' H ' ' A' ' 55' ' ' ARG . 4.1 mm -40.23 -27.6 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.741 0.305 . . . . 1.0 110.806 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 52' ' ' GLY . . . -69.81 41.64 0.44 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.801 -0.92 . . . . 1.0 110.801 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.485 ' H ' ' C ' ' A' ' 53' ' ' ILE . 1.9 ptp180 -80.11 -61.14 2.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.835 0.35 . . . . 1.0 110.953 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.401 ' H ' ' HG3' ' A' ' 55' ' ' ARG . . . -150.28 -89.87 0.07 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.761 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -92.71 -24.62 18.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.03 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.44 -16.83 0.64 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.571 0.701 . . . . 1.0 110.05 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 61' ' ' PHE . 21.1 pt-20 -73.29 -34.84 65.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.154 0.502 . . . . 1.0 111.207 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 tp -46.29 -17.31 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.392 0.615 . . . . 1.0 110.866 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.475 ' N ' ' O ' ' A' ' 59' ' ' GLU . 1.8 m-85 -57.22 -51.11 70.64 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.802 -0.636 . . . . 1.0 112.073 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.613 ' HA ' HD12 ' A' ' 65' ' ' ILE . 1.5 pt-20 -58.15 -36.99 73.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.111 0.482 . . . . 1.0 110.563 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.46 ' HG2' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -61.86 -44.75 96.19 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.244 0.545 . . . . 1.0 110.287 -178.806 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -62.76 -18.7 63.05 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.256 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.613 HD12 ' HA ' ' A' ' 62' ' ' GLU . 92.3 mt -86.29 -56.19 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.961 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.428 HG12 ' HA ' ' A' ' 71' ' ' GLN . 3.4 m -62.81 -38.6 82.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.913 0.387 . . . . 1.0 110.891 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.418 ' N ' HG23 ' A' ' 66' ' ' VAL . 85.0 mt-30 -61.45 -40.01 92.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.699 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -95.68 14.66 22.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.771 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 96.32 144.72 17.61 Favored Glycine 0 N--CA 1.464 0.524 0 N-CA-C 110.618 -0.993 . . . . 1.0 110.618 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.07 44.73 1.35 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.707 -0.957 . . . . 1.0 110.707 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.428 ' HA ' HG12 ' A' ' 66' ' ' VAL . 34.4 mm-40 -40.95 160.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.786 0.327 . . . . 1.0 110.689 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.9 mt -69.92 136.62 50.79 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 68.4 m -131.1 96.9 20.95 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.341 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.99 -178.71 4.85 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.527 2.151 . . . . 1.0 112.024 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -54.68 -47.82 73.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.766 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -64.03 -18.98 64.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.915 0.388 . . . . 1.0 110.352 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.87 -158.45 19.38 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.088 -0.805 . . . . 1.0 111.088 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -47.96 -44.99 26.25 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.412 2.075 . . . . 1.0 112.417 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.576 ' O ' HG12 ' A' ' 80' ' ' VAL . . . 156.44 -44.58 0.52 Allowed Glycine 0 C--O 1.223 -0.576 0 C-N-CA 120.467 -0.873 . . . . 1.0 111.128 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 79' ' ' GLY . 0.4 OUTLIER 82.91 166.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 124.038 0.493 . . . . 1.0 110.166 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.58 -35.22 0.31 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.904 -0.318 . . . . 1.0 110.453 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -117.26 144.06 45.23 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.655 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.945 HD12 HD12 ' A' ' 109' ' ' LEU . 58.2 mt -131.58 112.59 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.555 -0.458 . . . . 1.0 110.885 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 t -90.3 127.64 42.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.633 HG23 ' H ' ' A' ' 87' ' ' GLU . 28.7 m -133.16 166.44 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.885 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 88' ' ' GLY . 39.8 p-10 -73.66 17.48 0.16 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.76 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.633 ' H ' HG23 ' A' ' 85' ' ' VAL . 3.7 mt-10 73.71 -32.11 0.23 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.092 -0.504 . . . . 1.0 111.224 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -67.95 -20.35 72.55 Favored Glycine 0 C--N 1.314 -0.672 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.426 ' CE ' HH12 ' A' ' 93' ' ' ARG . 9.4 ttm -82.11 160.16 23.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.791 0.329 . . . . 1.0 110.826 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -113.52 142.06 46.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.83 -0.623 . . . . 1.0 109.891 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.57 ' CG ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -46.49 -53.27 11.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.497 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.57 ' N ' ' CG ' ' A' ' 91' ' ' TYR . 17.1 pt-20 -51.83 -38.25 55.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.645 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.426 HH12 ' CE ' ' A' ' 89' ' ' MET . 79.7 ttt-85 -80.44 -22.17 41.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.789 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.34 -37.32 77.54 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.334 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 99' ' ' ARG . 7.5 mp -60.6 -38.0 83.22 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.995 -0.282 . . . . 1.0 110.319 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -61.9 -35.88 79.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.79 0.329 . . . . 1.0 110.627 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.751 HD11 ' OG1' ' A' ' 51' ' ' THR . 3.9 mm? -62.24 -40.56 96.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.049 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -108.72 8.77 27.0 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.188 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 95' ' ' LEU . 1.6 mpt_? 45.96 58.24 4.55 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.8 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.444 ' HB2' HD12 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -109.52 112.44 58.88 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.147 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.74 -41.75 37.75 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.057 1.838 . . . . 1.0 112.72 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -162.08 128.59 3.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.958 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.761 HD13 HD11 ' A' ' 109' ' ' LEU . 60.4 mt -52.71 124.6 35.3 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-N 116.088 -0.506 . . . . 1.0 111.214 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.449 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 44.2 Cg_exo -49.67 -174.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.365 2.044 . . . . 1.0 112.419 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 32.1 Cg_exo -58.18 129.36 32.62 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.724 2.283 . . . . 1.0 111.908 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 72.18 -53.32 1.43 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-O 118.906 -0.941 . . . . 1.0 110.751 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -7.79 116.26 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 O-C-N 124.262 0.625 . . . . 1.0 111.178 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.529 ' C ' HD13 ' A' ' 109' ' ' LEU . 23.1 mt-30 -127.71 142.74 51.25 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.593 -0.276 . . . . 1.0 110.411 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 1.046 ' H ' HD22 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -93.38 120.96 34.27 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.767 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.5 m -110.25 168.0 4.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.996 -1.002 . . . . 1.0 110.606 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.21 -177.72 3.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.897 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.0 m -61.48 -41.63 97.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.11 -0.95 . . . . 1.0 110.511 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.47 -48.14 62.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.547 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.767 ' CE3' HG21 ' A' ' 110' ' ' VAL . 34.5 t90 -56.02 -41.22 74.59 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.229 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.6 tp -65.67 -56.64 11.06 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.142 -0.623 . . . . 1.0 110.613 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 m -46.22 -53.58 10.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.363 0.601 . . . . 1.0 110.061 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.2 mp -52.23 -49.23 64.39 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.268 -0.573 . . . . 1.0 109.863 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 12.8 t -52.15 -37.33 54.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.775 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.598 ' O ' ' NH2' ' A' ' 122' ' ' ARG . 90.2 mt -69.6 -57.5 5.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.42 0.629 . . . . 1.0 111.509 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -66.21 -21.24 66.3 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.469 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 75.9 mm-40 -88.82 -45.24 9.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.609 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.598 ' NH2' ' O ' ' A' ' 119' ' ' LEU . 0.1 OUTLIER 81.61 33.86 0.1 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.9 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.424 ' C ' ' CD ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -161.7 -176.12 5.11 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.579 -0.449 . . . . 1.0 110.536 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 tp -79.22 123.89 27.84 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.333 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.18 155.18 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 121.017 0.437 . . . . 1.0 110.623 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 126' ' ' ASP . 45.3 p-10 -61.38 107.94 0.86 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.251 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.541 HG23 ' N ' ' A' ' 128' ' ' ALA . 9.1 m -60.36 -42.82 92.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.65 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.541 ' N ' HG23 ' A' ' 127' ' ' VAL . . . -55.72 -22.66 24.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.48 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.9 -37.62 94.66 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.916 -0.873 . . . . 1.0 110.916 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 130' ' ' PHE . 0.3 OUTLIER -143.42 58.51 1.39 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.707 0.289 . . . . 1.0 110.899 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.9 m -119.17 150.8 39.43 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.141 0.496 . . . . 1.0 110.795 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.576 ' C ' ' H ' ' A' ' 134' ' ' ILE . 60.9 mt -81.34 -63.75 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 CA-C-N 115.301 -0.863 . . . . 1.0 110.181 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.512 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 19.4 t80 66.34 -35.66 0.23 Allowed 'General case' 0 C--O 1.221 -0.425 0 O-C-N 124.208 0.943 . . . . 1.0 111.347 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.601 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 155.7 -55.51 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.37 0 O-C-N 124.905 1.378 . . . . 1.0 110.048 -178.668 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 24.9 Cg_endo . . . . . 0 N--CA 1.491 1.361 0 C-N-CA 122.324 2.016 . . . . 1.0 111.821 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.455 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 39.9 mp0 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.894 0.378 . . . . 1.0 110.58 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.442 ' CH2' HD12 ' A' ' 41' ' ' LEU . 14.8 p-90 -163.81 -55.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.086 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.653 ' O ' HD23 ' A' ' 41' ' ' LEU . 1.2 tt -68.91 -18.18 64.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.372 0.606 . . . . 1.0 110.123 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 68' ' ' HIS . 15.8 m -61.5 -42.17 98.39 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.713 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.8 m -52.84 -60.61 3.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.882 0.373 . . . . 1.0 110.714 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -75.0 169.28 18.32 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.655 -0.498 . . . . 1.0 109.655 179.647 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -123.71 120.02 31.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.935 0.398 . . . . 1.0 110.738 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.637 ' O ' HD13 ' A' ' 72' ' ' LEU . . . -96.7 158.29 15.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.235 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.486 ' CE1' ' CD1' ' A' ' 98' ' ' LEU . 59.6 t-80 -156.04 114.88 3.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.231 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.7 m -101.23 139.9 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.739 -0.467 . . . . 1.0 109.739 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 53' ' ' ILE . 58.5 t -81.69 89.9 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.036 0.446 . . . . 1.0 110.527 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -58.24 -31.18 67.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.664 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 m -92.9 34.99 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.992 0.425 . . . . 1.0 110.364 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -178.87 -4.6 0.02 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.091 -0.804 . . . . 1.0 111.091 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -127.04 -1.35 4.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-O 120.748 0.309 . . . . 1.0 110.314 179.293 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.45 37.32 0.57 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.105 -0.798 . . . . 1.0 111.105 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.523 ' NE ' ' OD2' ' A' ' 86' ' ' ASP . 1.6 ptp180 -61.0 -37.76 83.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.829 0.347 . . . . 1.0 110.244 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -172.9 -103.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.401 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.687 ' CD ' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -85.98 -19.13 30.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.491 179.574 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.447 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -43.21 -36.53 1.78 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.573 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 61' ' ' PHE . 12.5 pt-20 -66.12 -44.46 84.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.342 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.1 tp -43.17 -18.13 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.775 0.798 . . . . 1.0 110.818 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 59' ' ' GLU . 6.5 m-85 -58.11 -48.38 80.37 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.562 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.689 ' HA ' HD12 ' A' ' 65' ' ' ILE . 14.6 pt-20 -60.47 -31.04 70.07 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.034 0.445 . . . . 1.0 111.544 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.421 ' H ' ' HG2' ' A' ' 63' ' ' LYS . 17.0 mmmt -65.96 -56.52 11.3 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.451 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 64' ' ' GLN . 2.3 pt20 -57.84 -30.06 65.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.421 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.849 HD11 HD21 ' A' ' 115' ' ' LEU . 68.5 mt -66.87 -39.82 84.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.411 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 62' ' ' GLU . 53.8 t -59.8 -41.62 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.232 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -68.24 -16.46 63.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.521 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.431 ' O ' ' OG ' ' A' ' 42' ' ' SER . 34.0 m170 -88.81 7.32 34.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.65 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.82 -7.22 82.18 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.052 -0.819 . . . . 1.0 111.052 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.56 98.06 2.3 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.589 -1.004 . . . . 1.0 110.589 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -79.54 144.31 34.04 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.89 -0.324 . . . . 1.0 110.756 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.637 HD13 ' O ' ' A' ' 46' ' ' ALA . 2.5 mm? -80.66 137.27 36.32 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 120.898 0.38 . . . . 1.0 110.531 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.8 m -133.68 90.54 27.87 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.465 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.5 -177.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.824 2.349 . . . . 1.0 112.139 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 77' ' ' GLY . . . -56.43 -41.73 76.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.514 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -64.14 -1.55 1.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.319 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 75' ' ' ALA . . . -136.56 86.67 0.24 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.318 -1.113 . . . . 1.0 110.318 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.76 139.26 59.18 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.626 2.218 . . . . 1.0 112.058 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.81 1.17 1.63 Allowed Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 80' ' ' VAL . 1.3 p -88.34 103.71 13.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.048 0.451 . . . . 1.0 110.6 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.99 -39.25 15.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.399 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.5 ' CD2' ' CZ2' ' A' ' 114' ' ' TRP . 77.5 m80 -106.58 138.82 42.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.951 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.482 HD13 HD22 ' A' ' 98' ' ' LEU . 85.7 mt -133.58 107.36 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.258 -0.428 . . . . 1.0 109.934 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.43 134.97 27.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.533 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.51 162.8 37.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.394 -0.821 . . . . 1.0 110.975 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 88' ' ' GLY . 67.8 t0 -63.99 103.45 0.59 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 116.027 -0.533 . . . . 1.0 109.635 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 86' ' ' ASP . 69.1 mt-10 -24.63 87.15 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 124.191 0.932 . . . . 1.0 110.926 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . 156.77 -25.41 0.5 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 -178.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.462 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 11.9 ttm -70.14 146.71 50.63 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.913 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -90.09 151.57 21.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.453 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.55 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.74 -46.86 87.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.108 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.55 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 10.5 pt-20 -57.99 -45.45 86.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.947 0.403 . . . . 1.0 110.776 -178.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.484 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 4.8 tmm_? -72.13 -21.82 61.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.13 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.49 -30.62 71.71 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.802 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 99' ' ' ARG . 7.0 mp -72.18 -44.81 62.46 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.212 0.32 . . . . 1.0 110.973 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -59.79 -48.28 82.32 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.25 -45.76 75.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.568 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.486 ' CD1' ' CE1' ' A' ' 47' ' ' HIS . 54.8 tp -72.77 -16.18 61.64 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.969 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.57 ' N ' ' O ' ' A' ' 95' ' ' LEU . 23.0 mmt85 67.35 27.15 8.27 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.11 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.5 tp -98.02 116.99 65.58 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.8 -23.26 35.72 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.22 1.947 . . . . 1.0 112.578 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -174.42 133.88 0.4 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.328 -0.397 . . . . 1.0 110.714 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 104' ' ' PRO . 1.0 OUTLIER -73.79 135.44 77.75 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.093 -178.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.533 ' O ' ' O ' ' A' ' 103' ' ' LEU . 60.7 Cg_exo -44.72 -174.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.645 2.23 . . . . 1.0 112.061 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 52.5 Cg_exo -51.95 -68.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.565 2.176 . . . . 1.0 113.087 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . -82.45 -50.43 4.77 Favored Glycine 0 CA--C 1.502 -0.753 0 N-CA-C 110.662 -0.975 . . . . 1.0 110.662 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.52 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -11.46 123.83 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 124.64 0.847 . . . . 1.0 111.44 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -130.76 154.26 48.17 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 110.018 -0.364 . . . . 1.0 110.018 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.86 110.36 22.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.783 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.74 HG21 ' CE3' ' A' ' 114' ' ' TRP . 13.9 m -107.25 169.07 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.661 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -96.52 -168.97 1.81 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.658 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -70.69 -34.66 72.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.878 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.403 ' HB3' ' CD1' ' A' ' 130' ' ' PHE . . . -57.21 -46.75 82.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.688 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.74 ' CE3' HG21 ' A' ' 110' ' ' VAL . 79.0 t90 -52.02 -59.83 3.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.628 -0.429 . . . . 1.0 110.678 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.849 HD21 HD11 ' A' ' 65' ' ' ILE . 32.0 tp -60.63 -51.24 70.25 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.441 -0.504 . . . . 1.0 110.503 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 117' ' ' LEU . 56.9 p -41.27 -60.71 1.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.087 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.439 ' N ' ' OG ' ' A' ' 116' ' ' SER . 11.0 mp -61.14 -49.62 76.51 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.055 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 9.3 t -55.49 -25.96 39.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 1.0 110.081 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -70.62 -52.27 22.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.478 0.656 . . . . 1.0 111.419 -178.779 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -78.39 -30.66 47.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.505 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 122' ' ' ARG . 0.4 OUTLIER -62.38 -48.5 79.45 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 118.473 -0.775 . . . . 1.0 110.165 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 121' ' ' GLU . 17.0 mmm180 90.27 32.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.816 1.323 . . . . 1.0 111.358 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.432 HH11 ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -173.9 163.18 4.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.435 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.4 tp -65.76 129.32 39.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.962 0.411 . . . . 1.0 111.175 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.442 HG23 ' CD1' ' A' ' 114' ' ' TRP . 17.3 m -113.32 154.0 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.364 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -61.96 146.92 48.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.431 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 129' ' ' GLY . 2.4 m -108.01 0.98 9.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.249 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.98 61.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.602 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 171.48 -28.15 0.11 Allowed Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 113' ' ' ALA . 60.7 m-85 -108.47 -11.53 15.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.718 0.295 . . . . 1.0 110.39 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -74.6 135.32 42.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.08 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 134' ' ' ILE . 57.5 mt -79.45 -65.95 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.129 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.53 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 19.7 t80 66.14 -36.33 0.24 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 118.438 -0.791 . . . . 1.0 111.154 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.609 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 155.67 -55.27 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 O-C-N 124.825 1.328 . . . . 1.0 110.272 -178.727 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 22.7 Cg_endo . . . . . 0 C--N 1.311 -1.401 0 C-N-CA 122.391 2.06 . . . . 1.0 111.982 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.549 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 57.8 mp0 . . . . . 0 CA--C 1.519 -0.224 0 CA-C-O 120.822 0.344 . . . . 1.0 110.433 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.502 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 3.5 p-90 -98.42 -56.69 2.39 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.391 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.402 HD12 ' CH2' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -56.15 -11.68 1.23 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.737 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.5 p -68.7 -32.55 72.44 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.644 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -61.02 -15.32 30.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.571 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.72 115.28 11.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.854 0.359 . . . . 1.0 110.628 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.418 ' HB3' HG23 ' A' ' 80' ' ' VAL . 88.9 mtm180 -75.31 139.94 42.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.078 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.717 ' HB3' HD13 ' A' ' 65' ' ' ILE . . . -119.33 169.74 9.73 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.458 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.406 ' C ' ' ND1' ' A' ' 47' ' ' HIS . 1.5 t-80 -147.89 120.09 8.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.439 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -97.1 127.16 49.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.508 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.66 HG12 ' H ' ' A' ' 52' ' ' GLY . 15.0 t -80.7 88.92 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.424 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -49.56 -36.84 24.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.548 -0.296 . . . . 1.0 110.571 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.0 p -76.26 -24.24 54.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.541 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.66 ' H ' HG12 ' A' ' 49' ' ' VAL . . . -110.14 1.58 29.84 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.367 -0.693 . . . . 1.0 111.367 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.644 ' N ' ' O ' ' A' ' 49' ' ' VAL . 35.0 mt -146.18 91.47 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.285 0.564 . . . . 1.0 110.309 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -145.45 19.68 1.87 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.076 -0.81 . . . . 1.0 111.076 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.657 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -58.25 -55.97 28.08 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.288 -0.264 . . . . 1.0 110.288 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 55' ' ' ARG . . . 158.14 -40.14 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 O-C-N 123.436 0.46 . . . . 1.0 110.576 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.731 ' O ' HD22 ' A' ' 60' ' ' LEU . 70.3 ttp85 -94.27 -60.66 1.68 Allowed 'General case' 0 C--O 1.211 -0.928 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.829 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.634 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -40.96 -43.08 2.03 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-O 121.262 0.553 . . . . 1.0 110.578 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 61' ' ' PHE . 11.3 pt-20 -45.45 -48.52 13.8 Favored 'General case' 0 C--N 1.314 -0.971 0 O-C-N 121.77 -0.581 . . . . 1.0 111.094 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.802 HD23 ' N ' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -39.45 -19.02 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.507 0.504 . . . . 1.0 109.962 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.802 ' N ' HD23 ' A' ' 60' ' ' LEU . 8.6 m-85 -52.73 -48.96 66.32 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.676 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.462 ' CG ' ' N ' ' A' ' 63' ' ' LYS . 13.9 pt-20 -63.02 -43.46 98.67 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.489 0.493 . . . . 1.0 110.528 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.462 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 17.5 mtpp -61.23 -42.58 98.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.223 0.535 . . . . 1.0 110.177 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.536 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 86.9 mm-40 -67.35 -31.27 71.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.205 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.751 HD11 HD11 ' A' ' 115' ' ' LEU . 46.5 mt -74.96 -57.86 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.047 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 67' ' ' GLN . 28.0 m -55.22 -42.75 67.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.271 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.533 ' N ' HG23 ' A' ' 66' ' ' VAL . 65.0 tt0 -65.81 -40.29 91.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.584 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 64' ' ' GLN . 46.5 m170 -86.01 -3.59 58.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.503 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 99.17 171.17 30.96 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.876 -0.89 . . . . 1.0 110.876 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 71' ' ' GLN . . . 102.17 -45.51 1.36 Allowed Glycine 0 N--CA 1.464 0.545 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 70' ' ' GLY . 25.1 mm100 54.92 158.65 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.7 0.286 . . . . 1.0 110.634 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.873 HD22 ' N ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -89.58 130.32 35.91 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.757 -0.461 . . . . 1.0 109.757 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 73.3 m -118.85 88.73 36.53 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.621 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 77' ' ' GLY . 31.8 Cg_exo -56.67 162.45 8.47 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.833 2.355 . . . . 1.0 112.055 178.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -47.23 -33.84 5.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.397 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -75.94 -20.51 57.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.896 0.379 . . . . 1.0 110.592 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 74' ' ' PRO . . . -85.9 -161.99 35.85 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.029 -0.828 . . . . 1.0 111.029 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -43.8 -41.63 11.78 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.563 2.175 . . . . 1.0 111.986 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.711 ' O ' HG12 ' A' ' 80' ' ' VAL . . . 136.19 -40.78 1.49 Allowed Glycine 0 C--O 1.22 -0.779 0 CA-C-O 119.219 -0.767 . . . . 1.0 111.695 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.742 HG13 ' N ' ' A' ' 81' ' ' THR . 0.3 OUTLIER 77.96 -171.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 124.034 0.491 . . . . 1.0 109.909 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.742 ' N ' HG13 ' A' ' 80' ' ' VAL . 0.6 OUTLIER -144.29 -32.19 0.43 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.824 177.56 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.561 ' HD1' HG23 ' A' ' 81' ' ' THR . 74.9 m80 -111.69 136.51 50.83 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.614 -0.266 . . . . 1.0 110.672 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 110' ' ' VAL . 30.2 mm -123.28 106.29 17.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.465 HG11 HD12 ' A' ' 115' ' ' LEU . 2.3 p -93.53 134.06 32.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.814 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 87' ' ' GLU . 3.1 m -132.79 157.44 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.206 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.576 ' O ' ' C ' ' A' ' 87' ' ' GLU . 10.1 t0 -54.78 77.72 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 123.373 0.42 . . . . 1.0 110.116 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' A' ' 85' ' ' VAL . 6.8 pt-20 -3.88 79.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 O-C-N 124.17 0.919 . . . . 1.0 111.76 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . 170.1 -22.11 0.08 OUTLIER Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.601 -0.727 . . . . 1.0 111.288 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.6 tpp -72.71 156.14 39.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.775 0.322 . . . . 1.0 110.786 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -96.35 144.1 26.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.135 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.604 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -51.47 -44.94 62.6 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.205 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.604 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 16.5 pt-20 -59.65 -44.16 93.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.929 0.395 . . . . 1.0 110.526 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.46 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 38.8 ttm105 -71.94 -41.16 68.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.767 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.15 -34.46 22.42 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.935 -0.575 . . . . 1.0 111.045 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 91' ' ' TYR . 5.6 mp -62.55 -47.3 84.49 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.66 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.548 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -73.0 -35.77 66.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.257 -178.649 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.62 -34.54 75.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.51 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.921 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -105.61 -1.94 24.05 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.204 -0.453 . . . . 1.0 111.005 -179.431 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.548 ' NH1' ' O ' ' A' ' 96' ' ' ARG . 72.9 mmt-85 70.57 61.68 0.2 Allowed 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 123.322 0.389 . . . . 1.0 110.858 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.624 ' HB2' HD11 ' A' ' 98' ' ' LEU . 9.3 tp -125.79 122.36 24.57 Favored Pre-proline 0 N--CA 1.449 -0.518 0 O-C-N 123.255 0.347 . . . . 1.0 111.376 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.83 -36.51 23.44 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.384 2.056 . . . . 1.0 112.012 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 179.47 139.63 0.11 Allowed 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.576 0.548 . . . . 1.0 110.915 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.7 mt -45.14 120.27 4.4 Favored Pre-proline 0 N--CA 1.445 -0.72 0 CA-C-N 115.843 -0.617 . . . . 1.0 111.166 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.15 165.36 32.9 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.409 2.073 . . . . 1.0 112.031 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.15 113.54 1.24 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.575 2.183 . . . . 1.0 111.805 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.84 62.58 1.67 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -164.09 143.13 7.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 1.0 110.641 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.504 ' N ' ' CD ' ' A' ' 108' ' ' GLN . 0.0 OUTLIER -140.16 152.99 46.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.088 0.471 . . . . 1.0 110.132 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.415 HD11 ' CD1' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -93.06 109.4 20.87 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.15 179.26 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.616 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.0 m -108.23 167.14 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.026 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -102.24 -171.18 1.92 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.838 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.4 t -64.84 -44.42 89.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.895 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.08 -38.0 49.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.514 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.616 ' CE3' HG21 ' A' ' 110' ' ' VAL . 75.2 t90 -61.65 -52.31 64.86 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.907 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.751 HD11 HD11 ' A' ' 65' ' ' ILE . 3.0 tt -63.13 -55.7 23.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.993 0.425 . . . . 1.0 110.986 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.9 t -43.94 -59.55 2.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.392 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.427 ' O ' ' OE2' ' A' ' 121' ' ' GLU . 9.4 mp -60.01 -49.82 76.15 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.464 -0.494 . . . . 1.0 110.364 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 123' ' ' ARG . 3.1 t -58.72 -22.08 56.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.142 -0.318 . . . . 1.0 110.142 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.535 ' O ' ' NH1' ' A' ' 122' ' ' ARG . 6.7 tp -71.22 -53.52 14.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.001 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.42 ' C ' ' H ' ' A' ' 122' ' ' ARG . 77.0 mt-30 -76.75 -33.08 58.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.603 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.535 ' O ' ' C ' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -77.26 18.17 0.42 Allowed 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.8 -178.496 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.535 ' C ' ' O ' ' A' ' 121' ' ' GLU . 81.6 mmt-85 20.56 52.77 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.719 0.637 . . . . 1.0 111.353 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.494 ' O ' ' SG ' ' A' ' 118' ' ' CYS . 0.5 OUTLIER -170.67 167.8 7.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.727 -0.669 . . . . 1.0 110.357 -178.342 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.482 HD11 ' NE2' ' A' ' 82' ' ' HIS . 5.0 tt -83.77 114.76 21.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.044 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 126' ' ' ASP . 55.2 t -80.45 155.7 4.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.155 0.502 . . . . 1.0 110.601 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.431 ' N ' HG12 ' A' ' 125' ' ' VAL . 66.2 t0 -66.46 117.26 8.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.505 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 131' ' ' SER . 2.9 m -64.14 -41.4 92.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.603 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.463 ' N ' ' CG2' ' A' ' 127' ' ' VAL . . . -53.75 -6.64 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.455 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 127' ' ' VAL . . . -87.86 -34.38 10.09 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -134.33 12.12 3.83 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.713 0.292 . . . . 1.0 110.433 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 127' ' ' VAL . 5.1 t -75.48 141.29 43.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.895 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.569 ' C ' ' H ' ' A' ' 134' ' ' ILE . 45.3 mt -83.25 -66.36 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.124 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.533 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 21.1 t80 66.76 -37.89 0.31 Allowed 'General case' 0 C--O 1.211 -0.926 0 O-C-N 124.011 0.819 . . . . 1.0 111.003 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.61 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 157.36 -54.66 0.0 OUTLIER Pre-proline 0 N--CA 1.45 -0.441 0 O-C-N 124.658 1.224 . . . . 1.0 110.755 -178.542 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 29.9 Cg_endo . . . . . 0 C--N 1.31 -1.476 0 C-N-CA 122.479 2.12 . . . . 1.0 111.684 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.394 0 N-CA-C 109.504 -1.438 . . . . 1.0 109.504 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.4 m -70.63 150.16 46.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.669 0.271 . . . . 1.0 110.391 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -117.96 55.77 0.87 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.525 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.8 t -138.43 144.48 40.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.539 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.99 -67.07 0.11 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -80.39 94.36 6.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.868 0.366 . . . . 1.0 110.616 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.512 ' C ' ' H ' ' A' ' 38' ' ' GLU . 1.7 tt0 -60.53 -47.18 87.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.592 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.614 ' C ' ' H ' ' A' ' 39' ' ' GLU . . . 57.24 2.78 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.66 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.512 ' H ' ' C ' ' A' ' 36' ' ' GLU . 99.4 mt-10 56.77 -3.15 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.455 -0.338 . . . . 1.0 110.91 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.614 ' H ' ' C ' ' A' ' 37' ' ' ALA . 96.1 mt-10 37.45 75.27 0.07 Allowed 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.782 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -90.24 -46.05 8.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.383 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.539 ' CD2' HG23 ' A' ' 65' ' ' ILE . 6.6 tp -62.42 -31.83 72.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.742 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 91.5 p -48.02 -14.71 0.05 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.532 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.459 ' N ' ' C ' ' A' ' 41' ' ' LEU . 32.9 t -64.55 -16.34 62.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.567 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.35 168.24 19.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.281 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.463 HH12 ' CA ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -118.11 112.19 19.86 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.966 0.413 . . . . 1.0 110.428 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.575 ' CB ' HD13 ' A' ' 65' ' ' ILE . . . -93.58 166.29 12.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.782 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -155.12 121.35 5.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.376 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.604 HG13 HD12 ' A' ' 53' ' ' ILE . 54.6 t -108.73 135.05 48.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.97 0.414 . . . . 1.0 110.215 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 52' ' ' GLY . 13.6 t -86.0 103.44 12.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.412 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.528 ' H ' ' HD2' ' A' ' 50' ' ' ARG . 6.8 mpt_? -63.55 -38.86 92.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.72 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.7 p -66.05 -30.56 71.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.404 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.567 ' H ' HG12 ' A' ' 49' ' ' VAL . . . -87.31 -67.48 1.33 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.21 -0.756 . . . . 1.0 111.21 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.604 HD12 HG13 ' A' ' 48' ' ' VAL . 3.1 mt -61.9 -94.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.971 -0.292 . . . . 1.0 110.214 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 53' ' ' ILE . . . 34.24 32.27 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.163 -0.775 . . . . 1.0 111.163 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.53 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 30.0 mtm180 -70.54 -60.34 2.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.829 0.347 . . . . 1.0 110.364 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 55' ' ' ARG . . . 170.72 -53.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.352 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.5 ttt-85 -101.99 -41.39 6.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.365 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.473 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -56.59 -41.4 76.92 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.048 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 61' ' ' PHE . 8.0 pt-20 -45.62 -46.44 14.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.734 -0.212 . . . . 1.0 110.584 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.8 tp -41.27 -17.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.12 0.486 . . . . 1.0 110.548 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.766 ' CD1' HD13 ' A' ' 115' ' ' LEU . 3.3 m-85 -49.42 -51.1 37.6 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.173 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.477 ' CD ' ' HZ2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -61.58 -40.09 93.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.542 -0.299 . . . . 1.0 110.675 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HZ2' ' CD ' ' A' ' 62' ' ' GLU . 13.9 mptt -61.68 -43.28 99.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.228 0.537 . . . . 1.0 110.249 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -63.6 -40.53 97.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.309 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 1.083 HD11 HD11 ' A' ' 115' ' ' LEU . 81.2 mt -64.32 -54.12 34.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.934 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.495 HG23 ' N ' ' A' ' 67' ' ' GLN . 28.9 m -64.01 -40.43 89.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.128 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.495 ' N ' HG23 ' A' ' 66' ' ' VAL . 55.9 tt0 -59.64 -18.62 43.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.273 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.3 m170 -97.3 1.86 50.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.487 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.07 0.51 59.98 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.057 -0.817 . . . . 1.0 111.057 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.686 ' O ' HG22 ' A' ' 65' ' ' ILE . . . -91.63 98.2 2.4 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.738 -0.945 . . . . 1.0 110.738 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.414 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 83.7 mt-30 -70.86 145.43 50.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.87 0.367 . . . . 1.0 110.568 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.626 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -136.34 156.65 48.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.084 0.469 . . . . 1.0 110.359 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.1 m -163.19 158.28 17.91 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.566 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.95 -153.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.952 2.435 . . . . 1.0 111.944 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 99' ' ' ARG . . . -47.62 -26.66 1.56 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.505 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' A' ' 77' ' ' GLY . 74.7 mt-30 -66.58 -20.12 65.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.281 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.463 ' CA ' HH12 ' A' ' 45' ' ' ARG . . . -37.51 103.88 0.03 OUTLIER Glycine 0 CA--C 1.538 1.475 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.44 ' HD2' HH22 ' A' ' 45' ' ' ARG . 52.2 Cg_exo -50.9 -28.76 24.71 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.647 2.232 . . . . 1.0 111.928 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.82 60.96 0.4 Allowed Glycine 0 CA--C 1.521 0.413 0 N-CA-C 111.099 -0.8 . . . . 1.0 111.099 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 80' ' ' VAL . 1.5 p -91.63 97.6 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.489 0.661 . . . . 1.0 110.249 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.19 -19.02 19.66 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.42 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -109.97 140.78 43.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.472 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.5 mm -131.1 106.18 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.614 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.4 t -91.21 131.35 38.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.52 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' A' ' 87' ' ' GLU . 27.9 m -132.73 162.59 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.607 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.586 ' C ' ' H ' ' A' ' 88' ' ' GLY . 15.3 t70 -68.92 18.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.375 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.563 ' H ' ' C ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER 68.87 -20.1 0.16 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.668 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -61.82 -67.71 1.98 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.2 ptp -63.54 145.82 54.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.641 0.258 . . . . 1.0 110.35 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -83.63 168.52 16.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.638 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.546 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.98 -53.32 59.18 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.466 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.546 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 15.7 pt-20 -50.39 -38.86 44.89 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.502 0.501 . . . . 1.0 110.107 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.441 ' HG3' ' HE ' ' A' ' 96' ' ' ARG . 67.7 ttt180 -74.81 -40.97 60.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.974 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -46.19 -27.89 1.11 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.642 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.594 HD22 ' N ' ' A' ' 95' ' ' LEU . 4.1 mm? -56.07 -59.51 4.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.268 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.441 ' HE ' ' HG3' ' A' ' 93' ' ' ARG . 41.2 ptt180 -78.1 -25.95 47.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.477 -0.329 . . . . 1.0 110.551 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.451 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -61.45 -42.24 98.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.932 -179.159 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -93.4 6.14 49.18 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.283 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 31.6 mmt-85 69.67 54.88 0.37 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.791 0.329 . . . . 1.0 111.065 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 95' ' ' LEU . 6.4 tp -146.78 116.83 4.56 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.781 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.35 -7.48 19.71 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.767 2.311 . . . . 1.0 112.876 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -179.85 140.68 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.699 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.516 ' CD1' HD11 ' A' ' 95' ' ' LEU . 1.7 mp -84.45 148.56 52.67 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.973 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.475 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 37.0 Cg_exo -59.34 -173.68 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.63 2.22 . . . . 1.0 111.657 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 29.8 Cg_exo -62.45 133.75 44.55 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.676 2.251 . . . . 1.0 111.798 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 72.42 -51.59 1.43 Allowed Glycine 0 C--O 1.22 -0.729 0 N-CA-C 110.935 -0.866 . . . . 1.0 110.935 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.537 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -17.8 129.71 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.905 0.415 . . . . 1.0 111.065 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -132.11 158.28 42.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.103 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.677 HD12 ' N ' ' A' ' 109' ' ' LEU . 3.4 mp -107.84 117.61 34.58 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.553 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.672 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.6 m -108.84 175.45 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.479 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -104.36 -174.67 2.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.811 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.0 p -64.04 -37.67 88.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.896 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.38 -44.45 76.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.586 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.672 ' CE3' HG21 ' A' ' 110' ' ' VAL . 60.8 t90 -57.51 -48.21 79.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.476 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 1.083 HD11 HD11 ' A' ' 65' ' ' ILE . 1.3 tt -58.77 -52.69 64.61 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.231 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.1 m -42.15 -57.43 2.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.519 -0.309 . . . . 1.0 110.629 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 121' ' ' GLU . 60.8 mt -55.0 -50.7 68.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.378 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.614 ' SG ' ' CE2' ' A' ' 114' ' ' TRP . 55.9 m -45.87 -33.52 3.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.456 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 65.5 mt -80.13 -50.93 9.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.915 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -70.18 -54.57 12.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.63 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 117' ' ' LEU . 79.9 mt-10 -75.54 7.6 3.55 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.538 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 121' ' ' GLU . 74.4 mtt85 25.09 53.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.54 0.525 . . . . 1.0 111.503 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -159.0 -170.24 2.95 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.306 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.4 tp -108.04 96.85 6.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.422 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.527 HG23 ' CD1' ' A' ' 114' ' ' TRP . 2.4 m -78.56 154.44 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.622 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -61.09 119.85 9.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.329 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.566 ' HB ' HG12 ' A' ' 110' ' ' VAL . 5.3 m -62.45 -42.05 94.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.719 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.52 ' N ' HG23 ' A' ' 127' ' ' VAL . . . -44.44 -19.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.553 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . -70.75 -40.71 64.81 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -135.95 34.65 2.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.682 0.277 . . . . 1.0 110.617 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.7 t -100.49 137.48 38.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.763 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 134' ' ' ILE . 39.6 mt -72.65 -71.85 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.373 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.568 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 20.6 t80 65.74 -36.55 0.23 Allowed 'General case' 0 C--O 1.208 -1.101 0 CA-C-O 118.306 -0.854 . . . . 1.0 110.804 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.624 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 156.3 -55.51 0.0 OUTLIER Pre-proline 0 N--CA 1.449 -0.506 0 O-C-N 124.736 1.272 . . . . 1.0 110.667 -178.612 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 29.8 Cg_endo . . . . . 0 C--N 1.304 -1.771 0 C-N-CA 122.617 2.212 . . . . 1.0 111.695 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.502 -1.439 . . . . 1.0 109.502 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 99.3 p -78.5 -7.26 57.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.723 0.297 . . . . 1.0 110.594 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -92.63 7.96 41.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.445 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.4 t -152.95 152.5 31.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.611 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.69 -44.55 97.34 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -171.47 80.63 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.37 . . . . 1.0 110.655 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 38' ' ' GLU . 20.7 pt-20 -65.97 -42.39 89.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.596 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 61.28 2.52 0.63 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.525 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 36' ' ' GLU . 96.8 mt-10 -76.8 -120.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.605 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 48.12 63.4 2.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.417 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.469 ' CZ3' HD12 ' A' ' 41' ' ' LEU . 1.9 p-90 -107.32 -32.54 7.72 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.528 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.476 HD23 HD11 ' A' ' 44' ' ' LEU . 1.6 mt -79.32 -9.53 59.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.035 0.445 . . . . 1.0 110.633 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.7 t -67.04 -21.75 65.9 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.81 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.6 t -63.64 -15.71 59.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.846 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.476 HD11 HD23 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -138.15 169.52 17.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.392 -179.725 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -118.86 107.33 13.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.415 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.513 ' HB3' HG21 ' A' ' 65' ' ' ILE . . . -92.46 151.18 20.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.26 -0.427 . . . . 1.0 109.927 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -136.71 120.76 17.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.583 . . . . 1.0 110.556 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.403 ' CG1' HG21 ' A' ' 53' ' ' ILE . 88.3 t -96.48 135.9 29.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.861 -0.609 . . . . 1.0 109.969 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.447 HG23 ' H ' ' A' ' 53' ' ' ILE . 29.5 m -85.92 126.93 40.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.923 -0.581 . . . . 1.0 111.123 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -71.4 -37.2 71.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.988 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.604 ' OG1' HD11 ' A' ' 97' ' ' LEU . 99.1 m -57.0 -48.79 77.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.615 -178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . -90.5 -83.61 1.39 Allowed Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.458 -1.057 . . . . 1.0 110.458 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.447 ' H ' HG23 ' A' ' 49' ' ' VAL . 5.3 mm -53.23 78.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.71 0.766 . . . . 1.0 110.266 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 52' ' ' GLY . . . -166.7 25.78 0.15 Allowed Glycine 0 C--N 1.313 -0.75 0 CA-C-N 114.884 -1.053 . . . . 1.0 111.462 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.452 ' NH2' ' OD2' ' A' ' 86' ' ' ASP . 11.9 ptp180 -72.62 -37.33 68.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.844 0.354 . . . . 1.0 110.77 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -179.32 -81.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.609 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -90.7 -20.27 22.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.53 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.48 -27.25 9.95 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 120.967 0.413 . . . . 1.0 110.399 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.437 ' C ' ' N ' ' A' ' 61' ' ' PHE . 2.1 pt-20 -70.58 -35.66 73.17 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.717 0.294 . . . . 1.0 110.57 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.3 tp -46.2 -19.35 0.07 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.967 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.437 ' N ' ' C ' ' A' ' 59' ' ' GLU . 5.1 m-85 -61.23 -44.6 97.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.956 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.553 ' HA ' HD12 ' A' ' 65' ' ' ILE . 8.9 pt-20 -62.47 -40.42 96.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.975 0.417 . . . . 1.0 110.672 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.445 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 39.0 mttp -65.71 -41.9 91.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.665 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.543 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 90.9 mt-30 -63.14 -19.03 64.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.618 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 1.13 HD11 HD11 ' A' ' 115' ' ' LEU . 70.6 mt -83.38 -57.42 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.83 0.348 . . . . 1.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 71' ' ' GLN . 3.5 m -64.58 -32.78 59.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.052 0.454 . . . . 1.0 110.604 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -70.56 -21.44 62.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.508 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 64' ' ' GLN . 60.1 m170 -96.26 14.71 23.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.978 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.22 2.3 57.99 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.984 -0.847 . . . . 1.0 110.984 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.59 -146.0 2.47 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.096 -1.202 . . . . 1.0 110.096 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.412 ' HA ' HG12 ' A' ' 66' ' ' VAL . 0.0 OUTLIER 171.98 149.05 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.14 -0.318 . . . . 1.0 110.14 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.6 mt -107.9 113.67 27.04 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.444 ' O ' ' O ' ' A' ' 74' ' ' PRO . 2.5 m -135.36 91.07 19.29 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.205 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 73' ' ' CYS . 52.5 Cg_exo -52.37 -162.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.599 2.199 . . . . 1.0 112.003 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -61.23 -33.62 73.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.565 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.09 -19.54 65.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.485 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.24 -161.51 14.04 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.056 -0.818 . . . . 1.0 111.056 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.95 -37.48 78.2 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.805 2.337 . . . . 1.0 111.924 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.566 ' O ' HG12 ' A' ' 80' ' ' VAL . . . 160.15 -40.75 0.45 Allowed Glycine 0 C--O 1.223 -0.59 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 79' ' ' GLY . 0.4 OUTLIER 80.41 162.29 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 N-CA-C 110.106 -0.331 . . . . 1.0 110.106 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.69 -41.93 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.936 0.398 . . . . 1.0 110.74 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -110.29 137.12 48.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.974 0.416 . . . . 1.0 110.993 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 77.3 mt -133.02 109.38 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.955 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.512 HG21 HD12 ' A' ' 115' ' ' LEU . 31.1 t -88.08 138.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.249 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 87' ' ' GLU . 35.3 m -134.64 152.57 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.378 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' GLY . 66.4 t0 -74.45 43.41 0.18 Allowed 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.655 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.494 ' CD ' ' NZ ' ' A' ' 111' ' ' LYS . 2.8 mt-10 40.66 22.19 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.633 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . -100.06 -64.58 0.81 Allowed Glycine 0 N--CA 1.463 0.457 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.442 ' CE ' HG21 ' A' ' 49' ' ' VAL . 13.2 ptp -77.73 156.19 30.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.857 0.36 . . . . 1.0 110.548 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -93.07 173.95 7.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.498 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.651 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.69 -50.4 73.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.164 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.651 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 15.4 pt-20 -51.67 -38.31 54.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.055 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.516 HH21 HH21 ' A' ' 96' ' ' ARG . 69.7 ttt180 -83.15 -21.84 33.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.604 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.404 ' O ' ' CD2' ' A' ' 98' ' ' LEU . . . -62.04 -35.41 78.52 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.389 -0.524 . . . . 1.0 111.912 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 95' ' ' LEU . 7.6 mp -60.83 -41.84 96.56 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.853 0.359 . . . . 1.0 110.649 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.516 HH21 HH21 ' A' ' 93' ' ' ARG . 13.7 ptt85 -69.47 -23.69 63.69 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.252 -0.579 . . . . 1.0 109.798 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.604 HD11 ' OG1' ' A' ' 51' ' ' THR . 0.2 OUTLIER -65.9 -41.29 91.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.37 0.605 . . . . 1.0 111.19 -177.553 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.766 HD23 ' H ' ' A' ' 98' ' ' LEU . 2.4 pt? -114.9 5.98 15.27 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.877 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.467 ' CD ' ' N ' ' A' ' 99' ' ' ARG . 1.2 mpt_? 58.05 57.35 4.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.609 -0.269 . . . . 1.0 110.441 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.2 tp -104.89 110.3 64.28 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 120.597 -0.441 . . . . 1.0 110.354 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.08 -40.94 58.98 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.151 1.901 . . . . 1.0 112.268 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -173.69 135.64 0.53 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.708 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.9 mp -53.28 111.69 2.94 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.187 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.453 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 46.9 Cg_exo -50.49 -174.49 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 122.097 1.865 . . . . 1.0 112.235 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 31.3 Cg_exo -58.57 113.58 1.62 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.836 2.357 . . . . 1.0 112.058 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 91.79 -66.53 2.23 Favored Glycine 0 C--O 1.221 -0.714 0 N-CA-C 110.413 -1.075 . . . . 1.0 110.413 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.52 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -13.42 125.68 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.109 0.535 . . . . 1.0 111.487 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -133.6 156.34 48.02 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.967 0.413 . . . . 1.0 110.35 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.85 112.89 24.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.917 -0.583 . . . . 1.0 109.614 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.551 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.4 m -107.27 168.74 3.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 123.705 0.628 . . . . 1.0 109.843 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.494 ' NZ ' ' CD ' ' A' ' 87' ' ' GLU . 3.6 mtpp -102.64 -177.67 3.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.746 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.9 m -60.48 -39.87 89.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.459 -0.791 . . . . 1.0 110.767 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.24 -39.32 66.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.687 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.551 ' CE3' HG21 ' A' ' 110' ' ' VAL . 76.1 t90 -60.76 -47.05 88.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.848 0.356 . . . . 1.0 110.714 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 1.13 HD11 HD11 ' A' ' 65' ' ' ILE . 0.6 OUTLIER -60.14 -52.28 66.02 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.219 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.2 p -51.06 -42.27 60.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.154 -0.475 . . . . 1.0 109.973 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 mt -61.32 -52.71 63.54 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.405 -0.518 . . . . 1.0 109.651 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.549 ' O ' ' N ' ' A' ' 122' ' ' ARG . 2.2 m -50.48 -36.37 33.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.702 -0.481 . . . . 1.0 109.702 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.6 mt -69.15 -52.92 23.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.148 0.499 . . . . 1.0 110.575 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -60.66 -27.42 67.81 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.096 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -103.32 -4.31 24.4 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.325 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.549 ' N ' ' O ' ' A' ' 118' ' ' CYS . 37.8 mmt180 44.23 47.95 7.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.717 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.517 ' HE ' HG12 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -172.36 -175.5 1.4 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.51 -179.287 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -86.37 126.73 34.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.973 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.517 HG12 ' HE ' ' A' ' 123' ' ' ARG . 20.4 m -114.15 155.4 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.572 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -60.94 159.21 11.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.052 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' GLY . 3.6 m -114.67 3.23 7.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.493 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.35 67.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.006 0.431 . . . . 1.0 110.582 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 159.27 -34.3 0.47 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.186 -0.765 . . . . 1.0 111.186 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -103.77 1.24 31.43 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.063 0.459 . . . . 1.0 110.428 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 t -90.13 140.99 29.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.906 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.581 ' C ' ' H ' ' A' ' 134' ' ' ILE . 60.7 mt -92.27 -72.46 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 116.266 -0.424 . . . . 1.0 109.883 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.528 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 19.1 t80 64.77 -36.13 0.19 Allowed 'General case' 0 C--O 1.222 -0.345 0 O-C-N 123.945 0.778 . . . . 1.0 111.303 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.585 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 155.17 -55.43 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.414 0 O-C-N 124.581 1.175 . . . . 1.0 110.14 -178.438 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.6 Cg_endo . . . . . 0 N--CA 1.492 1.411 0 C-N-CA 122.216 1.944 . . . . 1.0 111.974 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.599 -1.4 . . . . 1.0 109.599 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.2 t -68.54 131.11 44.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.753 0.311 . . . . 1.0 110.53 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -64.72 -41.82 95.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.929 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 m 38.54 67.82 0.38 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.192 -0.458 . . . . 1.0 111.041 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -114.59 6.98 22.49 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 56.3 mp0 -86.6 114.96 23.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.748 0.308 . . . . 1.0 110.474 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.425 ' HG2' ' H ' ' A' ' 38' ' ' GLU . 79.9 tt0 -67.26 -51.37 53.9 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.746 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' A' ' 39' ' ' GLU . . . 40.51 28.42 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.827 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.425 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 98.7 mt-10 57.09 4.5 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.778 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' A' ' 37' ' ' ALA . 95.4 mt-10 -104.77 75.17 1.18 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.478 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.577 ' CZ3' HD13 ' A' ' 41' ' ' LEU . 8.5 p-90 -100.08 -59.05 1.78 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.015 0.436 . . . . 1.0 110.276 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.577 HD13 ' CZ3' ' A' ' 40' ' ' TRP . 5.6 tp -62.7 -30.39 71.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.671 -0.695 . . . . 1.0 110.267 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.2 t -48.13 -14.17 0.05 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.676 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.471 ' N ' ' C ' ' A' ' 41' ' ' LEU . 42.1 p -68.3 -13.48 62.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.8 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.93 169.08 18.37 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.8 0.333 . . . . 1.0 110.547 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.41 HH11 ' HA3' ' A' ' 79' ' ' GLY . 93.7 mtt180 -122.08 137.92 54.64 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.154 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.698 ' HB3' HD13 ' A' ' 65' ' ' ILE . . . -124.13 166.17 16.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.467 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -153.76 129.19 9.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.713 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.3 m -100.8 137.42 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.373 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.539 ' O ' ' O ' ' A' ' 52' ' ' GLY . 13.5 t -98.35 135.25 33.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.857 -0.611 . . . . 1.0 109.996 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.554 ' CD ' ' H ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -62.05 -43.52 98.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.739 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.631 ' OG1' HD12 ' A' ' 97' ' ' LEU . 13.1 m -51.7 -21.35 2.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.384 0.612 . . . . 1.0 110.548 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 49' ' ' VAL . . . -156.99 120.17 0.96 Allowed Glycine 0 C--O 1.219 -0.782 0 N-CA-C 109.383 -1.487 . . . . 1.0 109.383 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.569 HG22 ' O ' ' A' ' 53' ' ' ILE . 4.7 mm 115.28 -6.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.047 1.339 . . . . 1.0 109.52 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.01 22.74 30.08 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.754 -0.939 . . . . 1.0 110.754 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -60.97 -57.1 14.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.638 0.256 . . . . 1.0 110.588 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.466 ' O ' ' CG ' ' A' ' 59' ' ' GLU . . . 179.74 -67.44 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.386 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -91.06 -27.5 18.56 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.581 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.406 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -57.36 -32.63 66.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.319 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 61' ' ' PHE . 3.3 pt-20 -66.48 -39.5 88.79 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 116.159 -0.473 . . . . 1.0 109.775 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 tp -41.67 -17.51 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.183 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.604 ' HA ' HE21 ' A' ' 64' ' ' GLN . 6.1 m-85 -60.49 -42.89 97.24 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.22 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.504 ' HA ' HD12 ' A' ' 65' ' ' ILE . 1.3 pt-20 -67.74 -32.12 72.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.664 0.268 . . . . 1.0 111.159 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -70.67 -56.77 5.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.877 0.37 . . . . 1.0 111.013 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.604 HE21 ' HA ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -51.96 -31.23 28.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.76 -0.655 . . . . 1.0 109.527 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.808 HD11 HD11 ' A' ' 115' ' ' LEU . 31.0 mt -65.74 -46.99 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.67 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.81 -43.72 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.439 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -58.7 -26.93 64.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.179 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.498 ' CG ' ' O ' ' A' ' 64' ' ' GLN . 5.2 m-70 -79.27 -2.11 39.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.549 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.44 -1.35 58.64 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.928 -0.869 . . . . 1.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.75 88.6 1.54 Allowed Glycine 0 N--CA 1.461 0.363 0 N-CA-C 110.689 -0.965 . . . . 1.0 110.689 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.581 ' CD ' ' H ' ' A' ' 71' ' ' GLN . 2.6 pm0 -59.82 146.34 42.19 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.7 mt -92.29 110.82 22.22 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 91.1 m -119.97 86.88 37.56 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.603 ' C ' ' H ' ' A' ' 76' ' ' GLN . 14.3 Cg_endo -55.21 -159.71 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 122.004 1.803 . . . . 1.0 112.64 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -54.61 -0.6 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.035 -0.529 . . . . 1.0 110.588 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.603 ' H ' ' C ' ' A' ' 74' ' ' PRO . 16.4 pt20 -62.78 -19.67 64.24 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.109 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -156.12 160.32 30.01 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 120.755 -0.736 . . . . 1.0 111.599 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.535 ' O ' ' O ' ' A' ' 79' ' ' GLY . 49.5 Cg_exo -52.17 -10.97 0.86 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.231 1.954 . . . . 1.0 112.09 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.548 ' O ' ' C ' ' A' ' 80' ' ' VAL . . . -53.0 -118.31 0.01 OUTLIER Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.712 -0.955 . . . . 1.0 110.712 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 80' ' ' VAL . 2.3 p 10.6 74.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.592 0.71 . . . . 1.0 111.889 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.19 -24.23 27.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.352 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.63 ' CD2' ' CZ2' ' A' ' 114' ' ' TRP . 79.2 m80 -116.67 140.22 49.65 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.808 0.337 . . . . 1.0 110.262 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.611 HD13 ' O ' ' A' ' 82' ' ' HIS . 2.9 mm -128.68 111.3 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.427 -0.583 . . . . 1.0 109.427 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 115' ' ' LEU . 1.6 p -96.14 133.68 36.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.204 0.526 . . . . 1.0 110.379 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.8 m -127.82 165.61 26.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.562 -0.744 . . . . 1.0 110.536 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 88' ' ' GLY . 26.2 p-10 -77.06 14.26 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.636 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 64.81 -2.91 0.62 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.343 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -75.27 -49.87 8.98 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.305 -0.718 . . . . 1.0 111.305 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.0 ptp -88.87 156.38 18.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.82 0.343 . . . . 1.0 110.709 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -83.55 166.27 18.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.283 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.698 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -58.8 -47.58 84.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.993 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.698 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 17.5 pt-20 -53.69 -38.23 64.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.888 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.48 ' HG3' HD23 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -70.23 -47.04 63.16 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.197 179.656 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.07 -31.07 17.64 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.99 -0.684 . . . . 1.0 111.349 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.03 -47.58 85.28 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.346 -0.541 . . . . 1.0 111.267 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -70.91 -42.54 69.79 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.582 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.631 HD12 ' OG1' ' A' ' 51' ' ' THR . 3.8 mm? -64.36 -43.64 93.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.826 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.947 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -84.67 -4.27 58.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.545 -179.189 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.405 ' O ' ' CB ' ' A' ' 75' ' ' ALA . 75.1 mmt-85 68.57 60.94 0.37 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.038 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.517 ' HB2' HD11 ' A' ' 98' ' ' LEU . 7.7 tp -129.58 111.45 17.68 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.764 -0.198 . . . . 1.0 110.799 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.66 -42.64 61.13 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.916 1.744 . . . . 1.0 111.947 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -174.34 130.31 0.36 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.567 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 104' ' ' PRO . 69.5 mt -37.37 100.48 0.2 Allowed Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.094 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' LEU . 54.8 Cg_exo -46.01 -178.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.276 1.984 . . . . 1.0 112.407 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.14 -43.42 59.28 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.634 2.222 . . . . 1.0 112.65 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.39 68.98 0.25 Allowed Glycine 0 N--CA 1.468 0.775 0 N-CA-C 110.97 -0.852 . . . . 1.0 110.97 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.64 138.6 7.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.82 0.343 . . . . 1.0 110.587 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -146.02 151.93 38.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.256 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.88 113.26 25.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.962 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.704 HG21 ' CE3' ' A' ' 114' ' ' TRP . 12.0 m -110.63 166.33 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.501 -0.772 . . . . 1.0 109.885 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.51 ' NZ ' ' O ' ' A' ' 130' ' ' PHE . 28.8 mtmm -98.4 -176.99 3.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.731 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.3 t -62.94 -39.55 94.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.569 -0.742 . . . . 1.0 110.527 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.42 -41.86 66.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.227 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.704 ' CE3' HG21 ' A' ' 110' ' ' VAL . 75.1 t90 -61.6 -53.64 53.58 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.613 -0.435 . . . . 1.0 110.592 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.808 HD11 HD11 ' A' ' 65' ' ' ILE . 3.3 tt -61.94 -53.12 60.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.472 -0.491 . . . . 1.0 109.817 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 80.9 p -51.59 -46.71 63.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.492 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.4 mt -64.91 -54.99 21.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.355 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 1.4 p -50.17 -30.91 12.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.386 0.612 . . . . 1.0 110.284 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.582 HD11 ' OE1' ' A' ' 64' ' ' GLN . 2.3 tp -70.01 -52.8 21.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.265 -0.88 . . . . 1.0 110.614 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -66.95 -37.87 85.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.564 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' A' ' 123' ' ' ARG . 78.3 mm-40 -78.98 9.03 4.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.181 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.479 ' NH2' ' NE1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER 36.06 32.68 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.788 -0.642 . . . . 1.0 111.092 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.438 ' CG ' ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -158.09 177.24 11.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.076 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.402 ' O ' ' NH1' ' A' ' 123' ' ' ARG . 5.6 tt -92.65 122.11 34.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.033 0.444 . . . . 1.0 110.766 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.425 HG23 ' CD1' ' A' ' 114' ' ' TRP . 3.2 m -100.0 152.23 4.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.347 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -62.18 150.21 39.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.286 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 129' ' ' GLY . 2.3 m -102.46 6.31 10.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.468 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.6 56.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.78 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 168.34 -37.75 0.21 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.51 ' O ' ' NZ ' ' A' ' 111' ' ' LYS . 50.4 m-85 -89.47 -18.24 27.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.728 0.299 . . . . 1.0 110.517 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.8 t -72.15 137.58 47.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.1 0.476 . . . . 1.0 110.78 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 134' ' ' ILE . 59.1 mt -83.62 -69.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.333 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.486 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 16.7 t80 62.34 -31.47 0.09 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.368 -0.833 . . . . 1.0 112.133 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.588 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 151.7 -55.12 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 124.6 1.16 . . . . 1.0 109.854 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.5 Cg_endo . . . . . 0 N--CA 1.497 1.688 0 C-N-CA 121.824 1.682 . . . . 1.0 112.137 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.505 -1.438 . . . . 1.0 109.505 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.7 m -152.83 101.76 2.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.851 0.358 . . . . 1.0 110.488 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -63.19 -41.24 99.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.528 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.6 m -100.24 134.96 42.41 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.583 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.3 -40.4 97.86 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -109.03 136.14 49.04 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.97 0.414 . . . . 1.0 110.381 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.629 ' CD ' ' H ' ' A' ' 36' ' ' GLU . 1.4 pm0 -66.97 -50.06 63.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.357 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 53.45 34.8 19.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.512 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -165.56 -38.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.663 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -138.95 92.21 2.58 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.566 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.633 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -109.99 -40.16 4.83 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.182 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.466 ' HG ' ' CE3' ' A' ' 40' ' ' TRP . 8.7 mt -79.61 1.86 24.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.42 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.2 t -54.99 -48.6 73.1 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.309 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.6 p -72.11 -37.28 69.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.929 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.2 mt -73.9 140.78 45.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.982 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.628 ' H ' HG22 ' A' ' 81' ' ' THR . 0.2 OUTLIER -124.94 102.81 7.71 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.979 178.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.482 ' O ' HD22 ' A' ' 72' ' ' LEU . . . -92.2 169.05 10.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.21 0.529 . . . . 1.0 110.845 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -156.33 124.14 5.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.672 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.572 HG12 HG13 ' A' ' 84' ' ' VAL . 14.4 m -103.04 143.72 14.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.047 0.451 . . . . 1.0 110.221 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 52' ' ' GLY . 18.9 m -97.07 161.21 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.449 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -81.25 -60.79 2.15 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.42 -0.354 . . . . 1.0 110.708 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.648 HG23 HD11 ' A' ' 97' ' ' LEU . 43.9 p -46.88 -12.08 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.983 0.42 . . . . 1.0 110.261 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.641 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -151.43 118.71 0.93 Allowed Glycine 0 C--O 1.205 -1.703 0 N-CA-C 109.46 -1.456 . . . . 1.0 109.46 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.641 ' HB ' ' O ' ' A' ' 52' ' ' GLY . 4.6 mm 102.22 -16.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.816 0.846 . . . . 1.0 110.452 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.5 29.13 1.23 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.661 -0.976 . . . . 1.0 110.661 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 32.6 mtt180 -66.66 -60.92 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.764 0.316 . . . . 1.0 110.56 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 55' ' ' ARG . . . 172.47 -61.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.249 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -87.7 -32.47 19.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.311 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.12 83.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.363 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 61' ' ' PHE . 9.3 pt-20 -66.42 -42.26 88.04 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.382 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.3 tp -45.84 -13.54 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.111 0.481 . . . . 1.0 110.833 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 59' ' ' GLU . 3.8 m-30 -56.72 -47.64 79.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.884 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' HA ' HD12 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -62.09 -40.09 94.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.437 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -55.95 -46.41 78.56 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.632 -0.427 . . . . 1.0 110.222 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.485 ' O ' ' CD2' ' A' ' 68' ' ' HIS . 77.9 mt-30 -65.02 -38.85 92.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.147 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 115' ' ' LEU . 77.5 mt -64.05 -43.69 97.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.48 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.16 -45.03 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.252 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -60.18 -26.01 66.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.318 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 64' ' ' GLN . 42.9 m170 -79.9 0.45 31.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.387 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.31 -19.31 54.42 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.871 -0.892 . . . . 1.0 110.871 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.34 94.04 0.63 Allowed Glycine 0 C--O 1.224 -0.478 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.44 ' C ' HD23 ' A' ' 72' ' ' LEU . 14.0 pt20 -77.13 145.23 37.9 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.975 -0.29 . . . . 1.0 110.439 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.483 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 4.6 mt -107.18 145.58 32.41 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.938 0.399 . . . . 1.0 110.302 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 72' ' ' LEU . 3.8 m -163.44 91.21 1.16 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.381 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 77' ' ' GLY . 43.7 Cg_endo -70.02 -167.09 0.22 Allowed 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.599 2.199 . . . . 1.0 111.989 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 98' ' ' LEU . . . -38.63 -27.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.837 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 74' ' ' PRO . 9.8 pt20 -64.03 1.58 0.67 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.399 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 74' ' ' PRO . . . 162.78 161.78 12.76 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.063 -0.815 . . . . 1.0 111.063 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.03 143.72 73.28 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.63 2.22 . . . . 1.0 111.817 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.403 ' HA2' ' HE ' ' A' ' 45' ' ' ARG . . . 116.42 66.01 0.38 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.224 -0.751 . . . . 1.0 111.224 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 80' ' ' VAL . 2.7 p -160.79 67.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.423 0.63 . . . . 1.0 110.475 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.628 HG22 ' H ' ' A' ' 45' ' ' ARG . 15.3 t -74.26 -33.29 63.24 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.003 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -117.37 146.0 43.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.938 0.399 . . . . 1.0 110.848 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.598 HD13 ' CD1' ' A' ' 98' ' ' LEU . 22.5 mt -137.51 111.43 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.839 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.572 HG13 HG12 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -95.15 140.59 16.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.121 0.486 . . . . 1.0 110.633 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.465 ' C ' ' H ' ' A' ' 87' ' ' GLU . 28.2 m -131.16 166.64 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.83 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.59 ' C ' ' H ' ' A' ' 88' ' ' GLY . 49.4 p-10 -73.07 14.16 0.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.665 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' A' ' 85' ' ' VAL . 18.6 mt-10 65.82 -15.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.776 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -64.13 -49.47 66.51 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.917 -0.873 . . . . 1.0 110.917 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.5 ptp -90.03 158.13 17.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.862 0.363 . . . . 1.0 110.471 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -89.1 -179.64 5.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.667 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -67.67 -37.59 82.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.37 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.538 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 15.2 pt-20 -58.91 -46.05 88.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.979 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.482 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 1.9 tmm_? -79.36 -24.34 42.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.022 -0.536 . . . . 1.0 111.231 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.55 -37.47 70.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.569 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.629 HD11 HD11 ' A' ' 103' ' ' LEU . 7.4 mp -60.96 -36.27 78.96 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.11 -0.236 . . . . 1.0 110.674 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.536 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 6.6 mmp_? -62.65 -36.86 84.22 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.247 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.648 HD11 HG23 ' A' ' 51' ' ' THR . 4.3 mm? -62.61 -42.21 99.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.054 0.454 . . . . 1.0 111.266 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.598 ' CD1' HD13 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -97.32 5.31 50.12 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.668 -0.696 . . . . 1.0 109.663 -178.781 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.536 ' NH1' ' O ' ' A' ' 96' ' ' ARG . 51.2 mmt-85 51.01 24.32 1.81 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.267 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.7 tp -86.53 121.37 72.23 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.776 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.07 -17.17 36.34 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.465 2.11 . . . . 1.0 112.399 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 176.78 152.8 0.2 Allowed 'General case' 0 C--O 1.235 0.297 0 O-C-N 123.323 0.389 . . . . 1.0 110.453 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.774 HD12 ' N ' ' A' ' 103' ' ' LEU . 3.8 mp -86.47 140.6 33.98 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.949 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.02 164.41 35.75 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.416 2.077 . . . . 1.0 111.952 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -40.69 135.19 2.16 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.6 2.2 . . . . 1.0 112.191 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 107' ' ' ALA . . . 80.74 -69.56 3.19 Favored Glycine 0 C--O 1.228 -0.226 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 106' ' ' GLY . . . -29.02 150.6 0.0 OUTLIER 'General case' 0 C--N 1.345 0.379 0 O-C-N 123.924 0.426 . . . . 1.0 110.964 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.511 ' OE1' HG11 ' A' ' 127' ' ' VAL . 9.7 pt20 -162.88 153.59 16.8 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.48 -0.488 . . . . 1.0 110.372 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.52 ' O ' ' OG ' ' A' ' 131' ' ' SER . 0.4 OUTLIER -85.37 112.56 20.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.915 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.472 HG21 ' CE3' ' A' ' 114' ' ' TRP . 11.2 m -104.68 172.58 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 123.475 0.484 . . . . 1.0 109.743 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -102.21 -173.73 2.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.661 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.1 m -63.57 -36.92 85.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.714 -0.675 . . . . 1.0 110.834 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.93 -36.23 65.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.502 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.472 ' CE3' HG21 ' A' ' 110' ' ' VAL . 89.3 t90 -68.67 -44.71 73.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.906 0.384 . . . . 1.0 110.542 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.54 HD11 HD11 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -66.97 -59.28 3.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.111 0.481 . . . . 1.0 111.037 -179.196 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.7 m -45.17 -58.24 3.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.614 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.8 mp -60.01 -52.99 63.04 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 120.629 -0.429 . . . . 1.0 110.645 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 46.5 t -55.39 -31.21 61.63 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.696 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.23 -55.25 12.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.029 0.442 . . . . 1.0 111.872 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -77.06 -38.94 51.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.993 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 62.7 mm-40 -53.17 -48.3 68.1 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.432 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 121' ' ' GLU . 7.0 tpt180 86.61 27.35 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.733 0.645 . . . . 1.0 111.168 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.42 ' C ' ' CD ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -159.49 -171.45 3.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.445 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.1 tp -91.7 135.65 33.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.439 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 m -120.42 154.44 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.331 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 126' ' ' ASP . 54.6 p-10 -61.73 146.14 50.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.343 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 129' ' ' GLY . 9.0 t -104.64 -23.48 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 110.218 -0.29 . . . . 1.0 110.218 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.16 68.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.978 0.418 . . . . 1.0 110.499 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 165.81 -27.17 0.18 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.141 -0.783 . . . . 1.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -106.7 -3.01 21.02 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.667 0.27 . . . . 1.0 110.583 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.52 ' OG ' ' O ' ' A' ' 109' ' ' LEU . 3.2 m -104.7 125.61 50.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.976 0.417 . . . . 1.0 110.767 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.58 ' C ' ' H ' ' A' ' 134' ' ' ILE . 3.2 mp -64.63 -50.09 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.331 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.526 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 17.0 t80 65.67 -36.7 0.23 Allowed 'General case' 0 C--O 1.217 -0.615 0 O-C-N 124.278 0.986 . . . . 1.0 111.212 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.615 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 156.67 -54.65 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.311 0 O-C-N 124.663 1.227 . . . . 1.0 110.452 -178.658 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 27.5 Cg_endo . . . . . 0 C--N 1.309 -1.54 0 C-N-CA 122.331 2.021 . . . . 1.0 111.682 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.458 -1.457 . . . . 1.0 109.458 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 83.0 p -72.0 146.29 47.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 1.0 110.491 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 34' ' ' GLY . 37.2 t30 -63.67 -40.28 96.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.592 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 t 65.89 -67.39 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.811 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 77.55 -6.02 48.21 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.789 -0.924 . . . . 1.0 110.789 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -156.8 73.31 0.76 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.728 0.299 . . . . 1.0 110.244 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.454 ' CG ' ' N ' ' A' ' 37' ' ' ALA . 14.6 pt-20 -65.46 -44.56 86.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.58 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.454 ' N ' ' CG ' ' A' ' 36' ' ' GLU . . . 38.67 50.34 1.6 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.114 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -66.26 -39.03 89.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.694 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 46.36 84.96 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.568 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.579 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -102.17 -50.89 3.51 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.832 0.349 . . . . 1.0 110.462 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.55 ' HG ' HD11 ' A' ' 44' ' ' LEU . 2.2 tp -80.87 -0.65 39.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.733 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.6 p -66.95 -15.59 63.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.424 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.3 p -67.19 -15.56 63.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.517 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.683 HD12 ' C ' ' A' ' 44' ' ' LEU . 4.2 pp -136.21 168.84 18.64 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.387 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -116.65 118.09 31.63 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.009 0.433 . . . . 1.0 110.334 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.598 ' CB ' HD13 ' A' ' 65' ' ' ILE . . . -95.6 161.47 14.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.475 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -153.96 118.09 4.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.375 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.53 HG13 HD12 ' A' ' 53' ' ' ILE . 76.1 t -107.32 135.09 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.241 0.543 . . . . 1.0 110.379 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.549 HG12 ' H ' ' A' ' 52' ' ' GLY . 19.0 t -73.7 99.1 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.447 -0.797 . . . . 1.0 110.206 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.529 HH21 HH12 ' A' ' 99' ' ' ARG . 84.8 mtm-85 -58.34 -37.8 75.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.42 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.9 p -75.92 -17.26 59.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.539 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.549 ' H ' HG12 ' A' ' 49' ' ' VAL . . . -97.44 -59.5 0.97 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.202 -0.759 . . . . 1.0 111.202 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.53 HD12 HG13 ' A' ' 48' ' ' VAL . 2.7 mt -86.42 71.32 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.161 0.505 . . . . 1.0 110.341 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -117.03 23.38 9.97 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 110.783 -0.927 . . . . 1.0 110.783 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.65 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 4.2 ptm180 -75.03 -63.41 1.27 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.551 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 55' ' ' ARG . . . 159.93 138.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? 68.54 -42.14 0.47 Allowed 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 124.191 0.932 . . . . 1.0 110.327 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' A' ' 56' ' ' ALA . . . -65.37 -28.65 69.43 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.868 -0.605 . . . . 1.0 110.532 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.72 -39.75 80.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.395 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.99 -19.05 0.63 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.182 0.515 . . . . 1.0 110.582 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -44.18 -50.96 8.51 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.732 -0.667 . . . . 1.0 111.036 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.415 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -64.45 -43.98 92.55 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.626 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -62.41 -43.06 99.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.375 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -59.21 -26.13 64.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.272 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.701 HD11 HD21 ' A' ' 115' ' ' LEU . 80.8 mt -86.28 -23.32 6.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.366 0.603 . . . . 1.0 110.38 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 62' ' ' GLU . 68.4 t -79.06 -37.66 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 O-C-N 122.056 -0.403 . . . . 1.0 110.706 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -68.08 -38.87 82.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.127 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.492 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -68.49 -6.41 24.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.274 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.44 7.11 52.25 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.465 -1.054 . . . . 1.0 110.465 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.7 96.89 2.19 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 110.267 -1.133 . . . . 1.0 110.267 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -68.32 144.13 54.92 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.734 -0.387 . . . . 1.0 110.287 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.0 mt -91.81 135.29 34.03 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.054 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.8 m -104.61 103.62 41.06 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.378 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 76' ' ' GLN . 56.3 Cg_endo -75.17 168.35 24.9 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.397 2.065 . . . . 1.0 111.955 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.57 -7.39 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.558 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 74' ' ' PRO . 42.0 mt-30 -76.43 -9.6 58.77 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 110.151 -0.315 . . . . 1.0 110.151 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -145.35 147.87 19.25 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.69 -16.44 33.66 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.698 2.266 . . . . 1.0 111.989 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -42.82 -25.92 0.39 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.437 -0.665 . . . . 1.0 111.437 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.435 HG11 HD11 ' A' ' 100' ' ' LEU . 12.8 p -64.79 138.88 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.965 0.412 . . . . 1.0 110.471 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.99 -34.27 0.23 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.536 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -108.78 125.05 51.52 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.619 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.412 ' O ' ' O ' ' A' ' 110' ' ' VAL . 22.5 mm -118.95 106.92 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.23 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.41 HG11 HD23 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -95.08 135.29 29.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.339 -0.846 . . . . 1.0 110.088 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.54 ' C ' ' H ' ' A' ' 87' ' ' GLU . 27.7 m -135.41 155.65 37.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.412 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 88' ' ' GLY . 53.5 p-10 -71.29 22.5 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.581 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 85' ' ' VAL . 29.9 mt-10 65.96 -13.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 1.0 111.017 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -61.81 -41.76 99.66 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.074 -0.811 . . . . 1.0 111.074 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.6 ptp -103.41 154.32 19.54 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.782 0.325 . . . . 1.0 110.53 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -90.16 172.81 8.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.133 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.594 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -58.53 -54.66 44.57 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.544 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.594 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 1.3 pp20? -52.07 -40.18 60.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.866 -0.606 . . . . 1.0 110.098 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -71.97 -39.13 69.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.832 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.91 -28.65 62.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.936 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.5 mp -61.82 -46.36 89.82 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.023 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.1 mmp_? -70.91 -40.98 71.84 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.38 -0.528 . . . . 1.0 111.345 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.92 -44.93 83.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.168 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.873 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.86 -13.93 59.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.63 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.529 HH12 HH21 ' A' ' 50' ' ' ARG . 2.9 mtp180 77.93 60.91 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 123.977 0.798 . . . . 1.0 111.937 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.736 HD12 HD11 ' A' ' 98' ' ' LEU . 3.3 mt -148.71 114.02 3.73 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 120.12 -0.632 . . . . 1.0 110.116 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.519 ' HD2' HD23 ' A' ' 100' ' ' LEU . 58.5 Cg_endo -73.49 -11.45 24.47 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.128 1.886 . . . . 1.0 112.602 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 179.43 133.8 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.427 0.454 . . . . 1.0 110.207 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.604 HD22 HD13 ' A' ' 100' ' ' LEU . 10.8 mt -88.85 146.66 37.29 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.958 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.65 165.7 26.61 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 122.206 1.937 . . . . 1.0 112.311 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -43.48 140.63 3.99 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.117 1.878 . . . . 1.0 112.282 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.48 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 82.31 -64.46 4.26 Favored Glycine 0 N--CA 1.453 -0.181 0 N-CA-C 110.305 -1.118 . . . . 1.0 110.305 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.48 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -22.33 134.87 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 O-C-N 124.134 0.549 . . . . 1.0 110.868 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.484 ' O ' ' NE2' ' A' ' 108' ' ' GLN . 0.0 OUTLIER -143.69 157.52 44.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.897 0.38 . . . . 1.0 110.145 -177.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 109' ' ' LEU . 4.0 mp -108.24 121.8 45.64 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.773 -0.648 . . . . 1.0 110.778 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.471 HG13 ' NE2' ' A' ' 108' ' ' GLN . 3.1 m -108.06 -178.23 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.109 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -109.28 -176.63 3.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.501 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.4 m -60.98 -37.79 83.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.817 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.445 ' O ' HD13 ' A' ' 117' ' ' LEU . . . -56.06 -47.34 78.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.944 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.461 ' CE3' HG21 ' A' ' 110' ' ' VAL . 72.9 t90 -56.43 -37.9 70.86 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.312 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.701 HD21 HD11 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -68.56 -61.16 1.94 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.268 -0.573 . . . . 1.0 110.929 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.9 t -49.39 -52.21 30.0 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.388 -0.525 . . . . 1.0 110.47 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 113' ' ' ALA . 7.1 mp -48.93 -44.88 40.88 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.068 -0.514 . . . . 1.0 109.937 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.529 ' SG ' HG23 ' A' ' 125' ' ' VAL . 74.5 m -60.25 -43.42 96.11 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.362 -0.535 . . . . 1.0 110.832 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 65.9 mt -50.21 -57.9 6.77 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.589 -0.444 . . . . 1.0 111.386 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -73.22 -49.01 30.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.727 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 74.6 mm-40 -54.27 -48.35 71.31 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.472 -0.491 . . . . 1.0 110.362 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 121' ' ' GLU . 8.7 tpp180 79.48 39.59 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.836 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.418 ' C ' ' CD ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -165.48 -173.18 2.69 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.428 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.3 tp -82.52 122.24 27.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.014 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.529 HG23 ' SG ' ' A' ' 118' ' ' CYS . 40.2 t -97.19 154.7 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-O 121.274 0.559 . . . . 1.0 110.432 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.449 ' N ' HG12 ' A' ' 125' ' ' VAL . 64.1 t0 -69.29 115.38 8.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.394 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.461 HG23 ' N ' ' A' ' 128' ' ' ALA . 5.0 m -64.16 -39.64 86.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.607 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.461 ' N ' HG23 ' A' ' 127' ' ' VAL . . . -53.73 -25.52 19.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.506 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.69 -38.6 93.31 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.243 -0.743 . . . . 1.0 111.243 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.74 43.01 1.98 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.848 0.356 . . . . 1.0 110.883 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 127' ' ' VAL . 8.7 t -107.84 132.9 52.93 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.288 0.566 . . . . 1.0 111.182 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.57 ' C ' ' H ' ' A' ' 134' ' ' ILE . 54.8 mt -75.64 -69.23 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 CA-C-N 115.084 -0.962 . . . . 1.0 109.881 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.493 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 15.8 t80 65.83 -36.58 0.24 Allowed 'General case' 0 C--O 1.223 -0.335 0 O-C-N 124.514 1.134 . . . . 1.0 111.578 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.57 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 156.03 -55.78 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.512 0 O-C-N 125.009 1.443 . . . . 1.0 109.752 -178.279 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 30.0 Cg_endo . . . . . 0 N--CA 1.49 1.298 0 C-N-CA 122.169 1.912 . . . . 1.0 112.01 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.428 -1.469 . . . . 1.0 109.428 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.2 p -61.19 -41.85 97.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.804 0.335 . . . . 1.0 110.546 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -136.17 130.48 33.28 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.584 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 96.6 p -76.81 158.8 30.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.366 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 150.35 -78.97 0.21 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -135.18 126.14 27.65 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.99 0.424 . . . . 1.0 110.341 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.681 ' C ' ' H ' ' A' ' 38' ' ' GLU . 3.6 pm0 -108.03 23.3 14.7 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.767 -0.652 . . . . 1.0 111.062 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.17 26.36 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.415 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.681 ' H ' ' C ' ' A' ' 36' ' ' GLU . 94.6 mt-10 -145.89 29.66 1.09 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.49 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -130.31 70.89 1.44 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.643 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 1.1 p-90 -86.83 -49.81 7.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.094 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.581 HD13 ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -62.58 -35.11 78.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.73 0.776 . . . . 1.0 110.019 -179.164 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.66 -33.77 64.38 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.338 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 t -43.54 -25.67 0.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.795 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.83 167.87 18.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.343 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.401 ' O ' HG22 ' A' ' 81' ' ' THR . 27.2 ttm180 -115.94 112.65 22.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 1.0 110.167 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.474 ' HB3' HD13 ' A' ' 65' ' ' ILE . . . -92.36 165.95 12.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.49 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.529 ' CE1' ' O ' ' A' ' 73' ' ' CYS . 49.1 t60 -144.33 122.11 11.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.154 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.469 ' O ' ' NH1' ' A' ' 50' ' ' ARG . 71.5 t -110.95 133.97 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.341 -0.391 . . . . 1.0 110.31 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.2 m -71.94 134.01 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.39 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.486 ' N ' ' CD ' ' A' ' 50' ' ' ARG . 9.6 mpt_? -64.27 -40.75 96.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.546 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.483 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 7.6 p -104.19 138.19 41.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.1 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.26 -16.44 56.9 Favored Glycine 0 C--O 1.226 -0.402 0 N-CA-C 111.012 -0.835 . . . . 1.0 111.012 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.523 ' C ' ' H ' ' A' ' 55' ' ' ARG . 1.5 mm -117.75 -23.23 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.991 0.424 . . . . 1.0 110.248 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.37 35.01 0.44 Allowed Glycine 0 C--N 1.314 -0.678 0 C-N-CA 120.242 -0.98 . . . . 1.0 111.25 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.523 ' H ' ' C ' ' A' ' 53' ' ' ILE . 2.0 ptp180 -76.71 -60.96 2.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.582 0.229 . . . . 1.0 110.602 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.591 ' C ' ' H ' ' A' ' 58' ' ' ALA . . . 171.68 125.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.06 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.7 ttp85 68.74 -32.34 0.22 Allowed 'General case' 0 CA--C 1.518 -0.275 0 O-C-N 123.502 0.501 . . . . 1.0 110.323 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 56' ' ' ALA . . . -63.55 -36.5 83.99 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.63 0.728 . . . . 1.0 110.09 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 61' ' ' PHE . 12.3 pt-20 -60.36 -39.19 86.3 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.353 -0.539 . . . . 1.0 110.852 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.0 tp -42.29 -17.95 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.313 0.577 . . . . 1.0 110.854 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.559 ' N ' ' O ' ' A' ' 59' ' ' GLU . 2.3 m-85 -51.39 -51.25 56.28 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.988 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.583 ' HA ' HD12 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -61.89 -37.38 84.36 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.047 -0.353 . . . . 1.0 110.047 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -62.47 -45.83 91.24 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.095 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -64.83 -18.5 65.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.254 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 62' ' ' GLU . 61.4 mt -85.53 -56.95 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.902 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.493 HG23 ' N ' ' A' ' 67' ' ' GLN . 12.2 m -65.32 -40.57 88.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.36 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.493 ' N ' HG23 ' A' ' 66' ' ' VAL . 53.3 tt0 -53.83 -41.45 67.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.22 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -96.89 10.95 37.58 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.397 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 97.13 139.94 11.0 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.656 -0.977 . . . . 1.0 110.656 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.84 61.11 0.13 Allowed Glycine 0 N--CA 1.466 0.664 0 N-CA-C 110.475 -1.05 . . . . 1.0 110.475 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -51.68 145.51 9.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.991 0.424 . . . . 1.0 110.405 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.3 mt -81.6 155.61 25.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.788 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.529 ' O ' ' CE1' ' A' ' 47' ' ' HIS . 1.3 m -158.56 156.39 27.15 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.409 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -59.98 125.87 18.81 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.546 2.164 . . . . 1.0 111.853 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.498 ' HB3' HD11 ' A' ' 98' ' ' LEU . . . -77.55 -0.27 25.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.989 -0.551 . . . . 1.0 110.623 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -61.52 0.73 0.28 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.865 0.364 . . . . 1.0 110.623 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 75' ' ' ALA . . . -166.25 -172.44 33.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -53.5 -4.28 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.912 2.408 . . . . 1.0 111.97 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 77' ' ' GLY . . . -38.75 -61.29 1.35 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 m -106.41 -168.09 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.994 0.426 . . . . 1.0 110.202 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.479 HG23 ' ND1' ' A' ' 82' ' ' HIS . 1.8 t -140.41 -30.06 0.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.864 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.479 ' ND1' HG23 ' A' ' 81' ' ' THR . 64.3 m80 -121.08 150.9 40.5 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.618 0.247 . . . . 1.0 110.788 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.3 mt -134.21 111.0 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.3 t -93.93 144.02 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.951 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.495 ' C ' ' H ' ' A' ' 87' ' ' GLU . 32.2 m -134.3 154.7 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.569 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 88' ' ' GLY . 31.3 t70 -71.82 19.83 0.06 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.747 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 85' ' ' VAL . 0.8 OUTLIER 69.0 -39.16 0.42 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.363 -0.38 . . . . 1.0 111.048 179.037 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -38.99 -57.15 2.08 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 89' ' ' MET . 0.0 OUTLIER -87.1 160.17 18.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.81 0.338 . . . . 1.0 110.534 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -97.15 -177.05 3.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.056 0.455 . . . . 1.0 110.362 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -62.5 -47.04 85.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.846 -0.615 . . . . 1.0 110.576 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.627 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 10.6 pt-20 -53.36 -50.89 64.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.921 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.451 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 29.5 ttp180 -71.25 -42.8 68.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.118 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -43.84 -35.16 1.82 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.943 -0.572 . . . . 1.0 110.783 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.9 mp -59.93 -61.15 2.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.049 0.452 . . . . 1.0 110.884 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.556 HH21 ' C ' ' A' ' 100' ' ' LEU . 5.9 mmp_? -68.31 -22.2 64.73 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.236 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -63.82 -36.96 85.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.994 -178.333 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.668 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -110.9 13.99 22.13 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.784 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 63.06 59.65 1.3 Allowed 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 120.547 -0.461 . . . . 1.0 110.991 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.556 ' C ' HH21 ' A' ' 96' ' ' ARG . 13.8 tp -124.56 127.83 25.11 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.848 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.18 -44.88 11.06 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.037 1.825 . . . . 1.0 112.058 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 176.6 136.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.228 0.537 . . . . 1.0 110.578 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.7 mt -41.91 116.21 1.63 Allowed Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 115.423 -0.808 . . . . 1.0 111.45 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -71.46 141.72 39.13 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.703 1.602 . . . . 1.0 111.922 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -40.77 93.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.451 2.101 . . . . 1.0 112.63 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.61 -56.55 0.59 Allowed Glycine 0 N--CA 1.465 0.585 0 N-CA-C 111.156 -0.778 . . . . 1.0 111.156 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.73 160.28 32.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.857 0.361 . . . . 1.0 110.947 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -149.16 156.6 42.42 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.44 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 131' ' ' SER . 1.3 mt -92.88 111.63 23.31 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.953 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.641 HG21 ' CE3' ' A' ' 114' ' ' TRP . 4.1 m -103.83 170.3 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -101.84 171.04 7.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.129 0.49 . . . . 1.0 111.607 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.2 m -56.05 -35.11 66.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.38 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.6 -38.18 86.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.729 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.641 ' CE3' HG21 ' A' ' 110' ' ' VAL . 74.8 t90 -60.47 -49.89 75.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.369 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.505 HD23 ' CD1' ' A' ' 61' ' ' PHE . 34.9 tp -63.05 -53.77 48.52 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.194 -0.603 . . . . 1.0 110.561 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.9 t -50.81 -46.67 59.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.3 mt -51.31 -48.77 62.25 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.356 -0.538 . . . . 1.0 109.813 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 122' ' ' ARG . 55.9 m -51.75 -34.89 41.32 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 38.9 mt -70.31 -54.53 12.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.002 0.43 . . . . 1.0 110.519 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -65.62 -38.35 89.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.231 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 80.7 mm-40 -79.79 -42.81 23.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.15 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 118' ' ' CYS . 5.2 tpp85 82.16 40.07 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.856 -0.611 . . . . 1.0 111.114 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -169.61 -173.44 1.65 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.342 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.6 tt -92.2 121.56 33.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.607 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.464 HG23 ' CD1' ' A' ' 114' ' ' TRP . 2.7 m -103.69 151.77 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.244 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 126' ' ' ASP . 48.4 p30 -66.78 147.71 52.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.24 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.578 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 31.3 m -101.29 -136.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.383 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 127' ' ' VAL . . . 74.59 -60.69 0.51 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.326 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.05 -53.55 33.01 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -69.98 -42.52 73.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.934 0.397 . . . . 1.0 110.502 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 109' ' ' LEU . 15.1 p -58.56 153.53 16.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.628 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 134' ' ' ILE . 2.9 mp -90.08 -57.46 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.238 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.516 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 17.6 t80 65.12 -35.63 0.19 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.263 0.977 . . . . 1.0 111.433 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.59 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 155.26 -56.06 0.0 OUTLIER Pre-proline 0 C--N 1.346 0.441 0 O-C-N 124.84 1.338 . . . . 1.0 109.862 -178.396 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.3 Cg_endo . . . . . 0 N--CA 1.49 1.301 0 C-N-CA 122.212 1.941 . . . . 1.0 112.012 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.588 -1.405 . . . . 1.0 109.588 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.3 t -63.33 -24.79 68.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 1.0 110.57 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.413 ' O ' ' O ' ' A' ' 33' ' ' SER . 23.8 t-20 -64.18 -41.38 97.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.57 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.413 ' O ' ' O ' ' A' ' 32' ' ' ASN . 5.3 p 60.84 129.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.604 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.92 -42.98 98.15 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -155.6 146.01 21.89 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.395 -0.224 . . . . 1.0 110.395 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 38' ' ' GLU . 2.1 mp0 -95.64 77.31 3.29 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.871 0.843 . . . . 1.0 110.47 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.27 -1.49 0.34 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.982 -1.008 . . . . 1.0 110.194 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.498 ' H ' ' C ' ' A' ' 36' ' ' GLU . 57.6 mp0 -74.01 -170.51 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.598 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 55.1 65.08 1.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.777 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.612 ' CZ2' ' ND1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -97.16 -33.87 11.33 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.167 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.448 ' HG ' ' CE3' ' A' ' 40' ' ' TRP . 29.1 mt -83.03 -0.86 50.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.237 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.3 p -58.55 -41.8 86.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.662 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.8 m -61.58 -60.82 3.1 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.25 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 pp -74.94 167.4 21.97 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -124.51 121.75 35.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 1.0 111.023 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.502 ' HB3' HD13 ' A' ' 65' ' ' ILE . . . -103.63 124.85 49.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.865 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -111.11 120.58 42.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.247 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.589 ' H ' HD22 ' A' ' 72' ' ' LEU . 51.3 t -111.1 132.39 59.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.967 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.743 HG23 ' H ' ' A' ' 53' ' ' ILE . 27.0 m -78.58 84.09 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.434 0.635 . . . . 1.0 110.27 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.621 HH11 HD13 ' A' ' 72' ' ' LEU . 76.1 mtm-85 -54.52 -43.67 72.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.464 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.443 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 66.7 p -62.14 -22.92 66.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.323 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.03 -74.42 1.11 Allowed Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.258 -0.737 . . . . 1.0 111.258 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.743 ' H ' HG23 ' A' ' 49' ' ' VAL . 5.3 mt -53.37 122.16 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 CA-C-O 121.942 0.877 . . . . 1.0 109.978 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -174.64 25.97 0.07 OUTLIER Glycine 0 C--N 1.302 -1.326 0 CA-C-N 114.315 -1.311 . . . . 1.0 112.066 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -75.31 -47.32 28.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.829 0.347 . . . . 1.0 111.305 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -168.84 -114.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.932 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.482 ' CD ' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -63.5 -19.58 64.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.334 -0.393 . . . . 1.0 110.677 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.403 ' CB ' HG23 ' A' ' 53' ' ' ILE . . . -40.61 -47.54 2.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.056 0.455 . . . . 1.0 110.639 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -68.37 -37.48 80.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.183 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 57' ' ' ARG . 4.9 tp -48.77 -18.38 0.26 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.196 0.522 . . . . 1.0 111.019 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.421 ' HB3' HD13 ' A' ' 115' ' ' LEU . 20.4 m-85 -69.38 -43.35 73.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.924 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.597 ' HA ' HD12 ' A' ' 65' ' ' ILE . 9.5 pt-20 -58.48 -39.51 80.17 Favored 'General case' 0 C--N 1.317 -0.83 0 O-C-N 123.356 0.41 . . . . 1.0 110.494 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.434 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 41.1 mttp -63.44 -40.36 96.93 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.575 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -65.66 -18.88 65.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.711 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.597 HD12 ' HA ' ' A' ' 62' ' ' GLU . 71.0 mt -85.29 -62.37 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.079 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.7 m -45.09 -35.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.729 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -65.57 -46.09 80.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.91 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.612 ' ND1' ' CZ2' ' A' ' 40' ' ' TRP . 1.3 m170 -97.7 23.67 7.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.436 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 83.44 -179.4 52.55 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.134 -0.787 . . . . 1.0 111.134 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 71' ' ' GLN . . . 74.87 27.73 64.14 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.891 -0.883 . . . . 1.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.527 ' O ' ' NE2' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -44.18 170.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.835 0.35 . . . . 1.0 110.733 -179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.621 HD13 HH11 ' A' ' 50' ' ' ARG . 40.6 mt -73.46 147.26 44.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.249 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.44 ' O ' ' CG2' ' A' ' 80' ' ' VAL . 0.8 OUTLIER -161.59 96.26 1.3 Allowed Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.47 147.47 12.59 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.497 2.131 . . . . 1.0 112.232 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 77' ' ' GLY . . . -51.47 -46.8 63.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.717 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.667 ' CD ' ' H ' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -65.13 1.37 1.01 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.125 0.488 . . . . 1.0 110.29 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 75' ' ' ALA . . . -93.31 -117.78 2.66 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 110.772 -0.931 . . . . 1.0 110.772 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.46 -57.65 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.528 2.152 . . . . 1.0 112.381 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.528 ' O ' HG12 ' A' ' 80' ' ' VAL . . . -162.78 -73.57 0.02 OUTLIER Glycine 0 C--O 1.224 -0.473 0 C-N-CA 120.681 -0.771 . . . . 1.0 111.497 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 79' ' ' GLY . 0.4 OUTLIER 74.83 162.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 123.87 0.394 . . . . 1.0 110.256 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.53 -30.48 0.11 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.251 -0.432 . . . . 1.0 111.274 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -111.84 141.81 45.01 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.153 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.1 mp -132.74 108.32 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.973 -0.558 . . . . 1.0 109.784 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.528 HG11 HD12 ' A' ' 115' ' ' LEU . 12.2 t -92.96 135.25 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 115.802 -0.636 . . . . 1.0 111.043 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.552 ' C ' ' H ' ' A' ' 87' ' ' GLU . 30.0 m -132.34 159.26 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.475 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 88' ' ' GLY . 47.4 p30 -67.05 12.31 0.08 Allowed 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.465 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.552 ' H ' ' C ' ' A' ' 85' ' ' VAL . 7.9 mt-10 70.5 -22.95 0.17 Allowed 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.291 0.369 . . . . 1.0 110.842 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -58.74 -46.63 93.15 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.686 -0.966 . . . . 1.0 110.686 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.2 ptp -88.85 145.04 25.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.848 0.356 . . . . 1.0 110.178 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -80.08 173.19 12.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.385 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.615 ' CG ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.19 -53.02 63.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.561 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.615 ' N ' ' CG ' ' A' ' 91' ' ' TYR . 14.2 pt-20 -53.47 -41.44 66.18 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 123.55 0.531 . . . . 1.0 110.521 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.716 ' HE ' ' CZ ' ' A' ' 96' ' ' ARG . 46.5 ttt180 -69.64 -40.15 76.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.082 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.48 ' O ' ' CD2' ' A' ' 98' ' ' LEU . . . -51.5 -26.48 8.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.938 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.1 mp -57.15 -41.04 78.41 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.735 -0.603 . . . . 1.0 110.802 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.716 ' CZ ' ' HE ' ' A' ' 93' ' ' ARG . 23.3 ptt180 -63.39 -34.18 77.17 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.413 -0.515 . . . . 1.0 109.986 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.445 ' HA ' HD13 ' A' ' 97' ' ' LEU . 3.3 mm? -60.53 -47.9 84.13 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.794 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.484 ' O ' ' NE2' ' A' ' 76' ' ' GLN . 0.1 OUTLIER -93.14 16.36 13.16 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.742 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 41.97 56.2 3.56 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.527 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.443 HD13 ' HB3' ' A' ' 75' ' ' ALA . 4.8 tp -132.2 113.9 14.75 Favored Pre-proline 0 C--O 1.219 -0.526 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.597 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.16 2.07 5.96 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.361 2.041 . . . . 1.0 112.723 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 179.96 142.61 0.16 Allowed 'General case' 0 C--O 1.238 0.466 0 O-C-N 123.429 0.455 . . . . 1.0 110.742 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.3 mm? -84.8 145.0 43.05 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-O 120.888 0.375 . . . . 1.0 111.119 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' A' ' 106' ' ' GLY . 44.2 Cg_endo -69.18 161.99 43.62 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.353 2.035 . . . . 1.0 111.88 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.97 23.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.874 2.383 . . . . 1.0 111.974 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 104' ' ' PRO . . . -161.5 63.6 0.27 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -172.82 149.33 1.95 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.655 0.264 . . . . 1.0 110.469 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -139.32 156.05 47.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.063 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.474 ' H ' HD12 ' A' ' 109' ' ' LEU . 1.9 mp -101.65 113.27 26.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.628 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.734 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.5 m -107.13 163.99 4.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.137 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm -93.71 -172.75 2.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.685 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.2 t -65.35 -41.18 94.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.985 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.63 -51.44 48.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.661 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.734 ' CE3' HG21 ' A' ' 110' ' ' VAL . 63.5 t90 -50.55 -49.58 55.65 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.484 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.528 HD12 HG11 ' A' ' 84' ' ' VAL . 2.0 tt -57.95 -50.97 71.56 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.32 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.7 t -48.54 -51.96 24.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.06 0.457 . . . . 1.0 110.08 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.1 mp -57.44 -50.98 71.27 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.448 -0.501 . . . . 1.0 110.259 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.625 ' SG ' ' CE2' ' A' ' 114' ' ' TRP . 56.3 m -44.35 -27.06 0.39 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.049 0.452 . . . . 1.0 110.099 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 80.2 mt -83.36 -47.68 11.2 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.564 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -68.44 -54.2 18.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.472 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 122' ' ' ARG . 78.4 mt-10 -77.86 5.4 9.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.508 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.456 ' C ' ' O ' ' A' ' 121' ' ' GLU . 81.4 mtt85 28.63 44.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.52 0.513 . . . . 1.0 111.257 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.445 ' CG ' ' O ' ' A' ' 121' ' ' GLU . 0.9 OUTLIER -159.99 167.83 27.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.532 -179.134 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 tp -74.08 100.08 3.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.046 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.508 HG13 ' CD1' ' A' ' 114' ' ' TRP . 0.3 OUTLIER -80.44 154.93 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 121.252 0.548 . . . . 1.0 110.091 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 126' ' ' ASP . 14.6 p-10 -59.81 117.73 5.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.434 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.562 HG23 ' N ' ' A' ' 128' ' ' ALA . 13.0 m -68.03 -44.57 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.691 -0.686 . . . . 1.0 111.077 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.562 ' N ' HG23 ' A' ' 127' ' ' VAL . . . -43.85 -18.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.685 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . -69.9 -38.39 75.32 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.344 -0.702 . . . . 1.0 111.344 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -129.48 13.76 6.02 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.625 0.25 . . . . 1.0 110.679 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.5 p -73.16 136.4 44.78 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.848 0.356 . . . . 1.0 110.69 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.569 ' C ' ' H ' ' A' ' 134' ' ' ILE . 59.1 mt -74.52 -66.93 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.875 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.548 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 25.1 t80 66.26 -36.14 0.24 Allowed 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 123.878 0.736 . . . . 1.0 111.42 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.617 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 155.72 -55.3 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 O-C-N 124.768 1.293 . . . . 1.0 110.271 -178.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.3 Cg_endo . . . . . 0 C--N 1.31 -1.46 0 C-N-CA 122.498 2.132 . . . . 1.0 111.994 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.505 -1.438 . . . . 1.0 109.505 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.1 m -70.91 150.47 45.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.761 0.315 . . . . 1.0 110.417 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -83.7 98.62 9.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.494 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.5 p -159.59 163.44 35.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.548 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.86 -88.05 0.07 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.756 -0.938 . . . . 1.0 110.756 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.51 125.7 32.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.87 0.367 . . . . 1.0 110.325 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 38' ' ' GLU . 20.5 pt-20 -62.61 -44.45 96.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.675 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.404 ' N ' ' CG ' ' A' ' 36' ' ' GLU . . . 51.58 5.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.831 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.546 ' H ' ' C ' ' A' ' 36' ' ' GLU . 96.7 mt-10 -145.1 106.32 4.19 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.869 0.366 . . . . 1.0 110.338 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -106.62 92.54 4.15 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.539 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.601 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -101.07 -38.22 8.25 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.355 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.507 HD23 HD11 ' A' ' 44' ' ' LEU . 6.4 mt -76.49 -12.39 60.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.886 0.374 . . . . 1.0 110.9 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t -69.69 -17.78 63.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.996 0.427 . . . . 1.0 110.402 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.7 t -74.1 -13.9 60.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.107 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.507 HD11 HD23 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -136.42 168.99 18.4 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.993 0.425 . . . . 1.0 110.046 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.494 ' H ' ' HB ' ' A' ' 81' ' ' THR . 93.5 mtt180 -114.99 124.1 50.8 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.602 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.723 ' O ' HD13 ' A' ' 72' ' ' LEU . . . -107.44 155.08 20.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.828 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.627 ' CE1' ' NH1' ' A' ' 50' ' ' ARG . 25.0 t-80 -155.25 123.32 5.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.528 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.2 m -99.52 145.37 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.849 0.357 . . . . 1.0 110.243 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.42 ' HB ' HD23 ' A' ' 97' ' ' LEU . 27.2 m -73.68 143.94 13.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.579 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.627 ' NH1' ' CE1' ' A' ' 47' ' ' HIS . 8.4 mpt_? -63.33 -42.62 98.98 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.857 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 p -100.99 136.28 41.09 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.946 0.403 . . . . 1.0 110.437 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.67 -19.85 53.01 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.048 -0.821 . . . . 1.0 111.048 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.632 HG22 ' O ' ' A' ' 53' ' ' ILE . 40.6 mm -127.51 3.81 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.096 0.474 . . . . 1.0 110.586 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.59 26.29 24.52 Favored Glycine 0 N--CA 1.467 0.724 0 N-CA-C 110.39 -1.084 . . . . 1.0 110.39 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.683 HH22 HH21 ' A' ' 57' ' ' ARG . 16.2 mtm-85 -63.25 -47.2 83.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 1.0 110.723 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 55' ' ' ARG . . . 165.52 -62.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.171 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.683 HH21 HH22 ' A' ' 55' ' ' ARG . 5.1 ppt_? -92.04 -25.56 18.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.598 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.44 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . . . -62.64 -37.87 88.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.475 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 61' ' ' PHE . 3.1 pt-20 -65.32 -39.96 93.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.295 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 tp -44.19 -16.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.228 0.537 . . . . 1.0 110.886 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 59' ' ' GLU . 6.6 m-85 -58.91 -43.54 91.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.657 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.476 ' HA ' HD12 ' A' ' 65' ' ' ILE . 13.8 pt-20 -67.2 -42.61 83.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.988 0.423 . . . . 1.0 111.063 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.456 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 95.2 mttt -63.86 -44.62 92.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.19 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -56.0 -37.58 69.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.806 -0.634 . . . . 1.0 109.995 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.91 HD11 HD11 ' A' ' 115' ' ' LEU . 67.8 mt -63.62 -44.43 98.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.667 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.406 ' CG2' HD23 ' A' ' 72' ' ' LEU . 73.7 t -59.37 -44.74 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.812 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.444 ' O ' ' OE1' ' A' ' 36' ' ' GLU . 99.6 mm-40 -55.97 -35.62 66.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.69 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.415 ' HB3' ' CZ2' ' A' ' 40' ' ' TRP . 2.0 m-70 -103.99 16.55 26.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.136 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 90.58 153.18 28.65 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.868 -0.893 . . . . 1.0 110.868 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.0 51.43 0.6 Allowed Glycine 0 N--CA 1.468 0.786 0 N-CA-C 110.058 -1.217 . . . . 1.0 110.058 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -43.46 143.23 0.96 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 1.0 110.401 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 46' ' ' ALA . 3.0 mm? -80.07 136.39 36.55 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.059 0.457 . . . . 1.0 110.143 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 79' ' ' GLY . 69.3 m -141.61 103.45 5.9 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.971 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.489 ' O ' ' N ' ' A' ' 77' ' ' GLY . 58.7 Cg_endo -73.94 167.59 26.85 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.712 1.608 . . . . 1.0 111.747 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.487 ' HB2' HD12 ' A' ' 100' ' ' LEU . . . -44.09 -48.31 8.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.531 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -67.75 -19.64 65.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.473 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 74' ' ' PRO . . . -78.77 -165.89 29.5 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.252 -0.739 . . . . 1.0 111.252 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.33 -42.28 61.46 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.751 2.301 . . . . 1.0 112.351 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 73' ' ' CYS . . . 170.19 -161.85 35.01 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.024 -0.83 . . . . 1.0 111.024 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -169.8 138.83 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.494 ' HB ' ' H ' ' A' ' 45' ' ' ARG . 95.4 m -104.21 -47.99 3.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.781 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -124.94 155.05 40.2 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.95 0.405 . . . . 1.0 111.087 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 83' ' ' ILE . 4.4 mp -134.34 113.19 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.056 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.655 HG21 HD12 ' A' ' 115' ' ' LEU . 59.2 t -93.43 134.96 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.362 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.81 HG23 ' H ' ' A' ' 87' ' ' GLU . 3.7 m -127.21 163.68 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.646 -0.707 . . . . 1.0 110.708 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.416 ' HA ' HD11 ' A' ' 53' ' ' ILE . 8.5 p-10 -69.56 19.0 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.229 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.81 ' H ' HG23 ' A' ' 85' ' ' VAL . 12.9 mt-10 70.02 -51.76 0.64 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.51 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.14 -28.52 61.43 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.699 -0.961 . . . . 1.0 110.699 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.6 tpp -72.66 140.45 47.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.051 0.453 . . . . 1.0 110.823 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -88.18 153.63 21.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.769 -0.651 . . . . 1.0 109.67 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -56.26 -45.87 79.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.015 179.712 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.566 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 11.6 pt-20 -53.92 -49.72 68.01 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.621 -0.432 . . . . 1.0 111.135 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.484 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 21.9 ttm105 -70.51 -38.01 74.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.085 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.482 ' O ' HD23 ' A' ' 98' ' ' LEU . . . -46.56 -43.37 17.07 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 116.048 -0.523 . . . . 1.0 111.923 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.477 ' CD1' HD11 ' A' ' 109' ' ' LEU . 4.8 mp -58.3 -39.92 80.62 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.774 -0.579 . . . . 1.0 110.773 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.53 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 84.3 mmt-85 -69.24 -29.42 67.34 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.742 -0.383 . . . . 1.0 110.947 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.42 HD23 ' HB ' ' A' ' 49' ' ' VAL . 9.0 mp -65.26 -40.98 94.69 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.379 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -109.51 15.58 22.85 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.024 0.44 . . . . 1.0 110.655 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.53 ' NH1' ' O ' ' A' ' 96' ' ' ARG . 60.7 mmt-85 50.38 57.44 6.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.544 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' A' ' 75' ' ' ALA . 12.8 tp -107.24 115.07 60.4 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 121.075 -0.25 . . . . 1.0 110.458 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.22 -48.01 20.03 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.839 1.693 . . . . 1.0 112.384 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -175.98 137.51 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.645 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 103' ' ' LEU . 52.8 mt -37.06 100.76 0.21 Allowed Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.267 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.442 ' HD3' HD21 ' A' ' 100' ' ' LEU . 86.4 Cg_exo -43.18 157.44 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.099 1.866 . . . . 1.0 112.176 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.91 85.37 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.509 2.139 . . . . 1.0 111.898 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 137.33 -36.19 1.98 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.154 -0.778 . . . . 1.0 111.154 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.12 153.05 32.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.602 0.239 . . . . 1.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -144.23 155.48 43.89 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.477 HD11 ' CD1' ' A' ' 95' ' ' LEU . 0.8 OUTLIER -88.12 114.5 24.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.463 179.47 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.468 HG21 ' CE3' ' A' ' 114' ' ' TRP . 2.5 m -110.63 171.31 3.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 123.759 0.662 . . . . 1.0 109.478 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.555 ' NZ ' ' O ' ' A' ' 130' ' ' PHE . 30.1 mtmm -104.82 -178.49 3.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.832 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.1 t -60.13 -39.24 85.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.099 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.07 -49.59 60.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.523 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.518 ' CD1' HG12 ' A' ' 127' ' ' VAL . 75.0 t90 -56.18 -46.33 79.42 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.2 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.91 HD11 HD11 ' A' ' 65' ' ' ILE . 1.1 tt -67.43 -55.98 11.46 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.051 0.453 . . . . 1.0 110.377 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -41.37 -57.08 2.28 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.696 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.5 mp -58.64 -47.12 85.51 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 123' ' ' ARG . 0.5 OUTLIER -44.92 -42.62 8.28 Favored 'General case' 0 C--O 1.214 -0.766 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.725 177.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.48 -49.44 69.07 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 119.676 -0.81 . . . . 1.0 110.94 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -71.59 -51.91 20.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.971 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -70.62 -39.08 73.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.799 -0.637 . . . . 1.0 111.431 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 118' ' ' CYS . 67.1 mtt85 63.99 54.38 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.269 0.557 . . . . 1.0 111.133 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.894 ' NH2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -152.1 -164.72 2.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.239 -0.891 . . . . 1.0 111.125 -179.369 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.8 tp -119.94 91.67 3.6 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.593 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.894 HG22 ' NH2' ' A' ' 123' ' ' ARG . 29.0 m -81.2 153.32 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.952 0.406 . . . . 1.0 110.158 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -69.97 121.89 18.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.21 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 129' ' ' GLY . 17.6 m -72.44 -126.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.886 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.438 ' N ' HG23 ' A' ' 127' ' ' VAL . . . 63.81 -63.3 0.14 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 1.0 110.71 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . -59.53 -46.21 94.33 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.616 -0.994 . . . . 1.0 110.616 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.555 ' O ' ' NZ ' ' A' ' 111' ' ' LYS . 60.0 m-85 -86.54 -7.67 58.18 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.948 -0.389 . . . . 1.0 109.948 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.2 p -78.66 157.58 28.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.925 0.393 . . . . 1.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.575 ' C ' ' H ' ' A' ' 134' ' ' ILE . 62.2 mt -93.37 -59.67 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.406 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.475 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 16.3 t80 63.62 -32.97 0.12 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.941 -1.027 . . . . 1.0 111.904 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.575 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.6 OUTLIER 152.46 -55.64 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 124.848 1.259 . . . . 1.0 109.634 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 34.6 Cg_endo . . . . . 0 N--CA 1.496 1.638 0 C-N-CA 121.783 1.656 . . . . 1.0 112.074 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.459 -1.456 . . . . 1.0 109.459 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.1 m -133.29 152.51 51.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.869 0.366 . . . . 1.0 110.485 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -153.22 46.04 0.66 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.559 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.4 p -153.31 155.58 36.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.599 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.72 -40.1 90.09 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.951 -0.86 . . . . 1.0 110.951 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -58.97 142.12 51.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.558 0.218 . . . . 1.0 110.444 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -42.75 -73.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.896 0.379 . . . . 1.0 110.707 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 53.4 15.72 0.75 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.255 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.58 139.23 57.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.488 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -95.31 133.98 38.6 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.387 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.569 ' CZ2' ' NE ' ' A' ' 122' ' ' ARG . 3.6 p-90 -140.26 -38.46 0.45 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.392 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.99 -6.23 59.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.762 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.6 m -64.01 -33.03 74.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.903 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.499 ' OG ' HD23 ' A' ' 44' ' ' LEU . 3.9 p -57.16 -43.45 82.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.939 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.499 HD23 ' OG ' ' A' ' 43' ' ' SER . 0.1 OUTLIER -100.59 107.87 19.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.125 0.488 . . . . 1.0 110.732 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.553 ' O ' HG22 ' A' ' 81' ' ' THR . 2.7 mpt_? -68.72 110.21 4.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.519 -0.764 . . . . 1.0 109.338 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.626 ' HB3' HG21 ' A' ' 65' ' ' ILE . . . -91.2 162.83 14.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.875 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.691 ' HB2' HG11 ' A' ' 80' ' ' VAL . 85.0 t60 -148.08 131.92 17.05 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.945 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.733 HG12 HG21 ' A' ' 53' ' ' ILE . 1.5 t -121.98 116.49 49.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.35 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.462 ' O ' HG22 ' A' ' 53' ' ' ILE . 15.7 t -56.95 81.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.717 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 48' ' ' VAL . 33.1 ptt-85 -70.27 -8.3 49.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.779 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.6 p -92.89 0.43 57.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.61 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 54' ' ' GLY . . . -147.44 -46.67 0.03 OUTLIER Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.123 -0.791 . . . . 1.0 111.123 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.733 HG21 HG12 ' A' ' 48' ' ' VAL . 3.8 tt -64.24 3.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.774 0.321 . . . . 1.0 110.422 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 52' ' ' GLY . . . -70.24 50.99 0.78 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 53' ' ' ILE . 0.3 OUTLIER -70.38 -43.66 69.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.803 0.335 . . . . 1.0 110.236 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -177.21 -81.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.035 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 60' ' ' LEU . 8.9 ptm180 -95.47 -21.12 18.51 Favored 'General case' 0 C--O 1.207 -1.138 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.923 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.59 -37.05 17.0 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.89 -0.724 . . . . 1.0 111.033 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -51.55 -26.1 7.99 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.559 -0.456 . . . . 1.0 110.804 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.66 HD13 ' HB2' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -63.64 -22.87 67.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.201 0.524 . . . . 1.0 110.96 -179.589 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.509 ' HB2' HG11 ' A' ' 48' ' ' VAL . 21.7 m-85 -52.62 -46.71 67.17 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.923 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.695 ' HA ' HD12 ' A' ' 65' ' ' ILE . 5.3 pt-20 -65.71 -36.01 82.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.833 0.349 . . . . 1.0 110.645 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.66 ' HB2' HD13 ' A' ' 60' ' ' LEU . 5.7 mptp? -62.79 -48.67 78.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.19 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.434 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 62.4 mt-30 -60.38 -37.75 81.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.931 -0.577 . . . . 1.0 109.711 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.695 HD12 ' HA ' ' A' ' 62' ' ' GLU . 57.8 mt -61.6 -48.08 90.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.095 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.6 t -62.8 -46.54 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 120.583 -0.447 . . . . 1.0 110.297 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 63' ' ' LYS . 1.2 mp0 -67.32 -35.03 78.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.24 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.434 ' CG ' ' O ' ' A' ' 64' ' ' GLN . 61.7 m170 -88.19 0.28 56.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.542 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 98.72 147.27 21.83 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.72 -0.952 . . . . 1.0 110.72 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.47 55.53 0.71 Allowed Glycine 0 N--CA 1.464 0.554 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -40.19 145.13 0.17 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.679 0.276 . . . . 1.0 110.676 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.425 ' C ' ' SG ' ' A' ' 73' ' ' CYS . 8.8 mt -74.54 140.38 44.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.258 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.638 ' O ' HG13 ' A' ' 80' ' ' VAL . 2.6 m -145.12 87.87 7.01 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.233 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.16 -150.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.808 2.339 . . . . 1.0 111.849 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.53 -26.21 68.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.454 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -64.04 -20.56 66.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.52 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.1 -166.64 24.93 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.77 -43.47 57.62 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.71 2.274 . . . . 1.0 112.072 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . 131.48 31.17 0.52 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.896 -0.882 . . . . 1.0 110.896 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.691 HG11 ' HB2' ' A' ' 47' ' ' HIS . 31.1 m 37.44 -158.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 120.758 0.313 . . . . 1.0 110.904 179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.553 HG22 ' O ' ' A' ' 45' ' ' ARG . 2.5 t -142.04 -18.44 0.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.706 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.806 ' O ' HD13 ' A' ' 83' ' ' ILE . 68.7 m80 -130.98 160.03 35.73 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.022 0.439 . . . . 1.0 110.744 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.806 HD13 ' O ' ' A' ' 82' ' ' HIS . 5.1 mm -138.15 112.69 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.702 -0.681 . . . . 1.0 111.473 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.734 HG21 HD23 ' A' ' 115' ' ' LEU . 5.1 t -94.59 129.78 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.441 ' C ' ' H ' ' A' ' 87' ' ' GLU . 16.0 m -132.02 167.02 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.392 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 88' ' ' GLY . 49.1 t0 -77.91 30.06 0.17 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.219 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 85' ' ' VAL . 31.3 mt-10 64.72 -66.65 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.873 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . -48.64 -17.33 0.76 Allowed Glycine 0 CA--C 1.52 0.381 0 N-CA-C 110.871 -0.892 . . . . 1.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.487 ' SD ' ' CD1' ' A' ' 97' ' ' LEU . 3.4 ttm -77.4 147.37 36.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.122 0.486 . . . . 1.0 110.495 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 91' ' ' TYR . 92.1 m-20 -100.64 142.75 31.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.591 -0.731 . . . . 1.0 109.855 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.601 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -36.73 -56.4 0.84 Allowed 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.285 -179.55 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.601 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 5.0 pt-20 -56.1 -59.57 4.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.773 -0.648 . . . . 1.0 109.953 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.512 ' H ' ' CG ' ' A' ' 92' ' ' GLU . 79.0 ttt180 -42.51 -42.22 3.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.857 0.36 . . . . 1.0 110.22 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 91' ' ' TYR . . . -55.88 -48.61 75.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.73 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 99' ' ' ARG . 7.9 mp -57.48 -44.38 84.85 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.325 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.455 ' C ' ' CD ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -62.24 -42.43 99.31 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.807 179.275 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.487 ' CD1' ' SD ' ' A' ' 89' ' ' MET . 24.8 mt -63.19 -51.75 65.08 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.737 -0.385 . . . . 1.0 111.228 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.884 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -77.73 -18.5 56.47 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.173 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 95' ' ' LEU . 3.2 mtp180 76.35 63.54 0.05 OUTLIER 'General case' 0 CA--C 1.509 -0.608 0 O-C-N 124.469 1.106 . . . . 1.0 111.685 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.598 ' HB2' HD11 ' A' ' 98' ' ' LEU . 4.7 tp -136.45 118.3 11.61 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 120.465 -0.494 . . . . 1.0 111.089 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.98 -38.62 56.55 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.919 1.746 . . . . 1.0 112.067 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -163.19 136.48 5.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.609 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.501 HD11 HD21 ' A' ' 109' ' ' LEU . 11.8 mt -75.99 148.8 82.03 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.024 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.34 167.75 17.81 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.033 1.822 . . . . 1.0 112.467 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -56.1 146.35 70.78 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.497 2.131 . . . . 1.0 112.296 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.05 -19.52 6.5 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.901 -0.879 . . . . 1.0 110.901 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.97 151.76 34.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 1.0 110.428 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -156.73 128.86 7.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.365 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.501 HD21 HD11 ' A' ' 103' ' ' LEU . 1.9 mp -84.11 127.64 34.04 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.711 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.495 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.8 m -121.31 176.14 4.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 O-C-N 123.723 0.639 . . . . 1.0 109.973 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -106.75 -176.57 3.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.738 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.478 ' OG ' ' CE2' ' A' ' 61' ' ' PHE . 6.8 t -60.05 -41.36 92.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.57 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.32 -48.24 62.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.611 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.505 ' CZ2' ' SG ' ' A' ' 118' ' ' CYS . 78.3 t90 -54.19 -41.1 68.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.002 0.429 . . . . 1.0 110.259 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.734 HD23 HG21 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -62.04 -55.56 27.95 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.129 -179.435 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 80.1 p -49.21 -42.87 41.6 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.055 0.455 . . . . 1.0 109.828 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.35 -55.74 22.05 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.426 -0.51 . . . . 1.0 109.896 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.505 ' SG ' ' CZ2' ' A' ' 114' ' ' TRP . 0.0 OUTLIER -44.63 -33.68 1.9 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 -179.328 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 94.0 mt -77.05 -51.33 11.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.568 -0.742 . . . . 1.0 111.184 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -65.56 -49.14 69.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.231 -0.441 . . . . 1.0 111.314 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.433 ' O ' ' CG ' ' A' ' 123' ' ' ARG . 65.2 mm-40 -77.48 1.44 19.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.282 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.569 ' NE ' ' CZ2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 38.79 32.24 0.05 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.585 179.396 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 121' ' ' GLU . 4.5 ppt_? -158.29 174.32 15.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.254 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.6 tt -82.15 126.17 31.74 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.943 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.0 m -108.96 154.74 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.539 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 40.3 p-10 -62.09 144.33 55.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.042 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.6 m -103.03 11.17 8.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.509 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.64 53.35 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.609 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.68 -34.47 0.12 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.089 -0.804 . . . . 1.0 111.089 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -99.74 5.92 45.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.022 0.439 . . . . 1.0 110.655 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.6 t -99.15 141.28 32.12 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.356 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.519 ' C ' ' H ' ' A' ' 134' ' ' ILE . 54.7 mt -88.18 -55.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-N 115.635 -0.711 . . . . 1.0 110.205 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.522 ' O ' HG12 ' A' ' 134' ' ' ILE . 10.9 t80 65.71 -40.6 0.32 Allowed 'General case' 0 C--O 1.221 -0.426 0 O-C-N 124.375 1.047 . . . . 1.0 111.461 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.572 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 159.38 -54.55 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 O-C-N 124.665 1.228 . . . . 1.0 109.915 -178.731 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 36.5 Cg_endo . . . . . 0 N--CA 1.491 1.351 0 C-N-CA 122.15 1.9 . . . . 1.0 111.929 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.495 -1.442 . . . . 1.0 109.495 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.2 t -61.28 -43.89 98.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.817 0.341 . . . . 1.0 110.572 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.5 t30 56.81 45.54 21.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.619 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.5 p -155.37 162.49 40.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.45 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.6 -22.39 41.19 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 56.5 mp0 -88.86 151.01 22.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.941 0.401 . . . . 1.0 110.47 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.469 ' O ' ' C ' ' A' ' 37' ' ' ALA . 10.1 pt-20 -61.19 -52.18 65.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.712 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . 25.3 60.75 0.06 Allowed 'General case' 0 N--CA 1.468 0.466 0 O-C-N 123.781 0.676 . . . . 1.0 110.959 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -127.3 40.92 3.62 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.483 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -45.6 137.06 5.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.307 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.599 ' CH2' HD12 ' A' ' 41' ' ' LEU . 1.6 p-90 -123.45 -50.62 1.87 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.547 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.599 HD12 ' CH2' ' A' ' 40' ' ' TRP . 1.3 mt -67.13 -21.75 65.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.757 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.0 t -61.37 -18.57 59.34 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.326 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.431 ' OG ' HD23 ' A' ' 44' ' ' LEU . 24.7 p -65.32 -15.0 62.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.333 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.441 ' N ' HD23 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -138.55 168.35 19.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.308 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -119.55 115.58 24.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.604 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.498 ' CB ' HD13 ' A' ' 65' ' ' ILE . . . -95.62 168.18 10.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.114 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -153.91 120.06 5.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.629 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.455 ' CG1' HG21 ' A' ' 53' ' ' ILE . 87.1 t -100.05 135.9 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.09 0.471 . . . . 1.0 110.252 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 49' ' ' VAL . 32.3 m -86.71 125.04 40.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.685 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.401 ' HG3' HH11 ' A' ' 50' ' ' ARG . 18.2 mmt85 -74.53 -39.11 62.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.745 -0.661 . . . . 1.0 111.246 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.751 ' OG1' HD11 ' A' ' 97' ' ' LEU . 45.1 p -59.51 -22.51 61.74 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.617 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . -115.85 -91.58 1.71 Allowed Glycine 0 N--CA 1.465 0.603 0 N-CA-C 110.738 -0.945 . . . . 1.0 110.738 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.485 ' C ' ' H ' ' A' ' 55' ' ' ARG . 4.1 mm -40.23 -27.6 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.741 0.305 . . . . 1.0 110.806 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 52' ' ' GLY . . . -69.81 41.64 0.44 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.801 -0.92 . . . . 1.0 110.801 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.485 ' H ' ' C ' ' A' ' 53' ' ' ILE . 1.9 ptp180 -80.11 -61.14 2.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.835 0.35 . . . . 1.0 110.953 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.401 ' H ' ' HG3' ' A' ' 55' ' ' ARG . . . -150.28 -89.87 0.07 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.761 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -92.71 -24.62 18.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.03 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.44 -16.83 0.64 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.571 0.701 . . . . 1.0 110.05 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 61' ' ' PHE . 21.1 pt-20 -73.29 -34.84 65.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.154 0.502 . . . . 1.0 111.207 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 tp -46.29 -17.31 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.392 0.615 . . . . 1.0 110.866 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.475 ' N ' ' O ' ' A' ' 59' ' ' GLU . 1.8 m-85 -57.22 -51.11 70.64 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.802 -0.636 . . . . 1.0 112.073 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.613 ' HA ' HD12 ' A' ' 65' ' ' ILE . 1.5 pt-20 -58.15 -36.99 73.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.111 0.482 . . . . 1.0 110.563 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.46 ' HG2' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -61.86 -44.75 96.19 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.244 0.545 . . . . 1.0 110.287 -178.806 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -62.76 -18.7 63.05 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.256 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.613 HD12 ' HA ' ' A' ' 62' ' ' GLU . 92.3 mt -86.29 -56.19 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.961 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.428 HG12 ' HA ' ' A' ' 71' ' ' GLN . 3.4 m -62.81 -38.6 82.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.913 0.387 . . . . 1.0 110.891 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.418 ' N ' HG23 ' A' ' 66' ' ' VAL . 85.0 mt-30 -61.45 -40.01 92.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.699 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -95.68 14.66 22.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.771 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 96.32 144.72 17.61 Favored Glycine 0 N--CA 1.464 0.524 0 N-CA-C 110.618 -0.993 . . . . 1.0 110.618 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.07 44.73 1.35 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.707 -0.957 . . . . 1.0 110.707 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.428 ' HA ' HG12 ' A' ' 66' ' ' VAL . 34.4 mm-40 -40.95 160.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.786 0.327 . . . . 1.0 110.689 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.9 mt -69.92 136.62 50.79 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 68.4 m -131.1 96.9 20.95 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.341 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.99 -178.71 4.85 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.527 2.151 . . . . 1.0 112.024 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -54.68 -47.82 73.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.766 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -64.03 -18.98 64.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.915 0.388 . . . . 1.0 110.352 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.87 -158.45 19.38 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.088 -0.805 . . . . 1.0 111.088 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -47.96 -44.99 26.25 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.412 2.075 . . . . 1.0 112.417 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.576 ' O ' HG12 ' A' ' 80' ' ' VAL . . . 156.44 -44.58 0.52 Allowed Glycine 0 C--O 1.223 -0.576 0 C-N-CA 120.467 -0.873 . . . . 1.0 111.128 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 79' ' ' GLY . 0.4 OUTLIER 82.91 166.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 124.038 0.493 . . . . 1.0 110.166 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.58 -35.22 0.31 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.904 -0.318 . . . . 1.0 110.453 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -117.26 144.06 45.23 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.655 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.945 HD12 HD12 ' A' ' 109' ' ' LEU . 58.2 mt -131.58 112.59 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.555 -0.458 . . . . 1.0 110.885 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 t -90.3 127.64 42.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.633 HG23 ' H ' ' A' ' 87' ' ' GLU . 28.7 m -133.16 166.44 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.885 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 88' ' ' GLY . 39.8 p-10 -73.66 17.48 0.16 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.76 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.633 ' H ' HG23 ' A' ' 85' ' ' VAL . 3.7 mt-10 73.71 -32.11 0.23 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.092 -0.504 . . . . 1.0 111.224 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -67.95 -20.35 72.55 Favored Glycine 0 C--N 1.314 -0.672 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.426 ' CE ' HH12 ' A' ' 93' ' ' ARG . 9.4 ttm -82.11 160.16 23.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.791 0.329 . . . . 1.0 110.826 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -113.52 142.06 46.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.83 -0.623 . . . . 1.0 109.891 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.57 ' CG ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -46.49 -53.27 11.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.497 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.57 ' N ' ' CG ' ' A' ' 91' ' ' TYR . 17.1 pt-20 -51.83 -38.25 55.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.645 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.426 HH12 ' CE ' ' A' ' 89' ' ' MET . 79.7 ttt-85 -80.44 -22.17 41.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.789 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.34 -37.32 77.54 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.334 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 99' ' ' ARG . 7.5 mp -60.6 -38.0 83.22 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.995 -0.282 . . . . 1.0 110.319 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -61.9 -35.88 79.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.79 0.329 . . . . 1.0 110.627 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.751 HD11 ' OG1' ' A' ' 51' ' ' THR . 3.9 mm? -62.24 -40.56 96.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.049 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -108.72 8.77 27.0 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.188 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 95' ' ' LEU . 1.6 mpt_? 45.96 58.24 4.55 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.8 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.444 ' HB2' HD12 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -109.52 112.44 58.88 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.147 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.74 -41.75 37.75 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.057 1.838 . . . . 1.0 112.72 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -162.08 128.59 3.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.958 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.761 HD13 HD11 ' A' ' 109' ' ' LEU . 60.4 mt -52.71 124.6 35.3 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-N 116.088 -0.506 . . . . 1.0 111.214 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.449 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 44.2 Cg_exo -49.67 -174.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.365 2.044 . . . . 1.0 112.419 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 32.1 Cg_exo -58.18 129.36 32.62 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.724 2.283 . . . . 1.0 111.908 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 72.18 -53.32 1.43 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-O 118.906 -0.941 . . . . 1.0 110.751 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -7.79 116.26 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 O-C-N 124.262 0.625 . . . . 1.0 111.178 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.529 ' C ' HD13 ' A' ' 109' ' ' LEU . 23.1 mt-30 -127.71 142.74 51.25 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.593 -0.276 . . . . 1.0 110.411 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 1.046 ' H ' HD22 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -93.38 120.96 34.27 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.767 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.5 m -110.25 168.0 4.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.996 -1.002 . . . . 1.0 110.606 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.21 -177.72 3.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.897 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.0 m -61.48 -41.63 97.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.11 -0.95 . . . . 1.0 110.511 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.47 -48.14 62.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.547 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.767 ' CE3' HG21 ' A' ' 110' ' ' VAL . 34.5 t90 -56.02 -41.22 74.59 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.229 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.6 tp -65.67 -56.64 11.06 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.142 -0.623 . . . . 1.0 110.613 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 m -46.22 -53.58 10.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.363 0.601 . . . . 1.0 110.061 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.2 mp -52.23 -49.23 64.39 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.268 -0.573 . . . . 1.0 109.863 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 12.8 t -52.15 -37.33 54.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.775 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.598 ' O ' ' NH2' ' A' ' 122' ' ' ARG . 90.2 mt -69.6 -57.5 5.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.42 0.629 . . . . 1.0 111.509 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -66.21 -21.24 66.3 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.469 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 75.9 mm-40 -88.82 -45.24 9.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.609 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.598 ' NH2' ' O ' ' A' ' 119' ' ' LEU . 0.1 OUTLIER 81.61 33.86 0.1 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.9 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.424 ' C ' ' CD ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -161.7 -176.12 5.11 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.579 -0.449 . . . . 1.0 110.536 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 tp -79.22 123.89 27.84 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.333 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.18 155.18 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 121.017 0.437 . . . . 1.0 110.623 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 126' ' ' ASP . 45.3 p-10 -61.38 107.94 0.86 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.251 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.541 HG23 ' N ' ' A' ' 128' ' ' ALA . 9.1 m -60.36 -42.82 92.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.65 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.541 ' N ' HG23 ' A' ' 127' ' ' VAL . . . -55.72 -22.66 24.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.48 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.9 -37.62 94.66 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.916 -0.873 . . . . 1.0 110.916 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 130' ' ' PHE . 0.3 OUTLIER -143.42 58.51 1.39 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.707 0.289 . . . . 1.0 110.899 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.9 m -119.17 150.8 39.43 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.141 0.496 . . . . 1.0 110.795 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.576 ' C ' ' H ' ' A' ' 134' ' ' ILE . 60.9 mt -81.34 -63.75 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 CA-C-N 115.301 -0.863 . . . . 1.0 110.181 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.512 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 19.4 t80 66.34 -35.66 0.23 Allowed 'General case' 0 C--O 1.221 -0.425 0 O-C-N 124.208 0.943 . . . . 1.0 111.347 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.601 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 155.7 -55.51 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.37 0 O-C-N 124.905 1.378 . . . . 1.0 110.048 -178.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 24.9 Cg_endo . . . . . 0 N--CA 1.491 1.361 0 C-N-CA 122.324 2.016 . . . . 1.0 111.821 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.586 -1.406 . . . . 1.0 109.586 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.5 m 54.29 30.68 12.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 1.0 110.612 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 11.3 p30 -67.93 116.15 8.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.536 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.2 m -89.26 -2.33 58.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.423 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.78 -57.87 11.57 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.024 -0.83 . . . . 1.0 111.024 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.483 ' HG3' ' H ' ' A' ' 36' ' ' GLU . 6.1 tp10 42.52 -160.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 1.0 110.552 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.483 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 21.3 pt-20 -65.14 -43.56 91.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.305 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 60.33 43.83 13.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.005 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 39' ' ' GLU . 3.9 pt-20 -153.76 -28.2 0.13 Allowed 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 110.207 -0.294 . . . . 1.0 110.207 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.455 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 39.9 mp0 50.57 173.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.58 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.442 ' CH2' HD12 ' A' ' 41' ' ' LEU . 14.8 p-90 -163.81 -55.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.086 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.653 ' O ' HD23 ' A' ' 41' ' ' LEU . 1.2 tt -68.91 -18.18 64.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.372 0.606 . . . . 1.0 110.123 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 68' ' ' HIS . 15.8 m -61.5 -42.17 98.39 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.713 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.8 m -52.84 -60.61 3.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.882 0.373 . . . . 1.0 110.714 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -75.0 169.28 18.32 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.655 -0.498 . . . . 1.0 109.655 179.647 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -123.71 120.02 31.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.935 0.398 . . . . 1.0 110.738 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.637 ' O ' HD13 ' A' ' 72' ' ' LEU . . . -96.7 158.29 15.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.235 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.486 ' CE1' ' CD1' ' A' ' 98' ' ' LEU . 59.6 t-80 -156.04 114.88 3.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.231 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.7 m -101.23 139.9 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.739 -0.467 . . . . 1.0 109.739 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 53' ' ' ILE . 58.5 t -81.69 89.9 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.036 0.446 . . . . 1.0 110.527 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -58.24 -31.18 67.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.664 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 m -92.9 34.99 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.992 0.425 . . . . 1.0 110.364 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -178.87 -4.6 0.02 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.091 -0.804 . . . . 1.0 111.091 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -127.04 -1.35 4.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-O 120.748 0.309 . . . . 1.0 110.314 179.293 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.45 37.32 0.57 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.105 -0.798 . . . . 1.0 111.105 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.523 ' NE ' ' OD2' ' A' ' 86' ' ' ASP . 1.6 ptp180 -61.0 -37.76 83.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.829 0.347 . . . . 1.0 110.244 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -172.9 -103.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.401 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.687 ' CD ' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -85.98 -19.13 30.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.491 179.574 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.447 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -43.21 -36.53 1.78 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.573 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 61' ' ' PHE . 12.5 pt-20 -66.12 -44.46 84.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.342 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.1 tp -43.17 -18.13 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.775 0.798 . . . . 1.0 110.818 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 59' ' ' GLU . 6.5 m-85 -58.11 -48.38 80.37 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.562 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.689 ' HA ' HD12 ' A' ' 65' ' ' ILE . 14.6 pt-20 -60.47 -31.04 70.07 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.034 0.445 . . . . 1.0 111.544 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.421 ' H ' ' HG2' ' A' ' 63' ' ' LYS . 17.0 mmmt -65.96 -56.52 11.3 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.451 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 64' ' ' GLN . 2.3 pt20 -57.84 -30.06 65.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.421 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.849 HD11 HD21 ' A' ' 115' ' ' LEU . 68.5 mt -66.87 -39.82 84.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.411 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 62' ' ' GLU . 53.8 t -59.8 -41.62 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.232 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -68.24 -16.46 63.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.521 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.431 ' O ' ' OG ' ' A' ' 42' ' ' SER . 34.0 m170 -88.81 7.32 34.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.65 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.82 -7.22 82.18 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.052 -0.819 . . . . 1.0 111.052 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.56 98.06 2.3 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.589 -1.004 . . . . 1.0 110.589 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -79.54 144.31 34.04 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.89 -0.324 . . . . 1.0 110.756 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.637 HD13 ' O ' ' A' ' 46' ' ' ALA . 2.5 mm? -80.66 137.27 36.32 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 120.898 0.38 . . . . 1.0 110.531 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.8 m -133.68 90.54 27.87 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.465 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.5 -177.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.824 2.349 . . . . 1.0 112.139 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 77' ' ' GLY . . . -56.43 -41.73 76.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.514 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -64.14 -1.55 1.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.319 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 75' ' ' ALA . . . -136.56 86.67 0.24 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.318 -1.113 . . . . 1.0 110.318 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.76 139.26 59.18 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.626 2.218 . . . . 1.0 112.058 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.81 1.17 1.63 Allowed Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 80' ' ' VAL . 1.3 p -88.34 103.71 13.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.048 0.451 . . . . 1.0 110.6 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.99 -39.25 15.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.399 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.5 ' CD2' ' CZ2' ' A' ' 114' ' ' TRP . 77.5 m80 -106.58 138.82 42.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.951 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.482 HD13 HD22 ' A' ' 98' ' ' LEU . 85.7 mt -133.58 107.36 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.258 -0.428 . . . . 1.0 109.934 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.43 134.97 27.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.533 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.51 162.8 37.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.394 -0.821 . . . . 1.0 110.975 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 88' ' ' GLY . 67.8 t0 -63.99 103.45 0.59 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 116.027 -0.533 . . . . 1.0 109.635 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 86' ' ' ASP . 69.1 mt-10 -24.63 87.15 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 124.191 0.932 . . . . 1.0 110.926 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . 156.77 -25.41 0.5 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 -178.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.462 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 11.9 ttm -70.14 146.71 50.63 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.913 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -90.09 151.57 21.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.453 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.55 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.74 -46.86 87.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.108 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.55 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 10.5 pt-20 -57.99 -45.45 86.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.947 0.403 . . . . 1.0 110.776 -178.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.484 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 4.8 tmm_? -72.13 -21.82 61.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.13 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.49 -30.62 71.71 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.802 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 99' ' ' ARG . 7.0 mp -72.18 -44.81 62.46 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.212 0.32 . . . . 1.0 110.973 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -59.79 -48.28 82.32 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.25 -45.76 75.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.568 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.486 ' CD1' ' CE1' ' A' ' 47' ' ' HIS . 54.8 tp -72.77 -16.18 61.64 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.969 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.57 ' N ' ' O ' ' A' ' 95' ' ' LEU . 23.0 mmt85 67.35 27.15 8.27 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.11 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.5 tp -98.02 116.99 65.58 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.8 -23.26 35.72 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.22 1.947 . . . . 1.0 112.578 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -174.42 133.88 0.4 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.328 -0.397 . . . . 1.0 110.714 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 104' ' ' PRO . 1.0 OUTLIER -73.79 135.44 77.75 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.093 -178.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.533 ' O ' ' O ' ' A' ' 103' ' ' LEU . 60.7 Cg_exo -44.72 -174.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.645 2.23 . . . . 1.0 112.061 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 52.5 Cg_exo -51.95 -68.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.565 2.176 . . . . 1.0 113.087 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . -82.45 -50.43 4.77 Favored Glycine 0 CA--C 1.502 -0.753 0 N-CA-C 110.662 -0.975 . . . . 1.0 110.662 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.52 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -11.46 123.83 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 124.64 0.847 . . . . 1.0 111.44 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -130.76 154.26 48.17 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 110.018 -0.364 . . . . 1.0 110.018 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.86 110.36 22.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.783 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.74 HG21 ' CE3' ' A' ' 114' ' ' TRP . 13.9 m -107.25 169.07 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.661 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -96.52 -168.97 1.81 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.658 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -70.69 -34.66 72.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.878 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.403 ' HB3' ' CD1' ' A' ' 130' ' ' PHE . . . -57.21 -46.75 82.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.688 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.74 ' CE3' HG21 ' A' ' 110' ' ' VAL . 79.0 t90 -52.02 -59.83 3.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.628 -0.429 . . . . 1.0 110.678 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.849 HD21 HD11 ' A' ' 65' ' ' ILE . 32.0 tp -60.63 -51.24 70.25 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.441 -0.504 . . . . 1.0 110.503 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 117' ' ' LEU . 56.9 p -41.27 -60.71 1.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.087 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.439 ' N ' ' OG ' ' A' ' 116' ' ' SER . 11.0 mp -61.14 -49.62 76.51 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.055 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 9.3 t -55.49 -25.96 39.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 1.0 110.081 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -70.62 -52.27 22.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.478 0.656 . . . . 1.0 111.419 -178.779 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -78.39 -30.66 47.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.505 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 122' ' ' ARG . 0.4 OUTLIER -62.38 -48.5 79.45 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 118.473 -0.775 . . . . 1.0 110.165 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 121' ' ' GLU . 17.0 mmm180 90.27 32.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.816 1.323 . . . . 1.0 111.358 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.432 HH11 ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -173.9 163.18 4.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.435 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.4 tp -65.76 129.32 39.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.962 0.411 . . . . 1.0 111.175 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.442 HG23 ' CD1' ' A' ' 114' ' ' TRP . 17.3 m -113.32 154.0 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.364 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -61.96 146.92 48.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.431 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 129' ' ' GLY . 2.4 m -108.01 0.98 9.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.249 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.98 61.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.602 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 171.48 -28.15 0.11 Allowed Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 113' ' ' ALA . 60.7 m-85 -108.47 -11.53 15.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.718 0.295 . . . . 1.0 110.39 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -74.6 135.32 42.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.08 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 134' ' ' ILE . 57.5 mt -79.45 -65.95 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.129 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.53 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 19.7 t80 66.14 -36.33 0.24 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 118.438 -0.791 . . . . 1.0 111.154 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.609 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 155.67 -55.27 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 O-C-N 124.825 1.328 . . . . 1.0 110.272 -178.727 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 22.7 Cg_endo . . . . . 0 C--N 1.311 -1.401 0 C-N-CA 122.391 2.06 . . . . 1.0 111.982 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.427 -1.469 . . . . 1.0 109.427 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 t -152.32 36.69 0.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.744 0.306 . . . . 1.0 110.485 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.45 ' CG ' ' H ' ' A' ' 33' ' ' SER . 49.2 t-20 -71.73 -129.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.589 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.45 ' H ' ' CG ' ' A' ' 32' ' ' ASN . 95.5 p -73.58 162.51 29.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.454 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -136.19 28.66 2.89 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.902 -0.879 . . . . 1.0 110.902 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -57.79 139.8 53.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.997 0.427 . . . . 1.0 110.577 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -65.43 -43.38 90.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.424 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 38.5 62.57 0.99 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.966 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -92.48 138.04 31.85 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.329 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.549 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 57.8 mp0 -115.72 95.21 5.02 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.433 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.502 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 3.5 p-90 -98.42 -56.69 2.39 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.391 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.402 HD12 ' CH2' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -56.15 -11.68 1.23 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.737 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.5 p -68.7 -32.55 72.44 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.644 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -61.02 -15.32 30.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.571 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.72 115.28 11.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.854 0.359 . . . . 1.0 110.628 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.418 ' HB3' HG23 ' A' ' 80' ' ' VAL . 88.9 mtm180 -75.31 139.94 42.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.078 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.717 ' HB3' HD13 ' A' ' 65' ' ' ILE . . . -119.33 169.74 9.73 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.458 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.406 ' C ' ' ND1' ' A' ' 47' ' ' HIS . 1.5 t-80 -147.89 120.09 8.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.439 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -97.1 127.16 49.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.508 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.66 HG12 ' H ' ' A' ' 52' ' ' GLY . 15.0 t -80.7 88.92 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.424 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -49.56 -36.84 24.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.548 -0.296 . . . . 1.0 110.571 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.0 p -76.26 -24.24 54.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.541 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.66 ' H ' HG12 ' A' ' 49' ' ' VAL . . . -110.14 1.58 29.84 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.367 -0.693 . . . . 1.0 111.367 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.644 ' N ' ' O ' ' A' ' 49' ' ' VAL . 35.0 mt -146.18 91.47 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.285 0.564 . . . . 1.0 110.309 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -145.45 19.68 1.87 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.076 -0.81 . . . . 1.0 111.076 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.657 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -58.25 -55.97 28.08 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.288 -0.264 . . . . 1.0 110.288 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 55' ' ' ARG . . . 158.14 -40.14 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 O-C-N 123.436 0.46 . . . . 1.0 110.576 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.731 ' O ' HD22 ' A' ' 60' ' ' LEU . 70.3 ttp85 -94.27 -60.66 1.68 Allowed 'General case' 0 C--O 1.211 -0.928 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.829 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.634 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -40.96 -43.08 2.03 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-O 121.262 0.553 . . . . 1.0 110.578 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 61' ' ' PHE . 11.3 pt-20 -45.45 -48.52 13.8 Favored 'General case' 0 C--N 1.314 -0.971 0 O-C-N 121.77 -0.581 . . . . 1.0 111.094 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.802 HD23 ' N ' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -39.45 -19.02 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.507 0.504 . . . . 1.0 109.962 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.802 ' N ' HD23 ' A' ' 60' ' ' LEU . 8.6 m-85 -52.73 -48.96 66.32 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.676 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.462 ' CG ' ' N ' ' A' ' 63' ' ' LYS . 13.9 pt-20 -63.02 -43.46 98.67 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.489 0.493 . . . . 1.0 110.528 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.462 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 17.5 mtpp -61.23 -42.58 98.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.223 0.535 . . . . 1.0 110.177 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.536 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 86.9 mm-40 -67.35 -31.27 71.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.205 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.751 HD11 HD11 ' A' ' 115' ' ' LEU . 46.5 mt -74.96 -57.86 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.047 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 67' ' ' GLN . 28.0 m -55.22 -42.75 67.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.271 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.533 ' N ' HG23 ' A' ' 66' ' ' VAL . 65.0 tt0 -65.81 -40.29 91.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.584 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 64' ' ' GLN . 46.5 m170 -86.01 -3.59 58.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.503 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 99.17 171.17 30.96 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.876 -0.89 . . . . 1.0 110.876 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 71' ' ' GLN . . . 102.17 -45.51 1.36 Allowed Glycine 0 N--CA 1.464 0.545 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 70' ' ' GLY . 25.1 mm100 54.92 158.65 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.7 0.286 . . . . 1.0 110.634 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.873 HD22 ' N ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -89.58 130.32 35.91 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.757 -0.461 . . . . 1.0 109.757 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 73.3 m -118.85 88.73 36.53 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.621 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 77' ' ' GLY . 31.8 Cg_exo -56.67 162.45 8.47 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.833 2.355 . . . . 1.0 112.055 178.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -47.23 -33.84 5.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.397 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -75.94 -20.51 57.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.896 0.379 . . . . 1.0 110.592 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 74' ' ' PRO . . . -85.9 -161.99 35.85 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.029 -0.828 . . . . 1.0 111.029 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -43.8 -41.63 11.78 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.563 2.175 . . . . 1.0 111.986 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.711 ' O ' HG12 ' A' ' 80' ' ' VAL . . . 136.19 -40.78 1.49 Allowed Glycine 0 C--O 1.22 -0.779 0 CA-C-O 119.219 -0.767 . . . . 1.0 111.695 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.742 HG13 ' N ' ' A' ' 81' ' ' THR . 0.3 OUTLIER 77.96 -171.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 124.034 0.491 . . . . 1.0 109.909 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.742 ' N ' HG13 ' A' ' 80' ' ' VAL . 0.6 OUTLIER -144.29 -32.19 0.43 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.824 177.56 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.561 ' HD1' HG23 ' A' ' 81' ' ' THR . 74.9 m80 -111.69 136.51 50.83 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.614 -0.266 . . . . 1.0 110.672 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 110' ' ' VAL . 30.2 mm -123.28 106.29 17.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.465 HG11 HD12 ' A' ' 115' ' ' LEU . 2.3 p -93.53 134.06 32.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.814 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 87' ' ' GLU . 3.1 m -132.79 157.44 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.206 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.576 ' O ' ' C ' ' A' ' 87' ' ' GLU . 10.1 t0 -54.78 77.72 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 123.373 0.42 . . . . 1.0 110.116 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' A' ' 85' ' ' VAL . 6.8 pt-20 -3.88 79.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 O-C-N 124.17 0.919 . . . . 1.0 111.76 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . 170.1 -22.11 0.08 OUTLIER Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.601 -0.727 . . . . 1.0 111.288 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.6 tpp -72.71 156.14 39.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.775 0.322 . . . . 1.0 110.786 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -96.35 144.1 26.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.135 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.604 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -51.47 -44.94 62.6 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.205 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.604 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 16.5 pt-20 -59.65 -44.16 93.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.929 0.395 . . . . 1.0 110.526 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.46 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 38.8 ttm105 -71.94 -41.16 68.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.767 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.15 -34.46 22.42 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.935 -0.575 . . . . 1.0 111.045 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 91' ' ' TYR . 5.6 mp -62.55 -47.3 84.49 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.66 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.548 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -73.0 -35.77 66.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.257 -178.649 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.62 -34.54 75.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.51 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.921 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -105.61 -1.94 24.05 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.204 -0.453 . . . . 1.0 111.005 -179.431 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.548 ' NH1' ' O ' ' A' ' 96' ' ' ARG . 72.9 mmt-85 70.57 61.68 0.2 Allowed 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 123.322 0.389 . . . . 1.0 110.858 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.624 ' HB2' HD11 ' A' ' 98' ' ' LEU . 9.3 tp -125.79 122.36 24.57 Favored Pre-proline 0 N--CA 1.449 -0.518 0 O-C-N 123.255 0.347 . . . . 1.0 111.376 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.83 -36.51 23.44 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.384 2.056 . . . . 1.0 112.012 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 179.47 139.63 0.11 Allowed 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.576 0.548 . . . . 1.0 110.915 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.7 mt -45.14 120.27 4.4 Favored Pre-proline 0 N--CA 1.445 -0.72 0 CA-C-N 115.843 -0.617 . . . . 1.0 111.166 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.15 165.36 32.9 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.409 2.073 . . . . 1.0 112.031 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.15 113.54 1.24 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.575 2.183 . . . . 1.0 111.805 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.84 62.58 1.67 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -164.09 143.13 7.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 1.0 110.641 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.504 ' N ' ' CD ' ' A' ' 108' ' ' GLN . 0.0 OUTLIER -140.16 152.99 46.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.088 0.471 . . . . 1.0 110.132 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.415 HD11 ' CD1' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -93.06 109.4 20.87 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.15 179.26 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.616 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.0 m -108.23 167.14 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.026 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -102.24 -171.18 1.92 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.838 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.4 t -64.84 -44.42 89.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.895 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.08 -38.0 49.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.514 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.616 ' CE3' HG21 ' A' ' 110' ' ' VAL . 75.2 t90 -61.65 -52.31 64.86 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.907 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.751 HD11 HD11 ' A' ' 65' ' ' ILE . 3.0 tt -63.13 -55.7 23.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.993 0.425 . . . . 1.0 110.986 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.9 t -43.94 -59.55 2.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.392 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.427 ' O ' ' OE2' ' A' ' 121' ' ' GLU . 9.4 mp -60.01 -49.82 76.15 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.464 -0.494 . . . . 1.0 110.364 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 123' ' ' ARG . 3.1 t -58.72 -22.08 56.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.142 -0.318 . . . . 1.0 110.142 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.535 ' O ' ' NH1' ' A' ' 122' ' ' ARG . 6.7 tp -71.22 -53.52 14.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.001 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.42 ' C ' ' H ' ' A' ' 122' ' ' ARG . 77.0 mt-30 -76.75 -33.08 58.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.603 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.535 ' O ' ' C ' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -77.26 18.17 0.42 Allowed 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.8 -178.496 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.535 ' C ' ' O ' ' A' ' 121' ' ' GLU . 81.6 mmt-85 20.56 52.77 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.719 0.637 . . . . 1.0 111.353 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.494 ' O ' ' SG ' ' A' ' 118' ' ' CYS . 0.5 OUTLIER -170.67 167.8 7.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.727 -0.669 . . . . 1.0 110.357 -178.342 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.482 HD11 ' NE2' ' A' ' 82' ' ' HIS . 5.0 tt -83.77 114.76 21.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.044 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 126' ' ' ASP . 55.2 t -80.45 155.7 4.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.155 0.502 . . . . 1.0 110.601 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.431 ' N ' HG12 ' A' ' 125' ' ' VAL . 66.2 t0 -66.46 117.26 8.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.505 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 131' ' ' SER . 2.9 m -64.14 -41.4 92.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.603 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.463 ' N ' ' CG2' ' A' ' 127' ' ' VAL . . . -53.75 -6.64 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.455 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 127' ' ' VAL . . . -87.86 -34.38 10.09 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -134.33 12.12 3.83 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.713 0.292 . . . . 1.0 110.433 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 127' ' ' VAL . 5.1 t -75.48 141.29 43.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.895 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.569 ' C ' ' H ' ' A' ' 134' ' ' ILE . 45.3 mt -83.25 -66.36 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.124 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.533 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 21.1 t80 66.76 -37.89 0.31 Allowed 'General case' 0 C--O 1.211 -0.926 0 O-C-N 124.011 0.819 . . . . 1.0 111.003 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.61 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 157.36 -54.66 0.0 OUTLIER Pre-proline 0 N--CA 1.45 -0.441 0 O-C-N 124.658 1.224 . . . . 1.0 110.755 -178.542 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 29.9 Cg_endo . . . . . 0 C--N 1.31 -1.476 0 C-N-CA 122.479 2.12 . . . . 1.0 111.684 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.769 0.319 . . . . 1.0 110.782 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -90.24 -46.05 8.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.383 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.539 ' CD2' HG23 ' A' ' 65' ' ' ILE . 6.6 tp -62.42 -31.83 72.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.742 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 91.5 p -48.02 -14.71 0.05 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.532 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.459 ' N ' ' C ' ' A' ' 41' ' ' LEU . 32.9 t -64.55 -16.34 62.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.567 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.35 168.24 19.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.281 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.463 HH12 ' CA ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -118.11 112.19 19.86 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.966 0.413 . . . . 1.0 110.428 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.575 ' CB ' HD13 ' A' ' 65' ' ' ILE . . . -93.58 166.29 12.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.782 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -155.12 121.35 5.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.376 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.604 HG13 HD12 ' A' ' 53' ' ' ILE . 54.6 t -108.73 135.05 48.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.97 0.414 . . . . 1.0 110.215 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 52' ' ' GLY . 13.6 t -86.0 103.44 12.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.412 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.528 ' H ' ' HD2' ' A' ' 50' ' ' ARG . 6.8 mpt_? -63.55 -38.86 92.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.72 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.7 p -66.05 -30.56 71.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.404 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.567 ' H ' HG12 ' A' ' 49' ' ' VAL . . . -87.31 -67.48 1.33 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.21 -0.756 . . . . 1.0 111.21 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.604 HD12 HG13 ' A' ' 48' ' ' VAL . 3.1 mt -61.9 -94.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.971 -0.292 . . . . 1.0 110.214 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 53' ' ' ILE . . . 34.24 32.27 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.163 -0.775 . . . . 1.0 111.163 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.53 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 30.0 mtm180 -70.54 -60.34 2.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.829 0.347 . . . . 1.0 110.364 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 55' ' ' ARG . . . 170.72 -53.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.352 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.5 ttt-85 -101.99 -41.39 6.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.365 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.473 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -56.59 -41.4 76.92 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.048 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 61' ' ' PHE . 8.0 pt-20 -45.62 -46.44 14.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.734 -0.212 . . . . 1.0 110.584 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.8 tp -41.27 -17.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.12 0.486 . . . . 1.0 110.548 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.766 ' CD1' HD13 ' A' ' 115' ' ' LEU . 3.3 m-85 -49.42 -51.1 37.6 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.173 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.477 ' CD ' ' HZ2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -61.58 -40.09 93.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.542 -0.299 . . . . 1.0 110.675 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HZ2' ' CD ' ' A' ' 62' ' ' GLU . 13.9 mptt -61.68 -43.28 99.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.228 0.537 . . . . 1.0 110.249 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -63.6 -40.53 97.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.309 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 1.083 HD11 HD11 ' A' ' 115' ' ' LEU . 81.2 mt -64.32 -54.12 34.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.934 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.495 HG23 ' N ' ' A' ' 67' ' ' GLN . 28.9 m -64.01 -40.43 89.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.128 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.495 ' N ' HG23 ' A' ' 66' ' ' VAL . 55.9 tt0 -59.64 -18.62 43.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.273 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.3 m170 -97.3 1.86 50.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.487 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.07 0.51 59.98 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.057 -0.817 . . . . 1.0 111.057 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.686 ' O ' HG22 ' A' ' 65' ' ' ILE . . . -91.63 98.2 2.4 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.738 -0.945 . . . . 1.0 110.738 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.414 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 83.7 mt-30 -70.86 145.43 50.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.87 0.367 . . . . 1.0 110.568 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.626 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -136.34 156.65 48.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.084 0.469 . . . . 1.0 110.359 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.1 m -163.19 158.28 17.91 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.566 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.95 -153.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.952 2.435 . . . . 1.0 111.944 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 99' ' ' ARG . . . -47.62 -26.66 1.56 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.505 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' A' ' 77' ' ' GLY . 74.7 mt-30 -66.58 -20.12 65.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.281 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.463 ' CA ' HH12 ' A' ' 45' ' ' ARG . . . -37.51 103.88 0.03 OUTLIER Glycine 0 CA--C 1.538 1.475 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.44 ' HD2' HH22 ' A' ' 45' ' ' ARG . 52.2 Cg_exo -50.9 -28.76 24.71 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.647 2.232 . . . . 1.0 111.928 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.82 60.96 0.4 Allowed Glycine 0 CA--C 1.521 0.413 0 N-CA-C 111.099 -0.8 . . . . 1.0 111.099 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 80' ' ' VAL . 1.5 p -91.63 97.6 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.489 0.661 . . . . 1.0 110.249 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.19 -19.02 19.66 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.42 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -109.97 140.78 43.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.472 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.5 mm -131.1 106.18 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.614 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.4 t -91.21 131.35 38.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.52 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' A' ' 87' ' ' GLU . 27.9 m -132.73 162.59 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.607 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.586 ' C ' ' H ' ' A' ' 88' ' ' GLY . 15.3 t70 -68.92 18.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.375 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.563 ' H ' ' C ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER 68.87 -20.1 0.16 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.668 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -61.82 -67.71 1.98 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.2 ptp -63.54 145.82 54.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.641 0.258 . . . . 1.0 110.35 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -83.63 168.52 16.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.638 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.546 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.98 -53.32 59.18 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.466 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.546 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 15.7 pt-20 -50.39 -38.86 44.89 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.502 0.501 . . . . 1.0 110.107 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.441 ' HG3' ' HE ' ' A' ' 96' ' ' ARG . 67.7 ttt180 -74.81 -40.97 60.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.974 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -46.19 -27.89 1.11 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.642 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.594 HD22 ' N ' ' A' ' 95' ' ' LEU . 4.1 mm? -56.07 -59.51 4.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.268 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.441 ' HE ' ' HG3' ' A' ' 93' ' ' ARG . 41.2 ptt180 -78.1 -25.95 47.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.477 -0.329 . . . . 1.0 110.551 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.451 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -61.45 -42.24 98.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.932 -179.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -93.4 6.14 49.18 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.283 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 31.6 mmt-85 69.67 54.88 0.37 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.791 0.329 . . . . 1.0 111.065 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 95' ' ' LEU . 6.4 tp -146.78 116.83 4.56 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.781 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.35 -7.48 19.71 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.767 2.311 . . . . 1.0 112.876 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -179.85 140.68 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.699 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.516 ' CD1' HD11 ' A' ' 95' ' ' LEU . 1.7 mp -84.45 148.56 52.67 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.973 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.475 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 37.0 Cg_exo -59.34 -173.68 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.63 2.22 . . . . 1.0 111.657 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 29.8 Cg_exo -62.45 133.75 44.55 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.676 2.251 . . . . 1.0 111.798 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 72.42 -51.59 1.43 Allowed Glycine 0 C--O 1.22 -0.729 0 N-CA-C 110.935 -0.866 . . . . 1.0 110.935 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.537 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -17.8 129.71 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.905 0.415 . . . . 1.0 111.065 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -132.11 158.28 42.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.103 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.677 HD12 ' N ' ' A' ' 109' ' ' LEU . 3.4 mp -107.84 117.61 34.58 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.553 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.672 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.6 m -108.84 175.45 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.479 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -104.36 -174.67 2.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.811 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.0 p -64.04 -37.67 88.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.896 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.38 -44.45 76.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.586 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.672 ' CE3' HG21 ' A' ' 110' ' ' VAL . 60.8 t90 -57.51 -48.21 79.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.476 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 1.083 HD11 HD11 ' A' ' 65' ' ' ILE . 1.3 tt -58.77 -52.69 64.61 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.231 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.1 m -42.15 -57.43 2.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.519 -0.309 . . . . 1.0 110.629 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 121' ' ' GLU . 60.8 mt -55.0 -50.7 68.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.378 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.614 ' SG ' ' CE2' ' A' ' 114' ' ' TRP . 55.9 m -45.87 -33.52 3.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.456 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 65.5 mt -80.13 -50.93 9.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.915 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -70.18 -54.57 12.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.63 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 117' ' ' LEU . 79.9 mt-10 -75.54 7.6 3.55 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.538 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 121' ' ' GLU . 74.4 mtt85 25.09 53.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.54 0.525 . . . . 1.0 111.503 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -159.0 -170.24 2.95 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.306 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.4 tp -108.04 96.85 6.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.422 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.527 HG23 ' CD1' ' A' ' 114' ' ' TRP . 2.4 m -78.56 154.44 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.622 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -61.09 119.85 9.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.329 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.566 ' HB ' HG12 ' A' ' 110' ' ' VAL . 5.3 m -62.45 -42.05 94.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.719 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.52 ' N ' HG23 ' A' ' 127' ' ' VAL . . . -44.44 -19.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.553 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . -70.75 -40.71 64.81 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -135.95 34.65 2.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.682 0.277 . . . . 1.0 110.617 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.7 t -100.49 137.48 38.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.763 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 134' ' ' ILE . 39.6 mt -72.65 -71.85 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.373 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.568 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 20.6 t80 65.74 -36.55 0.23 Allowed 'General case' 0 C--O 1.208 -1.101 0 CA-C-O 118.306 -0.854 . . . . 1.0 110.804 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.624 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 156.3 -55.51 0.0 OUTLIER Pre-proline 0 N--CA 1.449 -0.506 0 O-C-N 124.736 1.272 . . . . 1.0 110.667 -178.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 29.8 Cg_endo . . . . . 0 C--N 1.304 -1.771 0 C-N-CA 122.617 2.212 . . . . 1.0 111.695 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.856 0.36 . . . . 1.0 110.417 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.469 ' CZ3' HD12 ' A' ' 41' ' ' LEU . 1.9 p-90 -107.32 -32.54 7.72 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.528 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.476 HD23 HD11 ' A' ' 44' ' ' LEU . 1.6 mt -79.32 -9.53 59.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.035 0.445 . . . . 1.0 110.633 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.7 t -67.04 -21.75 65.9 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.81 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.6 t -63.64 -15.71 59.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.846 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.476 HD11 HD23 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -138.15 169.52 17.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.392 -179.725 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -118.86 107.33 13.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.415 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.513 ' HB3' HG21 ' A' ' 65' ' ' ILE . . . -92.46 151.18 20.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.26 -0.427 . . . . 1.0 109.927 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -136.71 120.76 17.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.583 . . . . 1.0 110.556 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.403 ' CG1' HG21 ' A' ' 53' ' ' ILE . 88.3 t -96.48 135.9 29.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.861 -0.609 . . . . 1.0 109.969 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.447 HG23 ' H ' ' A' ' 53' ' ' ILE . 29.5 m -85.92 126.93 40.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.923 -0.581 . . . . 1.0 111.123 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -71.4 -37.2 71.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.988 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.604 ' OG1' HD11 ' A' ' 97' ' ' LEU . 99.1 m -57.0 -48.79 77.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.615 -178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . -90.5 -83.61 1.39 Allowed Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.458 -1.057 . . . . 1.0 110.458 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.447 ' H ' HG23 ' A' ' 49' ' ' VAL . 5.3 mm -53.23 78.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.71 0.766 . . . . 1.0 110.266 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 52' ' ' GLY . . . -166.7 25.78 0.15 Allowed Glycine 0 C--N 1.313 -0.75 0 CA-C-N 114.884 -1.053 . . . . 1.0 111.462 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.452 ' NH2' ' OD2' ' A' ' 86' ' ' ASP . 11.9 ptp180 -72.62 -37.33 68.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.844 0.354 . . . . 1.0 110.77 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -179.32 -81.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.609 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -90.7 -20.27 22.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.53 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.48 -27.25 9.95 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 120.967 0.413 . . . . 1.0 110.399 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.437 ' C ' ' N ' ' A' ' 61' ' ' PHE . 2.1 pt-20 -70.58 -35.66 73.17 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.717 0.294 . . . . 1.0 110.57 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.3 tp -46.2 -19.35 0.07 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.967 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.437 ' N ' ' C ' ' A' ' 59' ' ' GLU . 5.1 m-85 -61.23 -44.6 97.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.956 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.553 ' HA ' HD12 ' A' ' 65' ' ' ILE . 8.9 pt-20 -62.47 -40.42 96.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.975 0.417 . . . . 1.0 110.672 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.445 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 39.0 mttp -65.71 -41.9 91.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.665 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.543 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 25.5 mt-30 -63.14 -19.03 64.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.618 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 1.13 HD11 HD11 ' A' ' 115' ' ' LEU . 70.6 mt -83.38 -57.42 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.83 0.348 . . . . 1.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 71' ' ' GLN . 3.5 m -64.58 -32.78 59.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.052 0.454 . . . . 1.0 110.604 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -70.56 -21.44 62.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.508 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 64' ' ' GLN . 60.1 m170 -96.26 14.71 23.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.978 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.22 2.3 57.99 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.984 -0.847 . . . . 1.0 110.984 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.59 -146.0 2.47 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.096 -1.202 . . . . 1.0 110.096 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.412 ' HA ' HG12 ' A' ' 66' ' ' VAL . 0.0 OUTLIER 171.98 149.05 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.14 -0.318 . . . . 1.0 110.14 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.6 mt -107.9 113.67 27.04 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.444 ' O ' ' O ' ' A' ' 74' ' ' PRO . 2.5 m -135.36 91.07 19.29 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.205 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 73' ' ' CYS . 52.5 Cg_exo -52.37 -162.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.599 2.199 . . . . 1.0 112.003 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -61.23 -33.62 73.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.565 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.09 -19.54 65.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.485 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.24 -161.51 14.04 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.056 -0.818 . . . . 1.0 111.056 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.95 -37.48 78.2 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.805 2.337 . . . . 1.0 111.924 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.566 ' O ' HG12 ' A' ' 80' ' ' VAL . . . 160.15 -40.75 0.45 Allowed Glycine 0 C--O 1.223 -0.59 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 79' ' ' GLY . 0.4 OUTLIER 80.41 162.29 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 N-CA-C 110.106 -0.331 . . . . 1.0 110.106 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.69 -41.93 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.936 0.398 . . . . 1.0 110.74 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -110.29 137.12 48.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.974 0.416 . . . . 1.0 110.993 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 77.3 mt -133.02 109.38 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.955 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.512 HG21 HD12 ' A' ' 115' ' ' LEU . 31.1 t -88.08 138.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.249 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 87' ' ' GLU . 35.3 m -134.64 152.57 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.378 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' GLY . 66.4 t0 -74.45 43.41 0.18 Allowed 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.655 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.494 ' CD ' ' NZ ' ' A' ' 111' ' ' LYS . 2.8 mt-10 40.66 22.19 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.633 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . -100.06 -64.58 0.81 Allowed Glycine 0 N--CA 1.463 0.457 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.442 ' CE ' HG21 ' A' ' 49' ' ' VAL . 13.2 ptp -77.73 156.19 30.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.857 0.36 . . . . 1.0 110.548 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -93.07 173.95 7.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.498 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.651 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.69 -50.4 73.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.164 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.651 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 15.4 pt-20 -51.67 -38.31 54.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.055 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.516 HH21 HH21 ' A' ' 96' ' ' ARG . 69.7 ttt180 -83.15 -21.84 33.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.604 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.404 ' O ' ' CD2' ' A' ' 98' ' ' LEU . . . -62.04 -35.41 78.52 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.389 -0.524 . . . . 1.0 111.912 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 95' ' ' LEU . 7.6 mp -60.83 -41.84 96.56 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.853 0.359 . . . . 1.0 110.649 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.516 HH21 HH21 ' A' ' 93' ' ' ARG . 13.7 ptt85 -69.47 -23.69 63.69 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.252 -0.579 . . . . 1.0 109.798 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.604 HD11 ' OG1' ' A' ' 51' ' ' THR . 0.2 OUTLIER -65.9 -41.29 91.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.37 0.605 . . . . 1.0 111.19 -177.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.766 HD23 ' H ' ' A' ' 98' ' ' LEU . 2.4 pt? -114.9 5.98 15.27 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.877 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.467 ' CD ' ' N ' ' A' ' 99' ' ' ARG . 1.2 mpt_? 58.05 57.35 4.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.609 -0.269 . . . . 1.0 110.441 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.2 tp -104.89 110.3 64.28 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 120.597 -0.441 . . . . 1.0 110.354 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.08 -40.94 58.98 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.151 1.901 . . . . 1.0 112.268 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -173.69 135.64 0.53 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.708 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.9 mp -53.28 111.69 2.94 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.187 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.453 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 46.9 Cg_exo -50.49 -174.49 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 122.097 1.865 . . . . 1.0 112.235 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 31.3 Cg_exo -58.57 113.58 1.62 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.836 2.357 . . . . 1.0 112.058 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 91.79 -66.53 2.23 Favored Glycine 0 C--O 1.221 -0.714 0 N-CA-C 110.413 -1.075 . . . . 1.0 110.413 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.52 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -13.42 125.68 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.109 0.535 . . . . 1.0 111.487 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -133.6 156.34 48.02 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.967 0.413 . . . . 1.0 110.35 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.85 112.89 24.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.917 -0.583 . . . . 1.0 109.614 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.551 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.4 m -107.27 168.74 3.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 123.705 0.628 . . . . 1.0 109.843 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.494 ' NZ ' ' CD ' ' A' ' 87' ' ' GLU . 3.6 mtpp -102.64 -177.67 3.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.746 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.9 m -60.48 -39.87 89.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.459 -0.791 . . . . 1.0 110.767 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.24 -39.32 66.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.687 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.551 ' CE3' HG21 ' A' ' 110' ' ' VAL . 76.1 t90 -60.76 -47.05 88.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.848 0.356 . . . . 1.0 110.714 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 1.13 HD11 HD11 ' A' ' 65' ' ' ILE . 0.6 OUTLIER -60.14 -52.28 66.02 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.219 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.2 p -51.06 -42.27 60.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.154 -0.475 . . . . 1.0 109.973 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 mt -61.32 -52.71 63.54 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.405 -0.518 . . . . 1.0 109.651 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.549 ' O ' ' N ' ' A' ' 122' ' ' ARG . 2.2 m -50.48 -36.37 33.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.702 -0.481 . . . . 1.0 109.702 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.6 mt -69.15 -52.92 23.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.148 0.499 . . . . 1.0 110.575 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -60.66 -27.42 67.81 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.096 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -103.32 -4.31 24.4 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.325 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.549 ' N ' ' O ' ' A' ' 118' ' ' CYS . 37.8 mmt180 44.23 47.95 7.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.717 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.517 ' HE ' HG12 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -172.36 -175.5 1.4 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.51 -179.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -86.37 126.73 34.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.973 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.517 HG12 ' HE ' ' A' ' 123' ' ' ARG . 20.4 m -114.15 155.4 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.572 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -60.94 159.21 11.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.052 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' GLY . 3.6 m -114.67 3.23 7.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.493 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.35 67.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.006 0.431 . . . . 1.0 110.582 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 159.27 -34.3 0.47 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.186 -0.765 . . . . 1.0 111.186 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -103.77 1.24 31.43 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.063 0.459 . . . . 1.0 110.428 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 t -90.13 140.99 29.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.906 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.581 ' C ' ' H ' ' A' ' 134' ' ' ILE . 60.7 mt -92.27 -72.46 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 116.266 -0.424 . . . . 1.0 109.883 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.528 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 19.1 t80 64.77 -36.13 0.19 Allowed 'General case' 0 C--O 1.222 -0.345 0 O-C-N 123.945 0.778 . . . . 1.0 111.303 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.585 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 155.17 -55.43 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.414 0 O-C-N 124.581 1.175 . . . . 1.0 110.14 -178.438 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.6 Cg_endo . . . . . 0 N--CA 1.492 1.411 0 C-N-CA 122.216 1.944 . . . . 1.0 111.974 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 120.782 0.325 . . . . 1.0 110.478 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.577 ' CZ3' HD13 ' A' ' 41' ' ' LEU . 8.5 p-90 -100.08 -59.05 1.78 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.015 0.436 . . . . 1.0 110.276 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.577 HD13 ' CZ3' ' A' ' 40' ' ' TRP . 5.6 tp -62.7 -30.39 71.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.671 -0.695 . . . . 1.0 110.267 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.2 t -48.13 -14.17 0.05 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.676 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.471 ' N ' ' C ' ' A' ' 41' ' ' LEU . 42.1 p -68.3 -13.48 62.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.8 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.93 169.08 18.37 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.8 0.333 . . . . 1.0 110.547 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.41 HH11 ' HA3' ' A' ' 79' ' ' GLY . 93.7 mtt180 -122.08 137.92 54.64 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.154 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.698 ' HB3' HD13 ' A' ' 65' ' ' ILE . . . -124.13 166.17 16.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.467 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -153.76 129.19 9.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.713 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.3 m -100.8 137.42 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.373 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.539 ' O ' ' O ' ' A' ' 52' ' ' GLY . 13.5 t -98.35 135.25 33.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.857 -0.611 . . . . 1.0 109.996 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.554 ' CD ' ' H ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -62.05 -43.52 98.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.739 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.631 ' OG1' HD12 ' A' ' 97' ' ' LEU . 13.1 m -51.7 -21.35 2.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.384 0.612 . . . . 1.0 110.548 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 49' ' ' VAL . . . -156.99 120.17 0.96 Allowed Glycine 0 C--O 1.219 -0.782 0 N-CA-C 109.383 -1.487 . . . . 1.0 109.383 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.569 HG22 ' O ' ' A' ' 53' ' ' ILE . 4.7 mm 115.28 -6.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.047 1.339 . . . . 1.0 109.52 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.01 22.74 30.08 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.754 -0.939 . . . . 1.0 110.754 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -60.97 -57.1 14.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.638 0.256 . . . . 1.0 110.588 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.466 ' O ' ' CG ' ' A' ' 59' ' ' GLU . . . 179.74 -67.44 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.386 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -91.06 -27.5 18.56 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.581 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.406 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -57.36 -32.63 66.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.319 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 61' ' ' PHE . 3.3 pt-20 -66.48 -39.5 88.79 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 116.159 -0.473 . . . . 1.0 109.775 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 tp -41.67 -17.51 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.183 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.579 ' N ' ' O ' ' A' ' 59' ' ' GLU . 6.1 m-85 -60.49 -42.89 97.24 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.22 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.504 ' HA ' HD12 ' A' ' 65' ' ' ILE . 1.3 pt-20 -67.74 -32.12 72.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.664 0.268 . . . . 1.0 111.159 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -70.67 -56.77 5.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.877 0.37 . . . . 1.0 111.013 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.724 ' NE2' HD11 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -51.96 -31.23 28.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.76 -0.655 . . . . 1.0 109.527 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.808 HD11 HD11 ' A' ' 115' ' ' LEU . 31.0 mt -65.74 -46.99 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.67 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.81 -43.72 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.439 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -58.7 -26.93 64.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.179 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.539 ' CE1' HE21 ' A' ' 64' ' ' GLN . 43.0 m170 -79.27 -2.11 39.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.549 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.44 -1.35 58.64 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.928 -0.869 . . . . 1.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.75 88.6 1.54 Allowed Glycine 0 N--CA 1.461 0.363 0 N-CA-C 110.689 -0.965 . . . . 1.0 110.689 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.581 ' CD ' ' H ' ' A' ' 71' ' ' GLN . 2.6 pm0 -59.82 146.34 42.19 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.7 mt -92.29 110.82 22.22 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 91.1 m -119.97 86.88 37.56 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.603 ' C ' ' H ' ' A' ' 76' ' ' GLN . 14.3 Cg_endo -55.21 -159.71 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 122.004 1.803 . . . . 1.0 112.64 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -54.61 -0.6 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.035 -0.529 . . . . 1.0 110.588 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.603 ' H ' ' C ' ' A' ' 74' ' ' PRO . 4.5 pt20 -62.78 -19.67 64.24 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.109 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -156.12 160.32 30.01 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 120.755 -0.736 . . . . 1.0 111.599 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.535 ' O ' ' O ' ' A' ' 79' ' ' GLY . 49.5 Cg_exo -52.17 -10.97 0.86 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.231 1.954 . . . . 1.0 112.09 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.548 ' O ' ' C ' ' A' ' 80' ' ' VAL . . . -53.0 -118.31 0.01 OUTLIER Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.712 -0.955 . . . . 1.0 110.712 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 80' ' ' VAL . 2.3 p 10.6 74.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.592 0.71 . . . . 1.0 111.889 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.19 -24.23 27.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.352 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.63 ' CD2' ' CZ2' ' A' ' 114' ' ' TRP . 79.2 m80 -116.67 140.22 49.65 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.808 0.337 . . . . 1.0 110.262 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.611 HD13 ' O ' ' A' ' 82' ' ' HIS . 2.9 mm -128.68 111.3 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.427 -0.583 . . . . 1.0 109.427 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 115' ' ' LEU . 1.6 p -96.14 133.68 36.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.204 0.526 . . . . 1.0 110.379 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.8 m -127.82 165.61 26.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.562 -0.744 . . . . 1.0 110.536 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 88' ' ' GLY . 26.2 p-10 -77.06 14.26 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.636 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 64.81 -2.91 0.62 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.343 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -75.27 -49.87 8.98 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.305 -0.718 . . . . 1.0 111.305 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.0 ptp -88.87 156.38 18.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.82 0.343 . . . . 1.0 110.709 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -83.55 166.27 18.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.283 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.698 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -58.8 -47.58 84.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.993 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.698 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 17.5 pt-20 -53.69 -38.23 64.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.888 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.48 ' HG3' HD23 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -70.23 -47.04 63.16 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.197 179.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.07 -31.07 17.64 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.99 -0.684 . . . . 1.0 111.349 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.03 -47.58 85.28 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.346 -0.541 . . . . 1.0 111.267 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -70.91 -42.54 69.79 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.582 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.631 HD12 ' OG1' ' A' ' 51' ' ' THR . 3.8 mm? -64.36 -43.64 93.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.826 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.947 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -84.67 -4.27 58.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.545 -179.189 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.405 ' O ' ' CB ' ' A' ' 75' ' ' ALA . 75.1 mmt-85 68.57 60.94 0.37 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.038 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.517 ' HB2' HD11 ' A' ' 98' ' ' LEU . 7.7 tp -129.58 111.45 17.68 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.764 -0.198 . . . . 1.0 110.799 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.66 -42.64 61.13 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.916 1.744 . . . . 1.0 111.947 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -174.34 130.31 0.36 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.567 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 104' ' ' PRO . 69.5 mt -37.37 100.48 0.2 Allowed Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.094 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' LEU . 54.8 Cg_exo -46.01 -178.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.276 1.984 . . . . 1.0 112.407 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.14 -43.42 59.28 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.634 2.222 . . . . 1.0 112.65 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.39 68.98 0.25 Allowed Glycine 0 N--CA 1.468 0.775 0 N-CA-C 110.97 -0.852 . . . . 1.0 110.97 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.64 138.6 7.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.82 0.343 . . . . 1.0 110.587 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -146.02 151.93 38.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.256 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.88 113.26 25.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.962 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.704 HG21 ' CE3' ' A' ' 114' ' ' TRP . 12.0 m -110.63 166.33 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.501 -0.772 . . . . 1.0 109.885 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.51 ' NZ ' ' O ' ' A' ' 130' ' ' PHE . 28.8 mtmm -98.4 -176.99 3.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.731 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.3 t -62.94 -39.55 94.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.569 -0.742 . . . . 1.0 110.527 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.42 -41.86 66.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.227 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.704 ' CE3' HG21 ' A' ' 110' ' ' VAL . 75.1 t90 -61.6 -53.64 53.58 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.613 -0.435 . . . . 1.0 110.592 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.808 HD11 HD11 ' A' ' 65' ' ' ILE . 3.3 tt -61.94 -53.12 60.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.472 -0.491 . . . . 1.0 109.817 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 80.9 p -51.59 -46.71 63.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.492 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.4 mt -64.91 -54.99 21.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.355 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 1.4 p -50.17 -30.91 12.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.386 0.612 . . . . 1.0 110.284 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.724 HD11 ' NE2' ' A' ' 64' ' ' GLN . 2.3 tp -70.01 -52.8 21.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.265 -0.88 . . . . 1.0 110.614 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -66.95 -37.87 85.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.564 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' A' ' 123' ' ' ARG . 78.3 mm-40 -78.98 9.03 4.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.181 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.479 ' NH2' ' NE1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER 36.06 32.68 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.788 -0.642 . . . . 1.0 111.092 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.438 ' CG ' ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -158.09 177.24 11.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.076 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.402 ' O ' ' NH1' ' A' ' 123' ' ' ARG . 5.6 tt -92.65 122.11 34.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.033 0.444 . . . . 1.0 110.766 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.425 HG23 ' CD1' ' A' ' 114' ' ' TRP . 3.2 m -100.0 152.23 4.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.347 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -62.18 150.21 39.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.286 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 129' ' ' GLY . 2.3 m -102.46 6.31 10.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.468 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.6 56.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.78 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 168.34 -37.75 0.21 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.51 ' O ' ' NZ ' ' A' ' 111' ' ' LYS . 50.4 m-85 -89.47 -18.24 27.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.728 0.299 . . . . 1.0 110.517 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.8 t -72.15 137.58 47.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.1 0.476 . . . . 1.0 110.78 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 134' ' ' ILE . 59.1 mt -83.62 -69.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.333 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.486 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 16.7 t80 62.34 -31.47 0.09 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.368 -0.833 . . . . 1.0 112.133 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.588 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 151.7 -55.12 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 124.6 1.16 . . . . 1.0 109.854 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.5 Cg_endo . . . . . 0 N--CA 1.497 1.688 0 C-N-CA 121.824 1.682 . . . . 1.0 112.137 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 120.698 0.285 . . . . 1.0 110.566 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.633 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -109.99 -40.16 4.83 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.182 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.466 ' HG ' ' CE3' ' A' ' 40' ' ' TRP . 8.7 mt -79.61 1.86 24.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.42 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.2 t -54.99 -48.6 73.1 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.309 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.6 p -72.11 -37.28 69.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.929 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.2 mt -73.9 140.78 45.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.982 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.628 ' H ' HG22 ' A' ' 81' ' ' THR . 0.2 OUTLIER -124.94 102.81 7.71 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.979 178.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.482 ' O ' HD22 ' A' ' 72' ' ' LEU . . . -92.2 169.05 10.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.21 0.529 . . . . 1.0 110.845 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -156.33 124.14 5.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.672 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.572 HG12 HG13 ' A' ' 84' ' ' VAL . 14.4 m -103.04 143.72 14.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.047 0.451 . . . . 1.0 110.221 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 52' ' ' GLY . 18.9 m -97.07 161.21 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.449 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -81.25 -60.79 2.15 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.42 -0.354 . . . . 1.0 110.708 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.648 HG23 HD11 ' A' ' 97' ' ' LEU . 43.9 p -46.88 -12.08 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.983 0.42 . . . . 1.0 110.261 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.641 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -151.43 118.71 0.93 Allowed Glycine 0 C--O 1.205 -1.703 0 N-CA-C 109.46 -1.456 . . . . 1.0 109.46 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.641 ' HB ' ' O ' ' A' ' 52' ' ' GLY . 4.6 mm 102.22 -16.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.816 0.846 . . . . 1.0 110.452 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.5 29.13 1.23 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.661 -0.976 . . . . 1.0 110.661 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 32.6 mtt180 -66.66 -60.92 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.764 0.316 . . . . 1.0 110.56 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 55' ' ' ARG . . . 172.47 -61.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.249 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -87.7 -32.47 19.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.311 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.12 83.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.363 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 61' ' ' PHE . 9.3 pt-20 -66.42 -42.26 88.04 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.382 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.3 tp -45.84 -13.54 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.111 0.481 . . . . 1.0 110.833 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 59' ' ' GLU . 3.8 m-30 -56.72 -47.64 79.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.884 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' HA ' HD12 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -62.09 -40.09 94.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.437 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -55.95 -46.41 78.56 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.632 -0.427 . . . . 1.0 110.222 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.485 ' O ' ' CD2' ' A' ' 68' ' ' HIS . 77.9 mt-30 -65.02 -38.85 92.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.147 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 115' ' ' LEU . 77.5 mt -64.05 -43.69 97.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.48 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.16 -45.03 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.252 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -60.18 -26.01 66.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.318 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 64' ' ' GLN . 42.9 m170 -79.9 0.45 31.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.387 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.31 -19.31 54.42 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.871 -0.892 . . . . 1.0 110.871 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.34 94.04 0.63 Allowed Glycine 0 C--O 1.224 -0.478 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.44 ' C ' HD23 ' A' ' 72' ' ' LEU . 14.0 pt20 -77.13 145.23 37.9 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.975 -0.29 . . . . 1.0 110.439 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.483 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 4.6 mt -107.18 145.58 32.41 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.938 0.399 . . . . 1.0 110.302 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 72' ' ' LEU . 3.8 m -163.44 91.21 1.16 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.381 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 77' ' ' GLY . 43.7 Cg_endo -70.02 -167.09 0.22 Allowed 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.599 2.199 . . . . 1.0 111.989 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 98' ' ' LEU . . . -38.63 -27.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.837 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 74' ' ' PRO . 1.7 pt20 -64.03 1.58 0.67 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.399 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 74' ' ' PRO . . . 162.78 161.78 12.76 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.063 -0.815 . . . . 1.0 111.063 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.03 143.72 73.28 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.63 2.22 . . . . 1.0 111.817 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.403 ' HA2' ' HE ' ' A' ' 45' ' ' ARG . . . 116.42 66.01 0.38 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.224 -0.751 . . . . 1.0 111.224 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 80' ' ' VAL . 2.7 p -160.79 67.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.423 0.63 . . . . 1.0 110.475 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.628 HG22 ' H ' ' A' ' 45' ' ' ARG . 15.3 t -74.26 -33.29 63.24 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.003 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -117.37 146.0 43.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.938 0.399 . . . . 1.0 110.848 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.598 HD13 ' CD1' ' A' ' 98' ' ' LEU . 22.5 mt -137.51 111.43 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.839 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.572 HG13 HG12 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -95.15 140.59 16.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.121 0.486 . . . . 1.0 110.633 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.465 ' C ' ' H ' ' A' ' 87' ' ' GLU . 28.2 m -131.16 166.64 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.83 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.59 ' C ' ' H ' ' A' ' 88' ' ' GLY . 49.4 p-10 -73.07 14.16 0.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.665 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' A' ' 85' ' ' VAL . 18.6 mt-10 65.82 -15.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.776 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -64.13 -49.47 66.51 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.917 -0.873 . . . . 1.0 110.917 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.5 ptp -90.03 158.13 17.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.862 0.363 . . . . 1.0 110.471 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -89.1 -179.64 5.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.667 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -67.67 -37.59 82.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.37 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.538 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 15.2 pt-20 -58.91 -46.05 88.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.979 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.482 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 1.9 tmm_? -79.36 -24.34 42.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.022 -0.536 . . . . 1.0 111.231 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.55 -37.47 70.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.569 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.629 HD11 HD11 ' A' ' 103' ' ' LEU . 7.4 mp -60.96 -36.27 78.96 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.11 -0.236 . . . . 1.0 110.674 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.536 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 6.6 mmp_? -62.65 -36.86 84.22 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.247 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.648 HD11 HG23 ' A' ' 51' ' ' THR . 4.3 mm? -62.61 -42.21 99.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.054 0.454 . . . . 1.0 111.266 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.598 ' CD1' HD13 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -97.32 5.31 50.12 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.668 -0.696 . . . . 1.0 109.663 -178.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.536 ' NH1' ' O ' ' A' ' 96' ' ' ARG . 51.2 mmt-85 51.01 24.32 1.81 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.267 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.7 tp -86.53 121.37 72.23 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.776 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.07 -17.17 36.34 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.465 2.11 . . . . 1.0 112.399 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 176.78 152.8 0.2 Allowed 'General case' 0 C--O 1.235 0.297 0 O-C-N 123.323 0.389 . . . . 1.0 110.453 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.774 HD12 ' N ' ' A' ' 103' ' ' LEU . 3.8 mp -86.47 140.6 33.98 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.949 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.02 164.41 35.75 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.416 2.077 . . . . 1.0 111.952 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -40.69 135.19 2.16 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.6 2.2 . . . . 1.0 112.191 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 107' ' ' ALA . . . 80.74 -69.56 3.19 Favored Glycine 0 C--O 1.228 -0.226 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 106' ' ' GLY . . . -29.02 150.6 0.0 OUTLIER 'General case' 0 C--N 1.345 0.379 0 O-C-N 123.924 0.426 . . . . 1.0 110.964 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.511 ' OE1' HG11 ' A' ' 127' ' ' VAL . 9.7 pt20 -162.88 153.59 16.8 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.48 -0.488 . . . . 1.0 110.372 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.52 ' O ' ' OG ' ' A' ' 131' ' ' SER . 0.4 OUTLIER -85.37 112.56 20.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.915 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.472 HG21 ' CE3' ' A' ' 114' ' ' TRP . 11.2 m -104.68 172.58 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 123.475 0.484 . . . . 1.0 109.743 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -102.21 -173.73 2.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.661 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.1 m -63.57 -36.92 85.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.714 -0.675 . . . . 1.0 110.834 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.93 -36.23 65.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.502 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.472 ' CE3' HG21 ' A' ' 110' ' ' VAL . 89.3 t90 -68.67 -44.71 73.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.906 0.384 . . . . 1.0 110.542 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.54 HD11 HD11 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -66.97 -59.28 3.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.111 0.481 . . . . 1.0 111.037 -179.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.7 m -45.17 -58.24 3.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.614 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.8 mp -60.01 -52.99 63.04 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 120.629 -0.429 . . . . 1.0 110.645 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 46.5 t -55.39 -31.21 61.63 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.696 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.23 -55.25 12.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.029 0.442 . . . . 1.0 111.872 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -77.06 -38.94 51.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.993 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 62.7 mm-40 -53.17 -48.3 68.1 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.432 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 121' ' ' GLU . 7.0 tpt180 86.61 27.35 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.733 0.645 . . . . 1.0 111.168 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.42 ' C ' ' CD ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -159.49 -171.45 3.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.445 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.1 tp -91.7 135.65 33.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.439 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 m -120.42 154.44 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.331 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 126' ' ' ASP . 54.6 p-10 -61.73 146.14 50.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.343 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 129' ' ' GLY . 9.0 t -104.64 -23.48 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 110.218 -0.29 . . . . 1.0 110.218 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.16 68.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.978 0.418 . . . . 1.0 110.499 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 165.81 -27.17 0.18 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.141 -0.783 . . . . 1.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -106.7 -3.01 21.02 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.667 0.27 . . . . 1.0 110.583 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.52 ' OG ' ' O ' ' A' ' 109' ' ' LEU . 3.2 m -104.7 125.61 50.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.976 0.417 . . . . 1.0 110.767 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.58 ' C ' ' H ' ' A' ' 134' ' ' ILE . 3.2 mp -64.63 -50.09 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.331 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.526 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 17.0 t80 65.67 -36.7 0.23 Allowed 'General case' 0 C--O 1.217 -0.615 0 O-C-N 124.278 0.986 . . . . 1.0 111.212 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.615 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 156.67 -54.65 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.311 0 O-C-N 124.663 1.227 . . . . 1.0 110.452 -178.658 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 27.5 Cg_endo . . . . . 0 C--N 1.309 -1.54 0 C-N-CA 122.331 2.021 . . . . 1.0 111.682 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.629 0.252 . . . . 1.0 110.568 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.579 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -102.17 -50.89 3.51 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.832 0.349 . . . . 1.0 110.462 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.55 ' HG ' HD11 ' A' ' 44' ' ' LEU . 2.2 tp -80.87 -0.65 39.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.733 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.6 p -66.95 -15.59 63.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.424 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.3 p -67.19 -15.56 63.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.517 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.683 HD12 ' C ' ' A' ' 44' ' ' LEU . 4.2 pp -136.21 168.84 18.64 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.387 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -116.65 118.09 31.63 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.009 0.433 . . . . 1.0 110.334 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.598 ' CB ' HD13 ' A' ' 65' ' ' ILE . . . -95.6 161.47 14.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.475 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -153.96 118.09 4.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.375 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.53 HG13 HD12 ' A' ' 53' ' ' ILE . 76.1 t -107.32 135.09 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.241 0.543 . . . . 1.0 110.379 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.549 HG12 ' H ' ' A' ' 52' ' ' GLY . 19.0 t -73.7 99.1 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.447 -0.797 . . . . 1.0 110.206 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.529 HH21 HH12 ' A' ' 99' ' ' ARG . 84.8 mtm-85 -58.34 -37.8 75.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.42 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.9 p -75.92 -17.26 59.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.539 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.549 ' H ' HG12 ' A' ' 49' ' ' VAL . . . -97.44 -59.5 0.97 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.202 -0.759 . . . . 1.0 111.202 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.53 HD12 HG13 ' A' ' 48' ' ' VAL . 2.7 mt -86.42 71.32 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.161 0.505 . . . . 1.0 110.341 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -117.03 23.38 9.97 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 110.783 -0.927 . . . . 1.0 110.783 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.65 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 4.2 ptm180 -75.03 -63.41 1.27 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.551 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 55' ' ' ARG . . . 159.93 138.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? 68.54 -42.14 0.47 Allowed 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 124.191 0.932 . . . . 1.0 110.327 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' A' ' 56' ' ' ALA . . . -65.37 -28.65 69.43 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.868 -0.605 . . . . 1.0 110.532 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.72 -39.75 80.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.395 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.99 -19.05 0.63 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.182 0.515 . . . . 1.0 110.582 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -44.18 -50.96 8.51 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.732 -0.667 . . . . 1.0 111.036 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.415 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -64.45 -43.98 92.55 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.626 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -62.41 -43.06 99.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.375 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -59.21 -26.13 64.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.272 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.701 HD11 HD21 ' A' ' 115' ' ' LEU . 80.8 mt -86.28 -23.32 6.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.366 0.603 . . . . 1.0 110.38 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 62' ' ' GLU . 68.4 t -79.06 -37.66 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 O-C-N 122.056 -0.403 . . . . 1.0 110.706 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -68.08 -38.87 82.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.127 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.492 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -68.49 -6.41 24.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.274 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.44 7.11 52.25 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.465 -1.054 . . . . 1.0 110.465 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.7 96.89 2.19 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 110.267 -1.133 . . . . 1.0 110.267 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -68.32 144.13 54.92 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.734 -0.387 . . . . 1.0 110.287 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.0 mt -91.81 135.29 34.03 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.054 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.8 m -104.61 103.62 41.06 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.378 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 76' ' ' GLN . 56.3 Cg_endo -75.17 168.35 24.9 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.397 2.065 . . . . 1.0 111.955 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.57 -7.39 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.558 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 74' ' ' PRO . 42.0 mt-30 -76.43 -9.6 58.77 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 110.151 -0.315 . . . . 1.0 110.151 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -145.35 147.87 19.25 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.69 -16.44 33.66 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.698 2.266 . . . . 1.0 111.989 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -42.82 -25.92 0.39 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.437 -0.665 . . . . 1.0 111.437 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.435 HG11 HD11 ' A' ' 100' ' ' LEU . 12.8 p -64.79 138.88 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.965 0.412 . . . . 1.0 110.471 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.99 -34.27 0.23 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.536 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -108.78 125.05 51.52 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.619 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.412 ' O ' ' O ' ' A' ' 110' ' ' VAL . 22.5 mm -118.95 106.92 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.23 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.41 HG11 HD23 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -95.08 135.29 29.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.339 -0.846 . . . . 1.0 110.088 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.54 ' C ' ' H ' ' A' ' 87' ' ' GLU . 27.7 m -135.41 155.65 37.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.412 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 88' ' ' GLY . 53.5 p-10 -71.29 22.5 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.581 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 85' ' ' VAL . 29.9 mt-10 65.96 -13.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 1.0 111.017 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -61.81 -41.76 99.66 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.074 -0.811 . . . . 1.0 111.074 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.6 ptp -103.41 154.32 19.54 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.782 0.325 . . . . 1.0 110.53 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -90.16 172.81 8.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.133 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.594 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -58.53 -54.66 44.57 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.544 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.594 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 1.3 pp20? -52.07 -40.18 60.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.866 -0.606 . . . . 1.0 110.098 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -71.97 -39.13 69.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.832 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.91 -28.65 62.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.936 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.5 mp -61.82 -46.36 89.82 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.023 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.1 mmp_? -70.91 -40.98 71.84 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.38 -0.528 . . . . 1.0 111.345 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.92 -44.93 83.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.168 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.873 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.86 -13.93 59.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.63 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.529 HH12 HH21 ' A' ' 50' ' ' ARG . 2.9 mtp180 77.93 60.91 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 123.977 0.798 . . . . 1.0 111.937 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.736 HD12 HD11 ' A' ' 98' ' ' LEU . 3.3 mt -148.71 114.02 3.73 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 120.12 -0.632 . . . . 1.0 110.116 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.519 ' HD2' HD23 ' A' ' 100' ' ' LEU . 58.5 Cg_endo -73.49 -11.45 24.47 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.128 1.886 . . . . 1.0 112.602 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 179.43 133.8 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.427 0.454 . . . . 1.0 110.207 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.604 HD22 HD13 ' A' ' 100' ' ' LEU . 10.8 mt -88.85 146.66 37.29 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.958 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.65 165.7 26.61 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 122.206 1.937 . . . . 1.0 112.311 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -43.48 140.63 3.99 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.117 1.878 . . . . 1.0 112.282 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.48 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 82.31 -64.46 4.26 Favored Glycine 0 N--CA 1.453 -0.181 0 N-CA-C 110.305 -1.118 . . . . 1.0 110.305 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.48 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -22.33 134.87 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 O-C-N 124.134 0.549 . . . . 1.0 110.868 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.484 ' O ' ' NE2' ' A' ' 108' ' ' GLN . 0.0 OUTLIER -143.69 157.52 44.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.897 0.38 . . . . 1.0 110.145 -177.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 109' ' ' LEU . 4.0 mp -108.24 121.8 45.64 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.773 -0.648 . . . . 1.0 110.778 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.471 HG13 ' NE2' ' A' ' 108' ' ' GLN . 3.1 m -108.06 -178.23 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.109 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -109.28 -176.63 3.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.501 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.4 m -60.98 -37.79 83.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.817 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.445 ' O ' HD13 ' A' ' 117' ' ' LEU . . . -56.06 -47.34 78.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.944 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.461 ' CE3' HG21 ' A' ' 110' ' ' VAL . 72.9 t90 -56.43 -37.9 70.86 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.312 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.701 HD21 HD11 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -68.56 -61.16 1.94 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.268 -0.573 . . . . 1.0 110.929 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.9 t -49.39 -52.21 30.0 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.388 -0.525 . . . . 1.0 110.47 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 113' ' ' ALA . 7.1 mp -48.93 -44.88 40.88 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.068 -0.514 . . . . 1.0 109.937 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.529 ' SG ' HG23 ' A' ' 125' ' ' VAL . 74.5 m -60.25 -43.42 96.11 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.362 -0.535 . . . . 1.0 110.832 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 65.9 mt -50.21 -57.9 6.77 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.589 -0.444 . . . . 1.0 111.386 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -73.22 -49.01 30.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.727 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 74.6 mm-40 -54.27 -48.35 71.31 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.472 -0.491 . . . . 1.0 110.362 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 121' ' ' GLU . 8.7 tpp180 79.48 39.59 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.836 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.418 ' C ' ' CD ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -165.48 -173.18 2.69 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.428 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.3 tp -82.52 122.24 27.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.014 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.529 HG23 ' SG ' ' A' ' 118' ' ' CYS . 40.2 t -97.19 154.7 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-O 121.274 0.559 . . . . 1.0 110.432 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.449 ' N ' HG12 ' A' ' 125' ' ' VAL . 64.1 t0 -69.29 115.38 8.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.394 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.461 HG23 ' N ' ' A' ' 128' ' ' ALA . 5.0 m -64.16 -39.64 86.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.607 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.461 ' N ' HG23 ' A' ' 127' ' ' VAL . . . -53.73 -25.52 19.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.506 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.69 -38.6 93.31 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.243 -0.743 . . . . 1.0 111.243 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.74 43.01 1.98 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.848 0.356 . . . . 1.0 110.883 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 127' ' ' VAL . 8.7 t -107.84 132.9 52.93 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.288 0.566 . . . . 1.0 111.182 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.57 ' C ' ' H ' ' A' ' 134' ' ' ILE . 54.8 mt -75.64 -69.23 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 CA-C-N 115.084 -0.962 . . . . 1.0 109.881 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.493 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 15.8 t80 65.83 -36.58 0.24 Allowed 'General case' 0 C--O 1.223 -0.335 0 O-C-N 124.514 1.134 . . . . 1.0 111.578 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.57 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 156.03 -55.78 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.512 0 O-C-N 125.009 1.443 . . . . 1.0 109.752 -178.279 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 30.0 Cg_endo . . . . . 0 N--CA 1.49 1.298 0 C-N-CA 122.169 1.912 . . . . 1.0 112.01 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 120.944 0.402 . . . . 1.0 110.643 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 1.1 p-90 -86.83 -49.81 7.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.094 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.581 HD13 ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -62.58 -35.11 78.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.73 0.776 . . . . 1.0 110.019 -179.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.66 -33.77 64.38 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.338 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 t -43.54 -25.67 0.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.795 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.83 167.87 18.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.343 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.401 ' O ' HG22 ' A' ' 81' ' ' THR . 27.2 ttm180 -115.94 112.65 22.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 1.0 110.167 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.474 ' HB3' HD13 ' A' ' 65' ' ' ILE . . . -92.36 165.95 12.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.49 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.529 ' CE1' ' O ' ' A' ' 73' ' ' CYS . 49.1 t60 -144.33 122.11 11.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.154 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.469 ' O ' ' NH1' ' A' ' 50' ' ' ARG . 71.5 t -110.95 133.97 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.341 -0.391 . . . . 1.0 110.31 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.2 m -71.94 134.01 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.39 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.486 ' N ' ' CD ' ' A' ' 50' ' ' ARG . 9.6 mpt_? -64.27 -40.75 96.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.546 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.483 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 7.6 p -104.19 138.19 41.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.1 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.26 -16.44 56.9 Favored Glycine 0 C--O 1.226 -0.402 0 N-CA-C 111.012 -0.835 . . . . 1.0 111.012 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.523 ' C ' ' H ' ' A' ' 55' ' ' ARG . 1.5 mm -117.75 -23.23 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.991 0.424 . . . . 1.0 110.248 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.37 35.01 0.44 Allowed Glycine 0 C--N 1.314 -0.678 0 C-N-CA 120.242 -0.98 . . . . 1.0 111.25 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.523 ' H ' ' C ' ' A' ' 53' ' ' ILE . 2.0 ptp180 -76.71 -60.96 2.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.582 0.229 . . . . 1.0 110.602 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.591 ' C ' ' H ' ' A' ' 58' ' ' ALA . . . 171.68 125.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.06 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.7 ttp85 68.74 -32.34 0.22 Allowed 'General case' 0 CA--C 1.518 -0.275 0 O-C-N 123.502 0.501 . . . . 1.0 110.323 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 56' ' ' ALA . . . -63.55 -36.5 83.99 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.63 0.728 . . . . 1.0 110.09 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 61' ' ' PHE . 12.3 pt-20 -60.36 -39.19 86.3 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.353 -0.539 . . . . 1.0 110.852 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.0 tp -42.29 -17.95 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.313 0.577 . . . . 1.0 110.854 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.559 ' N ' ' O ' ' A' ' 59' ' ' GLU . 2.3 m-85 -51.39 -51.25 56.28 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.988 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.583 ' HA ' HD12 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -61.89 -37.38 84.36 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.047 -0.353 . . . . 1.0 110.047 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -62.47 -45.83 91.24 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.095 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -64.83 -18.5 65.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.254 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 62' ' ' GLU . 61.4 mt -85.53 -56.95 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.902 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.493 HG23 ' N ' ' A' ' 67' ' ' GLN . 12.2 m -65.32 -40.57 88.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.36 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.493 ' N ' HG23 ' A' ' 66' ' ' VAL . 53.3 tt0 -53.83 -41.45 67.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.22 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -96.89 10.95 37.58 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.397 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 97.13 139.94 11.0 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.656 -0.977 . . . . 1.0 110.656 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.84 61.11 0.13 Allowed Glycine 0 N--CA 1.466 0.664 0 N-CA-C 110.475 -1.05 . . . . 1.0 110.475 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -51.68 145.51 9.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.991 0.424 . . . . 1.0 110.405 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.3 mt -81.6 155.61 25.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.788 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.529 ' O ' ' CE1' ' A' ' 47' ' ' HIS . 1.3 m -158.56 156.39 27.15 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.409 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -59.98 125.87 18.81 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.546 2.164 . . . . 1.0 111.853 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.498 ' HB3' HD11 ' A' ' 98' ' ' LEU . . . -77.55 -0.27 25.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.989 -0.551 . . . . 1.0 110.623 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -61.52 0.73 0.28 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.865 0.364 . . . . 1.0 110.623 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 75' ' ' ALA . . . -166.25 -172.44 33.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -53.5 -4.28 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.912 2.408 . . . . 1.0 111.97 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 77' ' ' GLY . . . -38.75 -61.29 1.35 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 m -106.41 -168.09 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.994 0.426 . . . . 1.0 110.202 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.479 HG23 ' ND1' ' A' ' 82' ' ' HIS . 1.8 t -140.41 -30.06 0.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.864 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.479 ' ND1' HG23 ' A' ' 81' ' ' THR . 64.3 m80 -121.08 150.9 40.5 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.618 0.247 . . . . 1.0 110.788 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.3 mt -134.21 111.0 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.3 t -93.93 144.02 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.951 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.495 ' C ' ' H ' ' A' ' 87' ' ' GLU . 32.2 m -134.3 154.7 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.569 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 88' ' ' GLY . 31.3 t70 -71.82 19.83 0.06 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.747 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 85' ' ' VAL . 0.8 OUTLIER 69.0 -39.16 0.42 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.363 -0.38 . . . . 1.0 111.048 179.037 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -38.99 -57.15 2.08 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 89' ' ' MET . 0.0 OUTLIER -87.1 160.17 18.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.81 0.338 . . . . 1.0 110.534 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -97.15 -177.05 3.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.056 0.455 . . . . 1.0 110.362 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -62.5 -47.04 85.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.846 -0.615 . . . . 1.0 110.576 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.627 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 10.6 pt-20 -53.36 -50.89 64.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.921 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.451 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 29.5 ttp180 -71.25 -42.8 68.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.118 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -43.84 -35.16 1.82 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.943 -0.572 . . . . 1.0 110.783 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.9 mp -59.93 -61.15 2.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.049 0.452 . . . . 1.0 110.884 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.556 HH21 ' C ' ' A' ' 100' ' ' LEU . 5.9 mmp_? -68.31 -22.2 64.73 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.236 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -63.82 -36.96 85.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.994 -178.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.668 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -110.9 13.99 22.13 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.784 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 63.06 59.65 1.3 Allowed 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 120.547 -0.461 . . . . 1.0 110.991 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.556 ' C ' HH21 ' A' ' 96' ' ' ARG . 13.8 tp -124.56 127.83 25.11 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.848 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.18 -44.88 11.06 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.037 1.825 . . . . 1.0 112.058 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.536 ' NE2' ' OH ' ' A' ' 91' ' ' TYR . 1.5 mm-40 176.6 136.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.228 0.537 . . . . 1.0 110.578 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.7 mt -41.91 116.21 1.63 Allowed Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 115.423 -0.808 . . . . 1.0 111.45 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -71.46 141.72 39.13 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.703 1.602 . . . . 1.0 111.922 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -40.77 93.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.451 2.101 . . . . 1.0 112.63 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.61 -56.55 0.59 Allowed Glycine 0 N--CA 1.465 0.585 0 N-CA-C 111.156 -0.778 . . . . 1.0 111.156 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.73 160.28 32.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.857 0.361 . . . . 1.0 110.947 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -149.16 156.6 42.42 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.44 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 131' ' ' SER . 1.3 mt -92.88 111.63 23.31 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.953 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.641 HG21 ' CE3' ' A' ' 114' ' ' TRP . 4.1 m -103.83 170.3 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -101.84 171.04 7.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.129 0.49 . . . . 1.0 111.607 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.2 m -56.05 -35.11 66.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.38 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.6 -38.18 86.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.729 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.641 ' CE3' HG21 ' A' ' 110' ' ' VAL . 74.8 t90 -60.47 -49.89 75.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.369 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.505 HD23 ' CD1' ' A' ' 61' ' ' PHE . 34.9 tp -63.05 -53.77 48.52 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.194 -0.603 . . . . 1.0 110.561 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.9 t -50.81 -46.67 59.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.3 mt -51.31 -48.77 62.25 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.356 -0.538 . . . . 1.0 109.813 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 122' ' ' ARG . 55.9 m -51.75 -34.89 41.32 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 38.9 mt -70.31 -54.53 12.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.002 0.43 . . . . 1.0 110.519 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -65.62 -38.35 89.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.231 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 80.7 mm-40 -79.79 -42.81 23.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.15 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 118' ' ' CYS . 5.2 tpp85 82.16 40.07 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.856 -0.611 . . . . 1.0 111.114 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -169.61 -173.44 1.65 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.342 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.6 tt -92.2 121.56 33.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.607 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.464 HG23 ' CD1' ' A' ' 114' ' ' TRP . 2.7 m -103.69 151.77 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.244 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 126' ' ' ASP . 48.4 p30 -66.78 147.71 52.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.24 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.578 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 31.3 m -101.29 -136.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.383 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 127' ' ' VAL . . . 74.59 -60.69 0.51 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.326 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.05 -53.55 33.01 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -69.98 -42.52 73.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.934 0.397 . . . . 1.0 110.502 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 109' ' ' LEU . 15.1 p -58.56 153.53 16.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.628 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 134' ' ' ILE . 2.9 mp -90.08 -57.46 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.238 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.516 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 17.6 t80 65.12 -35.63 0.19 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.263 0.977 . . . . 1.0 111.433 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.59 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 155.26 -56.06 0.0 OUTLIER Pre-proline 0 C--N 1.346 0.441 0 O-C-N 124.84 1.338 . . . . 1.0 109.862 -178.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.3 Cg_endo . . . . . 0 N--CA 1.49 1.301 0 C-N-CA 122.212 1.941 . . . . 1.0 112.012 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.856 0.36 . . . . 1.0 110.777 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.612 ' CZ2' ' ND1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -97.16 -33.87 11.33 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.167 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.448 ' HG ' ' CE3' ' A' ' 40' ' ' TRP . 29.1 mt -83.03 -0.86 50.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.237 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.3 p -58.55 -41.8 86.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.662 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.8 m -61.58 -60.82 3.1 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.25 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 pp -74.94 167.4 21.97 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -124.51 121.75 35.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 1.0 111.023 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.502 ' HB3' HD13 ' A' ' 65' ' ' ILE . . . -103.63 124.85 49.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.865 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -111.11 120.58 42.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.247 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.589 ' H ' HD22 ' A' ' 72' ' ' LEU . 51.3 t -111.1 132.39 59.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.967 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.743 HG23 ' H ' ' A' ' 53' ' ' ILE . 27.0 m -78.58 84.09 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.434 0.635 . . . . 1.0 110.27 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.621 HH11 HD13 ' A' ' 72' ' ' LEU . 76.1 mtm-85 -54.52 -43.67 72.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.464 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.443 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 66.7 p -62.14 -22.92 66.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.323 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.03 -74.42 1.11 Allowed Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.258 -0.737 . . . . 1.0 111.258 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.743 ' H ' HG23 ' A' ' 49' ' ' VAL . 5.3 mt -53.37 122.16 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 CA-C-O 121.942 0.877 . . . . 1.0 109.978 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -174.64 25.97 0.07 OUTLIER Glycine 0 C--N 1.302 -1.326 0 CA-C-N 114.315 -1.311 . . . . 1.0 112.066 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -75.31 -47.32 28.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.829 0.347 . . . . 1.0 111.305 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -168.84 -114.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.932 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.482 ' CD ' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -63.5 -19.58 64.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.334 -0.393 . . . . 1.0 110.677 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.403 ' CB ' HG23 ' A' ' 53' ' ' ILE . . . -40.61 -47.54 2.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.056 0.455 . . . . 1.0 110.639 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -68.37 -37.48 80.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.183 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 57' ' ' ARG . 4.9 tp -48.77 -18.38 0.26 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.196 0.522 . . . . 1.0 111.019 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.421 ' HB3' HD13 ' A' ' 115' ' ' LEU . 20.4 m-85 -69.38 -43.35 73.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.924 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.597 ' HA ' HD12 ' A' ' 65' ' ' ILE . 9.5 pt-20 -58.48 -39.51 80.17 Favored 'General case' 0 C--N 1.317 -0.83 0 O-C-N 123.356 0.41 . . . . 1.0 110.494 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.434 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 41.1 mttp -63.44 -40.36 96.93 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.575 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -65.66 -18.88 65.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.711 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.597 HD12 ' HA ' ' A' ' 62' ' ' GLU . 71.0 mt -85.29 -62.37 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.079 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.7 m -45.09 -35.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.729 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -65.57 -46.09 80.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.91 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.612 ' ND1' ' CZ2' ' A' ' 40' ' ' TRP . 1.3 m170 -97.7 23.67 7.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.436 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 83.44 -179.4 52.55 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.134 -0.787 . . . . 1.0 111.134 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 71' ' ' GLN . . . 74.87 27.73 64.14 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.891 -0.883 . . . . 1.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -44.18 170.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.835 0.35 . . . . 1.0 110.733 -179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.621 HD13 HH11 ' A' ' 50' ' ' ARG . 40.6 mt -73.46 147.26 44.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.249 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.44 ' O ' ' CG2' ' A' ' 80' ' ' VAL . 0.8 OUTLIER -161.59 96.26 1.3 Allowed Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.47 147.47 12.59 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.497 2.131 . . . . 1.0 112.232 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 77' ' ' GLY . . . -51.47 -46.8 63.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.717 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.667 ' CD ' ' H ' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -65.13 1.37 1.01 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.125 0.488 . . . . 1.0 110.29 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 75' ' ' ALA . . . -93.31 -117.78 2.66 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 110.772 -0.931 . . . . 1.0 110.772 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.46 -57.65 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.528 2.152 . . . . 1.0 112.381 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.528 ' O ' HG12 ' A' ' 80' ' ' VAL . . . -162.78 -73.57 0.02 OUTLIER Glycine 0 C--O 1.224 -0.473 0 C-N-CA 120.681 -0.771 . . . . 1.0 111.497 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 79' ' ' GLY . 0.4 OUTLIER 74.83 162.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 123.87 0.394 . . . . 1.0 110.256 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.53 -30.48 0.11 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.251 -0.432 . . . . 1.0 111.274 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -111.84 141.81 45.01 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.153 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.1 mp -132.74 108.32 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.973 -0.558 . . . . 1.0 109.784 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.528 HG11 HD12 ' A' ' 115' ' ' LEU . 12.2 t -92.96 135.25 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 115.802 -0.636 . . . . 1.0 111.043 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.552 ' C ' ' H ' ' A' ' 87' ' ' GLU . 30.0 m -132.34 159.26 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.475 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 88' ' ' GLY . 47.4 p30 -67.05 12.31 0.08 Allowed 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.465 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.552 ' H ' ' C ' ' A' ' 85' ' ' VAL . 7.9 mt-10 70.5 -22.95 0.17 Allowed 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.291 0.369 . . . . 1.0 110.842 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -58.74 -46.63 93.15 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.686 -0.966 . . . . 1.0 110.686 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.2 ptp -88.85 145.04 25.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.848 0.356 . . . . 1.0 110.178 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -80.08 173.19 12.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.385 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.615 ' CG ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.19 -53.02 63.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.561 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.615 ' N ' ' CG ' ' A' ' 91' ' ' TYR . 14.2 pt-20 -53.47 -41.44 66.18 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 123.55 0.531 . . . . 1.0 110.521 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.716 ' HE ' ' CZ ' ' A' ' 96' ' ' ARG . 46.5 ttt180 -69.64 -40.15 76.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.082 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.48 ' O ' ' CD2' ' A' ' 98' ' ' LEU . . . -51.5 -26.48 8.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.938 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.1 mp -57.15 -41.04 78.41 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.735 -0.603 . . . . 1.0 110.802 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.716 ' CZ ' ' HE ' ' A' ' 93' ' ' ARG . 23.3 ptt180 -63.39 -34.18 77.17 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.413 -0.515 . . . . 1.0 109.986 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.445 ' HA ' HD13 ' A' ' 97' ' ' LEU . 3.3 mm? -60.53 -47.9 84.13 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.794 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.484 ' O ' ' NE2' ' A' ' 76' ' ' GLN . 0.1 OUTLIER -93.14 16.36 13.16 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.742 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 41.97 56.2 3.56 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.527 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.443 HD13 ' HB3' ' A' ' 75' ' ' ALA . 4.8 tp -132.2 113.9 14.75 Favored Pre-proline 0 C--O 1.219 -0.526 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.597 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.16 2.07 5.96 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.361 2.041 . . . . 1.0 112.723 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 179.96 142.61 0.16 Allowed 'General case' 0 C--O 1.238 0.466 0 O-C-N 123.429 0.455 . . . . 1.0 110.742 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.3 mm? -84.8 145.0 43.05 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-O 120.888 0.375 . . . . 1.0 111.119 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' A' ' 106' ' ' GLY . 44.2 Cg_endo -69.18 161.99 43.62 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.353 2.035 . . . . 1.0 111.88 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.97 23.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.874 2.383 . . . . 1.0 111.974 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 104' ' ' PRO . . . -161.5 63.6 0.27 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -172.82 149.33 1.95 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.655 0.264 . . . . 1.0 110.469 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -139.32 156.05 47.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.063 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.474 ' H ' HD12 ' A' ' 109' ' ' LEU . 1.9 mp -101.65 113.27 26.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.628 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.734 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.5 m -107.13 163.99 4.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.137 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm -93.71 -172.75 2.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.685 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.2 t -65.35 -41.18 94.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.985 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.63 -51.44 48.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.661 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.734 ' CE3' HG21 ' A' ' 110' ' ' VAL . 63.5 t90 -50.55 -49.58 55.65 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.484 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.528 HD12 HG11 ' A' ' 84' ' ' VAL . 2.0 tt -57.95 -50.97 71.56 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.32 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.7 t -48.54 -51.96 24.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.06 0.457 . . . . 1.0 110.08 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.1 mp -57.44 -50.98 71.27 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.448 -0.501 . . . . 1.0 110.259 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.625 ' SG ' ' CE2' ' A' ' 114' ' ' TRP . 56.3 m -44.35 -27.06 0.39 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.049 0.452 . . . . 1.0 110.099 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 80.2 mt -83.36 -47.68 11.2 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.564 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -68.44 -54.2 18.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.472 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 122' ' ' ARG . 78.4 mt-10 -77.86 5.4 9.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.508 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.456 ' C ' ' O ' ' A' ' 121' ' ' GLU . 81.4 mtt85 28.63 44.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.52 0.513 . . . . 1.0 111.257 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.445 ' CG ' ' O ' ' A' ' 121' ' ' GLU . 0.9 OUTLIER -159.99 167.83 27.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.532 -179.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 tp -74.08 100.08 3.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.046 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.508 HG13 ' CD1' ' A' ' 114' ' ' TRP . 0.3 OUTLIER -80.44 154.93 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 121.252 0.548 . . . . 1.0 110.091 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 126' ' ' ASP . 14.6 p-10 -59.81 117.73 5.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.434 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.562 HG23 ' N ' ' A' ' 128' ' ' ALA . 13.0 m -68.03 -44.57 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.691 -0.686 . . . . 1.0 111.077 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.562 ' N ' HG23 ' A' ' 127' ' ' VAL . . . -43.85 -18.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.685 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . -69.9 -38.39 75.32 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.344 -0.702 . . . . 1.0 111.344 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -129.48 13.76 6.02 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.625 0.25 . . . . 1.0 110.679 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.5 p -73.16 136.4 44.78 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.848 0.356 . . . . 1.0 110.69 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.569 ' C ' ' H ' ' A' ' 134' ' ' ILE . 59.1 mt -74.52 -66.93 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.875 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.548 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 25.1 t80 66.26 -36.14 0.24 Allowed 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 123.878 0.736 . . . . 1.0 111.42 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.617 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 155.72 -55.3 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 O-C-N 124.768 1.293 . . . . 1.0 110.271 -178.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.3 Cg_endo . . . . . 0 C--N 1.31 -1.46 0 C-N-CA 122.498 2.132 . . . . 1.0 111.994 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 120.88 0.371 . . . . 1.0 110.539 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.601 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -101.07 -38.22 8.25 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.355 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.507 HD23 HD11 ' A' ' 44' ' ' LEU . 6.4 mt -76.49 -12.39 60.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.886 0.374 . . . . 1.0 110.9 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t -69.69 -17.78 63.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.996 0.427 . . . . 1.0 110.402 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.7 t -74.1 -13.9 60.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.107 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.507 HD11 HD23 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -136.42 168.99 18.4 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.993 0.425 . . . . 1.0 110.046 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.494 ' H ' ' HB ' ' A' ' 81' ' ' THR . 93.5 mtt180 -114.99 124.1 50.8 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.602 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.723 ' O ' HD13 ' A' ' 72' ' ' LEU . . . -107.44 155.08 20.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.828 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.627 ' CE1' ' NH1' ' A' ' 50' ' ' ARG . 25.0 t-80 -155.25 123.32 5.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.528 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.2 m -99.52 145.37 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.849 0.357 . . . . 1.0 110.243 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.42 ' HB ' HD23 ' A' ' 97' ' ' LEU . 27.2 m -73.68 143.94 13.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.579 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.627 ' NH1' ' CE1' ' A' ' 47' ' ' HIS . 8.4 mpt_? -63.33 -42.62 98.98 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.857 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 p -100.99 136.28 41.09 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.946 0.403 . . . . 1.0 110.437 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.67 -19.85 53.01 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.048 -0.821 . . . . 1.0 111.048 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.632 HG22 ' O ' ' A' ' 53' ' ' ILE . 40.6 mm -127.51 3.81 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.096 0.474 . . . . 1.0 110.586 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.59 26.29 24.52 Favored Glycine 0 N--CA 1.467 0.724 0 N-CA-C 110.39 -1.084 . . . . 1.0 110.39 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.683 HH22 HH21 ' A' ' 57' ' ' ARG . 16.2 mtm-85 -63.25 -47.2 83.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 1.0 110.723 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 55' ' ' ARG . . . 165.52 -62.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.171 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.683 HH21 HH22 ' A' ' 55' ' ' ARG . 5.1 ppt_? -92.04 -25.56 18.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.598 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.44 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . . . -62.64 -37.87 88.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.475 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 61' ' ' PHE . 3.1 pt-20 -65.32 -39.96 93.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.295 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 tp -44.19 -16.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.228 0.537 . . . . 1.0 110.886 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 59' ' ' GLU . 6.6 m-85 -58.91 -43.54 91.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.657 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.476 ' HA ' HD12 ' A' ' 65' ' ' ILE . 13.8 pt-20 -67.2 -42.61 83.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.988 0.423 . . . . 1.0 111.063 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.456 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 95.2 mttt -63.86 -44.62 92.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.19 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -56.0 -37.58 69.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.806 -0.634 . . . . 1.0 109.995 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.91 HD11 HD11 ' A' ' 115' ' ' LEU . 67.8 mt -63.62 -44.43 98.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.667 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.406 ' CG2' HD23 ' A' ' 72' ' ' LEU . 73.7 t -59.37 -44.74 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.812 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -55.97 -35.62 66.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.69 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.444 ' N ' ' CD2' ' A' ' 68' ' ' HIS . 1.9 m170 -103.99 16.55 26.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.136 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 90.58 153.18 28.65 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.868 -0.893 . . . . 1.0 110.868 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.0 51.43 0.6 Allowed Glycine 0 N--CA 1.468 0.786 0 N-CA-C 110.058 -1.217 . . . . 1.0 110.058 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -43.46 143.23 0.96 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 1.0 110.401 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 46' ' ' ALA . 3.0 mm? -80.07 136.39 36.55 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.059 0.457 . . . . 1.0 110.143 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 79' ' ' GLY . 69.3 m -141.61 103.45 5.9 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.971 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.489 ' O ' ' N ' ' A' ' 77' ' ' GLY . 58.7 Cg_endo -73.94 167.59 26.85 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.712 1.608 . . . . 1.0 111.747 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.487 ' HB2' HD12 ' A' ' 100' ' ' LEU . . . -44.09 -48.31 8.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.531 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -67.75 -19.64 65.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.473 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 74' ' ' PRO . . . -78.77 -165.89 29.5 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.252 -0.739 . . . . 1.0 111.252 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.33 -42.28 61.46 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.751 2.301 . . . . 1.0 112.351 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 73' ' ' CYS . . . 170.19 -161.85 35.01 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.024 -0.83 . . . . 1.0 111.024 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -169.8 138.83 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.494 ' HB ' ' H ' ' A' ' 45' ' ' ARG . 95.4 m -104.21 -47.99 3.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.781 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -124.94 155.05 40.2 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.95 0.405 . . . . 1.0 111.087 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 83' ' ' ILE . 4.4 mp -134.34 113.19 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.056 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.655 HG21 HD12 ' A' ' 115' ' ' LEU . 59.2 t -93.43 134.96 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.362 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.81 HG23 ' H ' ' A' ' 87' ' ' GLU . 3.7 m -127.21 163.68 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.646 -0.707 . . . . 1.0 110.708 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.416 ' HA ' HD11 ' A' ' 53' ' ' ILE . 8.5 p-10 -69.56 19.0 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.229 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.81 ' H ' HG23 ' A' ' 85' ' ' VAL . 12.9 mt-10 70.02 -51.76 0.64 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.51 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.14 -28.52 61.43 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.699 -0.961 . . . . 1.0 110.699 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.6 tpp -72.66 140.45 47.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.051 0.453 . . . . 1.0 110.823 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -88.18 153.63 21.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.769 -0.651 . . . . 1.0 109.67 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -56.26 -45.87 79.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.015 179.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.566 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 11.6 pt-20 -53.92 -49.72 68.01 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.621 -0.432 . . . . 1.0 111.135 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.484 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 21.9 ttm105 -70.51 -38.01 74.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.085 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.482 ' O ' HD23 ' A' ' 98' ' ' LEU . . . -46.56 -43.37 17.07 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 116.048 -0.523 . . . . 1.0 111.923 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.477 ' CD1' HD11 ' A' ' 109' ' ' LEU . 4.8 mp -58.3 -39.92 80.62 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.774 -0.579 . . . . 1.0 110.773 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.53 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 84.3 mmt-85 -69.24 -29.42 67.34 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.742 -0.383 . . . . 1.0 110.947 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.42 HD23 ' HB ' ' A' ' 49' ' ' VAL . 9.0 mp -65.26 -40.98 94.69 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.379 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -109.51 15.58 22.85 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.024 0.44 . . . . 1.0 110.655 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.53 ' NH1' ' O ' ' A' ' 96' ' ' ARG . 60.7 mmt-85 50.38 57.44 6.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.544 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' A' ' 75' ' ' ALA . 12.8 tp -107.24 115.07 60.4 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 121.075 -0.25 . . . . 1.0 110.458 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.22 -48.01 20.03 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.839 1.693 . . . . 1.0 112.384 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -175.98 137.51 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.645 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 103' ' ' LEU . 52.8 mt -37.06 100.76 0.21 Allowed Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.267 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.442 ' HD3' HD21 ' A' ' 100' ' ' LEU . 86.4 Cg_exo -43.18 157.44 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.099 1.866 . . . . 1.0 112.176 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.91 85.37 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.509 2.139 . . . . 1.0 111.898 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 137.33 -36.19 1.98 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.154 -0.778 . . . . 1.0 111.154 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.12 153.05 32.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.602 0.239 . . . . 1.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -144.23 155.48 43.89 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.477 HD11 ' CD1' ' A' ' 95' ' ' LEU . 0.8 OUTLIER -88.12 114.5 24.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.463 179.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.468 HG21 ' CE3' ' A' ' 114' ' ' TRP . 2.5 m -110.63 171.31 3.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 123.759 0.662 . . . . 1.0 109.478 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.555 ' NZ ' ' O ' ' A' ' 130' ' ' PHE . 30.1 mtmm -104.82 -178.49 3.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.832 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.1 t -60.13 -39.24 85.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.099 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.07 -49.59 60.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.523 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.518 ' CD1' HG12 ' A' ' 127' ' ' VAL . 75.0 t90 -56.18 -46.33 79.42 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.2 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.91 HD11 HD11 ' A' ' 65' ' ' ILE . 1.1 tt -67.43 -55.98 11.46 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.051 0.453 . . . . 1.0 110.377 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -41.37 -57.08 2.28 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.696 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.5 mp -58.64 -47.12 85.51 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 123' ' ' ARG . 0.5 OUTLIER -44.92 -42.62 8.28 Favored 'General case' 0 C--O 1.214 -0.766 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.725 177.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.48 -49.44 69.07 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 119.676 -0.81 . . . . 1.0 110.94 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -71.59 -51.91 20.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.971 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -70.62 -39.08 73.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.799 -0.637 . . . . 1.0 111.431 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 118' ' ' CYS . 67.1 mtt85 63.99 54.38 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.269 0.557 . . . . 1.0 111.133 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.894 ' NH2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -152.1 -164.72 2.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.239 -0.891 . . . . 1.0 111.125 -179.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.8 tp -119.94 91.67 3.6 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.593 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.894 HG22 ' NH2' ' A' ' 123' ' ' ARG . 29.0 m -81.2 153.32 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.952 0.406 . . . . 1.0 110.158 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -69.97 121.89 18.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.21 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 129' ' ' GLY . 17.6 m -72.44 -126.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.886 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.438 ' N ' HG23 ' A' ' 127' ' ' VAL . . . 63.81 -63.3 0.14 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 1.0 110.71 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . -59.53 -46.21 94.33 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.616 -0.994 . . . . 1.0 110.616 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.555 ' O ' ' NZ ' ' A' ' 111' ' ' LYS . 60.0 m-85 -86.54 -7.67 58.18 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.948 -0.389 . . . . 1.0 109.948 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.2 p -78.66 157.58 28.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.925 0.393 . . . . 1.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.575 ' C ' ' H ' ' A' ' 134' ' ' ILE . 62.2 mt -93.37 -59.67 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.406 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.475 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 16.3 t80 63.62 -32.97 0.12 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.941 -1.027 . . . . 1.0 111.904 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.575 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.6 OUTLIER 152.46 -55.64 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 124.848 1.259 . . . . 1.0 109.634 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 34.6 Cg_endo . . . . . 0 N--CA 1.496 1.638 0 C-N-CA 121.783 1.656 . . . . 1.0 112.074 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 N--CA 1.464 0.226 0 CA-C-O 120.856 0.36 . . . . 1.0 110.387 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.569 ' CZ2' ' NE ' ' A' ' 122' ' ' ARG . 3.6 p-90 -140.26 -38.46 0.45 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.392 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.99 -6.23 59.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.762 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.6 m -64.01 -33.03 74.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.903 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.499 ' OG ' HD23 ' A' ' 44' ' ' LEU . 3.9 p -57.16 -43.45 82.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.939 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.499 HD23 ' OG ' ' A' ' 43' ' ' SER . 0.1 OUTLIER -100.59 107.87 19.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.125 0.488 . . . . 1.0 110.732 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.553 ' O ' HG22 ' A' ' 81' ' ' THR . 2.7 mpt_? -68.72 110.21 4.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.519 -0.764 . . . . 1.0 109.338 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.626 ' HB3' HG21 ' A' ' 65' ' ' ILE . . . -91.2 162.83 14.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.875 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.691 ' HB2' HG11 ' A' ' 80' ' ' VAL . 85.0 t60 -148.08 131.92 17.05 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.945 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.733 HG12 HG21 ' A' ' 53' ' ' ILE . 1.5 t -121.98 116.49 49.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.35 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.462 ' O ' HG22 ' A' ' 53' ' ' ILE . 15.7 t -56.95 81.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.717 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 48' ' ' VAL . 33.1 ptt-85 -70.27 -8.3 49.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.779 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.6 p -92.89 0.43 57.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.61 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 54' ' ' GLY . . . -147.44 -46.67 0.03 OUTLIER Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.123 -0.791 . . . . 1.0 111.123 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.733 HG21 HG12 ' A' ' 48' ' ' VAL . 3.8 tt -64.24 3.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.774 0.321 . . . . 1.0 110.422 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 52' ' ' GLY . . . -70.24 50.99 0.78 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 53' ' ' ILE . 0.3 OUTLIER -70.38 -43.66 69.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.803 0.335 . . . . 1.0 110.236 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -177.21 -81.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.035 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 60' ' ' LEU . 8.9 ptm180 -95.47 -21.12 18.51 Favored 'General case' 0 C--O 1.207 -1.138 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.923 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.59 -37.05 17.0 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.89 -0.724 . . . . 1.0 111.033 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -51.55 -26.1 7.99 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.559 -0.456 . . . . 1.0 110.804 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.66 HD13 ' HB2' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -63.64 -22.87 67.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.201 0.524 . . . . 1.0 110.96 -179.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.509 ' HB2' HG11 ' A' ' 48' ' ' VAL . 21.7 m-85 -52.62 -46.71 67.17 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.923 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.695 ' HA ' HD12 ' A' ' 65' ' ' ILE . 5.3 pt-20 -65.71 -36.01 82.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.833 0.349 . . . . 1.0 110.645 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.66 ' HB2' HD13 ' A' ' 60' ' ' LEU . 5.7 mptp? -62.79 -48.67 78.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.19 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.434 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 62.4 mt-30 -60.38 -37.75 81.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.931 -0.577 . . . . 1.0 109.711 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.695 HD12 ' HA ' ' A' ' 62' ' ' GLU . 57.8 mt -61.6 -48.08 90.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.095 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.6 t -62.8 -46.54 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 120.583 -0.447 . . . . 1.0 110.297 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 63' ' ' LYS . 1.2 mp0 -67.32 -35.03 78.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.24 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.434 ' CG ' ' O ' ' A' ' 64' ' ' GLN . 61.7 m170 -88.19 0.28 56.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.542 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 98.72 147.27 21.83 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.72 -0.952 . . . . 1.0 110.72 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.47 55.53 0.71 Allowed Glycine 0 N--CA 1.464 0.554 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -40.19 145.13 0.17 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.679 0.276 . . . . 1.0 110.676 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.425 ' C ' ' SG ' ' A' ' 73' ' ' CYS . 8.8 mt -74.54 140.38 44.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.258 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.638 ' O ' HG13 ' A' ' 80' ' ' VAL . 2.6 m -145.12 87.87 7.01 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.233 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.16 -150.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.808 2.339 . . . . 1.0 111.849 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.53 -26.21 68.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.454 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -64.04 -20.56 66.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.52 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.1 -166.64 24.93 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.77 -43.47 57.62 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.71 2.274 . . . . 1.0 112.072 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . 131.48 31.17 0.52 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.896 -0.882 . . . . 1.0 110.896 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.691 HG11 ' HB2' ' A' ' 47' ' ' HIS . 31.1 m 37.44 -158.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 120.758 0.313 . . . . 1.0 110.904 179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.667 HG23 ' HD1' ' A' ' 82' ' ' HIS . 2.5 t -142.04 -18.44 0.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.706 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.806 ' O ' HD13 ' A' ' 83' ' ' ILE . 68.7 m80 -130.98 160.03 35.73 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.022 0.439 . . . . 1.0 110.744 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.806 HD13 ' O ' ' A' ' 82' ' ' HIS . 5.1 mm -138.15 112.69 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.702 -0.681 . . . . 1.0 111.473 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.734 HG21 HD23 ' A' ' 115' ' ' LEU . 5.1 t -94.59 129.78 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.441 ' C ' ' H ' ' A' ' 87' ' ' GLU . 16.0 m -132.02 167.02 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.392 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 88' ' ' GLY . 49.1 t0 -77.91 30.06 0.17 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.219 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 85' ' ' VAL . 31.3 mt-10 64.72 -66.65 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.873 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . -48.64 -17.33 0.76 Allowed Glycine 0 CA--C 1.52 0.381 0 N-CA-C 110.871 -0.892 . . . . 1.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.487 ' SD ' ' CD1' ' A' ' 97' ' ' LEU . 3.4 ttm -77.4 147.37 36.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.122 0.486 . . . . 1.0 110.495 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 91' ' ' TYR . 92.1 m-20 -100.64 142.75 31.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.591 -0.731 . . . . 1.0 109.855 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.601 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -36.73 -56.4 0.84 Allowed 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.285 -179.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.601 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 5.0 pt-20 -56.1 -59.57 4.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.773 -0.648 . . . . 1.0 109.953 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.512 ' H ' ' CG ' ' A' ' 92' ' ' GLU . 79.0 ttt180 -42.51 -42.22 3.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.857 0.36 . . . . 1.0 110.22 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 91' ' ' TYR . . . -55.88 -48.61 75.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.73 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 99' ' ' ARG . 7.9 mp -57.48 -44.38 84.85 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.325 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.455 ' C ' ' CD ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -62.24 -42.43 99.31 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.807 179.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.487 ' CD1' ' SD ' ' A' ' 89' ' ' MET . 24.8 mt -63.19 -51.75 65.08 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.737 -0.385 . . . . 1.0 111.228 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.884 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -77.73 -18.5 56.47 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.173 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 95' ' ' LEU . 3.2 mtp180 76.35 63.54 0.05 OUTLIER 'General case' 0 CA--C 1.509 -0.608 0 O-C-N 124.469 1.106 . . . . 1.0 111.685 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.598 ' HB2' HD11 ' A' ' 98' ' ' LEU . 4.7 tp -136.45 118.3 11.61 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 120.465 -0.494 . . . . 1.0 111.089 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.98 -38.62 56.55 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.919 1.746 . . . . 1.0 112.067 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -163.19 136.48 5.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.609 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.501 HD11 HD21 ' A' ' 109' ' ' LEU . 11.8 mt -75.99 148.8 82.03 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.024 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.34 167.75 17.81 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.033 1.822 . . . . 1.0 112.467 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -56.1 146.35 70.78 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.497 2.131 . . . . 1.0 112.296 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.05 -19.52 6.5 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.901 -0.879 . . . . 1.0 110.901 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.97 151.76 34.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 1.0 110.428 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.634 HE21 ' CD2' ' A' ' 82' ' ' HIS . 5.9 pt20 -156.73 128.86 7.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.365 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.501 HD21 HD11 ' A' ' 103' ' ' LEU . 1.9 mp -84.11 127.64 34.04 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.711 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.495 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.8 m -121.31 176.14 4.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 O-C-N 123.723 0.639 . . . . 1.0 109.973 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -106.75 -176.57 3.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.738 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.478 ' OG ' ' CE2' ' A' ' 61' ' ' PHE . 6.8 t -60.05 -41.36 92.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.57 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.32 -48.24 62.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.611 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.505 ' CZ2' ' SG ' ' A' ' 118' ' ' CYS . 78.3 t90 -54.19 -41.1 68.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.002 0.429 . . . . 1.0 110.259 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.734 HD23 HG21 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -62.04 -55.56 27.95 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.129 -179.435 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 80.1 p -49.21 -42.87 41.6 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.055 0.455 . . . . 1.0 109.828 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.35 -55.74 22.05 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.426 -0.51 . . . . 1.0 109.896 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.505 ' SG ' ' CZ2' ' A' ' 114' ' ' TRP . 0.0 OUTLIER -44.63 -33.68 1.9 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 -179.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 94.0 mt -77.05 -51.33 11.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.568 -0.742 . . . . 1.0 111.184 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -65.56 -49.14 69.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.231 -0.441 . . . . 1.0 111.314 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.433 ' O ' ' CG ' ' A' ' 123' ' ' ARG . 65.2 mm-40 -77.48 1.44 19.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.282 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.569 ' NE ' ' CZ2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 38.79 32.24 0.05 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.585 179.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 121' ' ' GLU . 4.5 ppt_? -158.29 174.32 15.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.254 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.6 tt -82.15 126.17 31.74 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.943 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.0 m -108.96 154.74 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.539 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 40.3 p-10 -62.09 144.33 55.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.042 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.6 m -103.03 11.17 8.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.509 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.64 53.35 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.609 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.68 -34.47 0.12 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.089 -0.804 . . . . 1.0 111.089 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -99.74 5.92 45.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.022 0.439 . . . . 1.0 110.655 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.6 t -99.15 141.28 32.12 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.356 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.519 ' C ' ' H ' ' A' ' 134' ' ' ILE . 54.7 mt -88.18 -55.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-N 115.635 -0.711 . . . . 1.0 110.205 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.522 ' O ' HG12 ' A' ' 134' ' ' ILE . 10.9 t80 65.71 -40.6 0.32 Allowed 'General case' 0 C--O 1.221 -0.426 0 O-C-N 124.375 1.047 . . . . 1.0 111.461 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.572 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 159.38 -54.55 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 O-C-N 124.665 1.228 . . . . 1.0 109.915 -178.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 36.5 Cg_endo . . . . . 0 N--CA 1.491 1.351 0 C-N-CA 122.15 1.9 . . . . 1.0 111.929 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.689 0.281 . . . . 1.0 110.307 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.599 ' CH2' HD12 ' A' ' 41' ' ' LEU . 1.6 p-90 -123.45 -50.62 1.87 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.547 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.599 HD12 ' CH2' ' A' ' 40' ' ' TRP . 1.3 mt -67.13 -21.75 65.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.757 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.0 t -61.37 -18.57 59.34 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.326 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.431 ' OG ' HD23 ' A' ' 44' ' ' LEU . 24.7 p -65.32 -15.0 62.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.333 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.441 ' N ' HD23 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -138.55 168.35 19.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.308 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -119.55 115.58 24.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.604 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.498 ' CB ' HD13 ' A' ' 65' ' ' ILE . . . -95.62 168.18 10.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.114 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -153.91 120.06 5.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.629 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.455 ' CG1' HG21 ' A' ' 53' ' ' ILE . 87.1 t -100.05 135.9 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.09 0.471 . . . . 1.0 110.252 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 49' ' ' VAL . 32.3 m -86.71 125.04 40.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.685 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.401 ' HG3' HH11 ' A' ' 50' ' ' ARG . 18.2 mmt85 -74.53 -39.11 62.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.745 -0.661 . . . . 1.0 111.246 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.751 ' OG1' HD11 ' A' ' 97' ' ' LEU . 45.1 p -59.51 -22.51 61.74 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.617 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . -115.85 -91.58 1.71 Allowed Glycine 0 N--CA 1.465 0.603 0 N-CA-C 110.738 -0.945 . . . . 1.0 110.738 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.485 ' C ' ' H ' ' A' ' 55' ' ' ARG . 4.1 mm -40.23 -27.6 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.741 0.305 . . . . 1.0 110.806 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 52' ' ' GLY . . . -69.81 41.64 0.44 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.801 -0.92 . . . . 1.0 110.801 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.485 ' H ' ' C ' ' A' ' 53' ' ' ILE . 1.9 ptp180 -80.11 -61.14 2.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.835 0.35 . . . . 1.0 110.953 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.401 ' H ' ' HG3' ' A' ' 55' ' ' ARG . . . -150.28 -89.87 0.07 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.761 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -92.71 -24.62 18.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.03 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.44 -16.83 0.64 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.571 0.701 . . . . 1.0 110.05 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 61' ' ' PHE . 21.1 pt-20 -73.29 -34.84 65.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.154 0.502 . . . . 1.0 111.207 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 tp -46.29 -17.31 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.392 0.615 . . . . 1.0 110.866 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.475 ' N ' ' O ' ' A' ' 59' ' ' GLU . 1.8 m-85 -57.22 -51.11 70.64 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.802 -0.636 . . . . 1.0 112.073 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.613 ' HA ' HD12 ' A' ' 65' ' ' ILE . 1.5 pt-20 -58.15 -36.99 73.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.111 0.482 . . . . 1.0 110.563 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.46 ' HG2' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -61.86 -44.75 96.19 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.244 0.545 . . . . 1.0 110.287 -178.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -62.76 -18.7 63.05 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.256 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.613 HD12 ' HA ' ' A' ' 62' ' ' GLU . 92.3 mt -86.29 -56.19 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.961 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.428 HG12 ' HA ' ' A' ' 71' ' ' GLN . 3.4 m -62.81 -38.6 82.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.913 0.387 . . . . 1.0 110.891 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.418 ' N ' HG23 ' A' ' 66' ' ' VAL . 85.0 mt-30 -61.45 -40.01 92.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.699 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -95.68 14.66 22.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.771 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 96.32 144.72 17.61 Favored Glycine 0 N--CA 1.464 0.524 0 N-CA-C 110.618 -0.993 . . . . 1.0 110.618 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.07 44.73 1.35 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.707 -0.957 . . . . 1.0 110.707 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.428 ' HA ' HG12 ' A' ' 66' ' ' VAL . 1.6 mm100 -40.95 160.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.786 0.327 . . . . 1.0 110.689 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.9 mt -69.92 136.62 50.79 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 68.4 m -131.1 96.9 20.95 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.341 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.99 -178.71 4.85 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.527 2.151 . . . . 1.0 112.024 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -54.68 -47.82 73.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.766 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -64.03 -18.98 64.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.915 0.388 . . . . 1.0 110.352 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.87 -158.45 19.38 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.088 -0.805 . . . . 1.0 111.088 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -47.96 -44.99 26.25 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.412 2.075 . . . . 1.0 112.417 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.576 ' O ' HG12 ' A' ' 80' ' ' VAL . . . 156.44 -44.58 0.52 Allowed Glycine 0 C--O 1.223 -0.576 0 C-N-CA 120.467 -0.873 . . . . 1.0 111.128 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 79' ' ' GLY . 0.4 OUTLIER 82.91 166.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 124.038 0.493 . . . . 1.0 110.166 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.58 -35.22 0.31 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.904 -0.318 . . . . 1.0 110.453 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -117.26 144.06 45.23 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.655 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.945 HD12 HD12 ' A' ' 109' ' ' LEU . 58.2 mt -131.58 112.59 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.555 -0.458 . . . . 1.0 110.885 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 t -90.3 127.64 42.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.633 HG23 ' H ' ' A' ' 87' ' ' GLU . 28.7 m -133.16 166.44 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.885 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 88' ' ' GLY . 39.8 p-10 -73.66 17.48 0.16 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.76 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.633 ' H ' HG23 ' A' ' 85' ' ' VAL . 3.7 mt-10 73.71 -32.11 0.23 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.092 -0.504 . . . . 1.0 111.224 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -67.95 -20.35 72.55 Favored Glycine 0 C--N 1.314 -0.672 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.426 ' CE ' HH12 ' A' ' 93' ' ' ARG . 9.4 ttm -82.11 160.16 23.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.791 0.329 . . . . 1.0 110.826 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -113.52 142.06 46.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.83 -0.623 . . . . 1.0 109.891 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.57 ' CG ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -46.49 -53.27 11.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.497 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.57 ' N ' ' CG ' ' A' ' 91' ' ' TYR . 17.1 pt-20 -51.83 -38.25 55.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.645 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.426 HH12 ' CE ' ' A' ' 89' ' ' MET . 79.7 ttt-85 -80.44 -22.17 41.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.789 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.34 -37.32 77.54 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.334 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 99' ' ' ARG . 7.5 mp -60.6 -38.0 83.22 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.995 -0.282 . . . . 1.0 110.319 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -61.9 -35.88 79.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.79 0.329 . . . . 1.0 110.627 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.751 HD11 ' OG1' ' A' ' 51' ' ' THR . 3.9 mm? -62.24 -40.56 96.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.049 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -108.72 8.77 27.0 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.188 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 95' ' ' LEU . 1.6 mpt_? 45.96 58.24 4.55 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.8 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.444 ' HB2' HD12 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -109.52 112.44 58.88 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.147 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.74 -41.75 37.75 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.057 1.838 . . . . 1.0 112.72 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -162.08 128.59 3.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.958 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.761 HD13 HD11 ' A' ' 109' ' ' LEU . 60.4 mt -52.71 124.6 35.3 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-N 116.088 -0.506 . . . . 1.0 111.214 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.449 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 44.2 Cg_exo -49.67 -174.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.365 2.044 . . . . 1.0 112.419 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 32.1 Cg_exo -58.18 129.36 32.62 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.724 2.283 . . . . 1.0 111.908 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 72.18 -53.32 1.43 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-O 118.906 -0.941 . . . . 1.0 110.751 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -7.79 116.26 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 O-C-N 124.262 0.625 . . . . 1.0 111.178 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.529 ' C ' HD13 ' A' ' 109' ' ' LEU . 23.1 mt-30 -127.71 142.74 51.25 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.593 -0.276 . . . . 1.0 110.411 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 1.046 ' H ' HD22 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -93.38 120.96 34.27 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.767 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.5 m -110.25 168.0 4.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.996 -1.002 . . . . 1.0 110.606 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.21 -177.72 3.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.897 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.0 m -61.48 -41.63 97.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.11 -0.95 . . . . 1.0 110.511 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.47 -48.14 62.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.547 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.767 ' CE3' HG21 ' A' ' 110' ' ' VAL . 34.5 t90 -56.02 -41.22 74.59 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.229 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.6 tp -65.67 -56.64 11.06 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.142 -0.623 . . . . 1.0 110.613 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 m -46.22 -53.58 10.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.363 0.601 . . . . 1.0 110.061 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.2 mp -52.23 -49.23 64.39 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.268 -0.573 . . . . 1.0 109.863 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 12.8 t -52.15 -37.33 54.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.775 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.598 ' O ' ' NH2' ' A' ' 122' ' ' ARG . 90.2 mt -69.6 -57.5 5.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.42 0.629 . . . . 1.0 111.509 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -66.21 -21.24 66.3 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.469 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 75.9 mm-40 -88.82 -45.24 9.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.609 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.598 ' NH2' ' O ' ' A' ' 119' ' ' LEU . 0.1 OUTLIER 81.61 33.86 0.1 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.9 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.424 ' C ' ' CD ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -161.7 -176.12 5.11 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.579 -0.449 . . . . 1.0 110.536 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 tp -79.22 123.89 27.84 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.333 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.18 155.18 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 121.017 0.437 . . . . 1.0 110.623 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 126' ' ' ASP . 45.3 p-10 -61.38 107.94 0.86 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.251 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.541 HG23 ' N ' ' A' ' 128' ' ' ALA . 9.1 m -60.36 -42.82 92.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.65 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.541 ' N ' HG23 ' A' ' 127' ' ' VAL . . . -55.72 -22.66 24.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.48 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.9 -37.62 94.66 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.916 -0.873 . . . . 1.0 110.916 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 130' ' ' PHE . 0.3 OUTLIER -143.42 58.51 1.39 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.707 0.289 . . . . 1.0 110.899 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.9 m -119.17 150.8 39.43 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.141 0.496 . . . . 1.0 110.795 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.576 ' C ' ' H ' ' A' ' 134' ' ' ILE . 60.9 mt -81.34 -63.75 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 CA-C-N 115.301 -0.863 . . . . 1.0 110.181 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.512 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 19.4 t80 66.34 -35.66 0.23 Allowed 'General case' 0 C--O 1.221 -0.425 0 O-C-N 124.208 0.943 . . . . 1.0 111.347 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.601 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 155.7 -55.51 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.37 0 O-C-N 124.905 1.378 . . . . 1.0 110.048 -178.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 24.9 Cg_endo . . . . . 0 N--CA 1.491 1.361 0 C-N-CA 122.324 2.016 . . . . 1.0 111.821 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.455 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 39.9 mp0 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.894 0.378 . . . . 1.0 110.58 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.442 ' CH2' HD12 ' A' ' 41' ' ' LEU . 14.8 p-90 -163.81 -55.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.086 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.653 ' O ' HD23 ' A' ' 41' ' ' LEU . 1.2 tt -68.91 -18.18 64.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.372 0.606 . . . . 1.0 110.123 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 68' ' ' HIS . 15.8 m -61.5 -42.17 98.39 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.713 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.8 m -52.84 -60.61 3.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.882 0.373 . . . . 1.0 110.714 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -75.0 169.28 18.32 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.655 -0.498 . . . . 1.0 109.655 179.647 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -123.71 120.02 31.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.935 0.398 . . . . 1.0 110.738 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.637 ' O ' HD13 ' A' ' 72' ' ' LEU . . . -96.7 158.29 15.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.235 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.486 ' CE1' ' CD1' ' A' ' 98' ' ' LEU . 59.6 t-80 -156.04 114.88 3.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.231 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.7 m -101.23 139.9 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.739 -0.467 . . . . 1.0 109.739 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 53' ' ' ILE . 58.5 t -81.69 89.9 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.036 0.446 . . . . 1.0 110.527 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -58.24 -31.18 67.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.664 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 m -92.9 34.99 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.992 0.425 . . . . 1.0 110.364 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -178.87 -4.6 0.02 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.091 -0.804 . . . . 1.0 111.091 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -127.04 -1.35 4.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-O 120.748 0.309 . . . . 1.0 110.314 179.293 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.45 37.32 0.57 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.105 -0.798 . . . . 1.0 111.105 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.523 ' NE ' ' OD2' ' A' ' 86' ' ' ASP . 1.6 ptp180 -61.0 -37.76 83.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.829 0.347 . . . . 1.0 110.244 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -172.9 -103.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.401 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.687 ' CD ' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -85.98 -19.13 30.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.491 179.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.447 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -43.21 -36.53 1.78 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.573 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 61' ' ' PHE . 12.5 pt-20 -66.12 -44.46 84.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.342 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.1 tp -43.17 -18.13 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.775 0.798 . . . . 1.0 110.818 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 59' ' ' GLU . 6.5 m-85 -58.11 -48.38 80.37 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.562 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.689 ' HA ' HD12 ' A' ' 65' ' ' ILE . 14.6 pt-20 -60.47 -31.04 70.07 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.034 0.445 . . . . 1.0 111.544 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.421 ' H ' ' HG2' ' A' ' 63' ' ' LYS . 17.0 mmmt -65.96 -56.52 11.3 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.451 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 64' ' ' GLN . 2.3 pt20 -57.84 -30.06 65.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.421 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.849 HD11 HD21 ' A' ' 115' ' ' LEU . 68.5 mt -66.87 -39.82 84.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.411 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 62' ' ' GLU . 53.8 t -59.8 -41.62 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.232 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -68.24 -16.46 63.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.521 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.431 ' O ' ' OG ' ' A' ' 42' ' ' SER . 34.0 m170 -88.81 7.32 34.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.65 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.82 -7.22 82.18 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.052 -0.819 . . . . 1.0 111.052 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.56 98.06 2.3 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.589 -1.004 . . . . 1.0 110.589 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -79.54 144.31 34.04 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.89 -0.324 . . . . 1.0 110.756 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.637 HD13 ' O ' ' A' ' 46' ' ' ALA . 2.5 mm? -80.66 137.27 36.32 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 120.898 0.38 . . . . 1.0 110.531 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.8 m -133.68 90.54 27.87 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.465 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.5 -177.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.824 2.349 . . . . 1.0 112.139 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 77' ' ' GLY . . . -56.43 -41.73 76.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.514 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -64.14 -1.55 1.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.319 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 75' ' ' ALA . . . -136.56 86.67 0.24 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.318 -1.113 . . . . 1.0 110.318 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.76 139.26 59.18 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.626 2.218 . . . . 1.0 112.058 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.81 1.17 1.63 Allowed Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 80' ' ' VAL . 1.3 p -88.34 103.71 13.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.048 0.451 . . . . 1.0 110.6 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.99 -39.25 15.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.399 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.5 ' CD2' ' CZ2' ' A' ' 114' ' ' TRP . 77.5 m80 -106.58 138.82 42.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.951 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.482 HD13 HD22 ' A' ' 98' ' ' LEU . 85.7 mt -133.58 107.36 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.258 -0.428 . . . . 1.0 109.934 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.43 134.97 27.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.533 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.51 162.8 37.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.394 -0.821 . . . . 1.0 110.975 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 88' ' ' GLY . 67.8 t0 -63.99 103.45 0.59 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 116.027 -0.533 . . . . 1.0 109.635 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 86' ' ' ASP . 69.1 mt-10 -24.63 87.15 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 124.191 0.932 . . . . 1.0 110.926 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . 156.77 -25.41 0.5 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 -178.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.462 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 11.9 ttm -70.14 146.71 50.63 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.913 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -90.09 151.57 21.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.453 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.55 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.74 -46.86 87.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.108 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.55 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 10.5 pt-20 -57.99 -45.45 86.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.947 0.403 . . . . 1.0 110.776 -178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.484 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 4.8 tmm_? -72.13 -21.82 61.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.13 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.49 -30.62 71.71 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.802 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 99' ' ' ARG . 7.0 mp -72.18 -44.81 62.46 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.212 0.32 . . . . 1.0 110.973 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -59.79 -48.28 82.32 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.25 -45.76 75.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.568 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.486 ' CD1' ' CE1' ' A' ' 47' ' ' HIS . 54.8 tp -72.77 -16.18 61.64 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.969 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.57 ' N ' ' O ' ' A' ' 95' ' ' LEU . 23.0 mmt85 67.35 27.15 8.27 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.11 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.5 tp -98.02 116.99 65.58 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.8 -23.26 35.72 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.22 1.947 . . . . 1.0 112.578 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -174.42 133.88 0.4 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.328 -0.397 . . . . 1.0 110.714 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 104' ' ' PRO . 1.0 OUTLIER -73.79 135.44 77.75 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.093 -178.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.533 ' O ' ' O ' ' A' ' 103' ' ' LEU . 60.7 Cg_exo -44.72 -174.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.645 2.23 . . . . 1.0 112.061 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 52.5 Cg_exo -51.95 -68.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.565 2.176 . . . . 1.0 113.087 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . -82.45 -50.43 4.77 Favored Glycine 0 CA--C 1.502 -0.753 0 N-CA-C 110.662 -0.975 . . . . 1.0 110.662 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.52 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -11.46 123.83 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 124.64 0.847 . . . . 1.0 111.44 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -130.76 154.26 48.17 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 110.018 -0.364 . . . . 1.0 110.018 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.86 110.36 22.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.783 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.74 HG21 ' CE3' ' A' ' 114' ' ' TRP . 13.9 m -107.25 169.07 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.661 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -96.52 -168.97 1.81 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.658 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -70.69 -34.66 72.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.878 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.403 ' HB3' ' CD1' ' A' ' 130' ' ' PHE . . . -57.21 -46.75 82.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.688 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.74 ' CE3' HG21 ' A' ' 110' ' ' VAL . 79.0 t90 -52.02 -59.83 3.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.628 -0.429 . . . . 1.0 110.678 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.849 HD21 HD11 ' A' ' 65' ' ' ILE . 32.0 tp -60.63 -51.24 70.25 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.441 -0.504 . . . . 1.0 110.503 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 117' ' ' LEU . 56.9 p -41.27 -60.71 1.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.087 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.439 ' N ' ' OG ' ' A' ' 116' ' ' SER . 11.0 mp -61.14 -49.62 76.51 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.055 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 9.3 t -55.49 -25.96 39.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 1.0 110.081 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -70.62 -52.27 22.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.478 0.656 . . . . 1.0 111.419 -178.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -78.39 -30.66 47.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.505 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 122' ' ' ARG . 0.4 OUTLIER -62.38 -48.5 79.45 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 118.473 -0.775 . . . . 1.0 110.165 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 121' ' ' GLU . 17.0 mmm180 90.27 32.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.816 1.323 . . . . 1.0 111.358 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.432 HH11 ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -173.9 163.18 4.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.435 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.4 tp -65.76 129.32 39.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.962 0.411 . . . . 1.0 111.175 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.442 HG23 ' CD1' ' A' ' 114' ' ' TRP . 17.3 m -113.32 154.0 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.364 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -61.96 146.92 48.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.431 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 129' ' ' GLY . 2.4 m -108.01 0.98 9.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.249 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.98 61.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.602 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 171.48 -28.15 0.11 Allowed Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 113' ' ' ALA . 60.7 m-85 -108.47 -11.53 15.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.718 0.295 . . . . 1.0 110.39 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -74.6 135.32 42.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.08 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 134' ' ' ILE . 57.5 mt -79.45 -65.95 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.129 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.53 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 19.7 t80 66.14 -36.33 0.24 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 118.438 -0.791 . . . . 1.0 111.154 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.609 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 155.67 -55.27 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 O-C-N 124.825 1.328 . . . . 1.0 110.272 -178.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 22.7 Cg_endo . . . . . 0 C--N 1.311 -1.401 0 C-N-CA 122.391 2.06 . . . . 1.0 111.982 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.549 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 57.8 mp0 . . . . . 0 CA--C 1.519 -0.224 0 CA-C-O 120.822 0.344 . . . . 1.0 110.433 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.502 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 3.5 p-90 -98.42 -56.69 2.39 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.391 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.402 HD12 ' CH2' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -56.15 -11.68 1.23 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.737 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.5 p -68.7 -32.55 72.44 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.644 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -61.02 -15.32 30.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.571 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.72 115.28 11.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.854 0.359 . . . . 1.0 110.628 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.418 ' HB3' HG23 ' A' ' 80' ' ' VAL . 88.9 mtm180 -75.31 139.94 42.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.078 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.717 ' HB3' HD13 ' A' ' 65' ' ' ILE . . . -119.33 169.74 9.73 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.458 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.406 ' C ' ' ND1' ' A' ' 47' ' ' HIS . 1.5 t-80 -147.89 120.09 8.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.439 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -97.1 127.16 49.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.508 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.66 HG12 ' H ' ' A' ' 52' ' ' GLY . 15.0 t -80.7 88.92 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.424 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -49.56 -36.84 24.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.548 -0.296 . . . . 1.0 110.571 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.0 p -76.26 -24.24 54.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.541 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.66 ' H ' HG12 ' A' ' 49' ' ' VAL . . . -110.14 1.58 29.84 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.367 -0.693 . . . . 1.0 111.367 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.644 ' N ' ' O ' ' A' ' 49' ' ' VAL . 35.0 mt -146.18 91.47 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.285 0.564 . . . . 1.0 110.309 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -145.45 19.68 1.87 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.076 -0.81 . . . . 1.0 111.076 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.657 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -58.25 -55.97 28.08 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.288 -0.264 . . . . 1.0 110.288 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 55' ' ' ARG . . . 158.14 -40.14 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 O-C-N 123.436 0.46 . . . . 1.0 110.576 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.731 ' O ' HD22 ' A' ' 60' ' ' LEU . 70.3 ttp85 -94.27 -60.66 1.68 Allowed 'General case' 0 C--O 1.211 -0.928 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.829 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.634 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -40.96 -43.08 2.03 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-O 121.262 0.553 . . . . 1.0 110.578 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 61' ' ' PHE . 11.3 pt-20 -45.45 -48.52 13.8 Favored 'General case' 0 C--N 1.314 -0.971 0 O-C-N 121.77 -0.581 . . . . 1.0 111.094 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.802 HD23 ' N ' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -39.45 -19.02 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.507 0.504 . . . . 1.0 109.962 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.802 ' N ' HD23 ' A' ' 60' ' ' LEU . 8.6 m-85 -52.73 -48.96 66.32 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.676 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.462 ' CG ' ' N ' ' A' ' 63' ' ' LYS . 13.9 pt-20 -63.02 -43.46 98.67 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.489 0.493 . . . . 1.0 110.528 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.462 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 17.5 mtpp -61.23 -42.58 98.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.223 0.535 . . . . 1.0 110.177 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.536 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 86.9 mm-40 -67.35 -31.27 71.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.205 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.751 HD11 HD11 ' A' ' 115' ' ' LEU . 46.5 mt -74.96 -57.86 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.047 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 67' ' ' GLN . 28.0 m -55.22 -42.75 67.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.271 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.533 ' N ' HG23 ' A' ' 66' ' ' VAL . 8.5 tt0 -65.81 -40.29 91.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.584 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 64' ' ' GLN . 46.5 m170 -86.01 -3.59 58.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.503 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 99.17 171.17 30.96 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.876 -0.89 . . . . 1.0 110.876 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 71' ' ' GLN . . . 102.17 -45.51 1.36 Allowed Glycine 0 N--CA 1.464 0.545 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 70' ' ' GLY . 25.1 mm100 54.92 158.65 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.7 0.286 . . . . 1.0 110.634 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.873 HD22 ' N ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -89.58 130.32 35.91 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.757 -0.461 . . . . 1.0 109.757 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 73.3 m -118.85 88.73 36.53 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.621 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 77' ' ' GLY . 31.8 Cg_exo -56.67 162.45 8.47 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.833 2.355 . . . . 1.0 112.055 178.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -47.23 -33.84 5.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.397 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -75.94 -20.51 57.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.896 0.379 . . . . 1.0 110.592 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 74' ' ' PRO . . . -85.9 -161.99 35.85 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.029 -0.828 . . . . 1.0 111.029 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -43.8 -41.63 11.78 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.563 2.175 . . . . 1.0 111.986 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.711 ' O ' HG12 ' A' ' 80' ' ' VAL . . . 136.19 -40.78 1.49 Allowed Glycine 0 C--O 1.22 -0.779 0 CA-C-O 119.219 -0.767 . . . . 1.0 111.695 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.742 HG13 ' N ' ' A' ' 81' ' ' THR . 0.3 OUTLIER 77.96 -171.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 124.034 0.491 . . . . 1.0 109.909 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.742 ' N ' HG13 ' A' ' 80' ' ' VAL . 0.6 OUTLIER -144.29 -32.19 0.43 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.824 177.56 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.689 ' CD2' HE22 ' A' ' 108' ' ' GLN . 74.9 m80 -111.69 136.51 50.83 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.614 -0.266 . . . . 1.0 110.672 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 110' ' ' VAL . 30.2 mm -123.28 106.29 17.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.465 HG11 HD12 ' A' ' 115' ' ' LEU . 2.3 p -93.53 134.06 32.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.814 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 87' ' ' GLU . 3.1 m -132.79 157.44 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.206 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.576 ' O ' ' C ' ' A' ' 87' ' ' GLU . 10.1 t0 -54.78 77.72 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 123.373 0.42 . . . . 1.0 110.116 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' A' ' 85' ' ' VAL . 6.8 pt-20 -3.88 79.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 O-C-N 124.17 0.919 . . . . 1.0 111.76 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . 170.1 -22.11 0.08 OUTLIER Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.601 -0.727 . . . . 1.0 111.288 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.6 tpp -72.71 156.14 39.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.775 0.322 . . . . 1.0 110.786 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -96.35 144.1 26.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.135 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.604 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -51.47 -44.94 62.6 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.205 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.604 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 16.5 pt-20 -59.65 -44.16 93.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.929 0.395 . . . . 1.0 110.526 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.46 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 38.8 ttm105 -71.94 -41.16 68.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.767 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.15 -34.46 22.42 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.935 -0.575 . . . . 1.0 111.045 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 91' ' ' TYR . 5.6 mp -62.55 -47.3 84.49 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.66 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.548 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -73.0 -35.77 66.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.257 -178.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.62 -34.54 75.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.51 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.921 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -105.61 -1.94 24.05 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.204 -0.453 . . . . 1.0 111.005 -179.431 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.548 ' NH1' ' O ' ' A' ' 96' ' ' ARG . 72.9 mmt-85 70.57 61.68 0.2 Allowed 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 123.322 0.389 . . . . 1.0 110.858 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.624 ' HB2' HD11 ' A' ' 98' ' ' LEU . 9.3 tp -125.79 122.36 24.57 Favored Pre-proline 0 N--CA 1.449 -0.518 0 O-C-N 123.255 0.347 . . . . 1.0 111.376 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.83 -36.51 23.44 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.384 2.056 . . . . 1.0 112.012 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 179.47 139.63 0.11 Allowed 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.576 0.548 . . . . 1.0 110.915 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.7 mt -45.14 120.27 4.4 Favored Pre-proline 0 N--CA 1.445 -0.72 0 CA-C-N 115.843 -0.617 . . . . 1.0 111.166 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.15 165.36 32.9 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.409 2.073 . . . . 1.0 112.031 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.15 113.54 1.24 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.575 2.183 . . . . 1.0 111.805 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.84 62.58 1.67 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -164.09 143.13 7.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 1.0 110.641 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.689 HE22 ' CD2' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -140.16 152.99 46.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.088 0.471 . . . . 1.0 110.132 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.415 HD11 ' CD1' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -93.06 109.4 20.87 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.15 179.26 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.616 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.0 m -108.23 167.14 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.026 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -102.24 -171.18 1.92 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.838 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.4 t -64.84 -44.42 89.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.895 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.08 -38.0 49.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.514 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.616 ' CE3' HG21 ' A' ' 110' ' ' VAL . 75.2 t90 -61.65 -52.31 64.86 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.907 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.751 HD11 HD11 ' A' ' 65' ' ' ILE . 3.0 tt -63.13 -55.7 23.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.993 0.425 . . . . 1.0 110.986 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.9 t -43.94 -59.55 2.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.392 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.427 ' O ' ' OE2' ' A' ' 121' ' ' GLU . 9.4 mp -60.01 -49.82 76.15 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.464 -0.494 . . . . 1.0 110.364 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 123' ' ' ARG . 3.1 t -58.72 -22.08 56.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.142 -0.318 . . . . 1.0 110.142 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.535 ' O ' ' NH1' ' A' ' 122' ' ' ARG . 6.7 tp -71.22 -53.52 14.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.001 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.42 ' C ' ' H ' ' A' ' 122' ' ' ARG . 77.0 mt-30 -76.75 -33.08 58.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.603 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.535 ' O ' ' C ' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -77.26 18.17 0.42 Allowed 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.8 -178.496 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.535 ' C ' ' O ' ' A' ' 121' ' ' GLU . 81.6 mmt-85 20.56 52.77 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.719 0.637 . . . . 1.0 111.353 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.494 ' O ' ' SG ' ' A' ' 118' ' ' CYS . 0.5 OUTLIER -170.67 167.8 7.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.727 -0.669 . . . . 1.0 110.357 -178.342 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.482 HD11 ' NE2' ' A' ' 82' ' ' HIS . 5.0 tt -83.77 114.76 21.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.044 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 126' ' ' ASP . 55.2 t -80.45 155.7 4.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.155 0.502 . . . . 1.0 110.601 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.431 ' N ' HG12 ' A' ' 125' ' ' VAL . 66.2 t0 -66.46 117.26 8.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.505 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 131' ' ' SER . 2.9 m -64.14 -41.4 92.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.603 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.463 ' N ' ' CG2' ' A' ' 127' ' ' VAL . . . -53.75 -6.64 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.455 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 127' ' ' VAL . . . -87.86 -34.38 10.09 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -134.33 12.12 3.83 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.713 0.292 . . . . 1.0 110.433 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 127' ' ' VAL . 5.1 t -75.48 141.29 43.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.895 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.569 ' C ' ' H ' ' A' ' 134' ' ' ILE . 45.3 mt -83.25 -66.36 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.124 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.533 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 21.1 t80 66.76 -37.89 0.31 Allowed 'General case' 0 C--O 1.211 -0.926 0 O-C-N 124.011 0.819 . . . . 1.0 111.003 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.61 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 157.36 -54.66 0.0 OUTLIER Pre-proline 0 N--CA 1.45 -0.441 0 O-C-N 124.658 1.224 . . . . 1.0 110.755 -178.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 29.9 Cg_endo . . . . . 0 C--N 1.31 -1.476 0 C-N-CA 122.479 2.12 . . . . 1.0 111.684 -178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.394 0 N-CA-C 109.504 -1.438 . . . . 1.0 109.504 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.4 m -70.63 150.16 46.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.669 0.271 . . . . 1.0 110.391 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -117.96 55.77 0.87 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.525 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.8 t -138.43 144.48 40.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.539 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 173.99 -67.07 0.11 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -80.39 94.36 6.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.868 0.366 . . . . 1.0 110.616 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.512 ' C ' ' H ' ' A' ' 38' ' ' GLU . 1.7 tt0 -60.53 -47.18 87.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.592 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.614 ' C ' ' H ' ' A' ' 39' ' ' GLU . . . 57.24 2.78 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.66 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.512 ' H ' ' C ' ' A' ' 36' ' ' GLU . 99.4 mt-10 56.77 -3.15 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.455 -0.338 . . . . 1.0 110.91 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.614 ' H ' ' C ' ' A' ' 37' ' ' ALA . 96.1 mt-10 37.45 75.27 0.07 Allowed 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.782 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -90.24 -46.05 8.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.383 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.539 ' CD2' HG23 ' A' ' 65' ' ' ILE . 6.6 tp -62.42 -31.83 72.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.742 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 91.5 p -48.02 -14.71 0.05 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.532 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.459 ' N ' ' C ' ' A' ' 41' ' ' LEU . 32.9 t -64.55 -16.34 62.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.567 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.35 168.24 19.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.281 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.463 HH12 ' CA ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -118.11 112.19 19.86 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.966 0.413 . . . . 1.0 110.428 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.575 ' CB ' HD13 ' A' ' 65' ' ' ILE . . . -93.58 166.29 12.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.782 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -155.12 121.35 5.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.376 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.604 HG13 HD12 ' A' ' 53' ' ' ILE . 54.6 t -108.73 135.05 48.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.97 0.414 . . . . 1.0 110.215 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 52' ' ' GLY . 13.6 t -86.0 103.44 12.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.412 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.528 ' H ' ' HD2' ' A' ' 50' ' ' ARG . 6.8 mpt_? -63.55 -38.86 92.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.72 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.7 p -66.05 -30.56 71.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.404 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.567 ' H ' HG12 ' A' ' 49' ' ' VAL . . . -87.31 -67.48 1.33 Allowed Glycine 0 CA--C 1.522 0.482 0 N-CA-C 111.21 -0.756 . . . . 1.0 111.21 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.604 HD12 HG13 ' A' ' 48' ' ' VAL . 3.1 mt -61.9 -94.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.971 -0.292 . . . . 1.0 110.214 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 53' ' ' ILE . . . 34.24 32.27 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.163 -0.775 . . . . 1.0 111.163 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.53 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 30.0 mtm180 -70.54 -60.34 2.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.829 0.347 . . . . 1.0 110.364 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 55' ' ' ARG . . . 170.72 -53.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.352 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.5 ttt-85 -101.99 -41.39 6.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.354 -0.384 . . . . 1.0 110.365 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.473 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -56.59 -41.4 76.92 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.048 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 61' ' ' PHE . 8.0 pt-20 -45.62 -46.44 14.47 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.734 -0.212 . . . . 1.0 110.584 179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.8 tp -41.27 -17.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.12 0.486 . . . . 1.0 110.548 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.766 ' CD1' HD13 ' A' ' 115' ' ' LEU . 3.3 m-85 -49.42 -51.1 37.6 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.173 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.477 ' CD ' ' HZ2' ' A' ' 63' ' ' LYS . 0.9 OUTLIER -61.58 -40.09 93.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.542 -0.299 . . . . 1.0 110.675 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.477 ' HZ2' ' CD ' ' A' ' 62' ' ' GLU . 13.9 mptt -61.68 -43.28 99.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.228 0.537 . . . . 1.0 110.249 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -63.6 -40.53 97.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.309 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 1.083 HD11 HD11 ' A' ' 115' ' ' LEU . 81.2 mt -64.32 -54.12 34.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.934 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.495 HG23 ' N ' ' A' ' 67' ' ' GLN . 28.9 m -64.01 -40.43 89.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.128 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.495 ' N ' HG23 ' A' ' 66' ' ' VAL . 55.9 tt0 -59.64 -18.62 43.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.273 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.3 m170 -97.3 1.86 50.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.487 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.07 0.51 59.98 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.057 -0.817 . . . . 1.0 111.057 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.686 ' O ' HG22 ' A' ' 65' ' ' ILE . . . -91.63 98.2 2.4 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.738 -0.945 . . . . 1.0 110.738 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.414 ' O ' ' NE ' ' A' ' 45' ' ' ARG . 83.7 mt-30 -70.86 145.43 50.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.87 0.367 . . . . 1.0 110.568 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.626 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -136.34 156.65 48.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.084 0.469 . . . . 1.0 110.359 -179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.1 m -163.19 158.28 17.91 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.566 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.95 -153.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.952 2.435 . . . . 1.0 111.944 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 99' ' ' ARG . . . -47.62 -26.66 1.56 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.505 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.403 ' O ' ' C ' ' A' ' 77' ' ' GLY . 74.7 mt-30 -66.58 -20.12 65.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.281 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.463 ' CA ' HH12 ' A' ' 45' ' ' ARG . . . -37.51 103.88 0.03 OUTLIER Glycine 0 CA--C 1.538 1.475 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.44 ' HD2' HH22 ' A' ' 45' ' ' ARG . 52.2 Cg_exo -50.9 -28.76 24.71 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.647 2.232 . . . . 1.0 111.928 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.82 60.96 0.4 Allowed Glycine 0 CA--C 1.521 0.413 0 N-CA-C 111.099 -0.8 . . . . 1.0 111.099 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 80' ' ' VAL . 1.5 p -91.63 97.6 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.489 0.661 . . . . 1.0 110.249 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.19 -19.02 19.66 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.42 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -109.97 140.78 43.59 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.472 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 24.5 mm -131.1 106.18 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.614 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.4 t -91.21 131.35 38.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.52 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' A' ' 87' ' ' GLU . 27.9 m -132.73 162.59 39.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.607 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.586 ' C ' ' H ' ' A' ' 88' ' ' GLY . 15.3 t70 -68.92 18.06 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.375 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.563 ' H ' ' C ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER 68.87 -20.1 0.16 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.668 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.586 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -61.82 -67.71 1.98 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.2 ptp -63.54 145.82 54.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.641 0.258 . . . . 1.0 110.35 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -83.63 168.52 16.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.638 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.546 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.98 -53.32 59.18 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.466 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.546 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 15.7 pt-20 -50.39 -38.86 44.89 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 123.502 0.501 . . . . 1.0 110.107 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.441 ' HG3' ' HE ' ' A' ' 96' ' ' ARG . 67.7 ttt180 -74.81 -40.97 60.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.974 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -46.19 -27.89 1.11 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.642 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.594 HD22 ' N ' ' A' ' 95' ' ' LEU . 4.1 mm? -56.07 -59.51 4.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.268 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.441 ' HE ' ' HG3' ' A' ' 93' ' ' ARG . 41.2 ptt180 -78.1 -25.95 47.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.477 -0.329 . . . . 1.0 110.551 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.451 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -61.45 -42.24 98.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.932 -179.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.828 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -93.4 6.14 49.18 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.283 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 75' ' ' ALA . 31.6 mmt-85 69.67 54.88 0.37 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.791 0.329 . . . . 1.0 111.065 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 95' ' ' LEU . 6.4 tp -146.78 116.83 4.56 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.781 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.35 -7.48 19.71 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.767 2.311 . . . . 1.0 112.876 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -179.85 140.68 0.14 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.699 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.516 ' CD1' HD11 ' A' ' 95' ' ' LEU . 1.7 mp -84.45 148.56 52.67 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.973 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.475 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 37.0 Cg_exo -59.34 -173.68 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.817 0 C-N-CA 122.63 2.22 . . . . 1.0 111.657 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 29.8 Cg_exo -62.45 133.75 44.55 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.676 2.251 . . . . 1.0 111.798 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 72.42 -51.59 1.43 Allowed Glycine 0 C--O 1.22 -0.729 0 N-CA-C 110.935 -0.866 . . . . 1.0 110.935 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.537 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -17.8 129.71 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.905 0.415 . . . . 1.0 111.065 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -132.11 158.28 42.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.103 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.677 HD12 ' N ' ' A' ' 109' ' ' LEU . 3.4 mp -107.84 117.61 34.58 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.553 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.672 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.6 m -108.84 175.45 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.479 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -104.36 -174.67 2.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.811 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.0 p -64.04 -37.67 88.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.896 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.38 -44.45 76.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.586 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.672 ' CE3' HG21 ' A' ' 110' ' ' VAL . 60.8 t90 -57.51 -48.21 79.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.476 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 1.083 HD11 HD11 ' A' ' 65' ' ' ILE . 1.3 tt -58.77 -52.69 64.61 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.231 -178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.1 m -42.15 -57.43 2.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.519 -0.309 . . . . 1.0 110.629 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 121' ' ' GLU . 60.8 mt -55.0 -50.7 68.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.378 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.614 ' SG ' ' CE2' ' A' ' 114' ' ' TRP . 55.9 m -45.87 -33.52 3.24 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.456 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 65.5 mt -80.13 -50.93 9.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.915 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -70.18 -54.57 12.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.63 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 117' ' ' LEU . 79.9 mt-10 -75.54 7.6 3.55 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.538 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 121' ' ' GLU . 74.4 mtt85 25.09 53.45 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.54 0.525 . . . . 1.0 111.503 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -159.0 -170.24 2.95 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.306 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.4 tp -108.04 96.85 6.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.422 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.527 HG23 ' CD1' ' A' ' 114' ' ' TRP . 2.4 m -78.56 154.44 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.622 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -61.09 119.85 9.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.329 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.566 ' HB ' HG12 ' A' ' 110' ' ' VAL . 5.3 m -62.45 -42.05 94.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.719 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.52 ' N ' HG23 ' A' ' 127' ' ' VAL . . . -44.44 -19.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.553 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.468 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . -70.75 -40.71 64.81 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -135.95 34.65 2.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.682 0.277 . . . . 1.0 110.617 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 11.7 t -100.49 137.48 38.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.763 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.595 ' C ' ' H ' ' A' ' 134' ' ' ILE . 39.6 mt -72.65 -71.85 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.373 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.568 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 20.6 t80 65.74 -36.55 0.23 Allowed 'General case' 0 C--O 1.208 -1.101 0 CA-C-O 118.306 -0.854 . . . . 1.0 110.804 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.624 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 156.3 -55.51 0.0 OUTLIER Pre-proline 0 N--CA 1.449 -0.506 0 O-C-N 124.736 1.272 . . . . 1.0 110.667 -178.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 29.8 Cg_endo . . . . . 0 C--N 1.304 -1.771 0 C-N-CA 122.617 2.212 . . . . 1.0 111.695 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.502 -1.439 . . . . 1.0 109.502 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 99.3 p -78.5 -7.26 57.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.723 0.297 . . . . 1.0 110.594 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -92.63 7.96 41.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.445 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.4 t -152.95 152.5 31.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.611 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.69 -44.55 97.34 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -171.47 80.63 0.07 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.878 0.37 . . . . 1.0 110.655 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 38' ' ' GLU . 20.7 pt-20 -65.97 -42.39 89.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.596 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 61.28 2.52 0.63 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.525 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.444 ' H ' ' C ' ' A' ' 36' ' ' GLU . 96.8 mt-10 -76.8 -120.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.605 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 48.12 63.4 2.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.417 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.469 ' CZ3' HD12 ' A' ' 41' ' ' LEU . 1.9 p-90 -107.32 -32.54 7.72 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.528 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.476 HD23 HD11 ' A' ' 44' ' ' LEU . 1.6 mt -79.32 -9.53 59.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.035 0.445 . . . . 1.0 110.633 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.7 t -67.04 -21.75 65.9 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.81 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.6 t -63.64 -15.71 59.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.846 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.476 HD11 HD23 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -138.15 169.52 17.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.392 -179.725 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -118.86 107.33 13.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.415 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.513 ' HB3' HG21 ' A' ' 65' ' ' ILE . . . -92.46 151.18 20.35 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.26 -0.427 . . . . 1.0 109.927 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -136.71 120.76 17.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.583 . . . . 1.0 110.556 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.403 ' CG1' HG21 ' A' ' 53' ' ' ILE . 88.3 t -96.48 135.9 29.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.861 -0.609 . . . . 1.0 109.969 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.447 HG23 ' H ' ' A' ' 53' ' ' ILE . 29.5 m -85.92 126.93 40.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.923 -0.581 . . . . 1.0 111.123 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 90.1 mtm-85 -71.4 -37.2 71.55 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.988 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.604 ' OG1' HD11 ' A' ' 97' ' ' LEU . 99.1 m -57.0 -48.79 77.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.615 -178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.593 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . -90.5 -83.61 1.39 Allowed Glycine 0 CA--C 1.521 0.412 0 N-CA-C 110.458 -1.057 . . . . 1.0 110.458 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.447 ' H ' HG23 ' A' ' 49' ' ' VAL . 5.3 mm -53.23 78.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-O 121.71 0.766 . . . . 1.0 110.266 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 52' ' ' GLY . . . -166.7 25.78 0.15 Allowed Glycine 0 C--N 1.313 -0.75 0 CA-C-N 114.884 -1.053 . . . . 1.0 111.462 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.452 ' NH2' ' OD2' ' A' ' 86' ' ' ASP . 11.9 ptp180 -72.62 -37.33 68.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.844 0.354 . . . . 1.0 110.77 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -179.32 -81.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.609 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -90.7 -20.27 22.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.53 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.48 -27.25 9.95 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 120.967 0.413 . . . . 1.0 110.399 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.437 ' C ' ' N ' ' A' ' 61' ' ' PHE . 2.1 pt-20 -70.58 -35.66 73.17 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.717 0.294 . . . . 1.0 110.57 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.3 tp -46.2 -19.35 0.07 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.967 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.437 ' N ' ' C ' ' A' ' 59' ' ' GLU . 5.1 m-85 -61.23 -44.6 97.0 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.956 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.553 ' HA ' HD12 ' A' ' 65' ' ' ILE . 8.9 pt-20 -62.47 -40.42 96.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.975 0.417 . . . . 1.0 110.672 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.445 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 39.0 mttp -65.71 -41.9 91.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.665 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.543 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 25.5 mt-30 -63.14 -19.03 64.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.618 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 1.13 HD11 HD11 ' A' ' 115' ' ' LEU . 70.6 mt -83.38 -57.42 4.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.83 0.348 . . . . 1.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 71' ' ' GLN . 3.5 m -64.58 -32.78 59.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.052 0.454 . . . . 1.0 110.604 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -70.56 -21.44 62.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.508 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.543 ' CG ' ' O ' ' A' ' 64' ' ' GLN . 60.1 m170 -96.26 14.71 23.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.978 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.22 2.3 57.99 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.984 -0.847 . . . . 1.0 110.984 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -77.59 -146.0 2.47 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.096 -1.202 . . . . 1.0 110.096 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.412 ' HA ' HG12 ' A' ' 66' ' ' VAL . 0.0 OUTLIER 171.98 149.05 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.14 -0.318 . . . . 1.0 110.14 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.6 mt -107.9 113.67 27.04 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.444 ' O ' ' O ' ' A' ' 74' ' ' PRO . 2.5 m -135.36 91.07 19.29 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.205 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 73' ' ' CYS . 52.5 Cg_exo -52.37 -162.73 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.599 2.199 . . . . 1.0 112.003 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -61.23 -33.62 73.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.565 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -64.09 -19.54 65.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.485 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.24 -161.51 14.04 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.056 -0.818 . . . . 1.0 111.056 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.95 -37.48 78.2 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.805 2.337 . . . . 1.0 111.924 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.566 ' O ' HG12 ' A' ' 80' ' ' VAL . . . 160.15 -40.75 0.45 Allowed Glycine 0 C--O 1.223 -0.59 0 N-CA-C 110.883 -0.887 . . . . 1.0 110.883 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 79' ' ' GLY . 0.4 OUTLIER 80.41 162.29 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 N-CA-C 110.106 -0.331 . . . . 1.0 110.106 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.69 -41.93 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.936 0.398 . . . . 1.0 110.74 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -110.29 137.12 48.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.974 0.416 . . . . 1.0 110.993 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 77.3 mt -133.02 109.38 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.961 -0.563 . . . . 1.0 109.955 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.512 HG21 HD12 ' A' ' 115' ' ' LEU . 31.1 t -88.08 138.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.249 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 87' ' ' GLU . 35.3 m -134.64 152.57 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.378 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 88' ' ' GLY . 66.4 t0 -74.45 43.41 0.18 Allowed 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.655 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.494 ' CD ' ' NZ ' ' A' ' 111' ' ' LYS . 2.8 mt-10 40.66 22.19 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.7 -0.682 . . . . 1.0 110.633 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . -100.06 -64.58 0.81 Allowed Glycine 0 N--CA 1.463 0.457 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.442 ' CE ' HG21 ' A' ' 49' ' ' VAL . 13.2 ptp -77.73 156.19 30.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.857 0.36 . . . . 1.0 110.548 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -93.07 173.95 7.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.498 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.651 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.69 -50.4 73.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.164 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.651 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 15.4 pt-20 -51.67 -38.31 54.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.055 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.516 HH21 HH21 ' A' ' 96' ' ' ARG . 69.7 ttt180 -83.15 -21.84 33.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.604 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.404 ' O ' ' CD2' ' A' ' 98' ' ' LEU . . . -62.04 -35.41 78.52 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.389 -0.524 . . . . 1.0 111.912 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 95' ' ' LEU . 7.6 mp -60.83 -41.84 96.56 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.853 0.359 . . . . 1.0 110.649 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.516 HH21 HH21 ' A' ' 93' ' ' ARG . 13.7 ptt85 -69.47 -23.69 63.69 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.252 -0.579 . . . . 1.0 109.798 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.604 HD11 ' OG1' ' A' ' 51' ' ' THR . 0.2 OUTLIER -65.9 -41.29 91.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.37 0.605 . . . . 1.0 111.19 -177.553 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.766 HD23 ' H ' ' A' ' 98' ' ' LEU . 2.4 pt? -114.9 5.98 15.27 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.877 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.467 ' CD ' ' N ' ' A' ' 99' ' ' ARG . 1.2 mpt_? 58.05 57.35 4.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.609 -0.269 . . . . 1.0 110.441 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.2 tp -104.89 110.3 64.28 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 120.597 -0.441 . . . . 1.0 110.354 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.08 -40.94 58.98 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.151 1.901 . . . . 1.0 112.268 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -173.69 135.64 0.53 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.708 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.9 mp -53.28 111.69 2.94 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.187 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.453 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 46.9 Cg_exo -50.49 -174.49 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 122.097 1.865 . . . . 1.0 112.235 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 31.3 Cg_exo -58.57 113.58 1.62 Allowed 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.836 2.357 . . . . 1.0 112.058 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 91.79 -66.53 2.23 Favored Glycine 0 C--O 1.221 -0.714 0 N-CA-C 110.413 -1.075 . . . . 1.0 110.413 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.52 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -13.42 125.68 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.109 0.535 . . . . 1.0 111.487 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -133.6 156.34 48.02 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 120.967 0.413 . . . . 1.0 110.35 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.85 112.89 24.63 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.917 -0.583 . . . . 1.0 109.614 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.551 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.4 m -107.27 168.74 3.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 123.705 0.628 . . . . 1.0 109.843 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.494 ' NZ ' ' CD ' ' A' ' 87' ' ' GLU . 3.6 mtpp -102.64 -177.67 3.46 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.746 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.9 m -60.48 -39.87 89.21 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.459 -0.791 . . . . 1.0 110.767 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.24 -39.32 66.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.687 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.551 ' CE3' HG21 ' A' ' 110' ' ' VAL . 76.1 t90 -60.76 -47.05 88.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.848 0.356 . . . . 1.0 110.714 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 1.13 HD11 HD11 ' A' ' 65' ' ' ILE . 0.6 OUTLIER -60.14 -52.28 66.02 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.219 -179.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 70.2 p -51.06 -42.27 60.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.154 -0.475 . . . . 1.0 109.973 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 11.1 mt -61.32 -52.71 63.54 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.405 -0.518 . . . . 1.0 109.651 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.549 ' O ' ' N ' ' A' ' 122' ' ' ARG . 2.2 m -50.48 -36.37 33.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.702 -0.481 . . . . 1.0 109.702 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.6 mt -69.15 -52.92 23.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.148 0.499 . . . . 1.0 110.575 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -60.66 -27.42 67.81 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.096 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -103.32 -4.31 24.4 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.325 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.549 ' N ' ' O ' ' A' ' 118' ' ' CYS . 37.8 mmt180 44.23 47.95 7.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.717 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.517 ' HE ' HG12 ' A' ' 125' ' ' VAL . 0.2 OUTLIER -172.36 -175.5 1.4 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.51 -179.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.3 tt -86.37 126.73 34.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.973 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.517 HG12 ' HE ' ' A' ' 123' ' ' ARG . 20.4 m -114.15 155.4 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.572 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -60.94 159.21 11.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.052 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' GLY . 3.6 m -114.67 3.23 7.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.493 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.35 67.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.006 0.431 . . . . 1.0 110.582 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 159.27 -34.3 0.47 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.186 -0.765 . . . . 1.0 111.186 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -103.77 1.24 31.43 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.063 0.459 . . . . 1.0 110.428 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.3 t -90.13 140.99 29.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.906 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.581 ' C ' ' H ' ' A' ' 134' ' ' ILE . 60.7 mt -92.27 -72.46 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 116.266 -0.424 . . . . 1.0 109.883 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.528 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 19.1 t80 64.77 -36.13 0.19 Allowed 'General case' 0 C--O 1.222 -0.345 0 O-C-N 123.945 0.778 . . . . 1.0 111.303 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.585 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 155.17 -55.43 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.414 0 O-C-N 124.581 1.175 . . . . 1.0 110.14 -178.438 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.6 Cg_endo . . . . . 0 N--CA 1.492 1.411 0 C-N-CA 122.216 1.944 . . . . 1.0 111.974 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.599 -1.4 . . . . 1.0 109.599 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.2 t -68.54 131.11 44.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.753 0.311 . . . . 1.0 110.53 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -64.72 -41.82 95.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.929 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.9 m 38.54 67.82 0.38 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.192 -0.458 . . . . 1.0 111.041 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -114.59 6.98 22.49 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 56.3 mp0 -86.6 114.96 23.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.748 0.308 . . . . 1.0 110.474 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.425 ' HG2' ' H ' ' A' ' 38' ' ' GLU . 79.9 tt0 -67.26 -51.37 53.9 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.746 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' A' ' 39' ' ' GLU . . . 40.51 28.42 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.827 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.425 ' H ' ' HG2' ' A' ' 36' ' ' GLU . 98.7 mt-10 57.09 4.5 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.778 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' A' ' 37' ' ' ALA . 95.4 mt-10 -104.77 75.17 1.18 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.478 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.577 ' CZ3' HD13 ' A' ' 41' ' ' LEU . 8.5 p-90 -100.08 -59.05 1.78 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.015 0.436 . . . . 1.0 110.276 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.577 HD13 ' CZ3' ' A' ' 40' ' ' TRP . 5.6 tp -62.7 -30.39 71.37 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.671 -0.695 . . . . 1.0 110.267 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.2 t -48.13 -14.17 0.05 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.676 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.471 ' N ' ' C ' ' A' ' 41' ' ' LEU . 42.1 p -68.3 -13.48 62.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.8 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.93 169.08 18.37 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.8 0.333 . . . . 1.0 110.547 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.41 HH11 ' HA3' ' A' ' 79' ' ' GLY . 93.7 mtt180 -122.08 137.92 54.64 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.154 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.698 ' HB3' HD13 ' A' ' 65' ' ' ILE . . . -124.13 166.17 16.27 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.467 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -153.76 129.19 9.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.713 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.3 m -100.8 137.42 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.373 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.539 ' O ' ' O ' ' A' ' 52' ' ' GLY . 13.5 t -98.35 135.25 33.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.857 -0.611 . . . . 1.0 109.996 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.554 ' CD ' ' H ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -62.05 -43.52 98.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.739 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.631 ' OG1' HD12 ' A' ' 97' ' ' LEU . 13.1 m -51.7 -21.35 2.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.384 0.612 . . . . 1.0 110.548 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 49' ' ' VAL . . . -156.99 120.17 0.96 Allowed Glycine 0 C--O 1.219 -0.782 0 N-CA-C 109.383 -1.487 . . . . 1.0 109.383 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.569 HG22 ' O ' ' A' ' 53' ' ' ILE . 4.7 mm 115.28 -6.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.047 1.339 . . . . 1.0 109.52 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -92.01 22.74 30.08 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.754 -0.939 . . . . 1.0 110.754 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -60.97 -57.1 14.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.638 0.256 . . . . 1.0 110.588 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.466 ' O ' ' CG ' ' A' ' 59' ' ' GLU . . . 179.74 -67.44 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.386 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -91.06 -27.5 18.56 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.581 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.406 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -57.36 -32.63 66.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.319 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 61' ' ' PHE . 3.3 pt-20 -66.48 -39.5 88.79 Favored 'General case' 0 C--O 1.217 -0.632 0 CA-C-N 116.159 -0.473 . . . . 1.0 109.775 179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 tp -41.67 -17.51 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.183 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.579 ' N ' ' O ' ' A' ' 59' ' ' GLU . 6.1 m-85 -60.49 -42.89 97.24 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.678 -0.692 . . . . 1.0 111.22 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.504 ' HA ' HD12 ' A' ' 65' ' ' ILE . 1.3 pt-20 -67.74 -32.12 72.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.664 0.268 . . . . 1.0 111.159 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -70.67 -56.77 5.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.877 0.37 . . . . 1.0 111.013 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.724 ' NE2' HD11 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -51.96 -31.23 28.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.76 -0.655 . . . . 1.0 109.527 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.808 HD11 HD11 ' A' ' 115' ' ' LEU . 31.0 mt -65.74 -46.99 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.67 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.81 -43.72 96.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.439 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -58.7 -26.93 64.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.91 -0.586 . . . . 1.0 110.179 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.539 ' CE1' HE21 ' A' ' 64' ' ' GLN . 43.0 m170 -79.27 -2.11 39.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.549 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.44 -1.35 58.64 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.928 -0.869 . . . . 1.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -88.75 88.6 1.54 Allowed Glycine 0 N--CA 1.461 0.363 0 N-CA-C 110.689 -0.965 . . . . 1.0 110.689 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.581 ' CD ' ' H ' ' A' ' 71' ' ' GLN . 2.6 pm0 -59.82 146.34 42.19 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.7 mt -92.29 110.82 22.22 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 91.1 m -119.97 86.88 37.56 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.603 ' C ' ' H ' ' A' ' 76' ' ' GLN . 14.3 Cg_endo -55.21 -159.71 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 122.004 1.803 . . . . 1.0 112.64 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -54.61 -0.6 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.035 -0.529 . . . . 1.0 110.588 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.603 ' H ' ' C ' ' A' ' 74' ' ' PRO . 4.5 pt20 -62.78 -19.67 64.24 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.109 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -156.12 160.32 30.01 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 120.755 -0.736 . . . . 1.0 111.599 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.535 ' O ' ' O ' ' A' ' 79' ' ' GLY . 49.5 Cg_exo -52.17 -10.97 0.86 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.231 1.954 . . . . 1.0 112.09 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.548 ' O ' ' C ' ' A' ' 80' ' ' VAL . . . -53.0 -118.31 0.01 OUTLIER Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.712 -0.955 . . . . 1.0 110.712 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 80' ' ' VAL . 2.3 p 10.6 74.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-O 121.592 0.71 . . . . 1.0 111.889 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.19 -24.23 27.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.352 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.63 ' CD2' ' CZ2' ' A' ' 114' ' ' TRP . 79.2 m80 -116.67 140.22 49.65 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.808 0.337 . . . . 1.0 110.262 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.611 HD13 ' O ' ' A' ' 82' ' ' HIS . 2.9 mm -128.68 111.3 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.427 -0.583 . . . . 1.0 109.427 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.687 HG11 HD12 ' A' ' 115' ' ' LEU . 1.6 p -96.14 133.68 36.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.204 0.526 . . . . 1.0 110.379 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.8 m -127.82 165.61 26.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.562 -0.744 . . . . 1.0 110.536 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 88' ' ' GLY . 26.2 p-10 -77.06 14.26 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.791 -0.64 . . . . 1.0 110.636 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 64.81 -2.91 0.62 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.343 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -75.27 -49.87 8.98 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.305 -0.718 . . . . 1.0 111.305 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 8.0 ptp -88.87 156.38 18.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.82 0.343 . . . . 1.0 110.709 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -83.55 166.27 18.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.283 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.698 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -58.8 -47.58 84.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.993 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.698 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 17.5 pt-20 -53.69 -38.23 64.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.888 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.48 ' HG3' HD23 ' A' ' 97' ' ' LEU . 0.8 OUTLIER -70.23 -47.04 63.16 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.197 179.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.07 -31.07 17.64 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 119.99 -0.684 . . . . 1.0 111.349 -177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.3 mp -60.03 -47.58 85.28 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 120.346 -0.541 . . . . 1.0 111.267 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -70.91 -42.54 69.79 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.582 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.631 HD12 ' OG1' ' A' ' 51' ' ' THR . 3.8 mm? -64.36 -43.64 93.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.826 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.947 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -84.67 -4.27 58.93 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.545 -179.189 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.405 ' O ' ' CB ' ' A' ' 75' ' ' ALA . 75.1 mmt-85 68.57 60.94 0.37 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.038 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.517 ' HB2' HD11 ' A' ' 98' ' ' LEU . 7.7 tp -129.58 111.45 17.68 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.764 -0.198 . . . . 1.0 110.799 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -52.66 -42.64 61.13 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.916 1.744 . . . . 1.0 111.947 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -174.34 130.31 0.36 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.567 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 104' ' ' PRO . 69.5 mt -37.37 100.48 0.2 Allowed Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.094 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 103' ' ' LEU . 54.8 Cg_exo -46.01 -178.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.276 1.984 . . . . 1.0 112.407 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.14 -43.42 59.28 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.634 2.222 . . . . 1.0 112.65 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.39 68.98 0.25 Allowed Glycine 0 N--CA 1.468 0.775 0 N-CA-C 110.97 -0.852 . . . . 1.0 110.97 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -162.64 138.6 7.29 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.82 0.343 . . . . 1.0 110.587 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -146.02 151.93 38.54 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.256 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.88 113.26 25.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.962 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.704 HG21 ' CE3' ' A' ' 114' ' ' TRP . 12.0 m -110.63 166.33 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.501 -0.772 . . . . 1.0 109.885 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.51 ' NZ ' ' O ' ' A' ' 130' ' ' PHE . 28.8 mtmm -98.4 -176.99 3.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.731 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 37.3 t -62.94 -39.55 94.95 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.569 -0.742 . . . . 1.0 110.527 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.42 -41.86 66.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.227 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.704 ' CE3' HG21 ' A' ' 110' ' ' VAL . 75.1 t90 -61.6 -53.64 53.58 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.613 -0.435 . . . . 1.0 110.592 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.808 HD11 HD11 ' A' ' 65' ' ' ILE . 3.3 tt -61.94 -53.12 60.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.472 -0.491 . . . . 1.0 109.817 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 80.9 p -51.59 -46.71 63.6 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.492 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 59.4 mt -64.91 -54.99 21.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.355 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 1.4 p -50.17 -30.91 12.33 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.386 0.612 . . . . 1.0 110.284 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.724 HD11 ' NE2' ' A' ' 64' ' ' GLN . 2.3 tp -70.01 -52.8 21.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.265 -0.88 . . . . 1.0 110.614 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -66.95 -37.87 85.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.564 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' A' ' 123' ' ' ARG . 78.3 mm-40 -78.98 9.03 4.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.181 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.479 ' NH2' ' NE1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER 36.06 32.68 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.788 -0.642 . . . . 1.0 111.092 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.438 ' CG ' ' O ' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -158.09 177.24 11.53 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.076 -179.557 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.402 ' O ' ' NH1' ' A' ' 123' ' ' ARG . 5.6 tt -92.65 122.11 34.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.033 0.444 . . . . 1.0 110.766 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.425 HG23 ' CD1' ' A' ' 114' ' ' TRP . 3.2 m -100.0 152.23 4.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.347 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 46.4 p-10 -62.18 150.21 39.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.286 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 129' ' ' GLY . 2.3 m -102.46 6.31 10.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.468 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.6 56.3 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.78 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 168.34 -37.75 0.21 Allowed Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.51 ' O ' ' NZ ' ' A' ' 111' ' ' LYS . 50.4 m-85 -89.47 -18.24 27.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.728 0.299 . . . . 1.0 110.517 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 1.8 t -72.15 137.58 47.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.1 0.476 . . . . 1.0 110.78 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.588 ' C ' ' H ' ' A' ' 134' ' ' ILE . 59.1 mt -83.62 -69.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.333 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.486 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 16.7 t80 62.34 -31.47 0.09 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.368 -0.833 . . . . 1.0 112.133 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.588 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 151.7 -55.12 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 124.6 1.16 . . . . 1.0 109.854 -178.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.5 Cg_endo . . . . . 0 N--CA 1.497 1.688 0 C-N-CA 121.824 1.682 . . . . 1.0 112.137 -178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.505 -1.438 . . . . 1.0 109.505 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.7 m -152.83 101.76 2.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.851 0.358 . . . . 1.0 110.488 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -63.19 -41.24 99.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.528 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.6 m -100.24 134.96 42.41 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.583 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.3 -40.4 97.86 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -109.03 136.14 49.04 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.97 0.414 . . . . 1.0 110.381 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.629 ' CD ' ' H ' ' A' ' 36' ' ' GLU . 1.4 pm0 -66.97 -50.06 63.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.357 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 53.45 34.8 19.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.512 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -165.56 -38.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.663 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -138.95 92.21 2.58 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.566 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.633 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -109.99 -40.16 4.83 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.182 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.466 ' HG ' ' CE3' ' A' ' 40' ' ' TRP . 8.7 mt -79.61 1.86 24.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.42 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.2 t -54.99 -48.6 73.1 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.309 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.6 p -72.11 -37.28 69.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.929 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.2 mt -73.9 140.78 45.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.982 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.628 ' H ' HG22 ' A' ' 81' ' ' THR . 0.2 OUTLIER -124.94 102.81 7.71 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.979 178.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.482 ' O ' HD22 ' A' ' 72' ' ' LEU . . . -92.2 169.05 10.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.21 0.529 . . . . 1.0 110.845 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -156.33 124.14 5.57 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.672 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.572 HG12 HG13 ' A' ' 84' ' ' VAL . 14.4 m -103.04 143.72 14.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.047 0.451 . . . . 1.0 110.221 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 52' ' ' GLY . 18.9 m -97.07 161.21 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.449 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -81.25 -60.79 2.15 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 116.42 -0.354 . . . . 1.0 110.708 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.648 HG23 HD11 ' A' ' 97' ' ' LEU . 43.9 p -46.88 -12.08 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.983 0.42 . . . . 1.0 110.261 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.641 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -151.43 118.71 0.93 Allowed Glycine 0 C--O 1.205 -1.703 0 N-CA-C 109.46 -1.456 . . . . 1.0 109.46 179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.641 ' HB ' ' O ' ' A' ' 52' ' ' GLY . 4.6 mm 102.22 -16.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.816 0.846 . . . . 1.0 110.452 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.5 29.13 1.23 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.661 -0.976 . . . . 1.0 110.661 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 32.6 mtt180 -66.66 -60.92 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.764 0.316 . . . . 1.0 110.56 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 55' ' ' ARG . . . 172.47 -61.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.249 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -87.7 -32.47 19.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.311 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.12 83.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.363 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 61' ' ' PHE . 9.3 pt-20 -66.42 -42.26 88.04 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.382 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.3 tp -45.84 -13.54 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.111 0.481 . . . . 1.0 110.833 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 59' ' ' GLU . 3.8 m-30 -56.72 -47.64 79.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.884 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' HA ' HD12 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -62.09 -40.09 94.68 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.136 -0.483 . . . . 1.0 110.437 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -55.95 -46.41 78.56 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.632 -0.427 . . . . 1.0 110.222 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.485 ' O ' ' CD2' ' A' ' 68' ' ' HIS . 77.9 mt-30 -65.02 -38.85 92.25 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.147 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.54 HD11 HD11 ' A' ' 115' ' ' LEU . 77.5 mt -64.05 -43.69 97.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.48 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.0 t -61.16 -45.03 99.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.252 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -60.18 -26.01 66.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.318 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.485 ' CD2' ' O ' ' A' ' 64' ' ' GLN . 42.9 m170 -79.9 0.45 31.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.387 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 99.31 -19.31 54.42 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.871 -0.892 . . . . 1.0 110.871 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.34 94.04 0.63 Allowed Glycine 0 C--O 1.224 -0.478 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.44 ' C ' HD23 ' A' ' 72' ' ' LEU . 14.0 pt20 -77.13 145.23 37.9 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.975 -0.29 . . . . 1.0 110.439 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.483 ' O ' ' SG ' ' A' ' 73' ' ' CYS . 4.6 mt -107.18 145.58 32.41 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.938 0.399 . . . . 1.0 110.302 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 72' ' ' LEU . 3.8 m -163.44 91.21 1.16 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.381 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 77' ' ' GLY . 43.7 Cg_endo -70.02 -167.09 0.22 Allowed 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.599 2.199 . . . . 1.0 111.989 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 98' ' ' LEU . . . -38.63 -27.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.837 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.482 ' N ' ' O ' ' A' ' 74' ' ' PRO . 1.7 pt20 -64.03 1.58 0.67 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.399 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 74' ' ' PRO . . . 162.78 161.78 12.76 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.063 -0.815 . . . . 1.0 111.063 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.03 143.72 73.28 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.63 2.22 . . . . 1.0 111.817 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.403 ' HA2' ' HE ' ' A' ' 45' ' ' ARG . . . 116.42 66.01 0.38 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.224 -0.751 . . . . 1.0 111.224 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 80' ' ' VAL . 2.7 p -160.79 67.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.423 0.63 . . . . 1.0 110.475 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.628 HG22 ' H ' ' A' ' 45' ' ' ARG . 15.3 t -74.26 -33.29 63.24 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.003 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 20.9 m80 -117.37 146.0 43.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.938 0.399 . . . . 1.0 110.848 -179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.598 HD13 ' CD1' ' A' ' 98' ' ' LEU . 22.5 mt -137.51 111.43 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-N 115.945 -0.57 . . . . 1.0 109.839 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.572 HG13 HG12 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -95.15 140.59 16.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.121 0.486 . . . . 1.0 110.633 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.465 ' C ' ' H ' ' A' ' 87' ' ' GLU . 28.2 m -131.16 166.64 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.83 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.59 ' C ' ' H ' ' A' ' 88' ' ' GLY . 49.4 p-10 -73.07 14.16 0.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.665 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' A' ' 85' ' ' VAL . 18.6 mt-10 65.82 -15.32 0.12 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.776 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -64.13 -49.47 66.51 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.917 -0.873 . . . . 1.0 110.917 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 16.5 ptp -90.03 158.13 17.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.862 0.363 . . . . 1.0 110.471 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -89.1 -179.64 5.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.667 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -67.67 -37.59 82.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.37 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.538 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 15.2 pt-20 -58.91 -46.05 88.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.979 -177.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.482 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 1.9 tmm_? -79.36 -24.34 42.76 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.022 -0.536 . . . . 1.0 111.231 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.55 -37.47 70.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.569 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.629 HD11 HD11 ' A' ' 103' ' ' LEU . 7.4 mp -60.96 -36.27 78.96 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 121.11 -0.236 . . . . 1.0 110.674 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.536 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 6.6 mmp_? -62.65 -36.86 84.22 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.247 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.648 HD11 HG23 ' A' ' 51' ' ' THR . 4.3 mm? -62.61 -42.21 99.45 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.054 0.454 . . . . 1.0 111.266 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.598 ' CD1' HD13 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -97.32 5.31 50.12 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.668 -0.696 . . . . 1.0 109.663 -178.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.536 ' NH1' ' O ' ' A' ' 96' ' ' ARG . 51.2 mmt-85 51.01 24.32 1.81 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.267 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.7 tp -86.53 121.37 72.23 Favored Pre-proline 0 N--CA 1.448 -0.542 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.776 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.07 -17.17 36.34 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.465 2.11 . . . . 1.0 112.399 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 176.78 152.8 0.2 Allowed 'General case' 0 C--O 1.235 0.297 0 O-C-N 123.323 0.389 . . . . 1.0 110.453 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.774 HD12 ' N ' ' A' ' 103' ' ' LEU . 3.8 mp -86.47 140.6 33.98 Favored Pre-proline 0 N--CA 1.453 -0.323 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.949 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.02 164.41 35.75 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.416 2.077 . . . . 1.0 111.952 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -40.69 135.19 2.16 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.6 2.2 . . . . 1.0 112.191 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 107' ' ' ALA . . . 80.74 -69.56 3.19 Favored Glycine 0 C--O 1.228 -0.226 0 N-CA-C 110.284 -1.126 . . . . 1.0 110.284 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 106' ' ' GLY . . . -29.02 150.6 0.0 OUTLIER 'General case' 0 C--N 1.345 0.379 0 O-C-N 123.924 0.426 . . . . 1.0 110.964 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.511 ' OE1' HG11 ' A' ' 127' ' ' VAL . 9.7 pt20 -162.88 153.59 16.8 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.48 -0.488 . . . . 1.0 110.372 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.52 ' O ' ' OG ' ' A' ' 131' ' ' SER . 0.4 OUTLIER -85.37 112.56 20.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.915 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.472 HG21 ' CE3' ' A' ' 114' ' ' TRP . 11.2 m -104.68 172.58 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 123.475 0.484 . . . . 1.0 109.743 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -102.21 -173.73 2.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.661 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.1 m -63.57 -36.92 85.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.714 -0.675 . . . . 1.0 110.834 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.93 -36.23 65.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.502 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.472 ' CE3' HG21 ' A' ' 110' ' ' VAL . 89.3 t90 -68.67 -44.71 73.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.906 0.384 . . . . 1.0 110.542 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.54 HD11 HD11 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -66.97 -59.28 3.62 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.111 0.481 . . . . 1.0 111.037 -179.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.7 m -45.17 -58.24 3.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.614 -178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.8 mp -60.01 -52.99 63.04 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 120.629 -0.429 . . . . 1.0 110.645 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 46.5 t -55.39 -31.21 61.63 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.696 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 14.0 tp -68.23 -55.25 12.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.029 0.442 . . . . 1.0 111.872 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -77.06 -38.94 51.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.993 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.509 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 62.7 mm-40 -53.17 -48.3 68.1 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.432 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 121' ' ' GLU . 7.0 tpt180 86.61 27.35 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 O-C-N 123.733 0.645 . . . . 1.0 111.168 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.42 ' C ' ' CD ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -159.49 -171.45 3.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.445 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.1 tp -91.7 135.65 33.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.439 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.2 m -120.42 154.44 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.331 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 126' ' ' ASP . 54.6 p-10 -61.73 146.14 50.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.761 -0.654 . . . . 1.0 110.343 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 129' ' ' GLY . 9.0 t -104.64 -23.48 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 110.218 -0.29 . . . . 1.0 110.218 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.16 68.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.978 0.418 . . . . 1.0 110.499 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 165.81 -27.17 0.18 Allowed Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.141 -0.783 . . . . 1.0 111.141 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -106.7 -3.01 21.02 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.667 0.27 . . . . 1.0 110.583 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.52 ' OG ' ' O ' ' A' ' 109' ' ' LEU . 3.2 m -104.7 125.61 50.97 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.976 0.417 . . . . 1.0 110.767 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.58 ' C ' ' H ' ' A' ' 134' ' ' ILE . 3.2 mp -64.63 -50.09 77.34 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.331 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.526 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 17.0 t80 65.67 -36.7 0.23 Allowed 'General case' 0 C--O 1.217 -0.615 0 O-C-N 124.278 0.986 . . . . 1.0 111.212 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.615 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 156.67 -54.65 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.311 0 O-C-N 124.663 1.227 . . . . 1.0 110.452 -178.658 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 27.5 Cg_endo . . . . . 0 C--N 1.309 -1.54 0 C-N-CA 122.331 2.021 . . . . 1.0 111.682 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 109.458 -1.457 . . . . 1.0 109.458 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 83.0 p -72.0 146.29 47.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 1.0 110.491 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 34' ' ' GLY . 37.2 t30 -63.67 -40.28 96.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.592 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 t 65.89 -67.39 0.14 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.811 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 77.55 -6.02 48.21 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 110.789 -0.924 . . . . 1.0 110.789 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -156.8 73.31 0.76 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.728 0.299 . . . . 1.0 110.244 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.454 ' CG ' ' N ' ' A' ' 37' ' ' ALA . 14.6 pt-20 -65.46 -44.56 86.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.58 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.454 ' N ' ' CG ' ' A' ' 36' ' ' GLU . . . 38.67 50.34 1.6 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.114 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -66.26 -39.03 89.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.694 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 46.36 84.96 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.568 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.579 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 0.1 OUTLIER -102.17 -50.89 3.51 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.832 0.349 . . . . 1.0 110.462 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.55 ' HG ' HD11 ' A' ' 44' ' ' LEU . 2.2 tp -80.87 -0.65 39.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.733 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.6 p -66.95 -15.59 63.79 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.424 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 78.3 p -67.19 -15.56 63.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.517 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.683 HD12 ' C ' ' A' ' 44' ' ' LEU . 4.2 pp -136.21 168.84 18.64 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.387 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -116.65 118.09 31.63 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.009 0.433 . . . . 1.0 110.334 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.598 ' CB ' HD13 ' A' ' 65' ' ' ILE . . . -95.6 161.47 14.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.475 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -153.96 118.09 4.79 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.375 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.53 HG13 HD12 ' A' ' 53' ' ' ILE . 76.1 t -107.32 135.09 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.241 0.543 . . . . 1.0 110.379 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.549 HG12 ' H ' ' A' ' 52' ' ' GLY . 19.0 t -73.7 99.1 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.447 -0.797 . . . . 1.0 110.206 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.529 HH21 HH12 ' A' ' 99' ' ' ARG . 84.8 mtm-85 -58.34 -37.8 75.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.42 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.9 p -75.92 -17.26 59.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.539 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.549 ' H ' HG12 ' A' ' 49' ' ' VAL . . . -97.44 -59.5 0.97 Allowed Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.202 -0.759 . . . . 1.0 111.202 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.53 HD12 HG13 ' A' ' 48' ' ' VAL . 2.7 mt -86.42 71.32 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.161 0.505 . . . . 1.0 110.341 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -117.03 23.38 9.97 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 110.783 -0.927 . . . . 1.0 110.783 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.65 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 4.2 ptm180 -75.03 -63.41 1.27 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.551 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 55' ' ' ARG . . . 159.93 138.49 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? 68.54 -42.14 0.47 Allowed 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 124.191 0.932 . . . . 1.0 110.327 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' A' ' 56' ' ' ALA . . . -65.37 -28.65 69.43 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.868 -0.605 . . . . 1.0 110.532 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.72 -39.75 80.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.395 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.99 -19.05 0.63 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.182 0.515 . . . . 1.0 110.582 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -44.18 -50.96 8.51 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.732 -0.667 . . . . 1.0 111.036 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.415 ' O ' HG23 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -64.45 -43.98 92.55 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.626 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -62.41 -43.06 99.72 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.375 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -59.21 -26.13 64.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.272 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.701 HD11 HD21 ' A' ' 115' ' ' LEU . 80.8 mt -86.28 -23.32 6.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.366 0.603 . . . . 1.0 110.38 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 62' ' ' GLU . 68.4 t -79.06 -37.66 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 O-C-N 122.056 -0.403 . . . . 1.0 110.706 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -68.08 -38.87 82.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.127 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.492 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -68.49 -6.41 24.87 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.274 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.44 7.11 52.25 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.465 -1.054 . . . . 1.0 110.465 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.7 96.89 2.19 Favored Glycine 0 C--N 1.339 0.72 0 N-CA-C 110.267 -1.133 . . . . 1.0 110.267 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -68.32 144.13 54.92 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.734 -0.387 . . . . 1.0 110.287 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.0 mt -91.81 135.29 34.03 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.054 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.8 m -104.61 103.62 41.06 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.378 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 76' ' ' GLN . 56.3 Cg_endo -75.17 168.35 24.9 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.397 2.065 . . . . 1.0 111.955 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.57 -7.39 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.558 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 74' ' ' PRO . 42.0 mt-30 -76.43 -9.6 58.77 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 110.151 -0.315 . . . . 1.0 110.151 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -145.35 147.87 19.25 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.69 -16.44 33.66 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.698 2.266 . . . . 1.0 111.989 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -42.82 -25.92 0.39 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.437 -0.665 . . . . 1.0 111.437 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.435 HG11 HD11 ' A' ' 100' ' ' LEU . 12.8 p -64.79 138.88 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.965 0.412 . . . . 1.0 110.471 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.99 -34.27 0.23 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.879 -0.601 . . . . 1.0 110.536 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -108.78 125.05 51.52 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.619 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.412 ' O ' ' O ' ' A' ' 110' ' ' VAL . 22.5 mm -118.95 106.92 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.23 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.41 HG11 HD23 ' A' ' 115' ' ' LEU . 0.1 OUTLIER -95.08 135.29 29.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.339 -0.846 . . . . 1.0 110.088 -179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.54 ' C ' ' H ' ' A' ' 87' ' ' GLU . 27.7 m -135.41 155.65 37.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.412 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 88' ' ' GLY . 53.5 p-10 -71.29 22.5 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.581 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 85' ' ' VAL . 29.9 mt-10 65.96 -13.8 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 1.0 111.017 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.558 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -61.81 -41.76 99.66 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 111.074 -0.811 . . . . 1.0 111.074 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.6 ptp -103.41 154.32 19.54 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.782 0.325 . . . . 1.0 110.53 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -90.16 172.81 8.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.133 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.594 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -58.53 -54.66 44.57 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.544 -179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.594 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 1.3 pp20? -52.07 -40.18 60.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.866 -0.606 . . . . 1.0 110.098 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -71.97 -39.13 69.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.832 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.91 -28.65 62.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.936 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.5 mp -61.82 -46.36 89.82 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 120.513 -0.475 . . . . 1.0 111.023 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.1 mmp_? -70.91 -40.98 71.84 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.38 -0.528 . . . . 1.0 111.345 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 94.9 mt -65.92 -44.93 83.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.168 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.873 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -79.86 -13.93 59.03 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.63 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.529 HH12 HH21 ' A' ' 50' ' ' ARG . 2.9 mtp180 77.93 60.91 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 123.977 0.798 . . . . 1.0 111.937 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.736 HD12 HD11 ' A' ' 98' ' ' LEU . 3.3 mt -148.71 114.02 3.73 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 120.12 -0.632 . . . . 1.0 110.116 178.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.519 ' HD2' HD23 ' A' ' 100' ' ' LEU . 58.5 Cg_endo -73.49 -11.45 24.47 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.128 1.886 . . . . 1.0 112.602 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 63.6 tp60 179.43 133.8 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.427 0.454 . . . . 1.0 110.207 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.604 HD22 HD13 ' A' ' 100' ' ' LEU . 10.8 mt -88.85 146.66 37.29 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.958 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.65 165.7 26.61 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 C-N-CA 122.206 1.937 . . . . 1.0 112.311 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -43.48 140.63 3.99 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.117 1.878 . . . . 1.0 112.282 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.48 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 82.31 -64.46 4.26 Favored Glycine 0 N--CA 1.453 -0.181 0 N-CA-C 110.305 -1.118 . . . . 1.0 110.305 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.48 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -22.33 134.87 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 O-C-N 124.134 0.549 . . . . 1.0 110.868 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.484 ' O ' ' NE2' ' A' ' 108' ' ' GLN . 0.0 OUTLIER -143.69 157.52 44.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.897 0.38 . . . . 1.0 110.145 -177.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.507 HD12 ' N ' ' A' ' 109' ' ' LEU . 4.0 mp -108.24 121.8 45.64 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.773 -0.648 . . . . 1.0 110.778 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.471 HG13 ' NE2' ' A' ' 108' ' ' GLN . 3.1 m -108.06 -178.23 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.109 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -109.28 -176.63 3.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.501 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.4 m -60.98 -37.79 83.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.817 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.445 ' O ' HD13 ' A' ' 117' ' ' LEU . . . -56.06 -47.34 78.12 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.944 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.461 ' CE3' HG21 ' A' ' 110' ' ' VAL . 72.9 t90 -56.43 -37.9 70.86 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.727 -0.389 . . . . 1.0 110.312 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.701 HD21 HD11 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -68.56 -61.16 1.94 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.268 -0.573 . . . . 1.0 110.929 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.9 t -49.39 -52.21 30.0 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.388 -0.525 . . . . 1.0 110.47 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 113' ' ' ALA . 7.1 mp -48.93 -44.88 40.88 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.068 -0.514 . . . . 1.0 109.937 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.529 ' SG ' HG23 ' A' ' 125' ' ' VAL . 74.5 m -60.25 -43.42 96.11 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.362 -0.535 . . . . 1.0 110.832 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 65.9 mt -50.21 -57.9 6.77 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.589 -0.444 . . . . 1.0 111.386 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -73.22 -49.01 30.29 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.727 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 74.6 mm-40 -54.27 -48.35 71.31 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.472 -0.491 . . . . 1.0 110.362 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 121' ' ' GLU . 8.7 tpp180 79.48 39.59 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.836 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.418 ' C ' ' CD ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -165.48 -173.18 2.69 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.415 -0.514 . . . . 1.0 110.428 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 11.3 tp -82.52 122.24 27.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.014 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.529 HG23 ' SG ' ' A' ' 118' ' ' CYS . 40.2 t -97.19 154.7 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-O 121.274 0.559 . . . . 1.0 110.432 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.449 ' N ' HG12 ' A' ' 125' ' ' VAL . 64.1 t0 -69.29 115.38 8.5 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.394 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.461 HG23 ' N ' ' A' ' 128' ' ' ALA . 5.0 m -64.16 -39.64 86.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.607 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.461 ' N ' HG23 ' A' ' 127' ' ' VAL . . . -53.73 -25.52 19.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.0 -0.545 . . . . 1.0 110.506 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -66.69 -38.6 93.31 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.243 -0.743 . . . . 1.0 111.243 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -139.74 43.01 1.98 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.848 0.356 . . . . 1.0 110.883 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 127' ' ' VAL . 8.7 t -107.84 132.9 52.93 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.288 0.566 . . . . 1.0 111.182 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.57 ' C ' ' H ' ' A' ' 134' ' ' ILE . 54.8 mt -75.64 -69.23 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.868 0 CA-C-N 115.084 -0.962 . . . . 1.0 109.881 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.493 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 15.8 t80 65.83 -36.58 0.24 Allowed 'General case' 0 C--O 1.223 -0.335 0 O-C-N 124.514 1.134 . . . . 1.0 111.578 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.57 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 156.03 -55.78 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.512 0 O-C-N 125.009 1.443 . . . . 1.0 109.752 -178.279 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 30.0 Cg_endo . . . . . 0 N--CA 1.49 1.298 0 C-N-CA 122.169 1.912 . . . . 1.0 112.01 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.428 -1.469 . . . . 1.0 109.428 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.2 p -61.19 -41.85 97.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.804 0.335 . . . . 1.0 110.546 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -136.17 130.48 33.28 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.584 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 96.6 p -76.81 158.8 30.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.366 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 150.35 -78.97 0.21 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.832 -0.907 . . . . 1.0 110.832 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -135.18 126.14 27.65 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.99 0.424 . . . . 1.0 110.341 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.681 ' C ' ' H ' ' A' ' 38' ' ' GLU . 3.6 pm0 -108.03 23.3 14.7 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.767 -0.652 . . . . 1.0 111.062 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.17 26.36 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.415 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.681 ' H ' ' C ' ' A' ' 36' ' ' GLU . 94.6 mt-10 -145.89 29.66 1.09 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.49 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -130.31 70.89 1.44 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.643 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 1.1 p-90 -86.83 -49.81 7.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.094 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.581 HD13 ' O ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -62.58 -35.11 78.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.73 0.776 . . . . 1.0 110.019 -179.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.66 -33.77 64.38 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.338 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 t -43.54 -25.67 0.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.795 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.83 167.87 18.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.343 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.401 ' O ' HG22 ' A' ' 81' ' ' THR . 27.2 ttm180 -115.94 112.65 22.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 1.0 110.167 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.474 ' HB3' HD13 ' A' ' 65' ' ' ILE . . . -92.36 165.95 12.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.87 -0.604 . . . . 1.0 110.49 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.529 ' CE1' ' O ' ' A' ' 73' ' ' CYS . 49.1 t60 -144.33 122.11 11.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.154 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.469 ' O ' ' NH1' ' A' ' 50' ' ' ARG . 71.5 t -110.95 133.97 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.341 -0.391 . . . . 1.0 110.31 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.2 m -71.94 134.01 30.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.39 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.486 ' N ' ' CD ' ' A' ' 50' ' ' ARG . 9.6 mpt_? -64.27 -40.75 96.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.546 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.483 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 7.6 p -104.19 138.19 41.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.1 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.26 -16.44 56.9 Favored Glycine 0 C--O 1.226 -0.402 0 N-CA-C 111.012 -0.835 . . . . 1.0 111.012 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.523 ' C ' ' H ' ' A' ' 55' ' ' ARG . 1.5 mm -117.75 -23.23 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.991 0.424 . . . . 1.0 110.248 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.37 35.01 0.44 Allowed Glycine 0 C--N 1.314 -0.678 0 C-N-CA 120.242 -0.98 . . . . 1.0 111.25 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.523 ' H ' ' C ' ' A' ' 53' ' ' ILE . 2.0 ptp180 -76.71 -60.96 2.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.582 0.229 . . . . 1.0 110.602 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.591 ' C ' ' H ' ' A' ' 58' ' ' ALA . . . 171.68 125.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.06 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 58.7 ttp85 68.74 -32.34 0.22 Allowed 'General case' 0 CA--C 1.518 -0.275 0 O-C-N 123.502 0.501 . . . . 1.0 110.323 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.591 ' H ' ' C ' ' A' ' 56' ' ' ALA . . . -63.55 -36.5 83.99 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.63 0.728 . . . . 1.0 110.09 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 61' ' ' PHE . 12.3 pt-20 -60.36 -39.19 86.3 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 120.353 -0.539 . . . . 1.0 110.852 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.0 tp -42.29 -17.95 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.313 0.577 . . . . 1.0 110.854 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.559 ' N ' ' O ' ' A' ' 59' ' ' GLU . 2.3 m-85 -51.39 -51.25 56.28 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.988 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.583 ' HA ' HD12 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -61.89 -37.38 84.36 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.047 -0.353 . . . . 1.0 110.047 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -62.47 -45.83 91.24 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.095 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -64.83 -18.5 65.19 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.254 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 62' ' ' GLU . 61.4 mt -85.53 -56.95 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.902 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.493 HG23 ' N ' ' A' ' 67' ' ' GLN . 12.2 m -65.32 -40.57 88.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.36 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.493 ' N ' HG23 ' A' ' 66' ' ' VAL . 53.3 tt0 -53.83 -41.45 67.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.22 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -96.89 10.95 37.58 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.397 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 97.13 139.94 11.0 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.656 -0.977 . . . . 1.0 110.656 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.84 61.11 0.13 Allowed Glycine 0 N--CA 1.466 0.664 0 N-CA-C 110.475 -1.05 . . . . 1.0 110.475 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -51.68 145.51 9.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.991 0.424 . . . . 1.0 110.405 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.3 mt -81.6 155.61 25.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.788 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.529 ' O ' ' CE1' ' A' ' 47' ' ' HIS . 1.3 m -158.56 156.39 27.15 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.409 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -59.98 125.87 18.81 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.546 2.164 . . . . 1.0 111.853 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.498 ' HB3' HD11 ' A' ' 98' ' ' LEU . . . -77.55 -0.27 25.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.989 -0.551 . . . . 1.0 110.623 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -61.52 0.73 0.28 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.865 0.364 . . . . 1.0 110.623 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 75' ' ' ALA . . . -166.25 -172.44 33.58 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -53.5 -4.28 0.2 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.912 2.408 . . . . 1.0 111.97 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 77' ' ' GLY . . . -38.75 -61.29 1.35 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 m -106.41 -168.09 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.994 0.426 . . . . 1.0 110.202 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.479 HG23 ' ND1' ' A' ' 82' ' ' HIS . 1.8 t -140.41 -30.06 0.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.864 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.479 ' ND1' HG23 ' A' ' 81' ' ' THR . 64.3 m80 -121.08 150.9 40.5 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.618 0.247 . . . . 1.0 110.788 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.3 mt -134.21 111.0 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.3 t -93.93 144.02 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.951 -178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.495 ' C ' ' H ' ' A' ' 87' ' ' GLU . 32.2 m -134.3 154.7 38.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.569 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.517 ' C ' ' H ' ' A' ' 88' ' ' GLY . 31.3 t70 -71.82 19.83 0.06 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.747 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 85' ' ' VAL . 0.8 OUTLIER 69.0 -39.16 0.42 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.363 -0.38 . . . . 1.0 111.048 179.037 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -38.99 -57.15 2.08 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 89' ' ' MET . 0.0 OUTLIER -87.1 160.17 18.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.81 0.338 . . . . 1.0 110.534 179.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -97.15 -177.05 3.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.056 0.455 . . . . 1.0 110.362 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -62.5 -47.04 85.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.846 -0.615 . . . . 1.0 110.576 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.627 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 10.6 pt-20 -53.36 -50.89 64.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.921 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.451 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 29.5 ttp180 -71.25 -42.8 68.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.118 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -43.84 -35.16 1.82 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.943 -0.572 . . . . 1.0 110.783 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.9 mp -59.93 -61.15 2.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.049 0.452 . . . . 1.0 110.884 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.556 HH21 ' C ' ' A' ' 100' ' ' LEU . 5.9 mmp_? -68.31 -22.2 64.73 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.236 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.535 HD13 ' O ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -63.82 -36.96 85.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.994 -178.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.668 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -110.9 13.99 22.13 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.784 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 63.06 59.65 1.3 Allowed 'General case' 0 CA--C 1.508 -0.637 0 C-N-CA 120.547 -0.461 . . . . 1.0 110.991 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.556 ' C ' HH21 ' A' ' 96' ' ' ARG . 13.8 tp -124.56 127.83 25.11 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.848 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.18 -44.88 11.06 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.037 1.825 . . . . 1.0 112.058 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.536 ' NE2' ' OH ' ' A' ' 91' ' ' TYR . 1.5 mm-40 176.6 136.53 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.228 0.537 . . . . 1.0 110.578 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.7 mt -41.91 116.21 1.63 Allowed Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 115.423 -0.808 . . . . 1.0 111.45 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -71.46 141.72 39.13 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.703 1.602 . . . . 1.0 111.922 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -40.77 93.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.451 2.101 . . . . 1.0 112.63 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.61 -56.55 0.59 Allowed Glycine 0 N--CA 1.465 0.585 0 N-CA-C 111.156 -0.778 . . . . 1.0 111.156 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.73 160.28 32.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.857 0.361 . . . . 1.0 110.947 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -149.16 156.6 42.42 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.44 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 131' ' ' SER . 1.3 mt -92.88 111.63 23.31 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.953 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.641 HG21 ' CE3' ' A' ' 114' ' ' TRP . 4.1 m -103.83 170.3 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -101.84 171.04 7.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.129 0.49 . . . . 1.0 111.607 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.2 m -56.05 -35.11 66.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.38 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.6 -38.18 86.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.729 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.641 ' CE3' HG21 ' A' ' 110' ' ' VAL . 74.8 t90 -60.47 -49.89 75.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.369 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.505 HD23 ' CD1' ' A' ' 61' ' ' PHE . 34.9 tp -63.05 -53.77 48.52 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.194 -0.603 . . . . 1.0 110.561 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 43.9 t -50.81 -46.67 59.96 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 21.3 mt -51.31 -48.77 62.25 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.356 -0.538 . . . . 1.0 109.813 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.521 ' O ' ' N ' ' A' ' 122' ' ' ARG . 55.9 m -51.75 -34.89 41.32 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 38.9 mt -70.31 -54.53 12.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.002 0.43 . . . . 1.0 110.519 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 47.5 mm-40 -65.62 -38.35 89.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.231 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 80.7 mm-40 -79.79 -42.81 23.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.15 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 118' ' ' CYS . 5.2 tpp85 82.16 40.07 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.856 -0.611 . . . . 1.0 111.114 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -169.61 -173.44 1.65 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.342 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.6 tt -92.2 121.56 33.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.607 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.464 HG23 ' CD1' ' A' ' 114' ' ' TRP . 2.7 m -103.69 151.77 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.244 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 126' ' ' ASP . 48.4 p30 -66.78 147.71 52.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.24 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.578 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 31.3 m -101.29 -136.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.383 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 127' ' ' VAL . . . 74.59 -60.69 0.51 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.326 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -65.05 -53.55 33.01 Favored Glycine 0 CA--C 1.521 0.434 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -69.98 -42.52 73.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.934 0.397 . . . . 1.0 110.502 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 109' ' ' LEU . 15.1 p -58.56 153.53 16.02 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.628 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.59 ' C ' ' H ' ' A' ' 134' ' ' ILE . 2.9 mp -90.08 -57.46 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.793 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.238 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.516 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 17.6 t80 65.12 -35.63 0.19 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.263 0.977 . . . . 1.0 111.433 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.59 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.5 OUTLIER 155.26 -56.06 0.0 OUTLIER Pre-proline 0 C--N 1.346 0.441 0 O-C-N 124.84 1.338 . . . . 1.0 109.862 -178.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.3 Cg_endo . . . . . 0 N--CA 1.49 1.301 0 C-N-CA 122.212 1.941 . . . . 1.0 112.012 -177.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.588 -1.405 . . . . 1.0 109.588 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.3 t -63.33 -24.79 68.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 1.0 110.57 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.413 ' O ' ' O ' ' A' ' 33' ' ' SER . 23.8 t-20 -64.18 -41.38 97.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.57 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.413 ' O ' ' O ' ' A' ' 32' ' ' ASN . 5.3 p 60.84 129.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.604 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.92 -42.98 98.15 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -155.6 146.01 21.89 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.395 -0.224 . . . . 1.0 110.395 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.498 ' C ' ' H ' ' A' ' 38' ' ' GLU . 2.1 mp0 -95.64 77.31 3.29 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.871 0.843 . . . . 1.0 110.47 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.27 -1.49 0.34 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.982 -1.008 . . . . 1.0 110.194 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.498 ' H ' ' C ' ' A' ' 36' ' ' GLU . 57.6 mp0 -74.01 -170.51 0.94 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.598 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 55.1 65.08 1.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.777 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.612 ' CZ2' ' ND1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -97.16 -33.87 11.33 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.167 -179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.448 ' HG ' ' CE3' ' A' ' 40' ' ' TRP . 29.1 mt -83.03 -0.86 50.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.237 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.3 p -58.55 -41.8 86.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.662 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.8 m -61.58 -60.82 3.1 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.25 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 pp -74.94 167.4 21.97 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.728 -0.471 . . . . 1.0 109.728 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -124.51 121.75 35.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 1.0 111.023 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.502 ' HB3' HD13 ' A' ' 65' ' ' ILE . . . -103.63 124.85 49.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.865 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -111.11 120.58 42.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.247 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.589 ' H ' HD22 ' A' ' 72' ' ' LEU . 51.3 t -111.1 132.39 59.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.967 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.743 HG23 ' H ' ' A' ' 53' ' ' ILE . 27.0 m -78.58 84.09 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.434 0.635 . . . . 1.0 110.27 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.621 HH11 HD13 ' A' ' 72' ' ' LEU . 76.1 mtm-85 -54.52 -43.67 72.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.464 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.443 ' OG1' ' CD1' ' A' ' 97' ' ' LEU . 66.7 p -62.14 -22.92 66.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.323 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.03 -74.42 1.11 Allowed Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.258 -0.737 . . . . 1.0 111.258 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.743 ' H ' HG23 ' A' ' 49' ' ' VAL . 5.3 mt -53.37 122.16 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 CA-C-O 121.942 0.877 . . . . 1.0 109.978 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -174.64 25.97 0.07 OUTLIER Glycine 0 C--N 1.302 -1.326 0 CA-C-N 114.315 -1.311 . . . . 1.0 112.066 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -75.31 -47.32 28.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.829 0.347 . . . . 1.0 111.305 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -168.84 -114.96 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.932 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.482 ' CD ' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -63.5 -19.58 64.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.334 -0.393 . . . . 1.0 110.677 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.403 ' CB ' HG23 ' A' ' 53' ' ' ILE . . . -40.61 -47.54 2.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.056 0.455 . . . . 1.0 110.639 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -68.37 -37.48 80.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.183 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 57' ' ' ARG . 4.9 tp -48.77 -18.38 0.26 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.196 0.522 . . . . 1.0 111.019 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.421 ' HB3' HD13 ' A' ' 115' ' ' LEU . 20.4 m-85 -69.38 -43.35 73.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.924 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.597 ' HA ' HD12 ' A' ' 65' ' ' ILE . 9.5 pt-20 -58.48 -39.51 80.17 Favored 'General case' 0 C--N 1.317 -0.83 0 O-C-N 123.356 0.41 . . . . 1.0 110.494 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.434 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 41.1 mttp -63.44 -40.36 96.93 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.575 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -65.66 -18.88 65.65 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.711 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.597 HD12 ' HA ' ' A' ' 62' ' ' GLU . 71.0 mt -85.29 -62.37 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.079 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.7 m -45.09 -35.27 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.729 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -65.57 -46.09 80.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.91 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.612 ' ND1' ' CZ2' ' A' ' 40' ' ' TRP . 1.3 m170 -97.7 23.67 7.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.436 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 83.44 -179.4 52.55 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.134 -0.787 . . . . 1.0 111.134 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 71' ' ' GLN . . . 74.87 27.73 64.14 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.891 -0.883 . . . . 1.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.435 ' O ' ' O ' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -44.18 170.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.835 0.35 . . . . 1.0 110.733 -179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.621 HD13 HH11 ' A' ' 50' ' ' ARG . 40.6 mt -73.46 147.26 44.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.249 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.44 ' O ' ' CG2' ' A' ' 80' ' ' VAL . 0.8 OUTLIER -161.59 96.26 1.3 Allowed Pre-proline 0 N--CA 1.45 -0.457 0 N-CA-C 109.928 -0.397 . . . . 1.0 109.928 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.47 147.47 12.59 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.497 2.131 . . . . 1.0 112.232 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 77' ' ' GLY . . . -51.47 -46.8 63.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.717 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.667 ' CD ' ' H ' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -65.13 1.37 1.01 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.125 0.488 . . . . 1.0 110.29 -179.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 75' ' ' ALA . . . -93.31 -117.78 2.66 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 110.772 -0.931 . . . . 1.0 110.772 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.46 -57.65 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.528 2.152 . . . . 1.0 112.381 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.528 ' O ' HG12 ' A' ' 80' ' ' VAL . . . -162.78 -73.57 0.02 OUTLIER Glycine 0 C--O 1.224 -0.473 0 C-N-CA 120.681 -0.771 . . . . 1.0 111.497 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 79' ' ' GLY . 0.4 OUTLIER 74.83 162.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 O-C-N 123.87 0.394 . . . . 1.0 110.256 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.53 -30.48 0.11 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.251 -0.432 . . . . 1.0 111.274 179.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -111.84 141.81 45.01 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.153 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.1 mp -132.74 108.32 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.973 -0.558 . . . . 1.0 109.784 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.528 HG11 HD12 ' A' ' 115' ' ' LEU . 12.2 t -92.96 135.25 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 115.802 -0.636 . . . . 1.0 111.043 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.552 ' C ' ' H ' ' A' ' 87' ' ' GLU . 30.0 m -132.34 159.26 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.475 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 88' ' ' GLY . 47.4 p30 -67.05 12.31 0.08 Allowed 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.465 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.552 ' H ' ' C ' ' A' ' 85' ' ' VAL . 7.9 mt-10 70.5 -22.95 0.17 Allowed 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.291 0.369 . . . . 1.0 110.842 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -58.74 -46.63 93.15 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.686 -0.966 . . . . 1.0 110.686 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 13.2 ptp -88.85 145.04 25.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.848 0.356 . . . . 1.0 110.178 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -80.08 173.19 12.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.385 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.615 ' CG ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.19 -53.02 63.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.561 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.615 ' N ' ' CG ' ' A' ' 91' ' ' TYR . 14.2 pt-20 -53.47 -41.44 66.18 Favored 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 123.55 0.531 . . . . 1.0 110.521 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.716 ' HE ' ' CZ ' ' A' ' 96' ' ' ARG . 46.5 ttt180 -69.64 -40.15 76.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.082 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.48 ' O ' ' CD2' ' A' ' 98' ' ' LEU . . . -51.5 -26.48 8.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.938 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.1 mp -57.15 -41.04 78.41 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.735 -0.603 . . . . 1.0 110.802 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.716 ' CZ ' ' HE ' ' A' ' 93' ' ' ARG . 23.3 ptt180 -63.39 -34.18 77.17 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.413 -0.515 . . . . 1.0 109.986 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.445 ' HA ' HD13 ' A' ' 97' ' ' LEU . 3.3 mm? -60.53 -47.9 84.13 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.794 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.484 ' O ' ' NE2' ' A' ' 76' ' ' GLN . 0.1 OUTLIER -93.14 16.36 13.16 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.742 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 41.97 56.2 3.56 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.527 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.443 HD13 ' HB3' ' A' ' 75' ' ' ALA . 4.8 tp -132.2 113.9 14.75 Favored Pre-proline 0 C--O 1.219 -0.526 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.597 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.16 2.07 5.96 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.361 2.041 . . . . 1.0 112.723 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 179.96 142.61 0.16 Allowed 'General case' 0 C--O 1.238 0.466 0 O-C-N 123.429 0.455 . . . . 1.0 110.742 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.582 ' CD2' ' N ' ' A' ' 103' ' ' LEU . 2.3 mm? -84.8 145.0 43.05 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-O 120.888 0.375 . . . . 1.0 111.119 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.525 ' C ' ' H ' ' A' ' 106' ' ' GLY . 44.2 Cg_endo -69.18 161.99 43.62 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.353 2.035 . . . . 1.0 111.88 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.97 23.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.874 2.383 . . . . 1.0 111.974 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.525 ' H ' ' C ' ' A' ' 104' ' ' PRO . . . -161.5 63.6 0.27 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -172.82 149.33 1.95 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.655 0.264 . . . . 1.0 110.469 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -139.32 156.05 47.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.063 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.474 ' H ' HD12 ' A' ' 109' ' ' LEU . 1.9 mp -101.65 113.27 26.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.628 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.734 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.5 m -107.13 163.99 4.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.137 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm -93.71 -172.75 2.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.685 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.2 t -65.35 -41.18 94.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.985 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -50.63 -51.44 48.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.661 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.734 ' CE3' HG21 ' A' ' 110' ' ' VAL . 63.5 t90 -50.55 -49.58 55.65 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.484 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.528 HD12 HG11 ' A' ' 84' ' ' VAL . 2.0 tt -57.95 -50.97 71.56 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.32 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.7 t -48.54 -51.96 24.98 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.06 0.457 . . . . 1.0 110.08 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.1 mp -57.44 -50.98 71.27 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.448 -0.501 . . . . 1.0 110.259 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.625 ' SG ' ' CE2' ' A' ' 114' ' ' TRP . 56.3 m -44.35 -27.06 0.39 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.049 0.452 . . . . 1.0 110.099 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 80.2 mt -83.36 -47.68 11.2 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.564 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -68.44 -54.2 18.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.472 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 122' ' ' ARG . 78.4 mt-10 -77.86 5.4 9.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.508 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.456 ' C ' ' O ' ' A' ' 121' ' ' GLU . 81.4 mtt85 28.63 44.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.52 0.513 . . . . 1.0 111.257 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.445 ' CG ' ' O ' ' A' ' 121' ' ' GLU . 0.9 OUTLIER -159.99 167.83 27.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.845 -0.616 . . . . 1.0 110.532 -179.134 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 tp -74.08 100.08 3.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.046 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.508 HG13 ' CD1' ' A' ' 114' ' ' TRP . 0.3 OUTLIER -80.44 154.93 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 121.252 0.548 . . . . 1.0 110.091 179.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 126' ' ' ASP . 14.6 p-10 -59.81 117.73 5.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.434 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.562 HG23 ' N ' ' A' ' 128' ' ' ALA . 13.0 m -68.03 -44.57 84.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.691 -0.686 . . . . 1.0 111.077 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.562 ' N ' HG23 ' A' ' 127' ' ' VAL . . . -43.85 -18.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.685 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . -69.9 -38.39 75.32 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.344 -0.702 . . . . 1.0 111.344 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -129.48 13.76 6.02 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.625 0.25 . . . . 1.0 110.679 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.5 p -73.16 136.4 44.78 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.848 0.356 . . . . 1.0 110.69 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.569 ' C ' ' H ' ' A' ' 134' ' ' ILE . 59.1 mt -74.52 -66.93 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.875 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.548 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 25.1 t80 66.26 -36.14 0.24 Allowed 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 123.878 0.736 . . . . 1.0 111.42 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.617 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 155.72 -55.3 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 O-C-N 124.768 1.293 . . . . 1.0 110.271 -178.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.617 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 28.3 Cg_endo . . . . . 0 C--N 1.31 -1.46 0 C-N-CA 122.498 2.132 . . . . 1.0 111.994 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.505 -1.438 . . . . 1.0 109.505 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.1 m -70.91 150.47 45.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.761 0.315 . . . . 1.0 110.417 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -83.7 98.62 9.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.494 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.5 p -159.59 163.44 35.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.548 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.86 -88.05 0.07 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.756 -0.938 . . . . 1.0 110.756 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -83.51 125.7 32.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.87 0.367 . . . . 1.0 110.325 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 38' ' ' GLU . 20.5 pt-20 -62.61 -44.45 96.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.675 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.404 ' N ' ' CG ' ' A' ' 36' ' ' GLU . . . 51.58 5.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.831 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.546 ' H ' ' C ' ' A' ' 36' ' ' GLU . 96.7 mt-10 -145.1 106.32 4.19 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.869 0.366 . . . . 1.0 110.338 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -106.62 92.54 4.15 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.539 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.601 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -101.07 -38.22 8.25 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.355 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.507 HD23 HD11 ' A' ' 44' ' ' LEU . 6.4 mt -76.49 -12.39 60.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.886 0.374 . . . . 1.0 110.9 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.8 t -69.69 -17.78 63.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.996 0.427 . . . . 1.0 110.402 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.7 t -74.1 -13.9 60.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.875 -0.602 . . . . 1.0 111.107 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.507 HD11 HD23 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -136.42 168.99 18.4 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.993 0.425 . . . . 1.0 110.046 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.494 ' H ' ' HB ' ' A' ' 81' ' ' THR . 93.5 mtt180 -114.99 124.1 50.8 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.602 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.723 ' O ' HD13 ' A' ' 72' ' ' LEU . . . -107.44 155.08 20.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.828 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.627 ' CE1' ' NH1' ' A' ' 50' ' ' ARG . 25.0 t-80 -155.25 123.32 5.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.528 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.2 m -99.52 145.37 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.849 0.357 . . . . 1.0 110.243 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.42 ' HB ' HD23 ' A' ' 97' ' ' LEU . 27.2 m -73.68 143.94 13.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.579 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.627 ' NH1' ' CE1' ' A' ' 47' ' ' HIS . 8.4 mpt_? -63.33 -42.62 98.98 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.857 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.0 p -100.99 136.28 41.09 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.946 0.403 . . . . 1.0 110.437 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.67 -19.85 53.01 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.048 -0.821 . . . . 1.0 111.048 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.632 HG22 ' O ' ' A' ' 53' ' ' ILE . 40.6 mm -127.51 3.81 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.096 0.474 . . . . 1.0 110.586 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.59 26.29 24.52 Favored Glycine 0 N--CA 1.467 0.724 0 N-CA-C 110.39 -1.084 . . . . 1.0 110.39 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.683 HH22 HH21 ' A' ' 57' ' ' ARG . 16.2 mtm-85 -63.25 -47.2 83.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 1.0 110.723 -178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 55' ' ' ARG . . . 165.52 -62.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.171 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.683 HH21 HH22 ' A' ' 55' ' ' ARG . 5.1 ppt_? -92.04 -25.56 18.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.598 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.44 ' HB2' ' NH1' ' A' ' 55' ' ' ARG . . . -62.64 -37.87 88.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.475 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.515 ' O ' ' N ' ' A' ' 61' ' ' PHE . 3.1 pt-20 -65.32 -39.96 93.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.295 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.0 tp -44.19 -16.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.228 0.537 . . . . 1.0 110.886 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 59' ' ' GLU . 6.6 m-85 -58.91 -43.54 91.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.657 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.476 ' HA ' HD12 ' A' ' 65' ' ' ILE . 13.8 pt-20 -67.2 -42.61 83.84 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.988 0.423 . . . . 1.0 111.063 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.456 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 95.2 mttt -63.86 -44.62 92.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.19 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.6 mm100 -56.0 -37.58 69.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.806 -0.634 . . . . 1.0 109.995 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.91 HD11 HD11 ' A' ' 115' ' ' LEU . 67.8 mt -63.62 -44.43 98.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.667 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.406 ' CG2' HD23 ' A' ' 72' ' ' LEU . 73.7 t -59.37 -44.74 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 120.898 -0.321 . . . . 1.0 110.812 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.444 ' O ' ' OE1' ' A' ' 36' ' ' GLU . 99.6 mm-40 -55.97 -35.62 66.94 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.69 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.444 ' N ' ' CD2' ' A' ' 68' ' ' HIS . 1.9 m170 -103.99 16.55 26.03 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.136 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 90.58 153.18 28.65 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.868 -0.893 . . . . 1.0 110.868 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.0 51.43 0.6 Allowed Glycine 0 N--CA 1.468 0.786 0 N-CA-C 110.058 -1.217 . . . . 1.0 110.058 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -43.46 143.23 0.96 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 1.0 110.401 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.723 HD13 ' O ' ' A' ' 46' ' ' ALA . 3.0 mm? -80.07 136.39 36.55 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.059 0.457 . . . . 1.0 110.143 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 79' ' ' GLY . 69.3 m -141.61 103.45 5.9 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.971 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.489 ' O ' ' N ' ' A' ' 77' ' ' GLY . 58.7 Cg_endo -73.94 167.59 26.85 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.712 1.608 . . . . 1.0 111.747 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.487 ' HB2' HD12 ' A' ' 100' ' ' LEU . . . -44.09 -48.31 8.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.531 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -67.75 -19.64 65.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.473 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 74' ' ' PRO . . . -78.77 -165.89 29.5 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.252 -0.739 . . . . 1.0 111.252 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -52.33 -42.28 61.46 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.751 2.301 . . . . 1.0 112.351 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 73' ' ' CYS . . . 170.19 -161.85 35.01 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.024 -0.83 . . . . 1.0 111.024 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.1 p -169.8 138.83 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.64 -0.504 . . . . 1.0 109.64 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.494 ' HB ' ' H ' ' A' ' 45' ' ' ARG . 95.4 m -104.21 -47.99 3.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.781 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -124.94 155.05 40.2 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.95 0.405 . . . . 1.0 111.087 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 83' ' ' ILE . 4.4 mp -134.34 113.19 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.056 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.655 HG21 HD12 ' A' ' 115' ' ' LEU . 59.2 t -93.43 134.96 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.362 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.81 HG23 ' H ' ' A' ' 87' ' ' GLU . 3.7 m -127.21 163.68 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.646 -0.707 . . . . 1.0 110.708 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.416 ' HA ' HD11 ' A' ' 53' ' ' ILE . 8.5 p-10 -69.56 19.0 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.229 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.81 ' H ' HG23 ' A' ' 85' ' ' VAL . 12.9 mt-10 70.02 -51.76 0.64 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.51 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -58.14 -28.52 61.43 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.699 -0.961 . . . . 1.0 110.699 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.6 tpp -72.66 140.45 47.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.051 0.453 . . . . 1.0 110.823 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -88.18 153.63 21.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.769 -0.651 . . . . 1.0 109.67 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -56.26 -45.87 79.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.015 179.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.566 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 11.6 pt-20 -53.92 -49.72 68.01 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.621 -0.432 . . . . 1.0 111.135 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.484 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 21.9 ttm105 -70.51 -38.01 74.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.085 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.482 ' O ' HD23 ' A' ' 98' ' ' LEU . . . -46.56 -43.37 17.07 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 116.048 -0.523 . . . . 1.0 111.923 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.477 ' CD1' HD11 ' A' ' 109' ' ' LEU . 4.8 mp -58.3 -39.92 80.62 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.774 -0.579 . . . . 1.0 110.773 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.53 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 84.3 mmt-85 -69.24 -29.42 67.34 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.742 -0.383 . . . . 1.0 110.947 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.42 HD23 ' HB ' ' A' ' 49' ' ' VAL . 9.0 mp -65.26 -40.98 94.69 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.522 -0.471 . . . . 1.0 111.379 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -109.51 15.58 22.85 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.024 0.44 . . . . 1.0 110.655 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.53 ' NH1' ' O ' ' A' ' 96' ' ' ARG . 60.7 mmt-85 50.38 57.44 6.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.544 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' A' ' 75' ' ' ALA . 12.8 tp -107.24 115.07 60.4 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 121.075 -0.25 . . . . 1.0 110.458 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -49.22 -48.01 20.03 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.839 1.693 . . . . 1.0 112.384 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -175.98 137.51 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.645 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 103' ' ' LEU . 52.8 mt -37.06 100.76 0.21 Allowed Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.267 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.442 ' HD3' HD21 ' A' ' 100' ' ' LEU . 86.4 Cg_exo -43.18 157.44 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.099 1.866 . . . . 1.0 112.176 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.91 85.37 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.509 2.139 . . . . 1.0 111.898 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 137.33 -36.19 1.98 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.154 -0.778 . . . . 1.0 111.154 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.12 153.05 32.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.602 0.239 . . . . 1.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -144.23 155.48 43.89 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.477 HD11 ' CD1' ' A' ' 95' ' ' LEU . 0.8 OUTLIER -88.12 114.5 24.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.463 179.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.468 HG21 ' CE3' ' A' ' 114' ' ' TRP . 2.5 m -110.63 171.31 3.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 123.759 0.662 . . . . 1.0 109.478 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.555 ' NZ ' ' O ' ' A' ' 130' ' ' PHE . 30.1 mtmm -104.82 -178.49 3.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.832 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.1 t -60.13 -39.24 85.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.485 -0.78 . . . . 1.0 110.099 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.07 -49.59 60.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.523 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.518 ' CD1' HG12 ' A' ' 127' ' ' VAL . 75.0 t90 -56.18 -46.33 79.42 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.2 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.91 HD11 HD11 ' A' ' 65' ' ' ILE . 1.1 tt -67.43 -55.98 11.46 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.051 0.453 . . . . 1.0 110.377 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -41.37 -57.08 2.28 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.696 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 10.5 mp -58.64 -47.12 85.51 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 123' ' ' ARG . 0.5 OUTLIER -44.92 -42.62 8.28 Favored 'General case' 0 C--O 1.214 -0.766 0 C-N-CA 120.509 -0.476 . . . . 1.0 110.725 177.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 66.1 mt -65.48 -49.44 69.07 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 119.676 -0.81 . . . . 1.0 110.94 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -71.59 -51.91 20.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.971 -178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -70.62 -39.08 73.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.799 -0.637 . . . . 1.0 111.431 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 118' ' ' CYS . 67.1 mtt85 63.99 54.38 1.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.269 0.557 . . . . 1.0 111.133 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.894 ' NH2' HG22 ' A' ' 125' ' ' VAL . 0.0 OUTLIER -152.1 -164.72 2.04 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.239 -0.891 . . . . 1.0 111.125 -179.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.8 tp -119.94 91.67 3.6 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.593 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.894 HG22 ' NH2' ' A' ' 123' ' ' ARG . 29.0 m -81.2 153.32 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.952 0.406 . . . . 1.0 110.158 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -69.97 121.89 18.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.21 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 129' ' ' GLY . 17.6 m -72.44 -126.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.683 -0.69 . . . . 1.0 109.886 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.438 ' N ' HG23 ' A' ' 127' ' ' VAL . . . 63.81 -63.3 0.14 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 1.0 110.71 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . -59.53 -46.21 94.33 Favored Glycine 0 CA--C 1.521 0.465 0 N-CA-C 110.616 -0.994 . . . . 1.0 110.616 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.555 ' O ' ' NZ ' ' A' ' 111' ' ' LYS . 60.0 m-85 -86.54 -7.67 58.18 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.948 -0.389 . . . . 1.0 109.948 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.2 p -78.66 157.58 28.59 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 120.925 0.393 . . . . 1.0 110.795 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.575 ' C ' ' H ' ' A' ' 134' ' ' ILE . 62.2 mt -93.37 -59.67 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.409 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.406 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.475 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 16.3 t80 63.62 -32.97 0.12 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.941 -1.027 . . . . 1.0 111.904 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.575 ' H ' ' C ' ' A' ' 132' ' ' ILE . 0.6 OUTLIER 152.46 -55.64 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 124.848 1.259 . . . . 1.0 109.634 -178.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 34.6 Cg_endo . . . . . 0 N--CA 1.496 1.638 0 C-N-CA 121.783 1.656 . . . . 1.0 112.074 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.459 -1.456 . . . . 1.0 109.459 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.1 m -133.29 152.51 51.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.869 0.366 . . . . 1.0 110.485 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 53.0 p30 -153.22 46.04 0.66 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.559 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.4 p -153.31 155.58 36.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.599 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.72 -40.1 90.09 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.951 -0.86 . . . . 1.0 110.951 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -58.97 142.12 51.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.558 0.218 . . . . 1.0 110.444 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -42.75 -73.96 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.896 0.379 . . . . 1.0 110.707 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 53.4 15.72 0.75 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.255 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.58 139.23 57.35 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.488 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -95.31 133.98 38.6 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.387 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.569 ' CZ2' ' NE ' ' A' ' 122' ' ' ARG . 3.6 p-90 -140.26 -38.46 0.45 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.392 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.99 -6.23 59.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.762 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.6 m -64.01 -33.03 74.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.903 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.499 ' OG ' HD23 ' A' ' 44' ' ' LEU . 3.9 p -57.16 -43.45 82.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.939 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.499 HD23 ' OG ' ' A' ' 43' ' ' SER . 0.1 OUTLIER -100.59 107.87 19.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.125 0.488 . . . . 1.0 110.732 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.553 ' O ' HG22 ' A' ' 81' ' ' THR . 2.7 mpt_? -68.72 110.21 4.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.519 -0.764 . . . . 1.0 109.338 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.626 ' HB3' HG21 ' A' ' 65' ' ' ILE . . . -91.2 162.83 14.48 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.875 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.691 ' HB2' HG11 ' A' ' 80' ' ' VAL . 85.0 t60 -148.08 131.92 17.05 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.865 -0.607 . . . . 1.0 109.945 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.733 HG12 HG21 ' A' ' 53' ' ' ILE . 1.5 t -121.98 116.49 49.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.35 179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.462 ' O ' HG22 ' A' ' 53' ' ' ILE . 15.7 t -56.95 81.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.717 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 48' ' ' VAL . 33.1 ptt-85 -70.27 -8.3 49.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.779 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.6 p -92.89 0.43 57.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.61 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 54' ' ' GLY . . . -147.44 -46.67 0.03 OUTLIER Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.123 -0.791 . . . . 1.0 111.123 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.733 HG21 HG12 ' A' ' 48' ' ' VAL . 3.8 tt -64.24 3.6 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.774 0.321 . . . . 1.0 110.422 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 52' ' ' GLY . . . -70.24 50.99 0.78 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 53' ' ' ILE . 0.3 OUTLIER -70.38 -43.66 69.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.803 0.335 . . . . 1.0 110.236 -179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -177.21 -81.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.035 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 60' ' ' LEU . 8.9 ptm180 -95.47 -21.12 18.51 Favored 'General case' 0 C--O 1.207 -1.138 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.923 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.59 -37.05 17.0 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.89 -0.724 . . . . 1.0 111.033 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -51.55 -26.1 7.99 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.559 -0.456 . . . . 1.0 110.804 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.66 HD13 ' HB2' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -63.64 -22.87 67.13 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.201 0.524 . . . . 1.0 110.96 -179.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.509 ' HB2' HG11 ' A' ' 48' ' ' VAL . 21.7 m-85 -52.62 -46.71 67.17 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.581 -0.736 . . . . 1.0 110.923 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.695 ' HA ' HD12 ' A' ' 65' ' ' ILE . 5.3 pt-20 -65.71 -36.01 82.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.833 0.349 . . . . 1.0 110.645 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.66 ' HB2' HD13 ' A' ' 60' ' ' LEU . 5.7 mptp? -62.79 -48.67 78.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.19 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.434 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 62.4 mt-30 -60.38 -37.75 81.72 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.931 -0.577 . . . . 1.0 109.711 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.695 HD12 ' HA ' ' A' ' 62' ' ' GLU . 57.8 mt -61.6 -48.08 90.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.095 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 99.6 t -62.8 -46.54 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 120.583 -0.447 . . . . 1.0 110.297 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.528 ' NE2' ' O ' ' A' ' 63' ' ' LYS . 1.2 mp0 -67.32 -35.03 78.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.24 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.434 ' CG ' ' O ' ' A' ' 64' ' ' GLN . 61.7 m170 -88.19 0.28 56.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.542 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 98.72 147.27 21.83 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.72 -0.952 . . . . 1.0 110.72 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.47 55.53 0.71 Allowed Glycine 0 N--CA 1.464 0.554 0 N-CA-C 110.582 -1.007 . . . . 1.0 110.582 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -40.19 145.13 0.17 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.679 0.276 . . . . 1.0 110.676 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.425 ' C ' ' SG ' ' A' ' 73' ' ' CYS . 8.8 mt -74.54 140.38 44.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.258 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.638 ' O ' HG13 ' A' ' 80' ' ' VAL . 2.6 m -145.12 87.87 7.01 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.233 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.16 -150.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.808 2.339 . . . . 1.0 111.849 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.53 -26.21 68.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.454 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -64.04 -20.56 66.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.52 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.1 -166.64 24.93 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.899 -0.88 . . . . 1.0 110.899 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.77 -43.47 57.62 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.71 2.274 . . . . 1.0 112.072 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' A' ' 80' ' ' VAL . . . 131.48 31.17 0.52 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.896 -0.882 . . . . 1.0 110.896 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.691 HG11 ' HB2' ' A' ' 47' ' ' HIS . 31.1 m 37.44 -158.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 120.758 0.313 . . . . 1.0 110.904 179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.667 HG23 ' HD1' ' A' ' 82' ' ' HIS . 2.5 t -142.04 -18.44 0.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.706 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.806 ' O ' HD13 ' A' ' 83' ' ' ILE . 68.7 m80 -130.98 160.03 35.73 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.022 0.439 . . . . 1.0 110.744 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.806 HD13 ' O ' ' A' ' 82' ' ' HIS . 5.1 mm -138.15 112.69 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.702 -0.681 . . . . 1.0 111.473 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.734 HG21 HD23 ' A' ' 115' ' ' LEU . 5.1 t -94.59 129.78 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.441 ' C ' ' H ' ' A' ' 87' ' ' GLU . 16.0 m -132.02 167.02 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.392 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 88' ' ' GLY . 49.1 t0 -77.91 30.06 0.17 Allowed 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.219 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 85' ' ' VAL . 31.3 mt-10 64.72 -66.65 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.873 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . -48.64 -17.33 0.76 Allowed Glycine 0 CA--C 1.52 0.381 0 N-CA-C 110.871 -0.892 . . . . 1.0 110.871 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.487 ' SD ' ' CD1' ' A' ' 97' ' ' LEU . 3.4 ttm -77.4 147.37 36.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.122 0.486 . . . . 1.0 110.495 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 91' ' ' TYR . 92.1 m-20 -100.64 142.75 31.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.591 -0.731 . . . . 1.0 109.855 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.601 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -36.73 -56.4 0.84 Allowed 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.285 -179.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.601 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 5.0 pt-20 -56.1 -59.57 4.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.773 -0.648 . . . . 1.0 109.953 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.512 ' H ' ' CG ' ' A' ' 92' ' ' GLU . 79.0 ttt180 -42.51 -42.22 3.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.857 0.36 . . . . 1.0 110.22 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 91' ' ' TYR . . . -55.88 -48.61 75.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.73 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.471 ' O ' ' N ' ' A' ' 99' ' ' ARG . 7.9 mp -57.48 -44.38 84.85 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.325 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.455 ' C ' ' CD ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -62.24 -42.43 99.31 Favored 'General case' 0 N--CA 1.429 -1.52 0 C-N-CA 120.735 -0.386 . . . . 1.0 110.807 179.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.487 ' CD1' ' SD ' ' A' ' 89' ' ' MET . 24.8 mt -63.19 -51.75 65.08 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.737 -0.385 . . . . 1.0 111.228 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.884 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -77.73 -18.5 56.47 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.173 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 95' ' ' LEU . 3.2 mtp180 76.35 63.54 0.05 OUTLIER 'General case' 0 CA--C 1.509 -0.608 0 O-C-N 124.469 1.106 . . . . 1.0 111.685 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.598 ' HB2' HD11 ' A' ' 98' ' ' LEU . 4.7 tp -136.45 118.3 11.61 Favored Pre-proline 0 CA--C 1.535 0.389 0 C-N-CA 120.465 -0.494 . . . . 1.0 111.089 178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.98 -38.62 56.55 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.919 1.746 . . . . 1.0 112.067 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -163.19 136.48 5.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.609 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.501 HD11 HD21 ' A' ' 109' ' ' LEU . 11.8 mt -75.99 148.8 82.03 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.024 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -66.34 167.75 17.81 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.033 1.822 . . . . 1.0 112.467 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -56.1 146.35 70.78 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.497 2.131 . . . . 1.0 112.296 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.05 -19.52 6.5 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.901 -0.879 . . . . 1.0 110.901 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.97 151.76 34.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 1.0 110.428 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.634 HE21 ' CD2' ' A' ' 82' ' ' HIS . 5.9 pt20 -156.73 128.86 7.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.365 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.501 HD21 HD11 ' A' ' 103' ' ' LEU . 1.9 mp -84.11 127.64 34.04 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.711 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.495 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.8 m -121.31 176.14 4.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 O-C-N 123.723 0.639 . . . . 1.0 109.973 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -106.75 -176.57 3.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.738 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.478 ' OG ' ' CE2' ' A' ' 61' ' ' PHE . 6.8 t -60.05 -41.36 92.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.57 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.32 -48.24 62.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.611 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.505 ' CZ2' ' SG ' ' A' ' 118' ' ' CYS . 78.3 t90 -54.19 -41.1 68.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.002 0.429 . . . . 1.0 110.259 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.734 HD23 HG21 ' A' ' 84' ' ' VAL . 0.3 OUTLIER -62.04 -55.56 27.95 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.156 -0.618 . . . . 1.0 110.129 -179.435 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 80.1 p -49.21 -42.87 41.6 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.055 0.455 . . . . 1.0 109.828 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.6 mp -63.35 -55.74 22.05 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.426 -0.51 . . . . 1.0 109.896 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.505 ' SG ' ' CZ2' ' A' ' 114' ' ' TRP . 0.0 OUTLIER -44.63 -33.68 1.9 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 -179.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 94.0 mt -77.05 -51.33 11.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.568 -0.742 . . . . 1.0 111.184 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -65.56 -49.14 69.94 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.231 -0.441 . . . . 1.0 111.314 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.433 ' O ' ' CG ' ' A' ' 123' ' ' ARG . 65.2 mm-40 -77.48 1.44 19.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.282 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.569 ' NE ' ' CZ2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER 38.79 32.24 0.05 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.585 179.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 121' ' ' GLU . 4.5 ppt_? -158.29 174.32 15.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.254 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.6 tt -82.15 126.17 31.74 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.943 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 19.0 m -108.96 154.74 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.539 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 40.3 p-10 -62.09 144.33 55.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.042 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.6 m -103.03 11.17 8.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.509 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.64 53.35 0.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.609 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.68 -34.47 0.12 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 111.089 -0.804 . . . . 1.0 111.089 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -99.74 5.92 45.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.022 0.439 . . . . 1.0 110.655 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 6.6 t -99.15 141.28 32.12 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.356 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.519 ' C ' ' H ' ' A' ' 134' ' ' ILE . 54.7 mt -88.18 -55.93 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 CA-C-N 115.635 -0.711 . . . . 1.0 110.205 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.522 ' O ' HG12 ' A' ' 134' ' ' ILE . 10.9 t80 65.71 -40.6 0.32 Allowed 'General case' 0 C--O 1.221 -0.426 0 O-C-N 124.375 1.047 . . . . 1.0 111.461 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.572 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 159.38 -54.55 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 O-C-N 124.665 1.228 . . . . 1.0 109.915 -178.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 36.5 Cg_endo . . . . . 0 N--CA 1.491 1.351 0 C-N-CA 122.15 1.9 . . . . 1.0 111.929 -177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.495 -1.442 . . . . 1.0 109.495 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.2 t -61.28 -43.89 98.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.817 0.341 . . . . 1.0 110.572 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.5 t30 56.81 45.54 21.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.619 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.5 p -155.37 162.49 40.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.45 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.6 -22.39 41.19 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.88 -0.888 . . . . 1.0 110.88 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 35' ' ' GLU . 56.5 mp0 -88.86 151.01 22.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.941 0.401 . . . . 1.0 110.47 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.469 ' O ' ' C ' ' A' ' 37' ' ' ALA . 10.1 pt-20 -61.19 -52.18 65.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.712 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' A' ' 36' ' ' GLU . . . 25.3 60.75 0.06 Allowed 'General case' 0 N--CA 1.468 0.466 0 O-C-N 123.781 0.676 . . . . 1.0 110.959 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -127.3 40.92 3.62 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.483 -178.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -45.6 137.06 5.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.307 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.599 ' CH2' HD12 ' A' ' 41' ' ' LEU . 1.6 p-90 -123.45 -50.62 1.87 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.547 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.599 HD12 ' CH2' ' A' ' 40' ' ' TRP . 1.3 mt -67.13 -21.75 65.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.757 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 24.0 t -61.37 -18.57 59.34 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.326 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.431 ' OG ' HD23 ' A' ' 44' ' ' LEU . 24.7 p -65.32 -15.0 62.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.333 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.441 ' N ' HD23 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -138.55 168.35 19.98 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.308 179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -119.55 115.58 24.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.604 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.498 ' CB ' HD13 ' A' ' 65' ' ' ILE . . . -95.62 168.18 10.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.114 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -153.91 120.06 5.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.629 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.455 ' CG1' HG21 ' A' ' 53' ' ' ILE . 87.1 t -100.05 135.9 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.09 0.471 . . . . 1.0 110.252 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 49' ' ' VAL . 32.3 m -86.71 125.04 40.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.685 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.401 ' HG3' HH11 ' A' ' 50' ' ' ARG . 18.2 mmt85 -74.53 -39.11 62.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.745 -0.661 . . . . 1.0 111.246 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.751 ' OG1' HD11 ' A' ' 97' ' ' LEU . 45.1 p -59.51 -22.51 61.74 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.617 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 54' ' ' GLY . . . -115.85 -91.58 1.71 Allowed Glycine 0 N--CA 1.465 0.603 0 N-CA-C 110.738 -0.945 . . . . 1.0 110.738 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.485 ' C ' ' H ' ' A' ' 55' ' ' ARG . 4.1 mm -40.23 -27.6 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.741 0.305 . . . . 1.0 110.806 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 52' ' ' GLY . . . -69.81 41.64 0.44 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.801 -0.92 . . . . 1.0 110.801 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.485 ' H ' ' C ' ' A' ' 53' ' ' ILE . 1.9 ptp180 -80.11 -61.14 2.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.835 0.35 . . . . 1.0 110.953 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.401 ' H ' ' HG3' ' A' ' 55' ' ' ARG . . . -150.28 -89.87 0.07 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.761 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 -92.71 -24.62 18.55 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.03 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.44 -16.83 0.64 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.571 0.701 . . . . 1.0 110.05 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 61' ' ' PHE . 21.1 pt-20 -73.29 -34.84 65.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.154 0.502 . . . . 1.0 111.207 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 tp -46.29 -17.31 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.392 0.615 . . . . 1.0 110.866 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.475 ' N ' ' O ' ' A' ' 59' ' ' GLU . 1.8 m-85 -57.22 -51.11 70.64 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.802 -0.636 . . . . 1.0 112.073 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.613 ' HA ' HD12 ' A' ' 65' ' ' ILE . 1.5 pt-20 -58.15 -36.99 73.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.111 0.482 . . . . 1.0 110.563 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.46 ' HG2' ' H ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -61.86 -44.75 96.19 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.244 0.545 . . . . 1.0 110.287 -178.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -62.76 -18.7 63.05 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.256 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.613 HD12 ' HA ' ' A' ' 62' ' ' GLU . 92.3 mt -86.29 -56.19 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.961 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.428 HG12 ' HA ' ' A' ' 71' ' ' GLN . 3.4 m -62.81 -38.6 82.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.913 0.387 . . . . 1.0 110.891 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.418 ' N ' HG23 ' A' ' 66' ' ' VAL . 85.0 mt-30 -61.45 -40.01 92.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.699 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -95.68 14.66 22.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.771 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 96.32 144.72 17.61 Favored Glycine 0 N--CA 1.464 0.524 0 N-CA-C 110.618 -0.993 . . . . 1.0 110.618 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.07 44.73 1.35 Allowed Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.707 -0.957 . . . . 1.0 110.707 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.428 ' HA ' HG12 ' A' ' 66' ' ' VAL . 1.6 mm100 -40.95 160.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.786 0.327 . . . . 1.0 110.689 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.9 mt -69.92 136.62 50.79 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 68.4 m -131.1 96.9 20.95 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.341 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -78.99 -178.71 4.85 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.527 2.151 . . . . 1.0 112.024 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -54.68 -47.82 73.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.766 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -64.03 -18.98 64.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.915 0.388 . . . . 1.0 110.352 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.87 -158.45 19.38 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.088 -0.805 . . . . 1.0 111.088 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -47.96 -44.99 26.25 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.412 2.075 . . . . 1.0 112.417 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.576 ' O ' HG12 ' A' ' 80' ' ' VAL . . . 156.44 -44.58 0.52 Allowed Glycine 0 C--O 1.223 -0.576 0 C-N-CA 120.467 -0.873 . . . . 1.0 111.128 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 79' ' ' GLY . 0.4 OUTLIER 82.91 166.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 124.038 0.493 . . . . 1.0 110.166 179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.58 -35.22 0.31 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.904 -0.318 . . . . 1.0 110.453 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -117.26 144.06 45.23 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.655 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.945 HD12 HD12 ' A' ' 109' ' ' LEU . 58.2 mt -131.58 112.59 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.555 -0.458 . . . . 1.0 110.885 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 t -90.3 127.64 42.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.922 -0.399 . . . . 1.0 109.922 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.633 HG23 ' H ' ' A' ' 87' ' ' GLU . 28.7 m -133.16 166.44 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.885 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 88' ' ' GLY . 39.8 p-10 -73.66 17.48 0.16 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.796 -0.638 . . . . 1.0 110.76 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.633 ' H ' HG23 ' A' ' 85' ' ' VAL . 3.7 mt-10 73.71 -32.11 0.23 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.092 -0.504 . . . . 1.0 111.224 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 86' ' ' ASP . . . -67.95 -20.35 72.55 Favored Glycine 0 C--N 1.314 -0.672 0 N-CA-C 110.499 -1.04 . . . . 1.0 110.499 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.426 ' CE ' HH12 ' A' ' 93' ' ' ARG . 9.4 ttm -82.11 160.16 23.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.791 0.329 . . . . 1.0 110.826 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -113.52 142.06 46.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.83 -0.623 . . . . 1.0 109.891 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.57 ' CG ' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -46.49 -53.27 11.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.497 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.57 ' N ' ' CG ' ' A' ' 91' ' ' TYR . 17.1 pt-20 -51.83 -38.25 55.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.645 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.426 HH12 ' CE ' ' A' ' 89' ' ' MET . 79.7 ttt-85 -80.44 -22.17 41.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.789 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.34 -37.32 77.54 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.517 -0.473 . . . . 1.0 111.334 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.568 ' O ' ' N ' ' A' ' 99' ' ' ARG . 7.5 mp -60.6 -38.0 83.22 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.995 -0.282 . . . . 1.0 110.319 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -61.9 -35.88 79.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.79 0.329 . . . . 1.0 110.627 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.751 HD11 ' OG1' ' A' ' 51' ' ' THR . 3.9 mm? -62.24 -40.56 96.56 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.049 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -108.72 8.77 27.0 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.188 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.568 ' N ' ' O ' ' A' ' 95' ' ' LEU . 1.6 mpt_? 45.96 58.24 4.55 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.8 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.444 ' HB2' HD12 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -109.52 112.44 58.88 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.147 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.74 -41.75 37.75 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.057 1.838 . . . . 1.0 112.72 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -162.08 128.59 3.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.958 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.761 HD13 HD11 ' A' ' 109' ' ' LEU . 60.4 mt -52.71 124.6 35.3 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-N 116.088 -0.506 . . . . 1.0 111.214 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.449 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 44.2 Cg_exo -49.67 -174.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.365 2.044 . . . . 1.0 112.419 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 32.1 Cg_exo -58.18 129.36 32.62 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.724 2.283 . . . . 1.0 111.908 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . 72.18 -53.32 1.43 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-O 118.906 -0.941 . . . . 1.0 110.751 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.526 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -7.79 116.26 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 O-C-N 124.262 0.625 . . . . 1.0 111.178 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.529 ' C ' HD13 ' A' ' 109' ' ' LEU . 23.1 mt-30 -127.71 142.74 51.25 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.593 -0.276 . . . . 1.0 110.411 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 1.046 ' H ' HD22 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -93.38 120.96 34.27 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 -179.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.767 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.5 m -110.25 168.0 4.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.996 -1.002 . . . . 1.0 110.606 -178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.21 -177.72 3.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.897 -179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.0 m -61.48 -41.63 97.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.11 -0.95 . . . . 1.0 110.511 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.47 -48.14 62.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.547 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.767 ' CE3' HG21 ' A' ' 110' ' ' VAL . 34.5 t90 -56.02 -41.22 74.59 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.229 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.6 tp -65.67 -56.64 11.06 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.142 -0.623 . . . . 1.0 110.613 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.0 m -46.22 -53.58 10.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.363 0.601 . . . . 1.0 110.061 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.2 mp -52.23 -49.23 64.39 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.268 -0.573 . . . . 1.0 109.863 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 12.8 t -52.15 -37.33 54.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.775 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.598 ' O ' ' NH2' ' A' ' 122' ' ' ARG . 90.2 mt -69.6 -57.5 5.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.42 0.629 . . . . 1.0 111.509 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -66.21 -21.24 66.3 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.469 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 122' ' ' ARG . 75.9 mm-40 -88.82 -45.24 9.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.609 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.598 ' NH2' ' O ' ' A' ' 119' ' ' LEU . 0.1 OUTLIER 81.61 33.86 0.1 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.9 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.424 ' C ' ' CD ' ' A' ' 123' ' ' ARG . 0.0 OUTLIER -161.7 -176.12 5.11 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 120.579 -0.449 . . . . 1.0 110.536 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.2 tp -79.22 123.89 27.84 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.333 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.18 155.18 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 121.017 0.437 . . . . 1.0 110.623 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 126' ' ' ASP . 45.3 p-10 -61.38 107.94 0.86 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.251 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.541 HG23 ' N ' ' A' ' 128' ' ' ALA . 9.1 m -60.36 -42.82 92.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.65 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.541 ' N ' HG23 ' A' ' 127' ' ' VAL . . . -55.72 -22.66 24.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.48 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.9 -37.62 94.66 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.916 -0.873 . . . . 1.0 110.916 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 130' ' ' PHE . 0.3 OUTLIER -143.42 58.51 1.39 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.707 0.289 . . . . 1.0 110.899 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 33.9 m -119.17 150.8 39.43 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.141 0.496 . . . . 1.0 110.795 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.576 ' C ' ' H ' ' A' ' 134' ' ' ILE . 60.9 mt -81.34 -63.75 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 CA-C-N 115.301 -0.863 . . . . 1.0 110.181 -178.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.512 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 19.4 t80 66.34 -35.66 0.23 Allowed 'General case' 0 C--O 1.221 -0.425 0 O-C-N 124.208 0.943 . . . . 1.0 111.347 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.601 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 155.7 -55.51 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.37 0 O-C-N 124.905 1.378 . . . . 1.0 110.048 -178.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 24.9 Cg_endo . . . . . 0 N--CA 1.491 1.361 0 C-N-CA 122.324 2.016 . . . . 1.0 111.821 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.586 -1.406 . . . . 1.0 109.586 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.5 m 54.29 30.68 12.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 1.0 110.612 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 11.3 p30 -67.93 116.15 8.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.536 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 52.2 m -89.26 -2.33 58.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.423 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -51.78 -57.87 11.57 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.024 -0.83 . . . . 1.0 111.024 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.483 ' HG3' ' H ' ' A' ' 36' ' ' GLU . 6.1 tp10 42.52 -160.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 1.0 110.552 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.483 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 21.3 pt-20 -65.14 -43.56 91.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.305 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 60.33 43.83 13.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.005 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 39' ' ' GLU . 3.9 pt-20 -153.76 -28.2 0.13 Allowed 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 110.207 -0.294 . . . . 1.0 110.207 179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.455 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 39.9 mp0 50.57 173.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.58 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.442 ' CH2' HD12 ' A' ' 41' ' ' LEU . 14.8 p-90 -163.81 -55.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.086 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.653 ' O ' HD23 ' A' ' 41' ' ' LEU . 1.2 tt -68.91 -18.18 64.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.372 0.606 . . . . 1.0 110.123 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 68' ' ' HIS . 15.8 m -61.5 -42.17 98.39 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.713 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.8 m -52.84 -60.61 3.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.882 0.373 . . . . 1.0 110.714 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -75.0 169.28 18.32 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.655 -0.498 . . . . 1.0 109.655 179.647 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -123.71 120.02 31.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.935 0.398 . . . . 1.0 110.738 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.637 ' O ' HD13 ' A' ' 72' ' ' LEU . . . -96.7 158.29 15.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.235 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.486 ' CE1' ' CD1' ' A' ' 98' ' ' LEU . 59.6 t-80 -156.04 114.88 3.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.231 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.7 m -101.23 139.9 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.739 -0.467 . . . . 1.0 109.739 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 53' ' ' ILE . 58.5 t -81.69 89.9 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.036 0.446 . . . . 1.0 110.527 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -58.24 -31.18 67.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.664 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 m -92.9 34.99 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.992 0.425 . . . . 1.0 110.364 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -178.87 -4.6 0.02 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.091 -0.804 . . . . 1.0 111.091 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -127.04 -1.35 4.17 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-O 120.748 0.309 . . . . 1.0 110.314 179.293 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.45 37.32 0.57 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 111.105 -0.798 . . . . 1.0 111.105 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.523 ' NE ' ' OD2' ' A' ' 86' ' ' ASP . 1.6 ptp180 -61.0 -37.76 83.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.829 0.347 . . . . 1.0 110.244 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -172.9 -103.42 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.401 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.687 ' CD ' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -85.98 -19.13 30.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.491 179.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.447 ' O ' ' CD1' ' A' ' 61' ' ' PHE . . . -43.21 -36.53 1.78 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.573 -178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 61' ' ' PHE . 12.5 pt-20 -66.12 -44.46 84.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.342 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.1 tp -43.17 -18.13 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.775 0.798 . . . . 1.0 110.818 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 59' ' ' GLU . 6.5 m-85 -58.11 -48.38 80.37 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.713 -0.676 . . . . 1.0 111.562 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.689 ' HA ' HD12 ' A' ' 65' ' ' ILE . 14.6 pt-20 -60.47 -31.04 70.07 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.034 0.445 . . . . 1.0 111.544 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.421 ' H ' ' HG2' ' A' ' 63' ' ' LYS . 17.0 mmmt -65.96 -56.52 11.3 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.929 -0.578 . . . . 1.0 111.451 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 64' ' ' GLN . 2.3 pt20 -57.84 -30.06 65.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.158 -0.473 . . . . 1.0 110.421 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.849 HD11 HD21 ' A' ' 115' ' ' LEU . 68.5 mt -66.87 -39.82 84.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.411 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 62' ' ' GLU . 53.8 t -59.8 -41.62 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.232 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 56.3 mm-40 -68.24 -16.46 63.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.521 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.431 ' O ' ' OG ' ' A' ' 42' ' ' SER . 34.0 m170 -88.81 7.32 34.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.65 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.82 -7.22 82.18 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.052 -0.819 . . . . 1.0 111.052 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -86.56 98.06 2.3 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.589 -1.004 . . . . 1.0 110.589 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -79.54 144.31 34.04 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.89 -0.324 . . . . 1.0 110.756 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.637 HD13 ' O ' ' A' ' 46' ' ' ALA . 2.5 mm? -80.66 137.27 36.32 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 120.898 0.38 . . . . 1.0 110.531 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.8 m -133.68 90.54 27.87 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.465 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -53.5 -177.96 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.824 2.349 . . . . 1.0 112.139 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 77' ' ' GLY . . . -56.43 -41.73 76.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.514 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -64.14 -1.55 1.62 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.319 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 75' ' ' ALA . . . -136.56 86.67 0.24 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.318 -1.113 . . . . 1.0 110.318 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.76 139.26 59.18 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.626 2.218 . . . . 1.0 112.058 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.81 1.17 1.63 Allowed Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.418 ' H ' HG12 ' A' ' 80' ' ' VAL . 1.3 p -88.34 103.71 13.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.048 0.451 . . . . 1.0 110.6 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.99 -39.25 15.85 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.399 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.5 ' CD2' ' CZ2' ' A' ' 114' ' ' TRP . 77.5 m80 -106.58 138.82 42.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.512 -0.313 . . . . 1.0 110.951 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.482 HD13 HD22 ' A' ' 98' ' ' LEU . 85.7 mt -133.58 107.36 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-N 116.258 -0.428 . . . . 1.0 109.934 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.43 134.97 27.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.533 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.2 m -130.51 162.8 37.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.394 -0.821 . . . . 1.0 110.975 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 88' ' ' GLY . 67.8 t0 -63.99 103.45 0.59 Allowed 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 116.027 -0.533 . . . . 1.0 109.635 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 86' ' ' ASP . 69.1 mt-10 -24.63 87.15 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 124.191 0.932 . . . . 1.0 110.926 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . 156.77 -25.41 0.5 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.988 -0.845 . . . . 1.0 110.988 -178.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.462 ' CG ' ' HE ' ' A' ' 93' ' ' ARG . 11.9 ttm -70.14 146.71 50.63 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.748 -0.381 . . . . 1.0 110.913 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -90.09 151.57 21.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.453 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.55 ' CD2' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -59.74 -46.86 87.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.108 179.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.55 ' N ' ' CD2' ' A' ' 91' ' ' TYR . 10.5 pt-20 -57.99 -45.45 86.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.947 0.403 . . . . 1.0 110.776 -178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.484 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 4.8 tmm_? -72.13 -21.82 61.41 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.13 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.49 -30.62 71.71 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.802 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 99' ' ' ARG . 7.0 mp -72.18 -44.81 62.46 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.212 0.32 . . . . 1.0 110.973 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -59.79 -48.28 82.32 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.25 -45.76 75.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.568 178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.486 ' CD1' ' CE1' ' A' ' 47' ' ' HIS . 54.8 tp -72.77 -16.18 61.64 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.856 -0.611 . . . . 1.0 109.969 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.57 ' N ' ' O ' ' A' ' 95' ' ' LEU . 23.0 mmt85 67.35 27.15 8.27 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.11 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.5 tp -98.02 116.99 65.58 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -68.8 -23.26 35.72 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.22 1.947 . . . . 1.0 112.578 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -174.42 133.88 0.4 Allowed 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.328 -0.397 . . . . 1.0 110.714 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.533 ' O ' ' O ' ' A' ' 104' ' ' PRO . 1.0 OUTLIER -73.79 135.44 77.75 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.093 -178.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.533 ' O ' ' O ' ' A' ' 103' ' ' LEU . 60.7 Cg_exo -44.72 -174.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.645 2.23 . . . . 1.0 112.061 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' A' ' 104' ' ' PRO . 52.5 Cg_exo -51.95 -68.71 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.565 2.176 . . . . 1.0 113.087 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 107' ' ' ALA . . . -82.45 -50.43 4.77 Favored Glycine 0 CA--C 1.502 -0.753 0 N-CA-C 110.662 -0.975 . . . . 1.0 110.662 -179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.52 ' C ' ' O ' ' A' ' 106' ' ' GLY . . . -11.46 123.83 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 O-C-N 124.64 0.847 . . . . 1.0 111.44 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -130.76 154.26 48.17 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 110.018 -0.364 . . . . 1.0 110.018 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.86 110.36 22.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.783 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.74 HG21 ' CE3' ' A' ' 114' ' ' TRP . 13.9 m -107.25 169.07 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.504 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.661 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -96.52 -168.97 1.81 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.658 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.6 m -70.69 -34.66 72.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.878 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.403 ' HB3' ' CD1' ' A' ' 130' ' ' PHE . . . -57.21 -46.75 82.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.688 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.74 ' CE3' HG21 ' A' ' 110' ' ' VAL . 79.0 t90 -52.02 -59.83 3.9 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.628 -0.429 . . . . 1.0 110.678 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.849 HD21 HD11 ' A' ' 65' ' ' ILE . 32.0 tp -60.63 -51.24 70.25 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 120.441 -0.504 . . . . 1.0 110.503 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 117' ' ' LEU . 56.9 p -41.27 -60.71 1.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.087 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.439 ' N ' ' OG ' ' A' ' 116' ' ' SER . 11.0 mp -61.14 -49.62 76.51 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.055 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 9.3 t -55.49 -25.96 39.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 1.0 110.081 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -70.62 -52.27 22.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.478 0.656 . . . . 1.0 111.419 -178.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -78.39 -30.66 47.94 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.547 -0.751 . . . . 1.0 110.505 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' A' ' 122' ' ' ARG . 0.4 OUTLIER -62.38 -48.5 79.45 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-O 118.473 -0.775 . . . . 1.0 110.165 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 121' ' ' GLU . 17.0 mmm180 90.27 32.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.816 1.323 . . . . 1.0 111.358 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.432 HH11 ' HB3' ' A' ' 121' ' ' GLU . 0.0 OUTLIER -173.9 163.18 4.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.435 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.4 tp -65.76 129.32 39.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.962 0.411 . . . . 1.0 111.175 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.442 HG23 ' CD1' ' A' ' 114' ' ' TRP . 17.3 m -113.32 154.0 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.364 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -61.96 146.92 48.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.431 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 129' ' ' GLY . 2.4 m -108.01 0.98 9.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.249 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.98 61.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.602 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 127' ' ' VAL . . . 171.48 -28.15 0.11 Allowed Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.127 -0.789 . . . . 1.0 111.127 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 113' ' ' ALA . 60.7 m-85 -108.47 -11.53 15.14 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.718 0.295 . . . . 1.0 110.39 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.2 t -74.6 135.32 42.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.08 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.586 ' C ' ' H ' ' A' ' 134' ' ' ILE . 57.5 mt -79.45 -65.95 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.797 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.129 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.53 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 19.7 t80 66.14 -36.33 0.24 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 118.438 -0.791 . . . . 1.0 111.154 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.609 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 155.67 -55.27 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.421 0 O-C-N 124.825 1.328 . . . . 1.0 110.272 -178.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 22.7 Cg_endo . . . . . 0 C--N 1.311 -1.401 0 C-N-CA 122.391 2.06 . . . . 1.0 111.982 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.427 -1.469 . . . . 1.0 109.427 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 t -152.32 36.69 0.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.744 0.306 . . . . 1.0 110.485 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.45 ' CG ' ' H ' ' A' ' 33' ' ' SER . 49.2 t-20 -71.73 -129.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.589 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.45 ' H ' ' CG ' ' A' ' 32' ' ' ASN . 95.5 p -73.58 162.51 29.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.454 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -136.19 28.66 2.89 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.902 -0.879 . . . . 1.0 110.902 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -57.79 139.8 53.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.997 0.427 . . . . 1.0 110.577 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -65.43 -43.38 90.65 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.424 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 38.5 62.57 0.99 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.966 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -92.48 138.04 31.85 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.329 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.549 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 57.8 mp0 -115.72 95.21 5.02 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.433 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.502 ' CD1' ' N ' ' A' ' 40' ' ' TRP . 3.5 p-90 -98.42 -56.69 2.39 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.391 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.402 HD12 ' CH2' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -56.15 -11.68 1.23 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.737 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.5 p -68.7 -32.55 72.44 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.644 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -61.02 -15.32 30.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.571 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.72 115.28 11.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.854 0.359 . . . . 1.0 110.628 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.418 ' HB3' HG23 ' A' ' 80' ' ' VAL . 88.9 mtm180 -75.31 139.94 42.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.078 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.717 ' HB3' HD13 ' A' ' 65' ' ' ILE . . . -119.33 169.74 9.73 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.458 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.406 ' C ' ' ND1' ' A' ' 47' ' ' HIS . 1.5 t-80 -147.89 120.09 8.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.439 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -97.1 127.16 49.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.508 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.66 HG12 ' H ' ' A' ' 52' ' ' GLY . 15.0 t -80.7 88.92 1.62 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.424 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -49.56 -36.84 24.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.548 -0.296 . . . . 1.0 110.571 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.0 p -76.26 -24.24 54.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.541 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.66 ' H ' HG12 ' A' ' 49' ' ' VAL . . . -110.14 1.58 29.84 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.367 -0.693 . . . . 1.0 111.367 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.644 ' N ' ' O ' ' A' ' 49' ' ' VAL . 35.0 mt -146.18 91.47 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.285 0.564 . . . . 1.0 110.309 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -145.45 19.68 1.87 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.076 -0.81 . . . . 1.0 111.076 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.657 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -58.25 -55.97 28.08 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 110.288 -0.264 . . . . 1.0 110.288 -179.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.657 ' HB2' ' O ' ' A' ' 55' ' ' ARG . . . 158.14 -40.14 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 O-C-N 123.436 0.46 . . . . 1.0 110.576 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.731 ' O ' HD22 ' A' ' 60' ' ' LEU . 70.3 ttp85 -94.27 -60.66 1.68 Allowed 'General case' 0 C--O 1.211 -0.928 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.829 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.634 ' O ' ' CD2' ' A' ' 61' ' ' PHE . . . -40.96 -43.08 2.03 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-O 121.262 0.553 . . . . 1.0 110.578 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 61' ' ' PHE . 11.3 pt-20 -45.45 -48.52 13.8 Favored 'General case' 0 C--N 1.314 -0.971 0 O-C-N 121.77 -0.581 . . . . 1.0 111.094 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.802 HD23 ' N ' ' A' ' 61' ' ' PHE . 0.4 OUTLIER -39.45 -19.02 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 O-C-N 123.507 0.504 . . . . 1.0 109.962 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.802 ' N ' HD23 ' A' ' 60' ' ' LEU . 8.6 m-85 -52.73 -48.96 66.32 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.676 -177.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.462 ' CG ' ' N ' ' A' ' 63' ' ' LYS . 13.9 pt-20 -63.02 -43.46 98.67 Favored 'General case' 0 C--N 1.318 -0.801 0 O-C-N 123.489 0.493 . . . . 1.0 110.528 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.462 ' N ' ' CG ' ' A' ' 62' ' ' GLU . 17.5 mtpp -61.23 -42.58 98.85 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.223 0.535 . . . . 1.0 110.177 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.536 ' O ' ' CG ' ' A' ' 68' ' ' HIS . 86.9 mm-40 -67.35 -31.27 71.41 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.205 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.751 HD11 HD11 ' A' ' 115' ' ' LEU . 46.5 mt -74.96 -57.86 5.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.047 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 67' ' ' GLN . 28.0 m -55.22 -42.75 67.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.271 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.533 ' N ' HG23 ' A' ' 66' ' ' VAL . 8.5 tt0 -65.81 -40.29 91.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.584 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 64' ' ' GLN . 46.5 m170 -86.01 -3.59 58.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.403 . . . . 1.0 110.503 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 65' ' ' ILE . . . 99.17 171.17 30.96 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.876 -0.89 . . . . 1.0 110.876 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 71' ' ' GLN . . . 102.17 -45.51 1.36 Allowed Glycine 0 N--CA 1.464 0.545 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.463 ' O ' ' O ' ' A' ' 70' ' ' GLY . 25.1 mm100 54.92 158.65 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.7 0.286 . . . . 1.0 110.634 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.873 HD22 ' N ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -89.58 130.32 35.91 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 109.757 -0.461 . . . . 1.0 109.757 -179.523 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 73.3 m -118.85 88.73 36.53 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.621 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 77' ' ' GLY . 31.8 Cg_exo -56.67 162.45 8.47 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.833 2.355 . . . . 1.0 112.055 178.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 99' ' ' ARG . . . -47.23 -33.84 5.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.397 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -75.94 -20.51 57.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.896 0.379 . . . . 1.0 110.592 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 74' ' ' PRO . . . -85.9 -161.99 35.85 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.029 -0.828 . . . . 1.0 111.029 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -43.8 -41.63 11.78 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.563 2.175 . . . . 1.0 111.986 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.711 ' O ' HG12 ' A' ' 80' ' ' VAL . . . 136.19 -40.78 1.49 Allowed Glycine 0 C--O 1.22 -0.779 0 CA-C-O 119.219 -0.767 . . . . 1.0 111.695 179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.742 HG13 ' N ' ' A' ' 81' ' ' THR . 0.3 OUTLIER 77.96 -171.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 O-C-N 124.034 0.491 . . . . 1.0 109.909 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.742 ' N ' HG13 ' A' ' 80' ' ' VAL . 0.6 OUTLIER -144.29 -32.19 0.43 Allowed 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.824 177.56 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.689 ' CD2' HE22 ' A' ' 108' ' ' GLN . 74.9 m80 -111.69 136.51 50.83 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.614 -0.266 . . . . 1.0 110.672 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.437 ' O ' ' O ' ' A' ' 110' ' ' VAL . 30.2 mm -123.28 106.29 17.12 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 N-CA-C 109.212 -0.662 . . . . 1.0 109.212 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.465 HG11 HD12 ' A' ' 115' ' ' LEU . 2.3 p -93.53 134.06 32.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.814 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.608 ' O ' ' N ' ' A' ' 87' ' ' GLU . 3.1 m -132.79 157.44 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.206 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.576 ' O ' ' C ' ' A' ' 87' ' ' GLU . 10.1 t0 -54.78 77.72 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 123.373 0.42 . . . . 1.0 110.116 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.608 ' N ' ' O ' ' A' ' 85' ' ' VAL . 6.8 pt-20 -3.88 79.14 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 O-C-N 124.17 0.919 . . . . 1.0 111.76 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 86' ' ' ASP . . . 170.1 -22.11 0.08 OUTLIER Glycine 0 CA--C 1.524 0.628 0 CA-C-N 115.601 -0.727 . . . . 1.0 111.288 -177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.6 tpp -72.71 156.14 39.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.775 0.322 . . . . 1.0 110.786 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -96.35 144.1 26.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.135 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.604 ' CD1' ' N ' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -51.47 -44.94 62.6 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.205 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.604 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 16.5 pt-20 -59.65 -44.16 93.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.929 0.395 . . . . 1.0 110.526 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.46 ' N ' ' CG ' ' A' ' 92' ' ' GLU . 38.8 ttm105 -71.94 -41.16 68.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.767 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.15 -34.46 22.42 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.935 -0.575 . . . . 1.0 111.045 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 91' ' ' TYR . 5.6 mp -62.55 -47.3 84.49 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.66 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.548 ' O ' ' NH1' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -73.0 -35.77 66.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.375 -0.375 . . . . 1.0 111.257 -178.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 20.0 mt -61.62 -34.54 75.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.51 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.921 ' O ' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -105.61 -1.94 24.05 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.204 -0.453 . . . . 1.0 111.005 -179.431 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.548 ' NH1' ' O ' ' A' ' 96' ' ' ARG . 72.9 mmt-85 70.57 61.68 0.2 Allowed 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 123.322 0.389 . . . . 1.0 110.858 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.624 ' HB2' HD11 ' A' ' 98' ' ' LEU . 9.3 tp -125.79 122.36 24.57 Favored Pre-proline 0 N--CA 1.449 -0.518 0 O-C-N 123.255 0.347 . . . . 1.0 111.376 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.83 -36.51 23.44 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.384 2.056 . . . . 1.0 112.012 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 179.47 139.63 0.11 Allowed 'General case' 0 C--O 1.235 0.32 0 O-C-N 123.576 0.548 . . . . 1.0 110.915 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.7 mt -45.14 120.27 4.4 Favored Pre-proline 0 N--CA 1.445 -0.72 0 CA-C-N 115.843 -0.617 . . . . 1.0 111.166 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.15 165.36 32.9 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.409 2.073 . . . . 1.0 112.031 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.15 113.54 1.24 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.575 2.183 . . . . 1.0 111.805 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.84 62.58 1.67 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -164.09 143.13 7.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 1.0 110.641 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.689 HE22 ' CD2' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -140.16 152.99 46.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.088 0.471 . . . . 1.0 110.132 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.415 HD11 ' CD1' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -93.06 109.4 20.87 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 116.052 -0.522 . . . . 1.0 111.15 179.26 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.616 HG21 ' CE3' ' A' ' 114' ' ' TRP . 3.0 m -108.23 167.14 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.026 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -102.24 -171.18 1.92 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.838 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.4 t -64.84 -44.42 89.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.895 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.08 -38.0 49.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.514 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.616 ' CE3' HG21 ' A' ' 110' ' ' VAL . 75.2 t90 -61.65 -52.31 64.86 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.907 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.751 HD11 HD11 ' A' ' 65' ' ' ILE . 3.0 tt -63.13 -55.7 23.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.993 0.425 . . . . 1.0 110.986 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.9 t -43.94 -59.55 2.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.392 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.427 ' O ' ' OE2' ' A' ' 121' ' ' GLU . 9.4 mp -60.01 -49.82 76.15 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.464 -0.494 . . . . 1.0 110.364 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 123' ' ' ARG . 3.1 t -58.72 -22.08 56.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.142 -0.318 . . . . 1.0 110.142 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.535 ' O ' ' NH1' ' A' ' 122' ' ' ARG . 6.7 tp -71.22 -53.52 14.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.001 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.42 ' C ' ' H ' ' A' ' 122' ' ' ARG . 77.0 mt-30 -76.75 -33.08 58.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.603 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.535 ' O ' ' C ' ' A' ' 122' ' ' ARG . 0.2 OUTLIER -77.26 18.17 0.42 Allowed 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 116.202 -0.453 . . . . 1.0 110.8 -178.496 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.535 ' C ' ' O ' ' A' ' 121' ' ' GLU . 81.6 mmt-85 20.56 52.77 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.719 0.637 . . . . 1.0 111.353 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.494 ' O ' ' SG ' ' A' ' 118' ' ' CYS . 0.5 OUTLIER -170.67 167.8 7.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.727 -0.669 . . . . 1.0 110.357 -178.342 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.482 HD11 ' NE2' ' A' ' 82' ' ' HIS . 5.0 tt -83.77 114.76 21.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.044 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 126' ' ' ASP . 55.2 t -80.45 155.7 4.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.155 0.502 . . . . 1.0 110.601 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.431 ' N ' HG12 ' A' ' 125' ' ' VAL . 66.2 t0 -66.46 117.26 8.42 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.596 -0.729 . . . . 1.0 110.505 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 131' ' ' SER . 2.9 m -64.14 -41.4 92.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.603 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.463 ' N ' ' CG2' ' A' ' 127' ' ' VAL . . . -53.75 -6.64 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.455 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 127' ' ' VAL . . . -87.86 -34.38 10.09 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -134.33 12.12 3.83 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.713 0.292 . . . . 1.0 110.433 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 127' ' ' VAL . 5.1 t -75.48 141.29 43.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.895 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.569 ' C ' ' H ' ' A' ' 134' ' ' ILE . 45.3 mt -83.25 -66.36 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.124 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.533 ' O ' ' CG1' ' A' ' 134' ' ' ILE . 21.1 t80 66.76 -37.89 0.31 Allowed 'General case' 0 C--O 1.211 -0.926 0 O-C-N 124.011 0.819 . . . . 1.0 111.003 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.61 ' N ' ' HD2' ' A' ' 135' ' ' PRO . 0.5 OUTLIER 157.36 -54.66 0.0 OUTLIER Pre-proline 0 N--CA 1.45 -0.441 0 O-C-N 124.658 1.224 . . . . 1.0 110.755 -178.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 134' ' ' ILE . 29.9 Cg_endo . . . . . 0 C--N 1.31 -1.476 0 C-N-CA 122.479 2.12 . . . . 1.0 111.684 -178.283 . . . . . . . . 1 1 . 1 stop_ save_